cid,chemicalid,chemicalname,genesymbol,geneid,taxname,taxid,interaction,pmids
   33,C004656,chloroacetaldehyde,PPARG,5468,Homo sapiens,9606,chloroacetaldehyde affects the activity of PPARG protein,25596134
176,D019342,Acetic Acid,PPARG,5468,Rattus norvegicus,10116,Gliclazide inhibits the reaction [Acetic Acid results in decreased expression of PPARG protein]|Acetic Acid results in decreased expression of PPARG protein,32045587
177,D000079,Acetaldehyde,PPARG,5468,Homo sapiens,9606,U 0126 inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]|Acetaldehyde inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein|[Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]]|Imatinib Mesylate inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]|ABL1 protein promotes the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]|PPARG protein promotes the reaction [Acetaldehyde results in increased expression of COL1A1 protein]|PPARG protein promotes the reaction [Acetaldehyde results in increased expression of COL1A1 mRNA]|U 0126 inhibits the reaction [Acetaldehyde inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein],17030193
241,D001554,Benzene,PPARG,5468,Homo sapiens,9606,Benzene results in increased expression of PPARG mRNA,19162166
264,D020148,Butyric Acid,PPARG,5468,Homo sapiens,9606,Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA]|[Butyric Acid co-treated with Lipopolysaccharides] results in increased expression of PPARG mRNA,29751049
264,D020148,Butyric Acid,PPARG,5468,Homo sapiens,9606,Butyric Acid results in increased expression of PPARG mRNA|Butyric Acid results in increased expression of PPARG protein,10833422
281,D002248,Carbon Monoxide,PPARG,5468,Mus musculus,10090,Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein]|PPARG protein promotes the reaction [Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]|[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein,22046279
299,D007631,Chlordecone,PPARG,5468,Danio rerio,7955,Chlordecone binds to and results in increased activity of PPARG protein,33049310
305,D002794,Choline,PPARG,5468,Mus musculus,10090,"3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of PPARG mRNA]|[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of PPARG mRNA",28973532
305,D002794,Choline,PPARG,5468,Mus musculus,10090,[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA|Rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG protein]|Rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA]|[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG protein,18991162
335,C034047,2-cresol,PPARG,5468,Rattus norvegicus,10116,Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA]|2-cresol results in increased expression of PPARG mRNA,21705299
338,D020156,Salicylic Acid,PPARG,5468,Rattus norvegicus,10116,Salicylic Acid inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA],25108154
370,D005707,Gallic Acid,PPARG,5468,Mus musculus,10090,Gallic Acid results in increased expression of PPARG protein,24036142
370,D005707,Gallic Acid,PPARG,5468,Rattus norvegicus,10116,Gallic Acid results in increased activity of PPARG protein,24433871
379,C031492,octanoic acid,PPARG,5468,Mus musculus,10090,[SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form]|[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form,14984747
460,D011429,Propolis,PPARG,5468,Homo sapiens,9606,Propolis results in decreased expression of PPARG mRNA,20706672
544,C015001,arsenite,PPARG,5468,Mus musculus,10090,arsenite results in increased expression of PPARG mRNA,15868481
679,D004121,Dimethyl Sulfoxide,PPARG,5468,Homo sapiens,9606,Dimethyl Sulfoxide results in decreased expression of PPARG mRNA,21878375
702,D000431,Ethanol,PPARG,5468,Homo sapiens,9606,Ethanol inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|Fomepizole inhibits the reaction [Ethanol inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]]|Ethanol inhibits the reaction [Pioglitazone results in increased activity of PPARG protein]|Cyanamide inhibits the reaction [Ethanol inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]]|Ethanol inhibits the reaction [9-deoxy-delta-9-prostaglandin D2 results in increased activity of PPARG protein],17030193
702,D000431,Ethanol,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [NFATC4 protein affects the reaction [Ethanol results in increased expression of IL6 protein]]|Ethanol results in decreased expression of PPARG mRNA|NFATC4 protein affects the reaction [Ethanol results in decreased expression of PPARG protein]|Ethanol results in decreased expression of PPARG protein|PPARG protein affects the reaction [NFATC4 protein affects the reaction [Ethanol results in increased expression of IL1A protein]]|NFATC4 protein affects the reaction [Ethanol results in decreased expression of PPARG mRNA],34192554
702,D000431,Ethanol,PPARG,5468,Homo sapiens,9606,Ethanol results in decreased expression of PPARG protein,28062356|34192554
702,D000431,Ethanol,PPARG,5468,Homo sapiens,9606,Ethanol results in increased expression of PPARG mRNA|PER1 protein promotes the reaction [Ethanol results in increased expression of PPARG mRNA]|PER1 gene mutant form inhibits the reaction [Ethanol results in increased expression of PPARG mRNA],24144995
702,D000431,Ethanol,PPARG,5468,Mus musculus,10090,acanthoic acid inhibits the reaction [Ethanol results in increased expression of PPARG protein],28964808
702,D000431,Ethanol,PPARG,5468,Mus musculus,10090,[ADORA1 gene mutant form results in increased susceptibility to Ethanol] which results in increased expression of PPARG mRNA,23692951
702,D000431,Ethanol,PPARG,5468,Mus musculus,10090,Ethanol affects the expression of PPARG mRNA,19167417
702,D000431,Ethanol,PPARG,5468,Mus musculus,10090,[Ethanol co-treated with Carbon Tetrachloride co-treated with 4-O-methylhonokiol] results in decreased expression of PPARG mRNA,28689299
702,D000431,Ethanol,PPARG,5468,Mus musculus,10090,[Ethanol co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA,32325186
702,D000431,Ethanol,PPARG,5468,Mus musculus,10090,Ethanol inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA],32171850
702,D000431,Ethanol,PPARG,5468,Mus musculus,10090,Rosiglitazone inhibits the reaction [Ethanol results in decreased expression of PPARG mRNA]|Ethanol results in decreased expression of PPARG mRNA,22173916
702,D000431,Ethanol,PPARG,5468,Mus musculus,10090,Ethanol results in increased expression of PPARG mRNA,18620774|18755807|20007851|24144995
702,D000431,Ethanol,PPARG,5468,Mus musculus,10090,Ethanol results in increased expression of PPARG protein,20007851|28964808|34116071
702,D000431,Ethanol,PPARG,5468,Mus musculus,10090,NFE2L2 gene mutant form inhibits the reaction [Ethanol results in increased expression of PPARG protein],34116071
702,D000431,Ethanol,PPARG,5468,Mus musculus,10090,Resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA],18755807
702,D000431,Ethanol,PPARG,5468,Mus musculus,10090,[Rosiglitazone co-treated with Ethanol] results in increased expression of PPARG mRNA,20007851
702,D000431,Ethanol,PPARG,5468,Rattus norvegicus,10116,Pioglitazone inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA]|[Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA,15318101
702,D000431,Ethanol,PPARG,5468,Rattus norvegicus,10116,Ethanol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA]|[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA],26854922
702,D000431,Ethanol,PPARG,5468,Rattus norvegicus,10116,SB 203580 inhibits the reaction [Ethanol results in decreased expression of PPARG protein]|Ethanol results in decreased expression of PPARG protein|[Ethanol results in decreased expression of PPARG protein] which results in decreased expression of ADIPOQ protein|Ethanol results in decreased expression of PPARG mRNA,24412557
702,D000431,Ethanol,PPARG,5468,Rattus norvegicus,10116,Ethanol results in increased expression of PPARG mRNA,18793633|26220516|26854922
702,D000431,Ethanol,PPARG,5468,Rattus norvegicus,10116,Resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA],18793633
750,D005998,Glycine,PPARG,5468,Mus musculus,10090,Glycine results in increased expression of PPARG mRNA,18930730
753,D005990,Glycerol,PPARG,5468,Rattus norvegicus,10116,ciglitazone inhibits the reaction [Glycerol results in decreased expression of PPARG protein]|Glycerol results in decreased expression of PPARG protein,16820301
784,D006861,Hydrogen Peroxide,PPARG,5468,Bos taurus,9913,Hydrogen Peroxide inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|[Rosiglitazone co-treated with Hydrogen Peroxide] results in increased expression of PPARG protein,17622750
784,D006861,Hydrogen Peroxide,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [bergenin inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein]]|bergenin inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein],34499403
784,D006861,Hydrogen Peroxide,PPARG,5468,Homo sapiens,9606,Hydrogen Peroxide affects the expression of PPARG mRNA,20044591
784,D006861,Hydrogen Peroxide,PPARG,5468,Homo sapiens,9606,Hydrogen Peroxide results in decreased expression of PPARG protein,27417252|34499403
784,D006861,Hydrogen Peroxide,PPARG,5468,Homo sapiens,9606,Hydrogen Peroxide results in increased degradation of PPARG protein|Polysaccharides inhibits the reaction [Hydrogen Peroxide results in increased degradation of PPARG protein]|Plant Extracts inhibits the reaction [Hydrogen Peroxide results in increased degradation of PPARG protein],25305479
784,D006861,Hydrogen Peroxide,PPARG,5468,Homo sapiens,9606,Hydrogen Peroxide results in increased expression of PPARG mRNA|myricitrin inhibits the reaction [Hydrogen Peroxide results in increased expression of PPARG mRNA],25130202
784,D006861,Hydrogen Peroxide,PPARG,5468,Homo sapiens,9606,Hydrogen Peroxide results in increased phosphorylation of and results in decreased activity of PPARG protein,17030193
784,D006861,Hydrogen Peroxide,PPARG,5468,Mus musculus,10090,PPARG gene polymorphism results in decreased abundance of Hydrogen Peroxide|PPARG protein affects the abundance of Hydrogen Peroxide,18083318
784,D006861,Hydrogen Peroxide,PPARG,5468,Rattus norvegicus,10116,Hydrogen Peroxide results in decreased expression of PPARG protein|stearic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein],17302992
864,D008063,Thioctic Acid,PPARG,5468,Rattus norvegicus,10116,[Thioctic Acid co-treated with Dietary Fats] results in increased expression of PPARG mRNA,22464149
880,D011765,Pyruvaldehyde,PPARG,5468,Rattus norvegicus,10116,"PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of TNF protein]]|PPARG mutant form inhibits the reaction [Rosiglitazone inhibits the reaction [Pyruvaldehyde results in increased expression of TNF protein]]|PPARG mutant form inhibits the reaction [Rosiglitazone inhibits the reaction [Pyruvaldehyde results in increased expression of IL1B protein]]|PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of IL1B protein]]|PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]|PPARG mutant form inhibits the reaction [Rosiglitazone inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]",23954466
896,D008550,Melatonin,PPARG,5468,Homo sapiens,9606,Pioglitazone promotes the reaction [Melatonin results in increased expression of PPARG protein]|Melatonin results in increased expression of PPARG protein|Melatonin promotes the reaction [Pioglitazone results in increased expression of PPARG protein]|GW 1929 inhibits the reaction [Melatonin results in increased expression of PPARG protein]|luzindole inhibits the reaction [Melatonin results in increased expression of PPARG protein],29734669
896,D008550,Melatonin,PPARG,5468,Homo sapiens,9606,Melatonin results in decreased expression of PPARG mRNA,20738756
896,D008550,Melatonin,PPARG,5468,Homo sapiens,9606,Melatonin results in increased expression of PPARG mRNA,33962019
896,D008550,Melatonin,PPARG,5468,Mus musculus,10090,Melatonin inhibits the reaction [Cisplatin results in decreased expression of PPARG protein],34428482
896,D008550,Melatonin,PPARG,5468,Sus scrofa,9823,Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG protein]|Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG mRNA],31535366
932,C005273,naringenin,PPARG,5468,Mus musculus,10090,naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]|HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]]|naringenin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Carboxymethylcellulose Sodium] results in decreased expression of PPARG protein],31063766
932,C005273,naringenin,PPARG,5468,Rattus norvegicus,10116,naringenin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]|naringenin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein],29223569
935,D009532,Nickel,PPARG,5468,Homo sapiens,9606,Nickel results in decreased expression of PPARG mRNA,24768652|25583101
936,D009536,Niacinamide,PPARG,5468,Canis lupus familiaris,9615,Niacinamide results in increased expression of PPARG protein|Niacinamide affects the reaction [PPARG protein binds to NCOR1 protein]|[Resveratrol results in decreased acetylation of RUNX2 protein] inhibits the reaction [Niacinamide results in increased expression of PPARG]|Resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein]|[Resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]] inhibits the reaction [Niacinamide results in increased expression of PPARG],22539994
936,D009536,Niacinamide,PPARG,5468,Sus scrofa,9823,Niacinamide results in increased expression of PPARG mRNA,17851734
938,D009525,Niacin,PPARG,5468,Homo sapiens,9606,HCAR2 protein promotes the reaction [Niacin results in increased expression of and results in increased activity of PPARG protein]|4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [Niacin results in increased activity of PPARG protein]|PTGS1 protein promotes the reaction [Niacin results in increased activity of PPARG protein]|PTGDS protein promotes the reaction [Niacin results in increased activity of PPARG protein]|HCAR3 protein promotes the reaction [Niacin results in increased activity of PPARG protein]|Aspirin inhibits the reaction [Niacin results in increased activity of PPARG protein],16386710
938,D009525,Niacin,PPARG,5468,Homo sapiens,9606,Niacin results in increased expression of and results in increased activity of PPARG protein,15037193|16386710
938,D009525,Niacin,PPARG,5468,Homo sapiens,9606,Niacin results in increased expression of PPARG mRNA,15037193|19131065|24767308
938,D009525,Niacin,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [Niacin results in increased expression of NR1H3 mRNA],15037193
938,D009525,Niacin,PPARG,5468,Mus musculus,10090,fluprostenol inhibits the reaction [Niacin results in increased expression of PPARG mRNA]|[Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG mRNA|[Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG protein,21236357
938,D009525,Niacin,PPARG,5468,Mus musculus,10090,PPARG protein promotes the reaction [Niacin promotes the reaction [APOA1 protein results in increased export of Cholesterol]]|PPARG protein promotes the reaction [Niacin results in increased expression of NR1H3 mRNA]|PPARG protein promotes the reaction [Niacin results in increased expression of ABCA1 mRNA]|Niacin results in increased expression of PPARG mRNA,19797938
938,D009525,Niacin,PPARG,5468,Oryctolagus cuniculus,9986,Niacin inhibits the reaction [Cholesterol results in decreased expression of PPARG mRNA],18402819
938,D009525,Niacin,PPARG,5468,Oryctolagus cuniculus,9986,[Niacin results in increased expression of PPARG mRNA] which results in increased export of Cholesterol|Niacin results in increased expression of PPARG mRNA,17395297|17963637
977,D010100,Oxygen,PPARG,5468,Homo sapiens,9606,Oxygen deficiency affects the activity of PPARG protein,25596134
977,D010100,Oxygen,PPARG,5468,Homo sapiens,9606,Oxygen deficiency results in decreased expression of PPARG protein,19520921
977,D010100,Oxygen,PPARG,5468,Homo sapiens,9606,Oxygen deficiency results in increased expression of PPARG mRNA,26516004
977,D010100,Oxygen,PPARG,5468,Mus musculus,10090,[Dexamethasone co-treated with Oxygen deficiency] results in increased expression of PPARG mRNA alternative form,16814746
977,D010100,Oxygen,PPARG,5468,Mus musculus,10090,Oxygen deficiency results in decreased expression of PPARG protein|Rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARG mRNA]|Oxygen deficiency results in decreased expression of PPARG mRNA|Rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARG protein],21531777
977,D010100,Oxygen,PPARG,5468,Mus musculus,10090,[Resveratrol co-treated with Oxygen deficiency] results in increased expression of PPARG protein|Oxygen deficiency results in increased expression of PPARG protein,21113404
977,D010100,Oxygen,PPARG,5468,Mus musculus,10090,Oxygen results in increased expression of PPARG mRNA,22535284
977,D010100,Oxygen,PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]]|ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]",27274199
977,D010100,Oxygen,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG protein]|Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG protein]]|Oxygen results in decreased expression of PPARG protein|Oxygen results in decreased expression of PPARG mRNA|2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA]],16617452
977,D010100,Oxygen,PPARG,5468,Rattus norvegicus,10116,Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein],30229846
977,D010100,Oxygen,PPARG,5468,Rattus norvegicus,10116,[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein,27274199|30229846
985,D010168,Palmitates,PPARG,5468,Homo sapiens,9606,Exenatide inhibits the reaction [Palmitates results in increased expression of PPARG mRNA]|Palmitates results in increased expression of PPARG mRNA,30253173
985,D010168,Palmitates,PPARG,5468,Rattus norvegicus,10116,Palmitates results in increased expression of PPARG mRNA|Rosiglitazone inhibits the reaction [Palmitates results in increased expression of PPARG mRNA],16620699
985,D019308,Palmitic Acid,PPARG,5468,Homo sapiens,9606,trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]|Palmitic Acid results in increased expression of PPARG protein|ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]],30208301
985,D019308,Palmitic Acid,PPARG,5468,Homo sapiens,9606,[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA,32613381
985,D019308,Palmitic Acid,PPARG,5468,Mus musculus,10090,[sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of PPARG mRNA|[Palmitic Acid co-treated with sodium arsenite] results in decreased expression of PPARG mRNA,34968464
985,D019308,Palmitic Acid,PPARG,5468,Mus musculus,10090,Palmitic Acid results in increased expression of PPARG mRNA,18154422
985,D019308,Palmitic Acid,PPARG,5468,Rattus norvegicus,10116,Salicylic Acid inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]|Metformin inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]|Resveratrol inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]|AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]|Palmitic Acid results in decreased expression of PPARG mRNA,25108154
985,D019308,Palmitic Acid,PPARG,5468,Rattus norvegicus,10116,Ethanol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA]|[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA],26854922
985,D019308,Palmitic Acid,PPARG,5468,Rattus norvegicus,10116,[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA,25048947|26190035|26854922
985,D019308,Palmitic Acid,PPARG,5468,Rattus norvegicus,10116,Triiodothyronine inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA]|tetrabromobisphenol A inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA],25048947
992,D010416,Pentachlorophenol,PPARG,5468,Danio rerio,7955,Pentachlorophenol results in increased expression of PPARG mRNA,27181905
996,D019800,Phenol,PPARG,5468,Homo sapiens,9606,Phenol results in increased expression of PPARG mRNA,17547211
1017,C032279,phthalic acid,PPARG,5468,Homo sapiens,9606,phthalic acid binds to PPARG protein,23843199
1048,C031280,pyrazole,PPARG,5468,Mus musculus,10090,pyrazole results in increased expression of PPARG mRNA,17945193
1066,D017378,Quinolinic Acid,PPARG,5468,Rattus norvegicus,10116,Quinolinic Acid results in decreased expression of PPARG mRNA|naringin inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA]|Pioglitazone inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA]|[naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA],30130594
1089,D064586,Selenic Acid,PPARG,5468,Mus musculus,10090,Selenic Acid results in increased expression of PPARG mRNA,16443359
1119,D013458,Sulfur Dioxide,PPARG,5468,Mus musculus,10090,PPARG protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased phosphorylation of RELA protein]]|JZL 184 inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein]|PPARG protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased expression of PTGS2 protein]]|Sulfur Dioxide results in decreased expression of PPARG protein|glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein],26209559
1123,D013654,Taurine,PPARG,5468,Homo sapiens,9606,Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARG protein],30362509
1123,D013654,Taurine,PPARG,5468,Rattus norvegicus,10116,Taurine inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein],30551535
1130,D013831,Thiamine,PPARG,5468,Rattus norvegicus,10116,Thiamine results in increased activity of PPARG protein|Thiamine inhibits the reaction [citreoviridin results in decreased activity of PPARG protein],31419397
1322,D019813,"1,2-Dimethylhydrazine",PPARG,5468,Mus musculus,10090,"1,2-Dimethylhydrazine results in decreased expression of PPARG mRNA|[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPARG mRNA",22206623
1483,C004554,"2,4,6-tribromophenol",PPARG,5468,Homo sapiens,9606,"2,4,6-tribromophenol binds to PPARG protein",25314719
1645,C025160,3-aminobenzamide,PPARG,5468,Rattus norvegicus,10116,3-aminobenzamide results in decreased ADP-ribosylation of PPARG protein|3-aminobenzamide results in increased activity of PPARG protein|3-aminobenzamide inhibits the reaction [NAD results in decreased activity of PPARG protein],18815186
1752,C041594,4-nonylphenol,PPARG,5468,Rattus norvegicus,10116,4-nonylphenol results in increased expression of PPARG mRNA,24388992
1983,D000082,Acetaminophen,PPARG,5468,Homo sapiens,9606,Acetaminophen results in decreased expression of PPARG mRNA,26690555
1983,D000082,Acetaminophen,PPARG,5468,Homo sapiens,9606,Acetaminophen results in increased expression of PPARG mRNA,29067470
1983,D000082,Acetaminophen,PPARG,5468,Mus musculus,10090,Acetaminophen affects the expression of PPARG mRNA,17562736
1983,D000082,Acetaminophen,PPARG,5468,Rattus norvegicus,10116,Acetaminophen affects the expression of PPARG mRNA,16701773
1988,C043377,acetochlor,PPARG,5468,Danio rerio,7955,acetochlor binds to and results in increased activity of PPARG protein|acetochlor binds to and results in decreased activity of PPARG protein,33049310
2051,C101044,RTKI cpd,PPARG,5468,Homo sapiens,9606,RTKI cpd inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA],31075703
2148,D011084,Polycyclic Aromatic Hydrocarbons,PPARG,5468,Mus musculus,10090,Polycyclic Aromatic Hydrocarbons results in increased expression of PPARG mRNA|Polycyclic Aromatic Hydrocarbons results in decreased methylation of PPARG gene,25347678
2153,D013806,Theophylline,PPARG,5468,Homo sapiens,9606,Theophylline results in increased expression of PPARG protein|Theophylline results in increased expression of PPARG mRNA,16569937
2157,D000638,Amiodarone,PPARG,5468,Homo sapiens,9606,"Amiodarone results in increased expression of PPARG mRNA|[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of FADS2 mRNA]|[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of SCD mRNA]|[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased uptake of 1-acyl-2-(12-((7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl)phosphatidylcholine]",21123845
2157,D000638,Amiodarone,PPARG,5468,Homo sapiens,9606,Amiodarone binds to and results in increased activity of PPARG protein,24489787
2244,D001241,Aspirin,PPARG,5468,Homo sapiens,9606,Aspirin inhibits the reaction [Niacin results in increased activity of PPARG protein],16386710
2244,D001241,Aspirin,PPARG,5468,Homo sapiens,9606,Aspirin results in decreased activity of PPARG protein,15646027
2244,D001241,Aspirin,PPARG,5468,Homo sapiens,9606,Aspirin results in increased expression of PPARG,18971601
2244,D001241,Aspirin,PPARG,5468,Homo sapiens,9606,Aspirin results in increased expression of PPARG protein|Aspirin results in increased expression of PPARG mRNA,19880272
2244,D001241,Aspirin,PPARG,5468,Mus musculus,10090,Aspirin results in increased expression of PPARG mRNA,19462226
2244,D001241,Aspirin,PPARG,5468,Rattus norvegicus,10116,Aspirin results in decreased expression of PPARG mRNA,18222077
2256,D001280,Atrazine,PPARG,5468,Cyprinus carpio,7962,Atrazine results in decreased expression of PPARG mRNA,31315571
2256,D001280,Atrazine,PPARG,5468,Homo sapiens,9606,[Atrazine co-treated with Arsenates] results in increased expression of PPARG mRNA,18585445
2256,D001280,Atrazine,PPARG,5468,Mus musculus,10090,Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA],24440342
2266,C010038,azelaic acid,PPARG,5468,Homo sapiens,9606,azelaic acid results in increased activity of PPARG protein|azelaic acid results in increased expression of PPARG mRNA,20545756
2268,D001387,Azinphosmethyl,PPARG,5468,Homo sapiens,9606,Azinphosmethyl binds to and results in increased activity of PPARG protein,33049310
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Homo sapiens,9606,"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in decreased activity of PPARG protein",12927354|14998300|15187150|15383218
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Homo sapiens,9606,"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in increased localization of and results in increased activity of PPARG protein",11030710
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Homo sapiens,9606,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Capsaicin results in increased activity of PPARG protein]",15383218
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Homo sapiens,9606,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eicosapentaenoic Acid results in increased activity of PPARG protein]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Docosahexaenoic Acids results in increased activity of PPARG protein]",15698426
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Homo sapiens,9606,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Indomethacin results in increased activity of PPARG protein]",12485869
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Homo sapiens,9606,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]",12927354
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Homo sapiens,9606,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein results in increased susceptibility to Troglitazone]",12824901
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Homo sapiens,9606,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]",30138673
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Homo sapiens,9606,"2,2-bis(4-glycidyloxyphenyl)propane results in decreased activity of PPARG protein",21543282
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Mus musculus,10090,"2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phloretin] affects the expression of PPARG mRNA]",32408695
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Mus musculus,10090,"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in decreased activity of PPARG protein",15187150|18272184|18643838|23795773
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Mus musculus,10090,"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in increased activity of PPARG protein|2,2-bis(4-glycidyloxyphenyl)propane results in increased expression of PPARG mRNA",11991651
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Mus musculus,10090,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [butylparaben results in increased expression of PPARG mRNA]",22956630
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Mus musculus,10090,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cytarabine results in increased expression of PPARG mRNA]",23264188
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Mus musculus,10090,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Dexamethasone results in increased expression of PPARG mRNA]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Dexamethasone results in increased expression of PPARG protein]",31709877
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Mus musculus,10090,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [magnolol binds to and results in increased activity of PPARG protein]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eugenol analog binds to and results in increased activity of PPARG protein]",20064974
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in decreased activity of PPARG protein",24011919|24188201|24433871|24612634
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]]",29953732
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA]",22989705
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Curcumin inhibits the reaction [Lipopolysaccharides results in decreased activity of PPARG protein]]",29480285
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Genistein results in increased activity of PPARG protein]",19903033
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG protein]]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG mRNA]]",24612634
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [TRIB3 protein affects the expression of PPARG protein]",21190014
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]]",27274199
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane results in decreased activity of PPARG protein",27363640
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane results in decreased expression of PPARG protein",22726273
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Sus scrofa,9823,"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in decreased activity of PPARG protein",14519784
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Sus scrofa,9823,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA]",30481989
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Sus scrofa,9823,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Troglitazone results in increased activity of PPARG protein]",14506076
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,Ursus maritimus,29073,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]",27602593
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,NULL,NULL,"2,2-bis(4-glycidyloxyphenyl)propane binds to and affects the activity of PPARG protein",16303604
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,NULL,NULL,"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in decreased activity of PPARG protein",10636887|11890746|12485869|12788809|14506076|14593122|14709329|15383218|15684285|15992368|16091293|16100529|17217567|17884933|18387855|19474210|19903033|19922793|20032081|20369229|23044841
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,NULL,NULL,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein]",10636887
2286,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",PPARG,5468,NULL,NULL,"2,2-bis(4-glycidyloxyphenyl)propane results in decreased activity of PPARG protein",16567512|16982041
2333,D001553,Benzbromarone,PPARG,5468,Mus musculus,10090,Benzbromarone affects the expression of PPARG mRNA,19048458
2333,D001553,Benzbromarone,PPARG,5468,NULL,NULL,Benzbromarone binds to PPARG protein,18274627
2336,D001564,Benzo(a)pyrene,PPARG,5468,Boreogadus saida,44932,[Benzo(a)pyrene co-treated with Ethinyl Estradiol] results in increased expression of PPARG mRNA|Benzo(a)pyrene results in increased expression of PPARG mRNA,34015484
2336,D001564,Benzo(a)pyrene,PPARG,5468,Homo sapiens,9606,Benzo(a)pyrene results in decreased expression of PPARG mRNA,20064835|30453624
2336,D001564,Benzo(a)pyrene,PPARG,5468,Homo sapiens,9606,Benzo(a)pyrene results in increased expression of PPARG mRNA,15735009
2336,D001564,Benzo(a)pyrene,PPARG,5468,Homo sapiens,9606,[Soot co-treated with Benzo(a)pyrene] results in decreased activity of PPARG protein,24464499
2336,D001564,Benzo(a)pyrene,PPARG,5468,Mus musculus,10090,Docosahexaenoic Acids promotes the reaction [Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein]]|Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein]|Benzo(a)pyrene results in increased activity of PPARG protein|Docosahexaenoic Acids promotes the reaction [Benzo(a)pyrene results in increased activity of PPARG protein],27329536
2336,D001564,Benzo(a)pyrene,PPARG,5468,Mus musculus,10090,Benzo(a)pyrene results in decreased expression of PPARG mRNA,19770486
2336,D001564,Benzo(a)pyrene,PPARG,5468,Mus musculus,10090,Benzo(a)pyrene results in increased expression of PPARG mRNA,22228805
2336,D001564,Benzo(a)pyrene,PPARG,5468,Rattus norvegicus,10116,[Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA|Benzo(a)pyrene results in increased expression of PPARG protein|[Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG protein,20920559
2336,D001564,Benzo(a)pyrene,PPARG,5468,Rattus norvegicus,10116,[IL27 protein co-treated with IFNL3 protein] inhibits the reaction [Benzo(a)pyrene results in decreased expression of PPARG protein]|Benzo(a)pyrene results in decreased expression of PPARG protein,34999049
2336,D001564,Benzo(a)pyrene,PPARG,5468,Rattus norvegicus,10116,Benzo(a)pyrene results in increased expression of PPARG mRNA,20920559|22374506
2337,D016264,Dextran Sulfate,PPARG,5468,Mus musculus,10090,Mesalamine inhibits the reaction [Dextran Sulfate affects the localization of PPARG protein]|Dextran Sulfate affects the localization of PPARG protein|ligustilide inhibits the reaction [Dextran Sulfate affects the localization of PPARG protein],33130971
2337,D016264,Dextran Sulfate,PPARG,5468,Mus musculus,10090,Dextran Sulfate results in increased expression of PPARG protein,23261717
2337,D016264,Dextran Sulfate,PPARG,5468,Mus musculus,10090,[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARG mRNA,29950665
2347,C027561,butylbenzyl phthalate,PPARG,5468,Homo sapiens,9606,butylbenzyl phthalate binds to and results in increased activity of PPARG protein,24155963|33049310
2347,C027561,butylbenzyl phthalate,PPARG,5468,Homo sapiens,9606,butylbenzyl phthalate binds to PPARG protein,23843199|32407875
2347,C027561,butylbenzyl phthalate,PPARG,5468,Homo sapiens,9606,butylbenzyl phthalate inhibits the reaction [GW 1929 binds to PPARG protein],31016361
2347,C027561,butylbenzyl phthalate,PPARG,5468,Homo sapiens,9606,butylbenzyl phthalate results in increased activity of PPARG protein,26172262
2347,C027561,butylbenzyl phthalate,PPARG,5468,Mus musculus,10090,[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG mRNA|[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG protein,26820058
2347,C027561,butylbenzyl phthalate,PPARG,5468,Mus musculus,10090,butylbenzyl phthalate binds to and results in increased activity of PPARG protein,33049310
2347,C027561,butylbenzyl phthalate,PPARG,5468,Mus musculus,10090,Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]|butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],28595985
2347,C027561,butylbenzyl phthalate,PPARG,5468,Mus musculus,10090,butylbenzyl phthalate results in increased expression of PPARG mRNA,27923775|34520170
2347,C027561,butylbenzyl phthalate,PPARG,5468,Mus musculus,10090,PPARG protein promotes the reaction [butylbenzyl phthalate binds to and results in increased activity of PPARG protein],24155963
2353,D001599,Berberine,PPARG,5468,Homo sapiens,9606,Berberine results in increased activity of and affects the localization of PPARG protein|Berberine inhibits the reaction [Bleomycin binds to PPARG protein]|Berberine results in increased expression of PPARG mRNA|PPARG mRNA promotes the reaction [Berberine results in increased expression of HGF protein]|PPARG mRNA results in increased susceptibility to Berberine|Berberine promotes the reaction [15-deoxyprostaglandin J2 affects the localization of and results in increased activity of PPARG protein]|15-deoxyprostaglandin J2 promotes the reaction [Berberine affects the localization of and results in increased activity of PPARG protein],29408570
2353,D001599,Berberine,PPARG,5468,Homo sapiens,9606,Berberine results in decreased expression of PPARG mRNA,26478571
2353,D001599,Berberine,PPARG,5468,Mus musculus,10090,Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA]|Berberine inhibits the reaction [Risperidone results in increased expression of PPARG mRNA]|Berberine inhibits the reaction [Clozapine results in increased expression of PPARG protein]|Berberine inhibits the reaction [Risperidone results in increased expression of PPARG protein],20564506
2361,D019324,beta-Naphthoflavone,PPARG,5468,Mus musculus,10090,beta-Naphthoflavone inhibits the reaction [Triclosan results in increased expression of PPARG protein],33722737
2374,C019359,"2,5-di-tert-butylhydroquinone",PPARG,5468,Homo sapiens,9606,"2,5-di-tert-butylhydroquinone binds to and results in increased activity of PPARG protein",33049310
2375,C053541,bicalutamide,PPARG,5468,Homo sapiens,9606,bicalutamide binds to and results in increased activity of PPARG protein,33049310
2396,C070515,bisindolylmaleimide I,PPARG,5468,Homo sapiens,9606,bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein],16945329
2513,D002101,Cacodylic Acid,PPARG,5468,Homo sapiens,9606,[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA,28793237
2513,D002101,Cacodylic Acid,PPARG,5468,Homo sapiens,9606,Cacodylic Acid results in decreased expression of PPARG mRNA,23221991
2519,D002110,Caffeine,PPARG,5468,Mus musculus,10090,Caffeine results in decreased expression of PPARG mRNA,23727198
2526,C031463,beta-glycerophosphoric acid,PPARG,5468,Homo sapiens,9606,[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA,25932594
2526,C031463,beta-glycerophosphoric acid,PPARG,5468,Mus musculus,10090,Rosiglitazone promotes the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA]|[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA|Tretinoin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA],32473317
2526,C031463,beta-glycerophosphoric acid,PPARG,5468,Mus musculus,10090,SRC protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA]]|[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA|Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA],14505802
2526,C031463,beta-glycerophosphoric acid,PPARG,5468,Sus scrofa,9823,"Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA",30481989
2554,D002220,Carbamazepine,PPARG,5468,Homo sapiens,9606,Carbamazepine affects the expression of PPARG mRNA,24752500
2662,D000068579,Celecoxib,PPARG,5468,Homo sapiens,9606,Celecoxib results in increased expression of PPARG mRNA|2-chloro-5-nitrobenzanilide inhibits the reaction [Celecoxib affects the localization of PPARG protein]|Celecoxib affects the localization of PPARG protein|N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Celecoxib affects the localization of PPARG protein]|Celecoxib results in increased expression of PPARG protein,23943857
2662,D000068579,Celecoxib,PPARG,5468,Homo sapiens,9606,[Celecoxib results in decreased activity of and results in decreased expression of PTGS2 protein] which results in increased expression of PPARG,19522023
2662,D000068579,Celecoxib,PPARG,5468,Mus musculus,10090,[Celecoxib co-treated with Docetaxel] results in increased expression of PPARG protein,16052515
2662,D000068579,Celecoxib,PPARG,5468,Rattus norvegicus,10116,Celecoxib inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA],19247274
2723,C007027,chloroxylenol,PPARG,5468,Danio rerio,7955,chloroxylenol binds to and results in increased activity of PPARG protein,33049310
2726,D002746,Chlorpromazine,PPARG,5468,Rattus norvegicus,10116,Chlorpromazine affects the activity of PPARG protein,25596134
2730,D004390,Chlorpyrifos,PPARG,5468,Danio rerio,7955,Chlorpyrifos affects the expression of PPARG mRNA,32738127
2730,D004390,Chlorpyrifos,PPARG,5468,Danio rerio,7955,Chlorpyrifos results in decreased expression of PPARG mRNA,30423371|31384916
2730,D004390,Chlorpyrifos,PPARG,5468,Homo sapiens,9606,Chlorpyrifos results in decreased expression of PPARG mRNA,31509763
2730,D004390,Chlorpyrifos,PPARG,5468,Homo sapiens,9606,Rosiglitazone inhibits the reaction [Chlorpyrifos results in decreased expression of PPARG protein]|Chlorpyrifos results in decreased expression of PPARG protein,24793810
2730,D004390,Chlorpyrifos,PPARG,5468,Mus musculus,10090,Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]|[Chlorpyrifos co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein,32017950
2730,D004390,Chlorpyrifos,PPARG,5468,Rattus norvegicus,10116,Chlorpyrifos results in increased expression of PPARG mRNA,33994353
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,ciglitazone binds to and results in decreased activity of PPARG protein,12391285
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,ciglitazone binds to and results in increased activity of PPARG protein,11030710|11343236|12604364|14998300|15187150|15866424|16326050|18162602|18393431|19036883
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,ciglitazone binds to PPARG protein,12839938|21511917
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PCK1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of BHMT mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of NR1H3 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of FAM102A mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of PDZK1 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of LPCAT3 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of SLC30A10 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of COPA mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of HADHA mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PLCXD1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of TNS1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of BDH1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CIDEC mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PLA2G2A mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of DOK4 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of OSMR mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of TMBIM1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ITIH3 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SLC50A1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of GRAMD2B mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of CEBPD mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of EFNA1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of RETSAT mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CDH1 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of ITGB5 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of CDH1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of LMCD1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CSTB mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of GK mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of HAMP mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ANGPTL4 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACADVL mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of COBLL1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PMM1 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of SQSTM1 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of GPX3 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of EPAS1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of AKR1C2 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SOWAHC mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACSM3 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of GK3P mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PRKCD mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CAT mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of CCL15 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of HPN mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of ELF5 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of NREP mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of GALNT2 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of TIMP3 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PSD4 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CYP1A2 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of RNASE4 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of TBC1D4 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of AQP3 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of VNN1 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of HCAR3 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of ACAA1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PALM2AKAP2 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PIM1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of GCN1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACADM mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of APOL1 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of SLC4A7 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of OAS1 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of AKR1C2 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ELF5 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of PNRC1 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of TGIF1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CYB5R3 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PLIN2 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of MPC1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of DLC1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MTMR4 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of PHKA2 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of PIM1 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of RNF10 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of FLNB mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PDZK1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CCL15 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CCL20 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of HMOX1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ATF7IP2 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MAGED4B mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CCL14 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PHLPP1 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of IL6ST mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of JAG1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of LIPC mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of STX7 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of AKR1C1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ANG mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of LOX mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of LPCAT1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of STBD1 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of HMGCS2 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SEPTIN10 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of FABP1 mRNA|[ciglitazone binds to PPARG protein] which results in increased expression of SORL1 mRNA|[ciglitazone binds to PPARG protein alternative form] which results in increased expression of GPX3 mRNA|[ciglitazone binds to PPARG protein] which resu,16197558
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,ciglitazone inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA],12604364
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,nimesulide inhibits the reaction [ciglitazone results in increased expression of PPARG mRNA]|ciglitazone promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]|N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [ciglitazone results in increased expression of PPARG mRNA]|nimesulide inhibits the reaction [ciglitazone promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]]|PPARG promotes the reaction [ciglitazone results in increased expression of PTGS2 protein]|PPARG promotes the reaction [ciglitazone results in increased expression of PTGS2 mRNA],11840453
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,ciglitazone results in increased activity of PPARG protein,12517972|16386710|16417216|21543282
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,ciglitazone results in increased expression of PPARG mRNA,11840453|14512786|21354099|21511917
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,ciglitazone results in increased expression of PPARG protein,21067863
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,ciglitazone results in increased localization of PPARG protein,12517972
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,monobutyl phthalate inhibits the reaction [ciglitazone binds to and results in increased activity of PPARG protein],16326050
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,Quercetin inhibits the reaction [ciglitazone results in increased activity of PPARG protein]|norathyriol inhibits the reaction [ciglitazone results in increased activity of PPARG protein],18393431
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein mutant form results in decreased susceptibility to ciglitazone,19922793
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [ciglitazone promotes the reaction [SR 11237 results in increased expression of RARB protein]],12839938
2750,C039671,ciglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [ciglitazone results in increased activity of DIO2 protein],19036883
2750,C039671,ciglitazone,PPARG,5468,Mus musculus,10090,ciglitazone binds to and results in increased activity of PPARG protein,12847270|15187150
2750,C039671,ciglitazone,PPARG,5468,Mus musculus,10090,[ciglitazone co-treated with Bucladesine] affects the expression of PPARG mRNA|ciglitazone results in increased expression of PPARG protein|[ciglitazone co-treated with Bucladesine] results in increased expression of PPARG protein,19698295
2750,C039671,ciglitazone,PPARG,5468,Mus musculus,10090,ciglitazone inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]],12847270
2750,C039671,ciglitazone,PPARG,5468,Mus musculus,10090,ciglitazone inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine],17019405
2750,C039671,ciglitazone,PPARG,5468,Mus musculus,10090,ciglitazone results in increased activity of PPARG protein,11683414|16023420
2750,C039671,ciglitazone,PPARG,5468,Mus musculus,10090,PPARG protein promotes the reaction [ciglitazone results in increased expression of PPARGC1A mRNA],16513826
2750,C039671,ciglitazone,PPARG,5468,Rattus norvegicus,10116,ciglitazone affects the localization of PPARG protein,20578043
2750,C039671,ciglitazone,PPARG,5468,Rattus norvegicus,10116,[ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose|ciglitazone binds to and results in increased activity of PPARG protein,18063688
2750,C039671,ciglitazone,PPARG,5468,Rattus norvegicus,10116,ciglitazone inhibits the reaction [Glycerol results in decreased expression of PPARG protein],16820301
2750,C039671,ciglitazone,PPARG,5468,NULL,NULL,ciglitazone binds to and affects the activity of PPARG protein,11409902|16303604
2750,C039671,ciglitazone,PPARG,5468,NULL,NULL,ciglitazone binds to and results in increased activity of PPARG protein,12065618|15684043|16616945|16844232|17019405|17425601|17437057|17940898|18599600|18827362|19140230|22493353|23872139
2750,C039671,ciglitazone,PPARG,5468,NULL,NULL,ciglitazone binds to PPARG protein,17499714|21525782
2754,D000077407,Cilostazol,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Cilostazol results in increased activity of PPARG protein]|Cilostazol results in increased activity of PPARG protein|zinc protoporphyrin inhibits the reaction [Cilostazol results in increased activity of PPARG protein]|HMOX1 protein promotes the reaction [Cilostazol results in increased activity of PPARG protein],21660147
2787,C006231,clinofibrate,PPARG,5468,Homo sapiens,9606,clinofibrate binds to PPARG protein,11779144
2794,D002991,Clofazimine,PPARG,5468,Rattus norvegicus,10116,Clofazimine results in increased expression of PPARG mRNA|Clofazimine results in increased expression of PPARG protein,31393584
2796,D002994,Clofibrate,PPARG,5468,Danio rerio,7955,Clofibrate results in increased expression of PPARG|Clofibrate results in increased expression of PPARG mRNA,24880017
2796,D002994,Clofibrate,PPARG,5468,Danio rerio,7955,Clofibrate results in increased expression of PPARG protein,15964169
2796,D002994,Clofibrate,PPARG,5468,Homo sapiens,9606,Clofibrate results in increased activity of [PPARG protein alternative form binds to RXRA protein],11779144
2796,D002994,Clofibrate,PPARG,5468,Mus musculus,10090,[Clofibrate co-treated with PPARG] results in increased expression of RORA mRNA|[Clofibrate co-treated with PPARG] results in increased expression of RORC mRNA|[Clofibrate co-treated with PPARG] results in increased expression of FABP4 mRNA,9543393
2796,D002994,Clofibrate,PPARG,5468,Rattus norvegicus,10116,PPARG results in increased susceptibility to Clofibrate|Clofibrate results in increased expression of PPARG mRNA,12699904
2796,D002994,Clofibrate,PPARG,5468,Rattus norvegicus,10116,Clofibrate results in increased expression of PPARG protein,12604186|12699904
2796,D002994,Clofibrate,PPARG,5468,Rattus norvegicus,10116,PPARG protein promotes the reaction [Clofibrate results in decreased expression of ALDH3A1 mRNA]|PPARG protein affects the susceptibility to Clofibrate,12604186
2797,D002995,Clofibric Acid,PPARG,5468,Homo sapiens,9606,Clofibric Acid binds to PPARG protein,11779144
2871,D003372,Coumaphos,PPARG,5468,Homo sapiens,9606,Coumaphos binds to and results in increased activity of PPARG protein,33049310
2907,D003520,Cyclophosphamide,PPARG,5468,Rattus norvegicus,10116,Plant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of PPARG mRNA]|Cyclophosphamide results in decreased expression of PPARG mRNA,25446862
2907,D003520,Cyclophosphamide,PPARG,5468,Rattus norvegicus,10116,Cyclophosphamide results in increased expression of PPARG mRNA,27281708
2912,C017160,cypermethrin,PPARG,5468,Danio rerio,7955,cypermethrin binds to and results in increased activity of PPARG protein,33049310
2969,C031071,decanoic acid,PPARG,5468,Homo sapiens,9606,decanoic acid binds to PPARG protein|decanoic acid results in increased activity of PPARG protein,24998974
3017,D003976,Diazinon,PPARG,5468,Homo sapiens,9606,Diazinon results in increased activity of PPARG protein,28728110
3026,D003993,Dibutyl Phthalate,PPARG,5468,Danio rerio,7955,Dibutyl Phthalate binds to and results in increased activity of PPARG protein,33049310
3026,D003993,Dibutyl Phthalate,PPARG,5468,Homo sapiens,9606,Dibutyl Phthalate binds to and results in increased activity of PPARG protein,24155963|27633901|33049310
3026,D003993,Dibutyl Phthalate,PPARG,5468,Homo sapiens,9606,Dibutyl Phthalate binds to PPARG protein,23843199
3026,D003993,Dibutyl Phthalate,PPARG,5468,Homo sapiens,9606,Dibutyl Phthalate results in increased activity of PPARG protein,26172262
3026,D003993,Dibutyl Phthalate,PPARG,5468,Homo sapiens,9606,Dibutyl Phthalate results in increased expression of PPARG protein,29061543
3033,D004008,Diclofenac,PPARG,5468,Homo sapiens,9606,Diclofenac affects the expression of PPARG mRNA,24752500
3033,D004008,Diclofenac,PPARG,5468,Homo sapiens,9606,Diclofenac inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30138673
3033,D004008,Diclofenac,PPARG,5468,Homo sapiens,9606,Diclofenac results in increased activity of PPARG protein,12065695|15273253|28728110
3035,D003633,Dichlorodiphenyl Dichloroethylene,PPARG,5468,Homo sapiens,9606,[Dichlorodiphenyl Dichloroethylene co-treated with [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of PPARG mRNA,26200599
3035,D003633,Dichlorodiphenyl Dichloroethylene,PPARG,5468,Ursus maritimus,29073,[Polychlorinated Biphenyls analog co-treated with Dichlorodiphenyl Dichloroethylene analog] inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|Dichlorodiphenyl Dichloroethylene inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],27602593
3036,D003634,DDT,PPARG,5468,Danio rerio,7955,DDT binds to and results in increased activity of PPARG protein,33049310
3036,D003634,DDT,PPARG,5468,Homo sapiens,9606,DDT results in increased expression of PPARG mRNA,25014179
3036,D003634,DDT,PPARG,5468,Mus musculus,10090,DDT results in increased activity of and results in increased localization of PPARG protein,11911853
3117,D004221,Disulfiram,PPARG,5468,Homo sapiens,9606,Disulfiram affects the expression of PPARG mRNA,32712770
3117,D004221,Disulfiram,PPARG,5468,Homo sapiens,9606,Disulfiram binds to and results in increased activity of PPARG protein,33049310
3120,D004237,Diuron,PPARG,5468,Mus musculus,10090,Diuron binds to and results in increased activity of PPARG protein,33049310
3120,D004237,Diuron,PPARG,5468,Rattus norvegicus,10116,Diuron results in increased expression of PPARG mRNA,21551480
3121,D014635,Valproic Acid,PPARG,5468,Homo sapiens,9606,"[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPARG mRNA",27188386
3121,D014635,Valproic Acid,PPARG,5468,Homo sapiens,9606,Valproic Acid affects the expression of PPARG mRNA,25979313
3121,D014635,Valproic Acid,PPARG,5468,Homo sapiens,9606,Valproic Acid binds to and results in increased activity of PPARG protein,24489787
3121,D014635,Valproic Acid,PPARG,5468,Homo sapiens,9606,Valproic Acid results in decreased methylation of PPARG gene,29154799
3121,D014635,Valproic Acid,PPARG,5468,Homo sapiens,9606,Valproic Acid results in increased expression of PPARG mRNA,24383497|28001369
3220,D004642,Emodin,PPARG,5468,Homo sapiens,9606,Emodin results in increased stability of and results in increased expression of PPARG mRNA|Emodin results in increased expression of PPARG protein,25448808
3224,D004726,Endosulfan,PPARG,5468,Rattus norvegicus,10116,Endosulfan results in increased expression of PPARG mRNA,29391264
3224,D004726,Endosulfan,PPARG,5468,Salmo salar,8030,Endosulfan results in decreased expression of PPARG mRNA,19874912
3224,D004726,Endosulfan,PPARG,5468,Ursus maritimus,29073,Endosulfan inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],27602593
3314,D005054,Eugenol,PPARG,5468,Homo sapiens,9606,"Eugenol analog binds to and results in increased activity of PPARG protein|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eugenol analog binds to and results in increased activity of PPARG protein]",20064974
3314,D005054,Eugenol,PPARG,5468,Mus musculus,10090,Eugenol results in increased expression of PPARG mRNA,21870829
3339,D011345,Fenofibrate,PPARG,5468,Homo sapiens,9606,Fenofibrate affects the activity of PPARG protein,25596134
3339,D011345,Fenofibrate,PPARG,5468,Homo sapiens,9606,Fenofibrate results in increased expression of PPARG mRNA,19201410|28034800
3339,D011345,Fenofibrate,PPARG,5468,Homo sapiens,9606,[Oleic Acid co-treated with Fenofibrate] results in increased expression of PPARG mRNA,24534255
3339,D011345,Fenofibrate,PPARG,5468,Mus musculus,10090,Fenofibrate results in increased expression of PPARG mRNA,19201410
3342,D005279,Fenoprofen,PPARG,5468,Homo sapiens,9606,Fenoprofen binds to and results in increased activity of PPARG protein,9013583
3346,D005284,Fenthion,PPARG,5468,Homo sapiens,9606,Fenthion binds to and results in increased activity of PPARG protein,33049310
3346,D005284,Fenthion,PPARG,5468,Homo sapiens,9606,Fenthion results in increased expression of PPARG mRNA,32473317
3352,C082360,fipronil,PPARG,5468,Mus musculus,10090,fipronil results in increased expression of PPARG protein|fipronil results in increased expression of PPARG mRNA,27103584
3365,D015725,Fluconazole,PPARG,5468,Rattus norvegicus,10116,Fluconazole results in increased expression of PPARG mRNA,20623750
3371,D005439,Flufenamic Acid,PPARG,5468,Homo sapiens,9606,Flufenamic Acid binds to and results in increased activity of PPARG protein,9013583
3371,D005439,Flufenamic Acid,PPARG,5468,Homo sapiens,9606,[Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein|Flufenamic Acid results in increased activity of PPARG protein,10866999
3385,D005472,Fluorouracil,PPARG,5468,Homo sapiens,9606,PPARG protein affects the susceptibility to Fluorouracil|Fluorouracil results in decreased expression of PPARG protein,15352031
3397,D005485,Flutamide,PPARG,5468,Homo sapiens,9606,Flutamide binds to and results in increased activity of PPARG protein,33049310
3406,D000077604,Fomepizole,PPARG,5468,Homo sapiens,9606,Fomepizole inhibits the reaction [Ethanol inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]],17030193
3444,C573694,bromuconazole,PPARG,5468,Homo sapiens,9606,bromuconazole binds to and results in increased activity of PPARG protein,33049310
3463,D015248,Gemfibrozil,PPARG,5468,Homo sapiens,9606,Gemfibrozil results in increased expression of PPARG mRNA,19201410
3475,D005907,Gliclazide,PPARG,5468,Rattus norvegicus,10116,Gliclazide inhibits the reaction [Acetic Acid results in decreased expression of PPARG protein],32045587
3488,D005905,Glyburide,PPARG,5468,Rattus norvegicus,10116,Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]|Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG protein],29223569
3672,D007052,Ibuprofen,PPARG,5468,Homo sapiens,9606,Ibuprofen affects the activity of PPARG protein,25596134
3672,D007052,Ibuprofen,PPARG,5468,Homo sapiens,9606,Ibuprofen binds to and results in increased activity of PPARG protein,9013583
3672,D007052,Ibuprofen,PPARG,5468,Mus musculus,10090,Ibuprofen binds to PPARG protein|Ibuprofen inhibits the reaction [Methamphetamine results in decreased expression of PPARG protein],18946735
3672,D007052,Ibuprofen,PPARG,5468,Mus musculus,10090,Ibuprofen results in increased expression of PPARG mRNA|Ibuprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in decreased expression of PPARG mRNA],16407166
3672,D007052,Ibuprofen,PPARG,5468,Rattus norvegicus,10116,Ibuprofen analog results in increased activity of PPARG protein,11755111
3690,D007069,Ifosfamide,PPARG,5468,Homo sapiens,9606,Ifosfamide affects the activity of PPARG protein,25596134
3712,C016517,indole-3-carbinol,PPARG,5468,Rattus norvegicus,10116,indole-3-carbinol affects the expression of PPARG mRNA,21396975
3715,D007213,Indomethacin,PPARG,5468,Homo sapiens,9606,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Indomethacin results in increased activity of PPARG protein]",12485869
3715,D007213,Indomethacin,PPARG,5468,Homo sapiens,9606,[Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of PPARG mRNA,34560244
3715,D007213,Indomethacin,PPARG,5468,Homo sapiens,9606,[Indomethacin co-treated with MK-886] affects the localization of PPARG protein|Indomethacin affects the localization of PPARG protein|Indomethacin promotes the reaction [MK-886 results in increased activity of PPARG protein],15899809
3715,D007213,Indomethacin,PPARG,5468,Homo sapiens,9606,Indomethacin analog results in increased activity of PPARG protein,17602619
3715,D007213,Indomethacin,PPARG,5468,Homo sapiens,9606,Indomethacin binds to and results in increased activity of PPARG protein|Indomethacin inhibits the reaction [Rosiglitazone binds to PPARG protein],9013583
3715,D007213,Indomethacin,PPARG,5468,Homo sapiens,9606,[Indomethacin co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA|[Indomethacin co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG protein,20206132
3715,D007213,Indomethacin,PPARG,5468,Homo sapiens,9606,[Indomethacin co-treated with juglone] results in increased expression of PPARG protein|[Indomethacin co-treated with juglone] results in increased expression of PPARG mRNA,31916655
3715,D007213,Indomethacin,PPARG,5468,Homo sapiens,9606,Indomethacin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in decreased expression of PPARG mRNA],16407166
3715,D007213,Indomethacin,PPARG,5468,Homo sapiens,9606,Indomethacin results in increased activity of PPARG protein,12065695|12485869|12606626|15273253|15899809|17602619
3715,D007213,Indomethacin,PPARG,5468,Homo sapiens,9606,Indomethacin results in increased expression of PPARG mRNA,12483719|31916655
3715,D007213,Indomethacin,PPARG,5468,Homo sapiens,9606,Indomethacin results in increased expression of PPARG protein,17341418|31916655
3715,D007213,Indomethacin,PPARG,5468,Homo sapiens,9606,[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PPARG mRNA,28628672
3715,D007213,Indomethacin,PPARG,5468,Mus musculus,10090,[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA|hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA]|hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG protein]|[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG protein,30055130
3715,D007213,Indomethacin,PPARG,5468,Mus musculus,10090,Indomethacin results in increased activity of PPARG protein,11683414
3715,D007213,Indomethacin,PPARG,5468,Mus musculus,10090,[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA|[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA alternative form|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA alternative form]|[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG protein|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA]|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG protein],33412187
3715,D007213,Indomethacin,PPARG,5468,Rattus norvegicus,10116,Indomethacin inhibits the reaction [Rosiglitazone binds to and affects the activity of PPARG protein],12897060
3715,D007213,Indomethacin,PPARG,5468,Rattus norvegicus,10116,Indomethacin results in increased activity of PPARG protein,11755111
3730,D007472,Iohexol,PPARG,5468,Homo sapiens,9606,Iohexol results in increased expression of PPARG mRNA,29705293
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of PPARG mRNA|[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of PPARG mRNA|[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Firemaster 550] results in increased expression of PPARG mRNA,28437481
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,[1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of PPARG mRNA,27003841
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA]|1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA,22645054
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA|avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA],31016361
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA|dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]|oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]|avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA],32407875
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,[bisphenol F co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein|[bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] affects the expression of PPARG protein|[bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA|[bisphenol F co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA,33865937
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,[Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of PPARG mRNA,34560244
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA|Rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],19186324
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,[Dichlorodiphenyl Dichloroethylene co-treated with [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of PPARG mRNA,26200599
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,"[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of PPARG protein|[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone co-treated with 4,4'-hexafluorisopropylidene diphenol] results in increased expression of PPARG mRNA|[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of PPARG mRNA",31596606
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PPARG mRNA,28628672
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,PPARG protein results in decreased susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone],26670611
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein|[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA|rosemarinic acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein],33476690
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,[Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA|[Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein,20206132|33865937
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,TGFB1 protein inhibits the reaction [[Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA],20206132
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Homo sapiens,9606,[Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] affects the expression of PPARG mRNA,33836827
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,"14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA]|14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]",30248417
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[1-Methyl-3-isobutylxanthine co-treated with bisphenol A co-treated with INS protein] results in increased expression of PPARG protein|[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG mRNA|[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG protein,26820058
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA,23503329|30248417|30409764
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein,25559859|27475717|30248417|30409764|31199990
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA|hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA]|hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG protein]|[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG protein,30055130
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA|[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG protein|beta-penta-O-galloyl-glucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG protein]|beta-penta-O-galloyl-glucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA],30721698
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,"2,2',3',4,4',5-hexachlorobiphenyl promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein",29704545
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,"2,2',4,4',5-brominated diphenyl ether promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]",30903904
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,Rosiglitazone promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|Rosiglitazone promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG protein]|[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in decreased methylation of PPARG promoter|[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG protein|[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG mRNA,29094436
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,"3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]|3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]",22298784
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,"[Chlorpyrifos co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein|Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]|[3,5,6-trichloro-2-pyridinol co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein|3,5,6-trichloro-2-pyridinol promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]",32017950
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA]|Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein],30409764
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,EGF protein promotes the reaction [Vanadates inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]|U 0126 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]|EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]|methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]|EGF protein inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|AG 1879 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]|Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein,16971554
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein],27475717
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein,28242765
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA|[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA,27273607
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] affects the expression of PPARG protein,32220626
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[bisphenol A co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] affects the expression of PPARG mRNA|[bisphenol A co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] affects the methylation of PPARG promoter,33203037
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]|bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]|Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form],22197818
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein|Diethylstilbestrol inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein]|bisphenol A promotes the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein]|T 0070907 inhibits the reaction [[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein]|[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein,26944108
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]|CTNNB1 protein promotes the reaction [sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]]|boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]|sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]|sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]|CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]],28285642
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]|butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],28595985
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|cannabigerol promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|cannabigerolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],30611848
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA,23152186|32017950|34302803
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein,18586010|32017950
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA,22298784|28031460|28285642|30903904
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein,22298784|28285642
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein,17290005
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]|[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA|[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA],16054899
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|dorsomorphin inhibits the reaction [rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]|rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein],30446312
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,Ethanol inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|GHRL protein inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA,32171850
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,Glycyrrhizic Acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA],34302803
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein]|[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein|(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein],26117538
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA,26972250|30446312
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein,11101056|24576443|30446312
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA|[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA alternative form|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA alternative form]|[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG protein|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA]|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG protein],33412187
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA,28595985|30611848|31009676
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,Ivermectin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein],31199990
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,(+)-JQ1 compound inhibits the reaction [Rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]|(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|Rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],26972250
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA|[Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA|[Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein|[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein,29288687
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein,32417366
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,potassium chromate(VI) inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein],24576443
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,Quercetin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein],18586010
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein],11101056
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,Rosiglitazone promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],28595985|30611848
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein],25559859
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of PPARG mRNA|[sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of PPARG mRNA,34968464
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA],23152186
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Mus musculus,10090,[triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA|[tetrabromobisphenol A co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA,34323617
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Rattus norvegicus,10116,[INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA,21350315
3758,D015056,1-Methyl-3-isobutylxanthine,PPARG,5468,Ursus maritimus,29073,mono-(2-ethylhexyl)phthalate promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|Environmental Pollutants inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA,27602593
3767,D007538,Isoniazid,PPARG,5468,Danio rerio,7955,"Isoniazid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of PPARG mRNA]",31857089
3767,D007538,Isoniazid,PPARG,5468,Homo sapiens,9606,Isoniazid results in decreased expression of PPARG protein|Isoniazid results in decreased expression of PPARG mRNA,24128855
3779,D007545,Isoproterenol,PPARG,5468,Mus musculus,10090,Isoproterenol results in decreased expression of PPARG mRNA|osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA],21854795
3779,D007545,Isoproterenol,PPARG,5468,Rattus norvegicus,10116,2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]|[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein|Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]]|Hesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein],24954035
3779,D007545,Isoproterenol,PPARG,5468,Rattus norvegicus,10116,Hesperidin inhibits the reaction [Isoproterenol results in decreased expression of PPARG protein]|Isoproterenol results in decreased expression of PPARG protein|Enalapril inhibits the reaction [Isoproterenol results in decreased expression of PPARG protein],30623541
3779,D007545,Isoproterenol,PPARG,5468,Rattus norvegicus,10116,Isoproterenol results in decreased expression of PPARG mRNA,24286936
3806,C005134,juglone,PPARG,5468,Homo sapiens,9606,[Indomethacin co-treated with juglone] results in increased expression of PPARG protein|juglone results in increased expression of PPARG mRNA|[Indomethacin co-treated with juglone] results in increased expression of PPARG mRNA|juglone results in increased expression of PPARG protein,31916655
3899,D000077339,Leflunomide,PPARG,5468,Homo sapiens,9606,Leflunomide results in increased expression of PPARG mRNA,28988120
3902,D000077289,Letrozole,PPARG,5468,Rattus norvegicus,10116,ADM protein inhibits the reaction [Letrozole results in decreased expression of PPARG mRNA]|Letrozole results in decreased expression of PPARG mRNA,33491863
3922,C095104,LG 100268,PPARG,5468,Homo sapiens,9606,LG 100268 binds to and results in increased activity of PPARG protein,15729575
3961,D019808,Losartan,PPARG,5468,Mus musculus,10090,Losartan inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA],18302760
3961,D019808,Losartan,PPARG,5468,Rattus norvegicus,10116,Losartan inhibits the reaction [AGT protein results in increased expression of PPARG mRNA],19109942
3969,C044660,LY 171883,PPARG,5468,Mus musculus,10090,LY 171883 results in increased activity of [PPARG protein co-treated with RXRA protein],8700121
3973,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,PPARG,5468,Rattus norvegicus,10116,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPARG mRNA|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPARG protein,17372590
4004,D008294,Malathion,PPARG,5468,Sus scrofa,9823,Malathion results in decreased expression of PPARG protein|Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG protein]|Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG mRNA]|Malathion results in decreased expression of PPARG mRNA,31535366
4008,C054218,manidipine,PPARG,5468,Homo sapiens,9606,manidipine results in decreased activity of PPARG protein,25257666
4075,D019804,Mesalamine,PPARG,5468,Homo sapiens,9606,[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Mesalamine] results in increased expression of PPARG protein|Mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of PPARG protein],27818126
4075,D019804,Mesalamine,PPARG,5468,Mus musculus,10090,Mesalamine inhibits the reaction [Dextran Sulfate affects the localization of PPARG protein],33130971
4091,D008687,Metformin,PPARG,5468,Homo sapiens,9606,Metformin results in decreased expression of PPARG mRNA,20956498
4091,D008687,Metformin,PPARG,5468,Mus musculus,10090,Metformin inhibits the reaction [IL13 protein results in increased expression of PPARG mRNA],26497364
4091,D008687,Metformin,PPARG,5468,Mus musculus,10090,Metformin results in increased expression of PPARG mRNA,21870829
4091,D008687,Metformin,PPARG,5468,Rattus norvegicus,10116,Metformin affects the activity of PPARG protein,25596134
4091,D008687,Metformin,PPARG,5468,Rattus norvegicus,10116,Metformin inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein],30256492
4091,D008687,Metformin,PPARG,5468,Rattus norvegicus,10116,Metformin inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA],25108154
4091,D008687,Metformin,PPARG,5468,Rattus norvegicus,10116,Metformin results in increased expression of PPARG mRNA,20724125
4130,D008743,Methyl Parathion,PPARG,5468,Homo sapiens,9606,Methyl Parathion binds to and results in increased activity of PPARG protein,33049310
4169,C051786,metolachlor,PPARG,5468,Homo sapiens,9606,metolachlor binds to and results in increased activity of PPARG protein,33049310
4211,D008939,Mitotane,PPARG,5468,Mus musculus,10090,Mitotane binds to and results in increased activity of PPARG protein,33049310
4463,D019829,Nevirapine,PPARG,5468,Homo sapiens,9606,Nevirapine results in increased expression of PPARG mRNA,21619898
4488,D009544,Niflumic Acid,PPARG,5468,Homo sapiens,9606,Niflumic Acid results in increased expression of PPARG protein,21067863
4493,C021277,nilutamide,PPARG,5468,Homo sapiens,9606,nilutamide binds to and results in increased activity of PPARG protein,33049310
4495,C012655,nimesulide,PPARG,5468,Homo sapiens,9606,nimesulide promotes the reaction [PPARG binds to PPARG promoter]|2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide results in increased expression of PPARG mRNA]|nimesulide results in increased expression of PPARG mRNA|2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide promotes the reaction [PPARG binds to PPARG promoter]],15705899
4495,C012655,nimesulide,PPARG,5468,Homo sapiens,9606,[nimesulide co-treated with Doxorubicin] results in increased expression of PPARG,14567645
4495,C012655,nimesulide,PPARG,5468,Homo sapiens,9606,nimesulide inhibits the reaction [ciglitazone results in increased expression of PPARG mRNA]|nimesulide inhibits the reaction [ciglitazone promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]]|nimesulide inhibits the reaction [pirinixic acid results in increased expression of PPARG mRNA]|nimesulide results in decreased expression of PPARG mRNA|nimesulide inhibits the reaction [pirinixic acid promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]],11840453
4495,C012655,nimesulide,PPARG,5468,Homo sapiens,9606,nimesulide results in increased expression of PPARG protein,14977856
4495,C012655,nimesulide,PPARG,5468,Homo sapiens,9606,PPARG mutant form inhibits the reaction [nimesulide results in increased expression of PPARG mRNA],15705899|15705899
4495,C012655,nimesulide,PPARG,5468,Rattus norvegicus,10116,nimesulide inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA],19247274
4553,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,PPARG,5468,Homo sapiens,9606,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Cannabidiol affects the localization of PPARG protein],23220503
4553,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,PPARG,5468,Homo sapiens,9606,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Celecoxib affects the localization of PPARG protein],23943857
4553,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,PPARG,5468,Homo sapiens,9606,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PPARG mRNA|N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [pirinixic acid results in increased expression of PPARG mRNA]|N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [ciglitazone results in increased expression of PPARG mRNA],11840453
4553,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,PPARG,5468,Homo sapiens,9606,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein],26863638
4553,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,PPARG,5468,Homo sapiens,9606,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased localization of PPARG protein,12517972
4614,D000077431,Oxaprozin,PPARG,5468,Homo sapiens,9606,Oxaprozin results in increased activity of PPARG protein,12065695
4632,C005290,oxybenzone,PPARG,5468,Homo sapiens,9606,oxybenzone binds to and results in increased activity of PPARG protein,33049310
4632,C005290,oxybenzone,PPARG,5468,Homo sapiens,9606,oxybenzone results in increased expression of PPARG mRNA|oxybenzone promotes the reaction [NCOA2 protein binds to PPARG protein]|oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]|oxybenzone binds to PPARG protein,32407875
4705,C088860,"4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline",PPARG,5468,Homo sapiens,9606,"4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline results in decreased expression of PPARG mRNA|[Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in increased expression of PPARG mRNA|4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline results in decreased expression of PPARG protein",32822399
4713,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,PPARG,5468,Homo sapiens,9606,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]],17030193
4713,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,PPARG,5468,Homo sapiens,9606,[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein],16945329
4713,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,PPARG,5468,Homo sapiens,9606,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased phosphorylation of PPARG protein,22593575
4713,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,PPARG,5468,Mus musculus,10090,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [diallyl trisulfide results in decreased expression of and results in decreased activity of PPARG protein],22137902
4713,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,PPARG,5468,Mus musculus,10090,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein],12758056|15050417
4713,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,PPARG,5468,Mus musculus,10090,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of PPARG protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [LEP protein inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA]]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of PPARG mRNA,21352814
4713,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,PPARG,5468,Rattus norvegicus,10116,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of PPARG protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of PPARG mRNA,17372590
4763,D010634,Phenobarbital,PPARG,5468,Homo sapiens,9606,Phenobarbital affects the expression of PPARG mRNA,19159669
4763,D010634,Phenobarbital,PPARG,5468,Mus musculus,10090,Phenobarbital results in increased expression of PPARG mRNA|NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PPARG mRNA],19482888
4763,D010634,Phenobarbital,PPARG,5468,Mus musculus,10090,Phenobarbital affects the expression of PPARG mRNA,23091169
4763,D010634,Phenobarbital,PPARG,5468,Rattus norvegicus,10116,Phenobarbital results in increased expression of PPARG mRNA,24090815
4788,D010693,Phloretin,PPARG,5468,Mus musculus,10090,"[cobaltous chloride co-treated with Phloretin] affects the expression of PPARG mRNA|2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phloretin] affects the expression of PPARG mRNA]|[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of PPARG mRNA",32408695
4793,C003117,phosalone,PPARG,5468,Danio rerio,7955,phosalone binds to and results in increased activity of PPARG protein,33049310
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Ro 41-5253 inhibits the reaction [Pioglitazone results in increased activity of PPARG protein]|Pioglitazone results in increased activity of and results in decreased expression of PPARG protein|[Dexamethasone co-treated with INS protein co-treated with Pioglitazone] results in increased expression of PPARG protein,17290005
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Ethanol inhibits the reaction [Pioglitazone results in increased activity of PPARG protein],17030193
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Pioglitazone promotes the reaction [Melatonin results in increased expression of PPARG protein]|luzindole inhibits the reaction [Pioglitazone results in increased expression of PPARG protein]|GW 1929 inhibits the reaction [Pioglitazone results in increased expression of PPARG protein]|Melatonin promotes the reaction [Pioglitazone results in increased expression of PPARG protein],29734669
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Pioglitazone binds to and results in increased activity of PPARG protein,15729575|19036883|20064974|20307981|21557540|23811337|9836514
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Pioglitazone binds to PPARG protein,11779144|22070604|23843199|32407875
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of PPARG protein],30965670
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Pioglitazone inhibits the reaction [GW 1929 binds to PPARG protein],31016361
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Pioglitazone promotes the reaction [PPARG protein binds to NPHS1 promoter],16687628
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Pioglitazone promotes the reaction [PPARG protein results in increased expression of PCSK9 mRNA],22593575
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Pioglitazone results in increased activity of PPARG protein,15273253|16324916|17030193|17290005|21597168|23150725
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Pioglitazone results in increased activity of [PPARG protein alternative form binds to RXRA protein],11779144
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Pioglitazone results in increased expression of PPARG mRNA,11172467|19201410|21354099|32473317
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Pioglitazone results in increased expression of PPARG mRNA alternative form,20860658
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,Pioglitazone results in increased expression of PPARG protein,11172467|26643070|29734669
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [Pioglitazone results in increased expression of CD36 protein],26643070
4829,D000077205,Pioglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [Pioglitazone results in increased activity of DIO2 protein],19036883
4829,D000077205,Pioglitazone,PPARG,5468,Mus musculus,10090,[ANGPT2 protein binds to and results in increased activity of AGTR2 protein] promotes the reaction [Pioglitazone binds to and results in increased activity of PPARG protein],15992368
4829,D000077205,Pioglitazone,PPARG,5468,Mus musculus,10090,Pioglitazone affects the expression of PPARG,21962020
4829,D000077205,Pioglitazone,PPARG,5468,Mus musculus,10090,Pioglitazone affects the expression of PPARG mRNA,19048458
4829,D000077205,Pioglitazone,PPARG,5468,Mus musculus,10090,Pioglitazone binds to and results in increased activity of PPARG protein,11991651|17084873|20064974|23795773
4829,D000077205,Pioglitazone,PPARG,5468,Mus musculus,10090,[Pioglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of RETSAT mRNA,19139408
4829,D000077205,Pioglitazone,PPARG,5468,Mus musculus,10090,[Pioglitazone co-treated with Alitretinoin] inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]|Pioglitazone inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine],17019405
4829,D000077205,Pioglitazone,PPARG,5468,Mus musculus,10090,PPARG protein affects the susceptibility to Pioglitazone|Pioglitazone promotes the reaction [PPARG protein binds to SCNN1G intron],16007095
4829,D000077205,Pioglitazone,PPARG,5468,Mus musculus,10090,"Pioglitazone promotes the reaction [Toluene 2,4-Diisocyanate results in increased localization of PPARG protein]",17015710
4829,D000077205,Pioglitazone,PPARG,5468,Mus musculus,10090,Pioglitazone results in increased expression of PPARG mRNA,11991651|16407166|19201410
4829,D000077205,Pioglitazone,PPARG,5468,Mus musculus,10090,PPARG protein affects the reaction [Pioglitazone results in increased expression of ADIPOQ mRNA],12927809
4829,D000077205,Pioglitazone,PPARG,5468,Rattus norvegicus,10116,T 0070907 inhibits the reaction [Pioglitazone affects the expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone affects the expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone affects the expression of PPARG mRNA]|Pioglitazone affects the expression of PPARG protein|T 0070907 inhibits the reaction [Pioglitazone affects the expression of PPARG mRNA]|Pioglitazone affects the expression of PPARG mRNA,28744220
4829,D000077205,Pioglitazone,PPARG,5468,Rattus norvegicus,10116,Pioglitazone inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA]|[naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA],30130594
4829,D000077205,Pioglitazone,PPARG,5468,Rattus norvegicus,10116,Pioglitazone affects the reaction [Puromycin Aminonucleoside results in increased expression of PPARG protein],16598202
4829,D000077205,Pioglitazone,PPARG,5468,Rattus norvegicus,10116,Pioglitazone binds to and results in increased activity of PPARG protein,15150131|16751799|19403437|29669060
4829,D000077205,Pioglitazone,PPARG,5468,Rattus norvegicus,10116,[Pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Phospholipids]|[Pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Diglycerides]|[Pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Triglycerides],19403437
4829,D000077205,Pioglitazone,PPARG,5468,Rattus norvegicus,10116,Pioglitazone inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA],12055599
4829,D000077205,Pioglitazone,PPARG,5468,Rattus norvegicus,10116,Pioglitazone inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA],22989705
4829,D000077205,Pioglitazone,PPARG,5468,Rattus norvegicus,10116,Pioglitazone inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA],15318101
4829,D000077205,Pioglitazone,PPARG,5468,Rattus norvegicus,10116,Pioglitazone inhibits the reaction [Fructose results in decreased activity of PPARG protein],25679220
4829,D000077205,Pioglitazone,PPARG,5468,Rattus norvegicus,10116,Pioglitazone inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA],27350165
4829,D000077205,Pioglitazone,PPARG,5468,Rattus norvegicus,10116,[Pioglitazone results in increased activity of PPARG protein] which results in decreased abundance of Triglycerides|Pioglitazone results in increased activity of PPARG protein|[Pioglitazone results in increased activity of PPARG protein] which results in increased abundance of Diglycerides,19439812
4829,D000077205,Pioglitazone,PPARG,5468,Sus scrofa,9823,Pioglitazone results in increased activity of PPARG protein|Troglitazone inhibits the reaction [Pioglitazone results in increased activity of PPARG protein],17065204
4829,D000077205,Pioglitazone,PPARG,5468,NULL,NULL,Pioglitazone binds to and results in decreased activity of PPARG protein,12676649
4829,D000077205,Pioglitazone,PPARG,5468,NULL,NULL,Pioglitazone binds to and results in increased activity of PPARG protein,11172467|11687581|15381068|15655531|15817521|15953354|16598202|17019405|18660453|19201410|20507283|20540935|21255596
4829,D000077205,Pioglitazone,PPARG,5468,NULL,NULL,Pioglitazone binds to PPARG protein,16573735|18274627|20860658|21525782|9920814
4829,D000077205,Pioglitazone,PPARG,5468,NULL,NULL,Pioglitazone results in increased activity of PPARG protein,16023994|21484566|21720023
4871,C474837,pomiferin,PPARG,5468,Homo sapiens,9606,pomiferin results in decreased expression of PPARG mRNA,20706672
4878,C412373,AG 1879,PPARG,5468,Mus musculus,10090,AG 1879 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]],16971554
4888,C043940,pyranoprofen,PPARG,5468,Homo sapiens,9606,pyranoprofen results in increased activity of PPARG protein,12065695
4933,D011411,Propanil,PPARG,5468,Homo sapiens,9606,Propanil binds to and results in increased activity of PPARG protein,33049310
4936,C002771,Omite,PPARG,5468,Danio rerio,7955,Omite binds to and results in increased activity of PPARG protein,33049310
5053,C100036,resmethrin,PPARG,5468,Homo sapiens,9606,resmethrin results in increased activity of PPARG protein,20143881
5073,D018967,Risperidone,PPARG,5468,Mus musculus,10090,Berberine inhibits the reaction [Risperidone results in increased expression of PPARG mRNA]|Risperidone results in increased expression of PPARG mRNA|Risperidone results in increased expression of PPARG protein|Berberine inhibits the reaction [Risperidone results in increased expression of PPARG protein],20564506
5152,D000068299,Salmeterol Xinafoate,PPARG,5468,Homo sapiens,9606,Salmeterol Xinafoate promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]],15531761
5166,C406525,SB 239063,PPARG,5468,Rattus norvegicus,10116,SB 239063 inhibits the reaction [25-hydroxyprotopanaxadiol results in increased phosphorylation of PPARG protein],33676887
5202,D012701,Serotonin,PPARG,5468,Homo sapiens,9606,Fluoxetine inhibits the reaction [Serotonin results in increased localization of PPARG protein]|Serotonin results in increased localization of PPARG protein|[Serotonin results in increased localization of and results in increased activity of PPARG protein] which results in increased expression of AQP3 mRNA|Serotonin binds to PPARG protein,25766885
5213,D012838,Silymarin,PPARG,5468,Mus musculus,10090,[Silymarin co-treated with Lipopolysaccharides co-treated with Galactosamine] results in increased expression of PPARG protein|[Silymarin co-treated with Lipopolysaccharides co-treated with Galactosamine] results in increased expression of PPARG mRNA,30236599
5213,D012838,Silymarin,PPARG,5468,Mus musculus,10090,Silymarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein]|Silymarin inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG protein]|Silymarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]|Silymarin inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA],28428136
5213,D012838,Silymarin,PPARG,5468,Rattus norvegicus,10116,"Silymarin inhibits the reaction [Drugs, Chinese Herbal results in decreased expression of PPARG mRNA]|Silymarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]",24582681
5269,C444426,splitomicin,PPARG,5468,Mus musculus,10090,splitomicin promotes the reaction [Resveratrol results in decreased expression of PPARG mRNA]|splitomicin promotes the reaction [Resveratrol results in decreased expression of PPARG protein],23525482
5281,C031183,stearic acid,PPARG,5468,Rattus norvegicus,10116,stearic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein],17302992
5291,D000068877,Imatinib Mesylate,PPARG,5468,Homo sapiens,9606,Imatinib Mesylate inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein],17030193
5339,D012460,Sulfasalazine,PPARG,5468,Mus musculus,10090,Sulfasalazine results in increased expression of PPARG mRNA,31830553
5339,D012460,Sulfasalazine,PPARG,5468,Rattus norvegicus,10116,Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]|Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA],26165751
5339,D012460,Sulfasalazine,PPARG,5468,Rattus norvegicus,10116,Sulfasalazine results in increased expression of PPARG mRNA,19365232
5350,C016766,sulforaphane,PPARG,5468,Homo sapiens,9606,sulforaphane results in increased expression of PPARG mRNA,26833863
5382,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",PPARG,5468,Mus musculus,10090,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of and results in decreased phosphorylation of PPARG protein",32123963
5394,D000077204,Temozolomide,PPARG,5468,Homo sapiens,9606,Temozolomide results in decreased expression of PPARG mRNA,31758290
5437,C089946,"2,4-thiazolidinedione",PPARG,5468,Homo sapiens,9606,"2,4-thiazolidinedione binds to and results in increased activity of PPARG protein",15521013
5437,C089946,"2,4-thiazolidinedione",PPARG,5468,Homo sapiens,9606,"2,4-thiazolidinedione binds to PPARG protein",15916743
5437,C089946,"2,4-thiazolidinedione",PPARG,5468,Rattus norvegicus,10116,"2,4-thiazolidinedione results in increased expression of PPARG mRNA",20724125
5437,C089946,"2,4-thiazolidinedione",PPARG,5468,Sus scrofa,9823,"2,4-thiazolidinedione binds to and results in increased activity of PPARG protein",14519784
5437,C089946,"2,4-thiazolidinedione",PPARG,5468,NULL,NULL,"2,4-thiazolidinedione binds to and affects the activity of PPARG protein",15867269
5519,C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",PPARG,5468,Sus scrofa,9823,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of and results in increased activity of PPARG protein]|N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of PPARG mRNA]",14519784
5564,D014260,Triclosan,PPARG,5468,Danio rerio,7955,Triclosan binds to and results in increased activity of PPARG protein,33049310
5564,D014260,Triclosan,PPARG,5468,Homo sapiens,9606,Triclosan affects the expression of PPARG mRNA,31714634
5564,D014260,Triclosan,PPARG,5468,Homo sapiens,9606,Triclosan binds to PPARG protein,25314719
5564,D014260,Triclosan,PPARG,5468,Homo sapiens,9606,Triclosan results in increased expression of PPARG mRNA,30510588
5564,D014260,Triclosan,PPARG,5468,Mus musculus,10090,Triclosan results in increased expression of PPARG protein|beta-Naphthoflavone inhibits the reaction [Triclosan results in increased expression of PPARG protein],33722737
5564,D014260,Triclosan,PPARG,5468,Mus musculus,10090,[Rosiglitazone results in increased activity of PPARG protein] inhibits the reaction [Triclosan results in decreased phosphorylation of AKT1 protein]|Thyroxine inhibits the reaction [Triclosan results in decreased expression of PPARG protein]|Triclosan results in decreased expression of PPARG protein,28973666
5564,D014260,Triclosan,PPARG,5468,Mus musculus,10090,Triclosan results in decreased expression of PPARG mRNA,15707987
5569,D014274,Trifluralin,PPARG,5468,Homo sapiens,9606,Trifluralin binds to and results in increased activity of PPARG protein,33049310
5570,C009560,trigonelline,PPARG,5468,Homo sapiens,9606,"trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]|trigonelline inhibits the reaction [[Cholesterol, Dietary co-treated with Dietary Fats] results in increased expression of PPARG protein]|ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]]",30208301
5591,D000077288,Troglitazone,PPARG,5468,Rattus norvegicus,10116,Troglitazone results in increased phosphorylation of and results in increased activity of PPARG protein|Troglitazone promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein]|Troglitazone promotes the reaction [PPARG protein binds to GFAP promoter]|CR8 compound inhibits the reaction [Troglitazone results in increased phosphorylation of PPARG protein]|[Troglitazone results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein,24481447
5591,D000077288,Troglitazone,PPARG,5468,Rattus norvegicus,10116,Troglitazone affects the activity of PPARG protein,25596134
5591,D000077288,Troglitazone,PPARG,5468,Rattus norvegicus,10116,[Troglitazone binds to and results in increased activity of PPARG mRNA] which results in decreased expression of SERPINE1 protein|[Troglitazone binds to and results in increased activity of PPARG mRNA] which results in decreased expression of SERPINE1 mRNA|Troglitazone binds to and results in increased activity of PPARG mRNA,11318962
5591,D000077288,Troglitazone,PPARG,5468,Rattus norvegicus,10116,Troglitazone binds to and results in increased activity of PPARG protein,15150131|18704104|19248225
5591,D000077288,Troglitazone,PPARG,5468,Rattus norvegicus,10116,[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of INSIG2 protein|[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein|[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of INSIG1 protein|[[[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides,19248225
5591,D000077288,Troglitazone,PPARG,5468,Rattus norvegicus,10116,Troglitazone results in increased activity of PPARG protein alternative form,15211114
5591,D000077288,Troglitazone,PPARG,5468,Rattus norvegicus,10116,Troglitazone results in increased expression of PPARG mRNA,10662598|21515302|21877759
5591,D000077288,Troglitazone,PPARG,5468,Rattus norvegicus,10116,Troglitazone results in increased expression of PPARG protein,10662598|11752099|28283887
5591,D000077288,Troglitazone,PPARG,5468,Sus scrofa,9823,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Troglitazone results in increased activity of PPARG protein]|Troglitazone results in increased activity of PPARG protein",14506076
5591,D000077288,Troglitazone,PPARG,5468,Sus scrofa,9823,Troglitazone inhibits the reaction [Pioglitazone results in increased activity of PPARG protein],17065204
5591,D000077288,Troglitazone,PPARG,5468,Sus scrofa,9823,Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA],30481989
5591,D000077288,Troglitazone,PPARG,5468,NULL,NULL,PPARG protein affects the reaction [Troglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of FOS mRNA]],10678274
5591,D000077288,Troglitazone,PPARG,5468,NULL,NULL,PPARG protein affects the reaction [Troglitazone results in decreased activity of TGFB1 protein],19120328
5591,D000077288,Troglitazone,PPARG,5468,NULL,NULL,Troglitazone binds to and results in increased activity of PPARG protein,10385688|11172467|11341955|11687581|11918743|12044893|12644321|15785241|16023420|16037295|16249460|16374840|16499875|16616945|16946405|16981146|17425601|17940898|18308446|18599600|18827362|19120328|19140230|19429239|19631733|19908241|20540935|21515302|21617575|23108036
5591,D000077288,Troglitazone,PPARG,5468,NULL,NULL,[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased secretion of LEP protein,16037295
5591,D000077288,Troglitazone,PPARG,5468,NULL,NULL,Troglitazone binds to PPARG protein,10753628|10813377|10814527|14508522|16303758|18274627|19632256|19854250|20860658|21525782
5591,D000077288,Troglitazone,PPARG,5468,NULL,NULL,[Troglitazone binds to PPARG protein] which binds to RXRA protein,15715931
5591,D000077288,Troglitazone,PPARG,5468,NULL,NULL,[Troglitazone co-treated with TNF protein] results in decreased expression of PPARG mRNA|Troglitazone promotes the reaction [PPARG protein results in decreased activity of RELA protein],12732648
5591,D000077288,Troglitazone,PPARG,5468,NULL,NULL,Troglitazone promotes the reaction [BMP2 protein affects the expression of PPARG mRNA],19122273
5591,D000077288,Troglitazone,PPARG,5468,NULL,NULL,Troglitazone promotes the reaction [PPARG protein binds to FABP4 enhancer],28437481
5591,D000077288,Troglitazone,PPARG,5468,NULL,NULL,Troglitazone results in increased activity of PPARG protein,10678274|10909982|11056218|11292061|12468449|12759900|16023994|19682441|21153920
5591,D000077288,Troglitazone,PPARG,5468,NULL,NULL,Troglitazone results in increased activity of [RXRA protein binds to PPARG protein],11752099
5591,D000077288,Troglitazone,PPARG,5468,Acanthogobius hasta,267130,Troglitazone affects the reaction [Iron affects the expression of PPARG mRNA]|Troglitazone results in increased expression of PPARG mRNA,28411055
5591,D000077288,Troglitazone,PPARG,5468,Bos taurus,9913,Troglitazone promotes the reaction [[PPARG protein binds to ASS1 promoter] which results in increased expression of ASS1 mRNA]|Troglitazone promotes the reaction [PPARG protein binds to ASS1 promoter],18375203
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,[1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of PPARG mRNA,27003841
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein results in increased susceptibility to Troglitazone]|PPARG protein results in increased susceptibility to Troglitazone",12824901
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Troglitazone results in increased abundance of Reactive Oxygen Species]|[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Troglitazone results in increased expression of PRODH]|[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Troglitazone affects the localization of CYCS protein],22108328
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Troglitazone results in increased activity of PPARG protein],15345676|23964924
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,[Tetradecanoylphorbol Acetate results in increased expression of PPARG] which affects the susceptibility to Troglitazone|[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of Troglitazone],16945329
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,PPARG gene SNP affects the susceptibility to Troglitazone,16249460
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,PPARG mutant form inhibits the reaction [Troglitazone results in increased expression of VEGFA protein],15705899
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [Troglitazone results in decreased expression of SPP1 mRNA],11426586
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone binds to and affects the activity of PPARG protein|PPARG protein affects the reaction [Troglitazone inhibits the reaction [TNF protein results in increased expression of FOS protein]]|PPARG protein affects the reaction [Troglitazone inhibits the reaction [TNF protein results in increased expression of FOS mRNA]]|PPARG protein affects the reaction [Troglitazone results in increased expression of ICAM1 mRNA]|PPARG protein affects the reaction [Troglitazone results in decreased susceptibility to TNF protein],11401521
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [Troglitazone results in decreased expression of FN1 protein],15908479
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [Troglitazone results in increased activity of DIO2 protein],19036883
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol|[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of HMGCS1 mRNA|[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of HMGCR mRNA|Pravastatin inhibits the reaction [[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol],12044893
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,sulindac sulfide analog inhibits the reaction [Troglitazone binds to PPARG protein]|Troglitazone analog binds to PPARG protein,18665581
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone binds to and results in increased activity of PPARG protein,10871190|11034103|11343236|12065695|14618613|15618651|15729575|18162602|19036883|22684020|23391484|33049310|9836514
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,[[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased expression of HMGCR mRNA|[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 mRNA|[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased abundance of Cholesterol|[[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased expression of LDLR mRNA|[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein|[[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased abundance of Cholesterol,16946405
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased degradation of CDKN1B protein|[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of and results in increased ubiquitination of CDKN1B protein,14618613
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of CDKN1B protein,11034103
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide,22684020
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone binds to PPARG protein,11779144|15383218|15641079|20008677
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone promotes the reaction [PPARG protein results in increased expression of FABP4 mRNA]|[Troglitazone binds to PPARG protein] which affects the localization of NCOA1 protein|Troglitazone inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein]|[Troglitazone binds to PPARG protein] which affects the localization of EP300 protein|Troglitazone promotes the reaction [PPARG protein results in increased expression of SORBS1 mRNA],10871190
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,"[Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in increased expression of PPARG mRNA",32822399
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone inhibits the reaction [Arsenic results in decreased expression of PPARG mRNA]|Troglitazone inhibits the reaction [Arsenic results in decreased expression of PPARG protein],23108036
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]|Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]|Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]]|Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]],20847119
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone inhibits the reaction [TNF protein results in decreased expression of PPARG mRNA],16483873
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone promotes the reaction [NCOA1 protein binds to and results in increased activity of PPARG protein],27551952
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone promotes the reaction [PPARG protein results in increased expression of PRODH mRNA]|Troglitazone promotes the reaction [PPARG protein binds to PRODH promoter],16303758
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone promotes the reaction [PPARG protein results in increased activity of [PPARG protein binds to RXRA protein]]|PPARG protein results in increased susceptibility to Troglitazone,15581905
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone results in increased phosphorylation of PPARG protein alternative form|Troglitazone results in decreased activity of PPARG protein alternative form,12475986
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone results in increased activity of PPARG protein,15345676|16149072|17409431|18155510|21543282|21617575|23964924|27551952|28571686|29421333
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,ZNF366 protein promotes the reaction [Troglitazone results in increased activity of [PPARG protein binds to RXRA protein]]|Troglitazone results in increased activity of [PPARG protein binds to RXRA protein],20008677
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,[Troglitazone results in increased activity of PPARG protein] which results in decreased expression of HMGB1 mRNA|[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 mRNA]|[Troglitazone results in increased activity of PPARG protein] which results in decreased expression of HMGB1 protein|[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 protein],21617575
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone results in increased expression of PPARG mRNA,10097144|11172467|14634802|15824748|16149072|16374840|16981146|17143939|21354099|22684020|25019995|32822399|9709955
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone results in increased expression of PPARG mRNA alternative form,11162573|11916926|20860658
5591,D000077288,Troglitazone,PPARG,5468,Homo sapiens,9606,Troglitazone results in increased expression of PPARG protein,11172467|14634802|16149072|16374840|17143939|32822399|9709955
5591,D000077288,Troglitazone,PPARG,5468,Mus musculus,10090,JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein]|[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein|(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein],26117538
5591,D000077288,Troglitazone,PPARG,5468,Mus musculus,10090,[Troglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [PPARG protein binds to CYP1A1 promoter]|PPARG protein affects the reaction [Troglitazone results in increased expression of CYP1A1 mRNA]|[Troglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [[PPARG protein binds to CYP1A1 promoter] which results in increased expression of CYP1A1 mRNA]|PPARG protein affects the reaction [Troglitazone results in increased activity of CYP1A1 protein],18308446
5591,D000077288,Troglitazone,PPARG,5468,Mus musculus,10090,PPARG protein promotes the reaction [Troglitazone results in increased expression of PPARGC1A mRNA],16513826
5591,D000077288,Troglitazone,PPARG,5468,Mus musculus,10090,Troglitazone binds to and results in decreased activity of PPARG protein,16368784
5591,D000077288,Troglitazone,PPARG,5468,Mus musculus,10090,Troglitazone binds to and results in increased activity of PPARG protein,10871190|19577614|33049310
5591,D000077288,Troglitazone,PPARG,5468,Mus musculus,10090,[Troglitazone co-treated with Diethylstilbestrol] results in increased expression of PPARG protein,22710028
5591,D000077288,Troglitazone,PPARG,5468,Mus musculus,10090,Troglitazone results in decreased expression of PPARG mRNA,12732648|16813520
5591,D000077288,Troglitazone,PPARG,5468,Mus musculus,10090,Troglitazone results in decreased methylation of PPARG promoter,24559133
5591,D000077288,Troglitazone,PPARG,5468,Mus musculus,10090,Troglitazone results in increased activity of PPARG protein,11683414|11911853|12732648|18799549
5591,D000077288,Troglitazone,PPARG,5468,Mus musculus,10090,[Troglitazone results in increased activity of PPARG protein] which results in increased expression of CD36 mRNA|[Troglitazone results in increased activity of PPARG protein] which results in increased expression of FABP4 mRNA|[Troglitazone results in increased activity of PPARG protein] which results in increased expression of UCP2 mRNA,11089532
5591,D000077288,Troglitazone,PPARG,5468,Mus musculus,10090,[Troglitazone results in increased activity of PPARG protein] which results in increased expression of ERO1A mRNA,17452443
5591,D000077288,Troglitazone,PPARG,5468,Mus musculus,10090,Troglitazone results in increased expression of PPARG mRNA,11113387|11752099|19122273|19682441|22710028
5591,D000077288,Troglitazone,PPARG,5468,Mus musculus,10090,Troglitazone results in increased expression of PPARG protein,11752099|19682441|30328325
5591,D000077288,Troglitazone,PPARG,5468,Rattus norvegicus,10116,[Troglitazone results in increased activity of PPARG protein] which results in decreased susceptibility to Lipopolysaccharides|2-chloro-5-nitrobenzanilide inhibits the reaction [[Troglitazone results in increased activity of PPARG protein] which results in increased expression of SFTPA1 mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]|[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]|[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]|[Troglitazone results in increased activity of PPARG protein] which results in increased expression of SFTPA1 mRNA,21153920
5694,C006253,pirinixic acid,PPARG,5468,Homo sapiens,9606,pirinixic acid analog binds to and affects the activity of PPARG protein,17610302
5694,C006253,pirinixic acid,PPARG,5468,Homo sapiens,9606,pirinixic acid analog binds to and results in increased activity of PPARG protein,18275039|20307981
5694,C006253,pirinixic acid,PPARG,5468,Homo sapiens,9606,pirinixic acid results in increased expression of PPARG mRNA|nimesulide inhibits the reaction [pirinixic acid results in increased expression of PPARG mRNA]|pirinixic acid promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]|N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [pirinixic acid results in increased expression of PPARG mRNA]|nimesulide inhibits the reaction [pirinixic acid promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]],11840453
5694,C006253,pirinixic acid,PPARG,5468,Homo sapiens,9606,pirinixic acid binds to and results in increased activity of PPARG protein,17610302|18275039|20307981|9013583
5694,C006253,pirinixic acid,PPARG,5468,Homo sapiens,9606,pirinixic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA],12604364
5694,C006253,pirinixic acid,PPARG,5468,Homo sapiens,9606,pirinixic acid results in increased activity of PPARG protein,16386710|26135921
5694,C006253,pirinixic acid,PPARG,5468,Mus musculus,10090,pirinixic acid promotes the reaction [PPARG protein binds to NFKBIA promoter]|[pirinixic acid results in increased activity of PPARG protein] which results in increased expression of NFKBIA mRNA,19438714
5694,C006253,pirinixic acid,PPARG,5468,Mus musculus,10090,pirinixic acid results in increased activity of PPARG protein,12401884|9703482
5694,C006253,pirinixic acid,PPARG,5468,Mus musculus,10090,pirinixic acid results in increased activity of [PPARG protein co-treated with RXRA protein],8700121
5694,C006253,pirinixic acid,PPARG,5468,Oryctolagus cuniculus,9986,pirinixic acid affects the localization of and results in increased activity of PPARG protein,16912651
5694,C006253,pirinixic acid,PPARG,5468,Rattus norvegicus,10116,pirinixic acid results in increased expression of PPARG mRNA,22539621
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA,25932594
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA|avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA],31016361
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA|dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]|oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]|avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA],32407875
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,[bisphenol F co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein|[bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] affects the expression of PPARG protein|[bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA|[bisphenol F co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA,33865937
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,[Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of PPARG mRNA,34560244
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA|Rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],19186324
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein|[Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein|[Dexamethasone co-treated with INS protein co-treated with Pioglitazone] results in increased expression of PPARG protein,17290005
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,Dexamethasone results in increased expression of PPARG mRNA,16569937|19853017|24418828|25047013|27003841
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,Dexamethasone results in increased expression of PPARG protein,16569937
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,[Dichlorodiphenyl Dichloroethylene co-treated with [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of PPARG mRNA,26200599
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,TGFB1 protein inhibits the reaction [[Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]|[Indomethacin co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA|[Indomethacin co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG protein,20206132
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,"[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of PPARG protein|[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone co-treated with 4,4'-hexafluorisopropylidene diphenol] results in increased expression of PPARG mRNA|[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of PPARG mRNA",31596606
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PPARG mRNA,28628672
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,PPARG protein results in decreased susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone],26670611
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein|[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA|rosemarinic acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein],33476690
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,[Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA|[Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein,20206132|33865937
5743,D003907,Dexamethasone,PPARG,5468,Homo sapiens,9606,[Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] affects the expression of PPARG mRNA,33836827
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,"14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA]|14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]",30248417
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA,23503329|30248417|30409764
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein,25559859|27475717|30248417|30409764|31199990
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA|hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA]|hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG protein]|[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG protein,30055130
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA|[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG protein|beta-penta-O-galloyl-glucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG protein]|beta-penta-O-galloyl-glucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA],30721698
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,"2,2',3',4,4',5-hexachlorobiphenyl promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein",29704545
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,"2,2',4,4',5-brominated diphenyl ether promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]",30903904
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,"Dexamethasone results in increased expression of PPARG protein|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Dexamethasone results in increased expression of PPARG mRNA]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Dexamethasone results in increased expression of PPARG protein]",31709877
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Rosiglitazone promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|Rosiglitazone promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG protein]|[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in decreased methylation of PPARG promoter|[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG protein|[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG mRNA,29094436
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,"3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]|3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]",22298784
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,"Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]|3,5,6-trichloro-2-pyridinol promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]",32017950
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA]|Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein],30409764
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,EGF protein promotes the reaction [Vanadates inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]|U 0126 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]|EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]|methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]|EGF protein inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|AG 1879 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]|Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein,16971554
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein],27475717
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein,28242765
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Rosiglitazone promotes the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA]|[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA|Tretinoin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA],32473317
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] affects the expression of PPARG protein,32220626
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[bisphenol A co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] affects the expression of PPARG mRNA|[bisphenol A co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] affects the methylation of PPARG promoter,33203037
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]|bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]|Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form],22197818
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein|Diethylstilbestrol inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein]|bisphenol A promotes the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein]|T 0070907 inhibits the reaction [[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein]|[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein,26944108
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]|CTNNB1 protein promotes the reaction [sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]]|boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]|sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]|sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]|CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]],28285642
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]|butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],28595985
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,butylparaben promotes the reaction [Dexamethasone results in increased expression of PPARG mRNA],22956630
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|cannabigerol promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|cannabigerolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],30611848
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA,23152186|32017950|34302803
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein,18586010|32017950
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA,22298784|28031460|28285642|30903904
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein,22298784|28285642
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,TGFB1 inhibits the reaction [[Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA]|TNF inhibits the reaction [[Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA]|[Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA,9543393
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[Dexamethasone co-treated with Oxygen deficiency] results in increased expression of PPARG mRNA alternative form|Dexamethasone results in increased expression of PPARG mRNA alternative form,16814746
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]|[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA|[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA],16054899
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Dexamethasone results in decreased expression of PPARG mRNA,16889531
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Dexamethasone results in increased expression of PPARG mRNA,22956630|25068083|25851902|31709877
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|dorsomorphin inhibits the reaction [rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]|rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein],30446312
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Ethanol inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|GHRL protein inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA,32171850
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Glycyrrhizic Acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA],34302803
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein]|[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein|(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein],26117538
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA,26972250|30446312
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein,11101056|24576443|30446312
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[INS1 protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA|sodium arsenite inhibits the reaction [[INS1 protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA],11812925
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA|[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA alternative form|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA alternative form]|[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG protein|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA]|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG protein],33412187
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA,28595985|30611848|31009676
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Ivermectin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein],31199990
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,(+)-JQ1 compound inhibits the reaction [Rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]|(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|Rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],26972250
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA|[Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA|[Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein|[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein,29288687
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein,32417366
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form]|[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form,14984747
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,potassium chromate(VI) inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein],24576443
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Quercetin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein],18586010
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein],11101056
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Rosiglitazone promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],28595985|30611848
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein],25559859
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of PPARG mRNA|[sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of PPARG mRNA,34968464
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA],23152186
5743,D003907,Dexamethasone,PPARG,5468,Mus musculus,10090,[triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA|[tetrabromobisphenol A co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA,34323617
5743,D003907,Dexamethasone,PPARG,5468,Rattus norvegicus,10116,Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]|Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein],16782535
5743,D003907,Dexamethasone,PPARG,5468,Rattus norvegicus,10116,Dexamethasone results in increased expression of PPARG mRNA,14568882|19118567
5743,D003907,Dexamethasone,PPARG,5468,Rattus norvegicus,10116,Dexamethasone results in increased expression of PPARG protein,14568882
5743,D003907,Dexamethasone,PPARG,5468,Rattus norvegicus,10116,[INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA,21350315
5743,D003907,Dexamethasone,PPARG,5468,Sus scrofa,9823,"Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA",30481989
5743,D003907,Dexamethasone,PPARG,5468,Sus scrofa,9823,Dexamethasone results in increased expression of PPARG,19852296
5743,D003907,Dexamethasone,PPARG,5468,Ursus maritimus,29073,mono-(2-ethylhexyl)phthalate promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|Environmental Pollutants inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA,27602593
5743,D003907,Dexamethasone,PPARG,5468,NULL,NULL,Dexamethasone promotes the reaction [PPARG protein binds to FABP4 enhancer],28437481
5753,D003345,Corticosterone,PPARG,5468,Mus musculus,10090,[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA|Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA],29751049
5754,D006854,Hydrocortisone,PPARG,5468,Homo sapiens,9606,[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein|[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA|rosemarinic acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein],33476690
5757,D004958,Estradiol,PPARG,5468,Danio rerio,7955,Estradiol results in decreased expression of PPARG mRNA,31352104
5757,D004958,Estradiol,PPARG,5468,Danio rerio,7955,Estradiol results in increased expression of PPARG protein,15964169
5757,D004958,Estradiol,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]],21734263
5757,D004958,Estradiol,PPARG,5468,Homo sapiens,9606,[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPARG mRNA,19619570
5757,D004958,Estradiol,PPARG,5468,Homo sapiens,9606,Estradiol results in decreased expression of PPARG mRNA,21632903|28591870|28711546
5757,D004958,Estradiol,PPARG,5468,Homo sapiens,9606,Estradiol results in increased expression of PPARG mRNA,19619570|21185374|31278978
5757,D004958,Estradiol,PPARG,5468,Mus musculus,10090,Estradiol results in increased expression of PPARG mRNA,18359623
5757,D004958,Estradiol,PPARG,5468,Rattus norvegicus,10116,[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]|[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]|Estradiol affects the expression of PPARG protein|Estradiol affects the expression of PPARG mRNA,22389237
5757,D004967,Estrogens,PPARG,5468,Homo sapiens,9606,Estrogens results in increased expression of PPARG mRNA,25014179
5803,C010642,"3,3',5-triiodothyroacetic acid",PPARG,5468,Homo sapiens,9606,"3,3',5-triiodothyroacetic acid binds to and results in increased activity of PPARG protein",33049310
5819,D013974,Thyroxine,PPARG,5468,Mus musculus,10090,Thyroxine inhibits the reaction [Triclosan results in decreased expression of PPARG protein],28973666
5819,D013974,Thyroxine,PPARG,5468,Xenopus laevis,8355,Thyroxine results in increased expression of PPARG mRNA,17403546
5839,D000450,Aldosterone,PPARG,5468,Mus musculus,10090,PPARG protein affects the abundance of Aldosterone,16007095
5892,D009243,NAD,PPARG,5468,Rattus norvegicus,10116,NAD results in decreased activity of PPARG protein|3-aminobenzamide inhibits the reaction [NAD results in decreased activity of PPARG protein],18815186
5920,D014284,Triiodothyronine,PPARG,5468,Danio rerio,7955,Triiodothyronine binds to and results in increased activity of PPARG protein,33049310
5920,D014284,Triiodothyronine,PPARG,5468,Homo sapiens,9606,[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein|[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA|rosemarinic acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein],33476690
5920,D014284,Triiodothyronine,PPARG,5468,Rattus norvegicus,10116,Triiodothyronine inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA],25048947
5921,D004052,Diethylnitrosamine,PPARG,5468,Mus musculus,10090,PPARG protein results in decreased susceptibility to Diethylnitrosamine,20512989
5921,D004052,Diethylnitrosamine,PPARG,5468,Rattus norvegicus,10116,[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG protein|[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA|Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG protein]|Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA],28935427
5921,D004052,Diethylnitrosamine,PPARG,5468,Rattus norvegicus,10116,[Diethylnitrosamine co-treated with Dietary Fats] results in increased expression of PPARG mRNA,30298849
5921,D004052,Diethylnitrosamine,PPARG,5468,Rattus norvegicus,10116,Diethylnitrosamine results in decreased expression of PPARG protein|Diethylnitrosamine results in decreased expression of PPARG mRNA,24954034
5943,D002251,Carbon Tetrachloride,PPARG,5468,Mus musculus,10090,hesperetin analog inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein]|Carbon Tetrachloride results in decreased expression of PPARG protein|Silymarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein]|Carbon Tetrachloride results in decreased expression of PPARG mRNA|Silymarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]|hesperetin analog inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA],28428136
5943,D002251,Carbon Tetrachloride,PPARG,5468,Mus musculus,10090,[Ethanol co-treated with Carbon Tetrachloride co-treated with 4-O-methylhonokiol] results in decreased expression of PPARG mRNA,28689299
5943,D002251,Carbon Tetrachloride,PPARG,5468,Rattus norvegicus,10116,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA],15876570
5943,D002251,Carbon Tetrachloride,PPARG,5468,Rattus norvegicus,10116,Carbon Tetrachloride affects the expression of PPARG protein,15959796
5943,D002251,Carbon Tetrachloride,PPARG,5468,Rattus norvegicus,10116,[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG protein|[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA|Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG protein]|Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA],28935427
5943,D002251,Carbon Tetrachloride,PPARG,5468,Rattus norvegicus,10116,Carbon Tetrachloride results in decreased activity of PPARG protein,25858767
5943,D002251,Carbon Tetrachloride,PPARG,5468,Rattus norvegicus,10116,Carbon Tetrachloride results in decreased expression of PPARG mRNA,12055599|15876570|18006644|24582681
5943,D002251,Carbon Tetrachloride,PPARG,5468,Rattus norvegicus,10116,Carbon Tetrachloride results in decreased expression of PPARG protein|puerarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein],23500774
5943,D002251,Carbon Tetrachloride,PPARG,5468,Rattus norvegicus,10116,Carbon Tetrachloride results in increased expression of PPARG mRNA|schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PPARG mRNA],31150632
5943,D002251,Carbon Tetrachloride,PPARG,5468,Rattus norvegicus,10116,Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA],18006644
5943,D002251,Carbon Tetrachloride,PPARG,5468,Rattus norvegicus,10116,Pioglitazone inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]|Rosiglitazone inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA],12055599
5943,D002251,Carbon Tetrachloride,PPARG,5468,Rattus norvegicus,10116,Silymarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA],24582681
5957,D000255,Adenosine Triphosphate,PPARG,5468,Homo sapiens,9606,UCP1 protein promotes the reaction [PPARG protein mutant form results in decreased abundance of Adenosine Triphosphate]|Rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]|PPARG protein mutant form results in decreased abundance of Adenosine Triphosphate|FASN protein promotes the reaction [Rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]]|PPARG protein results in decreased abundance of Adenosine Triphosphate|UCP1 protein promotes the reaction [Rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]],26670611
5971,C004471,allyl isothiocyanate,PPARG,5468,Rattus norvegicus,10116,allyl isothiocyanate inhibits the reaction [Dietary Fats results in decreased expression of PPARG protein]|allyl isothiocyanate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG protein],30927557
5984,D005632,Fructose,PPARG,5468,Rattus norvegicus,10116,"Metformin inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein]|[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein|Carnitine inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein]|Fatty Acids, Omega-3 inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein]",30256492
5984,D005632,Fructose,PPARG,5468,Rattus norvegicus,10116,geraniol inhibits the reaction [Fructose results in decreased activity of PPARG protein]|Fructose results in decreased activity of PPARG protein|Pioglitazone inhibits the reaction [Fructose results in decreased activity of PPARG protein],25679220
5984,D005632,Fructose,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone promotes the reaction [Fructose results in increased expression of PPARG mRNA]|Fructose results in increased expression of PPARG mRNA,19196556
5988,D013395,Sucrose,PPARG,5468,Mus musculus,10090,Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA]|[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA,24440342
5988,D019422,Dietary Sucrose,PPARG,5468,Mus musculus,10090,"[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] promotes the reaction [[Dietary Sucrose co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]|[Dietary Sucrose co-treated with Dietary Fats] results in decreased expression of PPARG mRNA",30722647
5988,D019422,Dietary Sucrose,PPARG,5468,Mus musculus,10090,[Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPARG mRNA,21462320|28433925
5988,D019422,Dietary Sucrose,PPARG,5468,Mus musculus,10090,Quercetin inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPARG mRNA],21462320
5991,D004997,Ethinyl Estradiol,PPARG,5468,Boreogadus saida,44932,[Benzo(a)pyrene co-treated with Ethinyl Estradiol] results in increased expression of PPARG mRNA,34015484
5991,D004997,Ethinyl Estradiol,PPARG,5468,Mus musculus,10090,ESR1 gene mutant form inhibits the reaction [Ethinyl Estradiol results in increased expression of PPARG mRNA]|Ethinyl Estradiol results in increased expression of PPARG mRNA,29112739
5994,D011374,Progesterone,PPARG,5468,Rattus norvegicus,10116,Progesterone results in increased expression of PPARG mRNA,16954335
5995,D043343,Testosterone Propionate,PPARG,5468,Danio rerio,7955,Testosterone Propionate binds to and results in decreased activity of PPARG protein,33049310
5997,D002784,Cholesterol,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Resveratrol results in decreased abundance of Cholesterol],20372816
5997,D002784,Cholesterol,PPARG,5468,Homo sapiens,9606,[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [APOA1 protein results in increased transport of Cholesterol]|[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of Cholesterol],12595494
5997,D002784,Cholesterol,PPARG,5468,Homo sapiens,9606,[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol|Pravastatin inhibits the reaction [[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol],12044893
5997,D002784,Cholesterol,PPARG,5468,Homo sapiens,9606,[[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased abundance of Cholesterol|[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased abundance of Cholesterol,16946405
5997,D002784,Cholesterol,PPARG,5468,Mus musculus,10090,Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA]|[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA,24440342
5997,D002784,Cholesterol,PPARG,5468,Mus musculus,10090,Losartan inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA]|Rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA]|[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA,18302760
5997,D002784,Cholesterol,PPARG,5468,Mus musculus,10090,PPARG protein promotes the reaction [Niacin promotes the reaction [APOA1 protein results in increased export of Cholesterol]],19797938
5997,D002784,Cholesterol,PPARG,5468,Oryctolagus cuniculus,9986,Niacin inhibits the reaction [Cholesterol results in decreased expression of PPARG mRNA]|Cholesterol results in decreased expression of PPARG mRNA,18402819
5997,D002784,Cholesterol,PPARG,5468,Oryctolagus cuniculus,9986,[Niacin results in increased expression of PPARG mRNA] which results in increased export of Cholesterol,17395297|17963637
6001,D015127,"9,10-Dimethyl-1,2-benzanthracene",PPARG,5468,Homo sapiens,9606,"9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of PPARG protein",33049310
6010,D008777,Methyltestosterone,PPARG,5468,Gallus gallus,9031,Methyltestosterone results in decreased expression of PPARG mRNA,29191790
6013,D013739,Testosterone,PPARG,5468,Homo sapiens,9606,Testosterone results in decreased expression of PPARG mRNA,21632903|33359661
6013,D013739,Testosterone,PPARG,5468,Mus musculus,10090,Testosterone results in decreased expression of PPARG mRNA,12960001|20844152
6013,D013739,Testosterone,PPARG,5468,Mus musculus,10090,Testosterone results in decreased expression of PPARG protein,12960001
6013,D013739,Testosterone,PPARG,5468,Ovis aries,9940,Testosterone affects the expression of PPARG mRNA,20843997
6020,D011692,Puromycin Aminonucleoside,PPARG,5468,Rattus norvegicus,10116,Puromycin Aminonucleoside results in increased expression of PPARG protein|Pioglitazone affects the reaction [Puromycin Aminonucleoside results in increased expression of PPARG protein],16598202
6124,D004128,Dimethylnitrosamine,PPARG,5468,Rattus norvegicus,10116,Dimethylnitrosamine results in decreased expression of PPARG mRNA,12055599|15099470
6128,D000735,Androstenedione,PPARG,5468,Danio rerio,7955,Androstenedione binds to and results in decreased activity of PPARG protein,33049310
6137,D008715,Methionine,PPARG,5468,Mus musculus,10090,"3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of PPARG mRNA]|[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of PPARG mRNA",28973532
6137,D008715,Methionine,PPARG,5468,Mus musculus,10090,[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA|Rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG protein]|Rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA]|[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG protein,18991162
6197,D003513,Cycloheximide,PPARG,5468,Bos taurus,9913,Cycloheximide inhibits the reaction [Rosiglitazone results in increased expression of PPARG protein],17622750
6199,D005363,Ficusin,PPARG,5468,Rattus norvegicus,10116,Ficusin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA],27350165
6230,D009640,Norethindrone,PPARG,5468,Mus musculus,10090,Norethindrone binds to and results in increased activity of PPARG protein,33049310
6253,D003561,Cytarabine,PPARG,5468,Mus musculus,10090,"Cytarabine results in increased expression of PPARG mRNA|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cytarabine results in increased expression of PPARG mRNA]",23264188
6294,D003632,Dichlorodiphenyldichloroethane,PPARG,5468,Danio rerio,7955,Dichlorodiphenyldichloroethane binds to and results in increased activity of PPARG protein,33049310
6336,C446685,systhane,PPARG,5468,Rattus norvegicus,10116,systhane results in increased expression of PPARG mRNA,32268158
6366,C029297,vinylidene chloride,PPARG,5468,Mus musculus,10090,vinylidene chloride results in increased expression of PPARG mRNA,26682919
6410,D020122,tert-Butylhydroperoxide,PPARG,5468,Homo sapiens,9606,tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]|Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]|Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]|Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]]|Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]|tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]|tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]|tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter],20847119
6410,D020122,tert-Butylhydroperoxide,PPARG,5468,Homo sapiens,9606,tert-Butylhydroperoxide results in increased activity of PPARG protein,16417216
6434,C018959,hexadecafluoro-nonanoic acid,PPARG,5468,Mus musculus,10090,hexadecafluoro-nonanoic acid results in increased expression of PPARG mRNA,18583369
6484,C056189,di-n-butyltin,PPARG,5468,Homo sapiens,9606,T 0070907 inhibits the reaction [di-n-butyltin results in increased expression of PPARG mRNA]|di-n-butyltin results in increased expression of PPARG mRNA,29787037
6529,D014317,Tritolyl Phosphates,PPARG,5468,Homo sapiens,9606,Tritolyl Phosphates results in increased expression of PPARG mRNA|Tritolyl Phosphates binds to and results in increased activity of PPARG protein,29410257
6529,D014317,Tritolyl Phosphates,PPARG,5468,Mus musculus,10090,"[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of PPARG mRNA",29112739
6529,D014317,Tritolyl Phosphates,PPARG,5468,Mus musculus,10090,"[tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in increased expression of PPARG mRNA",32360330
6529,D014317,Tritolyl Phosphates,PPARG,5468,Sparus aurata,8175,Tritolyl Phosphates results in increased expression of PPARG mRNA|Tritolyl Phosphates binds to PPARG protein,30090361
6540,C013320,tris(2-butoxyethyl) phosphate,PPARG,5468,Homo sapiens,9606,tris(2-butoxyethyl) phosphate binds to PPARG protein,25314719
6540,C013320,tris(2-butoxyethyl) phosphate,PPARG,5468,Salmo salar,8030,tris(2-butoxyethyl) phosphate results in decreased expression of PPARG protein|tris(2-butoxyethyl) phosphate results in decreased expression of PPARG mRNA,27484134
6544,C005940,isophorone,PPARG,5468,Homo sapiens,9606,isophorone binds to and results in decreased activity of PPARG protein,27633901
6562,C039175,methacrylaldehyde,PPARG,5468,Homo sapiens,9606,[Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PPARG mRNA|[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA,32699268
6575,D014241,Trichloroethylene,PPARG,5468,Mus musculus,10090,Trichloroethylene results in increased expression of PPARG mRNA|PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of PPARG mRNA],20709644
6575,D014241,Trichloroethylene,PPARG,5468,Rattus norvegicus,10116,Trichloroethylene results in increased expression of PPARG mRNA,33387578
6579,D020106,Acrylamide,PPARG,5468,Mus musculus,10090,Acrylamide promotes the reaction [Dietary Fats results in increased expression of PPARG protein]|Acrylamide promotes the reaction [Dietary Fats results in increased expression of PPARG mRNA]|Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA]|Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein],30409764
6597,D003999,Dichloroacetic Acid,PPARG,5468,Mus musculus,10090,Dichloroacetic Acid results in increased expression of PPARG mRNA,28962523
6618,C020806,tetrabromobisphenol A,PPARG,5468,Danio rerio,7955,tetrabromobisphenol A binds to and results in increased activity of PPARG protein,21561829|33049310
6618,C020806,tetrabromobisphenol A,PPARG,5468,Danio rerio,7955,tetrabromobisphenol A results in increased activity of PPARG protein,24591153
6618,C020806,tetrabromobisphenol A,PPARG,5468,Homo sapiens,9606,tetrabromobisphenol A binds to and results in increased activity of PPARG protein,21561829|21622942|23398518|33049310
6618,C020806,tetrabromobisphenol A,PPARG,5468,Homo sapiens,9606,tetrabromobisphenol A binds to PPARG protein,25314719
6618,C020806,tetrabromobisphenol A,PPARG,5468,Homo sapiens,9606,tetrabromobisphenol A inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30138673
6618,C020806,tetrabromobisphenol A,PPARG,5468,Homo sapiens,9606,tetrabromobisphenol A metabolite binds to and results in increased activity of PPARG protein,21622942
6618,C020806,tetrabromobisphenol A,PPARG,5468,Homo sapiens,9606,tetrabromobisphenol A results in increased activity of PPARG protein,24591153|28282128|30138673
6618,C020806,tetrabromobisphenol A,PPARG,5468,Homo sapiens,9606,tetrabromobisphenol A results in increased expression of PPARG mRNA,32473317
6618,C020806,tetrabromobisphenol A,PPARG,5468,Mus musculus,10090,tetrabromobisphenol A results in decreased expression of PPARG protein|GW 1929 inhibits the reaction [tetrabromobisphenol A results in decreased expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [tetrabromobisphenol A results in decreased expression of PPARG protein],24132472
6618,C020806,tetrabromobisphenol A,PPARG,5468,Mus musculus,10090,tetrabromobisphenol A binds to and results in increased activity of PPARG protein,33049310
6618,C020806,tetrabromobisphenol A,PPARG,5468,Mus musculus,10090,[tetrabromobisphenol A co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA,34323617
6618,C020806,tetrabromobisphenol A,PPARG,5468,Mus musculus,10090,tetrabromobisphenol A results in increased activity of PPARG protein,25777084|25863188|30496566
6618,C020806,tetrabromobisphenol A,PPARG,5468,Mus musculus,10090,tetrabromobisphenol A results in increased expression of PPARG mRNA,25863188|30496566
6618,C020806,tetrabromobisphenol A,PPARG,5468,Rattus norvegicus,10116,tetrabromobisphenol A inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA],25048947
6618,C020806,tetrabromobisphenol A,PPARG,5468,Rattus norvegicus,10116,tetrabromobisphenol A results in decreased expression of PPARG mRNA,26988606
6618,C020806,tetrabromobisphenol A,PPARG,5468,Ursus maritimus,29073,tetrabromobisphenol A results in increased activity of PPARG protein,27602593
6618,C020806,tetrabromobisphenol A,PPARG,5468,Xenopus laevis,8355,tetrabromobisphenol A binds to and results in increased activity of PPARG protein,21561829
6618,C020806,tetrabromobisphenol A,PPARG,5468,NULL,NULL,tetrabromobisphenol A binds to PPARG protein,23959441
6619,C041181,tetrachlorodian,PPARG,5468,Danio rerio,7955,tetrachlorodian binds to and results in increased activity of PPARG protein,21561829
6619,C041181,tetrachlorodian,PPARG,5468,Danio rerio,7955,tetrachlorodian results in increased activity of PPARG protein,24591153
6619,C041181,tetrachlorodian,PPARG,5468,Homo sapiens,9606,tetrachlorodian analog results in increased activity of PPARG protein,28282128
6619,C041181,tetrachlorodian,PPARG,5468,Homo sapiens,9606,tetrachlorodian binds to and results in increased activity of PPARG protein,21561829|33049310
6619,C041181,tetrachlorodian,PPARG,5468,Homo sapiens,9606,tetrachlorodian binds to PPARG protein,25314719
6619,C041181,tetrachlorodian,PPARG,5468,Homo sapiens,9606,tetrachlorodian inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30138673
6619,C041181,tetrachlorodian,PPARG,5468,Homo sapiens,9606,tetrachlorodian metabolite binds to and results in increased activity of PPARG protein,21622942
6619,C041181,tetrachlorodian,PPARG,5468,Homo sapiens,9606,tetrachlorodian results in increased activity of PPARG protein,24591153|26172262|30138673
6619,C041181,tetrachlorodian,PPARG,5468,Mus musculus,10090,tetrachlorodian binds to and results in increased activity of PPARG protein,33049310
6619,C041181,tetrachlorodian,PPARG,5468,NULL,NULL,tetrachlorodian binds to PPARG protein,23959441
6623,C006780,bisphenol A,PPARG,5468,Danio rerio,7955,bisphenol A results in increased expression of PPARG mRNA,31352104
6623,C006780,bisphenol A,PPARG,5468,Gallus gallus,9031,bisphenol A promotes the reaction [Dietary Fats results in increased expression of PPARG mRNA],33010594
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,U 0126 inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]|RTKI cpd inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA],31075703
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,bisphenol A analog binds to and results in increased activity of PPARG protein,21622942
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,bisphenol A analog binds to PPARG protein,29925285
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,bisphenol A analog results in increased expression of PPARG mRNA,32763284
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,bisphenol A binds to and results in increased activity of PPARG protein,21622942|24155963|27633901
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,bisphenol A binds to PPARG protein,23843199|29410257
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,HNF1B protein inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]|ginsenoside Rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]|bisphenol A results in increased expression of PPARG protein|ginsenoside Rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG protein]|HNF1B protein inhibits the reaction [bisphenol A results in increased expression of PPARG protein]|Dietary Fats promotes the reaction [bisphenol A results in increased expression of PPARG mRNA]|Fulvestrant inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]|Dietary Fats promotes the reaction [bisphenol A results in increased expression of PPARG protein]|bisphenol A inhibits the reaction [HNF1B protein binds to PPARG promoter]|PPARG protein affects the reaction [Fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]]|PPARG protein affects the reaction [bisphenol A results in decreased expression of HNF1B mRNA],32623698
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,bisphenol A inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30138673|30408883
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,[bisphenol A results in decreased expression of MIR27B] which results in increased expression of PPARG mRNA,30690568
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,bisphenol A results in decreased expression of PPARG mRNA,28711546
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,bisphenol A results in decreased methylation of PPARG gene,31601247
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,bisphenol A results in increased expression of PPARG mRNA,20064783|23090578|24418828|25143472|28483554|29275510|29721103|31075703|31278978|31778932|32623698|32763284
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,bisphenol A results in increased localization of PPARG protein,20064783
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [bisphenol A results in increased expression of FABP4 mRNA]|PPARG protein affects the reaction [bisphenol A results in increased expression of NR1H3 mRNA]|PPARG protein affects the reaction [bisphenol A results in increased expression of CD36 mRNA],31778932
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [bisphenol A results in increased secretion of APLN protein],28111160
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,SREBF1 protein affects the reaction [bisphenol A results in increased expression of PPARG mRNA],28483554
6623,C006780,bisphenol A,PPARG,5468,Homo sapiens,9606,[Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] affects the expression of PPARG mRNA,33836827
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,[1-Methyl-3-isobutylxanthine co-treated with bisphenol A co-treated with INS protein] results in increased expression of PPARG protein,26820058
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,bisphenol A affects the expression of PPARG protein,31319301
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,bisphenol A affects the methylation of PPARG promoter,27334623
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA|bisphenol A results in increased activity of PPARG protein,27273607
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,"[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] promotes the reaction [[Dietary Sucrose co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]",30722647
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,bisphenol A results in decreased methylation of PPARG promoter|[bisphenol A co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] affects the expression of PPARG mRNA|[bisphenol A co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] affects the methylation of PPARG promoter,33203037
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form],22197818
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,bisphenol A promotes the reaction [Dietary Fats results in increased expression of PPARG mRNA],33265944
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,bisphenol A promotes the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein]|T 0070907 inhibits the reaction [[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein]|[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein,26944108
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,bisphenol A results in decreased expression of PPARG mRNA,30133442
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,bisphenol A results in increased expression of PPARG,26942597
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,bisphenol A results in increased expression of PPARG mRNA,18359623|21932408|23704952|24959901|25111128|26944108|26996129|27145005|28483554|28796629|30149043|30566610|31319301|32623698|33203037
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,bisphenol A results in increased expression of PPARG protein,26996129|27145005|28796629|32623698
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,MAP2K3 protein inhibits the reaction [MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]]|MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]|MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG protein]|MAP2K3 protein inhibits the reaction [MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG protein]],26996129
6623,C006780,bisphenol A,PPARG,5468,Mus musculus,10090,Mifepristone inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA],27145005
6623,C006780,bisphenol A,PPARG,5468,Ovis aries,9940,bisphenol A results in increased expression of PPARG mRNA|bisphenol A results in decreased expression of PPARG mRNA,28938450
6623,C006780,bisphenol A,PPARG,5468,Rattus norvegicus,10116,[bisphenol A co-treated with tributyltin] results in increased expression of PPARG protein,31129395
6623,C006780,bisphenol A,PPARG,5468,Rattus norvegicus,10116,bisphenol A results in decreased expression of PPARG mRNA,23399309|25181051|28772150
6623,C006780,bisphenol A,PPARG,5468,Rattus norvegicus,10116,bisphenol A results in decreased methylation of PPARG gene,32701268
6623,C006780,bisphenol A,PPARG,5468,Rattus norvegicus,10116,bisphenol A results in increased expression of PPARG mRNA,20019905|32701268|34165232
6623,C006780,bisphenol A,PPARG,5468,Rattus norvegicus,10116,bisphenol A results in increased methylation of PPARG gene,28505145
6623,C006780,bisphenol A,PPARG,5468,Rattus norvegicus,10116,[Dietary Fats co-treated with bisphenol A] results in increased expression of PPARG mRNA,25112833
6623,C006780,bisphenol A,PPARG,5468,Rattus norvegicus,10116,lithospermate B inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA],34165232
6623,C006780,bisphenol A,PPARG,5468,Rattus norvegicus,10116,Wortmannin inhibits the reaction [bisphenol A results in decreased expression of PPARG mRNA],23399309
6623,C006780,bisphenol A,PPARG,5468,Sparus aurata,8175,bisphenol A results in increased expression of PPARG mRNA,26382854|29933238
6623,C006780,bisphenol A,PPARG,5468,Sparus aurata,8175,[nonylphenol co-treated with bisphenol A] results in increased expression of PPARG mRNA,28208108
6623,C006780,bisphenol A,PPARG,5468,Ursus maritimus,29073,bisphenol A inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],27602593
6625,C034224,"4,4'-dichlorodiphenyl sulfone",PPARG,5468,Homo sapiens,9606,"4,4'-dichlorodiphenyl sulfone binds to and results in increased activity of PPARG protein",33049310
6626,C543008,bis(4-hydroxyphenyl)sulfone,PPARG,5468,Danio rerio,7955,bis(4-hydroxyphenyl)sulfone results in increased expression of PPARG mRNA,30660906
6626,C543008,bis(4-hydroxyphenyl)sulfone,PPARG,5468,Homo sapiens,9606,bis(4-hydroxyphenyl)sulfone results in increased activity of PPARG protein|bis(4-hydroxyphenyl)sulfone analog results in increased activity of PPARG protein,29331639
6626,C543008,bis(4-hydroxyphenyl)sulfone,PPARG,5468,Homo sapiens,9606,bis(4-hydroxyphenyl)sulfone binds to and results in decreased activity of PPARG protein,27633901
6626,C543008,bis(4-hydroxyphenyl)sulfone,PPARG,5468,Homo sapiens,9606,bis(4-hydroxyphenyl)sulfone binds to and results in increased activity of PPARG protein,27633901|33049310
6626,C543008,bis(4-hydroxyphenyl)sulfone,PPARG,5468,Homo sapiens,9606,[bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] affects the expression of PPARG protein|[bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA,33865937
6626,C543008,bis(4-hydroxyphenyl)sulfone,PPARG,5468,Homo sapiens,9606,bis(4-hydroxyphenyl)sulfone inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30138673
6626,C543008,bis(4-hydroxyphenyl)sulfone,PPARG,5468,Homo sapiens,9606,bis(4-hydroxyphenyl)sulfone results in increased expression of PPARG mRNA,27003841|31778932
6626,C543008,bis(4-hydroxyphenyl)sulfone,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [bis(4-hydroxyphenyl)sulfone results in increased expression of FABP4 mRNA]|PPARG protein affects the reaction [bis(4-hydroxyphenyl)sulfone results in increased expression of CD36 mRNA]|PPARG protein affects the reaction [bis(4-hydroxyphenyl)sulfone results in increased expression of NR1H3 mRNA],31778932
6626,C543008,bis(4-hydroxyphenyl)sulfone,PPARG,5468,Mus musculus,10090,bis(4-hydroxyphenyl)sulfone binds to and results in increased activity of PPARG protein,33049310
6626,C543008,bis(4-hydroxyphenyl)sulfone,PPARG,5468,Mus musculus,10090,[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA|bis(4-hydroxyphenyl)sulfone results in increased activity of PPARG protein|bis(4-hydroxyphenyl)sulfone inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],27273607
6626,C543008,bis(4-hydroxyphenyl)sulfone,PPARG,5468,Mus musculus,10090,[bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] affects the expression of PPARG protein,32220626
6626,C543008,bis(4-hydroxyphenyl)sulfone,PPARG,5468,Mus musculus,10090,bis(4-hydroxyphenyl)sulfone results in increased expression of PPARG mRNA,30951980|30959087
6626,C543008,bis(4-hydroxyphenyl)sulfone,PPARG,5468,Mus musculus,10090,[Dietary Fats co-treated with bis(4-hydroxyphenyl)sulfone] affects the expression of PPARG mRNA,27241191
6636,D011078,Polychlorinated Biphenyls,PPARG,5468,Ursus maritimus,29073,"[Polychlorinated Biphenyls analog co-treated with Dichlorodiphenyl Dichloroethylene analog] inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|[Polychlorinated Biphenyls co-treated with Halogenated Diphenyl Ethers co-treated with Hydrocarbons, Chlorinated] inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|[Polychlorinated Biphenyls co-treated with Halogenated Diphenyl Ethers co-treated with Hydrocarbons, Chlorinated] results in decreased expression of PPARG mRNA",27602593
6643,C019566,p-tert-amylphenol,PPARG,5468,Danio rerio,7955,p-tert-amylphenol binds to and results in increased activity of PPARG protein,33049310
6654,C005451,alpha-pinene,PPARG,5468,Homo sapiens,9606,[Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PPARG mRNA|[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA,32699268
6720,C005805,quintozene,PPARG,5468,Homo sapiens,9606,quintozene results in increased activity of PPARG protein,20143881
6758,D012402,Rotenone,PPARG,5468,Homo sapiens,9606,[Rosiglitazone co-treated with Rotenone] results in increased expression of PPARG protein,24374061
6758,D012402,Rotenone,PPARG,5468,Homo sapiens,9606,Rotenone inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30818834
6758,D012402,Rotenone,PPARG,5468,Rattus norvegicus,10116,Rotenone results in decreased expression of PPARG protein|Rotenone results in decreased expression of PPARG mRNA,19693701
6777,C036042,dicyclohexyl phthalate,PPARG,5468,Xenopus tropicalis,8364,dicyclohexyl phthalate results in increased expression of PPARG mRNA,26924002
6781,C007379,diethyl phthalate,PPARG,5468,Homo sapiens,9606,diethyl phthalate binds to PPARG protein,23843199
6782,C025605,diisobutyl phthalate,PPARG,5468,Homo sapiens,9606,diisobutyl phthalate binds to and results in increased activity of PPARG protein,24155963|27633901
6782,C025605,diisobutyl phthalate,PPARG,5468,Homo sapiens,9606,diisobutyl phthalate results in increased activity of PPARG protein,26172262
6782,C025605,diisobutyl phthalate,PPARG,5468,Homo sapiens,9606,diisobutyl phthalate results in increased expression of PPARG protein,29061543
6786,C027387,di-n-hexyl phthalate,PPARG,5468,Homo sapiens,9606,di-n-hexyl phthalate binds to PPARG protein,23843199
6787,C019174,dinonylphthalate,PPARG,5468,Homo sapiens,9606,dinonylphthalate binds to PPARG protein,23843199
6788,C027718,didecyl phthalate,PPARG,5468,Homo sapiens,9606,didecyl phthalate binds to PPARG protein,23843199
6817,D011710,Pyocyanine,PPARG,5468,Mus musculus,10090,Pyocyanine results in decreased expression of PPARG mRNA,31078726
6867,C092582,7-dimethylamino-4-methylcoumarin,PPARG,5468,Homo sapiens,9606,7-dimethylamino-4-methylcoumarin binds to and results in increased activity of PPARG protein,33049310
6914,C024564,"2,4,6-trichlorophenol",PPARG,5468,Homo sapiens,9606,"2,4,6-trichlorophenol binds to PPARG protein",25314719
6986,C000590793,2-isopropyl-5-methylcyclohexanone,PPARG,5468,Homo sapiens,9606,2-isopropyl-5-methylcyclohexanone binds to and results in decreased activity of PPARG protein,27633901
7047,C037219,quinoline,PPARG,5468,Homo sapiens,9606,quinoline analog binds to and affects the activity of PPARG protein,17610302
7074,C012257,2-chloro-4-phenylphenol,PPARG,5468,Homo sapiens,9606,2-chloro-4-phenylphenol binds to and results in increased activity of PPARG protein,33049310
7099,D011370,Proflavine,PPARG,5468,Homo sapiens,9606,Proflavine inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30818834
7103,C019046,4-phenylphenol,PPARG,5468,Homo sapiens,9606,4-phenylphenol binds to and results in increased activity of PPARG protein,33049310
7108,C031637,phenothiazine,PPARG,5468,Homo sapiens,9606,phenothiazine binds to and results in increased activity of PPARG protein,33049310
7175,C006068,propylparaben,PPARG,5468,Homo sapiens,9606,propylparaben binds to and results in increased activity of PPARG protein,24155963|33049310
7175,C006068,propylparaben,PPARG,5468,Mus musculus,10090,PPARG protein promotes the reaction [propylparaben binds to and results in increased activity of PPARG protein],24155963
7175,C006068,propylparaben,PPARG,5468,Mus musculus,10090,propylparaben binds to and results in increased activity of PPARG protein,33049310
7175,C006068,propylparaben,PPARG,5468,Mus musculus,10090,propylparaben results in increased expression of PPARG mRNA,22956630
7180,C057775,benzylparaben,PPARG,5468,Mus musculus,10090,benzylparaben results in increased activity of PPARG protein,28527915
7180,C057775,benzylparaben,PPARG,5468,Mus musculus,10090,benzylparaben results in increased expression of PPARG mRNA,22956630|27659731
7184,C038091,butylparaben,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [butylparaben binds to and results in increased activity of PPARG protein]|butylparaben binds to and results in increased activity of PPARG protein,24155963
7184,C038091,butylparaben,PPARG,5468,Homo sapiens,9606,"PPARG mutant form inhibits the reaction [butylparaben results in increased expression of PLIN1 mRNA]|Mifepristone inhibits the reaction [butylparaben results in increased expression of PPARG mRNA]|butylparaben promotes the reaction [Dexamethasone results in increased expression of PPARG mRNA]|PPARG mutant form inhibits the reaction [butylparaben results in increased expression of FABP4 mRNA]|butylparaben results in increased expression of PPARG mRNA|2-chloro-5-nitrobenzanilide inhibits the reaction [butylparaben results in increased expression of PPARG mRNA]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [butylparaben results in increased expression of PPARG mRNA]",22956630
7184,C038091,butylparaben,PPARG,5468,Mus musculus,10090,PPARG protein promotes the reaction [butylparaben results in increased expression of CEBPA mRNA]|PPARG protein promotes the reaction [butylparaben results in decreased expression of ALPL mRNA]|butylparaben results in increased activity of PPARG protein|PPARG protein promotes the reaction [butylparaben results in increased expression of PLIN1 mRNA]|PPARG protein results in increased susceptibility to butylparaben|PPARG protein promotes the reaction [butylparaben results in increased expression of FABP4 mRNA]|PPARG protein inhibits the reaction [butylparaben results in decreased expression of SPP1 mRNA],28527915
7184,C038091,butylparaben,PPARG,5468,Mus musculus,10090,butylparaben results in increased expression of PPARG mRNA,22956630|27659731|28527915
7271,C009534,"2,4,5-trichlorophenol",PPARG,5468,Homo sapiens,9606,"2,4,5-trichlorophenol binds to and results in increased activity of PPARG protein",33049310
7410,C038699,acetophenone,PPARG,5468,Homo sapiens,9606,acetophenone binds to and results in decreased activity of PPARG protein,27633901
7430,C004354,dicloran,PPARG,5468,Danio rerio,7955,dicloran binds to and results in increased activity of PPARG protein,33049310
7456,C015358,methylparaben,PPARG,5468,Homo sapiens,9606,methylparaben binds to and results in increased activity of PPARG protein,24155963
7456,C015358,methylparaben,PPARG,5468,Mus musculus,10090,PPARG protein results in increased susceptibility to methylparaben|PPARG protein promotes the reaction [methylparaben results in decreased expression of BGLAP mRNA],28527915
7540,C013318,triphenyl phosphite,PPARG,5468,Homo sapiens,9606,triphenyl phosphite affects the activity of PPARG protein,26172262
7550,D011729,Pyridostigmine Bromide,PPARG,5468,Mus musculus,10090,[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA|Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA],29751049
7628,C032688,boric acid,PPARG,5468,Mus musculus,10090,CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]]|boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]|boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein],28285642
7636,C036758,2-ethylhexyl acrylate,PPARG,5468,Homo sapiens,9606,2-ethylhexyl acrylate binds to and results in increased activity of PPARG protein,27633901
7725,C020627,4-methylbenzaldehyde,PPARG,5468,Homo sapiens,9606,4-methylbenzaldehyde binds to and results in decreased activity of PPARG protein,27633901
7814,C029728,4-phenylenediamine,PPARG,5468,Homo sapiens,9606,4-phenylenediamine results in increased expression of PPARG mRNA,16314067
7847,D000171,Acrolein,PPARG,5468,Homo sapiens,9606,[Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PPARG mRNA|[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA,32699268
7847,D000171,Acrolein,PPARG,5468,Mus musculus,10090,Rosiglitazone inhibits the reaction [Acrolein results in decreased expression of PPARG protein]|Resveratrol inhibits the reaction [Acrolein results in decreased expression of PPARG protein]|Acrolein promotes the reaction [DDIT3 protein binds to PPARG promoter]|Acrolein results in decreased expression of PPARG protein,34813903
7847,D000171,Acrolein,PPARG,5468,Mus musculus,10090,[Acrolein promotes the reaction [DDIT3 protein binds to PPARG promoter]] which results in decreased expression of PPARG protein,34813903|34813903
7929,C031285,3-xylene,PPARG,5468,Rattus norvegicus,10116,3-xylene results in decreased expression of PPARG mRNA,12815608
8029,C039281,furan,PPARG,5468,Rattus norvegicus,10116,furan results in decreased expression of PPARG mRNA,25539665|26194646
8139,C089549,lauric acid methyl ester,PPARG,5468,Homo sapiens,9606,lauric acid methyl ester binds to and results in decreased activity of PPARG protein,27633901
8227,C004371,"N-(2-ethylhexyl)-5-norbornene-2,3-dicarboxamide",PPARG,5468,Danio rerio,7955,"N-(2-ethylhexyl)-5-norbornene-2,3-dicarboxamide binds to and results in increased activity of PPARG protein",33049310
8289,C005445,triphenyl phosphate,PPARG,5468,Danio rerio,7955,triphenyl phosphate binds to and results in increased activity of PPARG protein,33049310
8289,C005445,triphenyl phosphate,PPARG,5468,Danio rerio,7955,triphenyl phosphate results in increased expression of PPARG mRNA,23306105
8289,C005445,triphenyl phosphate,PPARG,5468,Homo sapiens,9606,[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of PPARG mRNA|triphenyl phosphate promotes the reaction [PPARG protein binds to FABP4 enhancer]|triphenyl phosphate analog promotes the reaction [PPARG protein binds to FABP4 enhancer]|[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of PPARG mRNA,28437481
8289,C005445,triphenyl phosphate,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [triphenyl phosphate results in increased expression of HSD3B1 mRNA],28282128
8289,C005445,triphenyl phosphate,PPARG,5468,Homo sapiens,9606,triphenyl phosphate binds to and results in decreased expression of PPARG protein,30966736
8289,C005445,triphenyl phosphate,PPARG,5468,Homo sapiens,9606,triphenyl phosphate binds to PPARG protein,25062436|25314719
8289,C005445,triphenyl phosphate,PPARG,5468,Homo sapiens,9606,triphenyl phosphate metabolite binds to PPARG protein,25314719
8289,C005445,triphenyl phosphate,PPARG,5468,Homo sapiens,9606,triphenyl phosphate results in increased activity of PPARG protein,26172262|28282128|28728110
8289,C005445,triphenyl phosphate,PPARG,5468,Homo sapiens,9606,triphenyl phosphate results in increased expression of PPARG mRNA,25062436|28934090
8289,C005445,triphenyl phosphate,PPARG,5468,Mus musculus,10090,[triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA,34323617
8289,C005445,triphenyl phosphate,PPARG,5468,Mus musculus,10090,triphenyl phosphate results in increased expression of PPARG mRNA,28163246
8289,C005445,triphenyl phosphate,PPARG,5468,Mus musculus,10090,"[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of PPARG mRNA",29112739
8289,C005445,triphenyl phosphate,PPARG,5468,Mus musculus,10090,"[tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in increased expression of PPARG mRNA",32360330
8295,C031324,tris(chloroethyl)phosphate,PPARG,5468,Danio rerio,7955,tris(chloroethyl)phosphate results in increased expression of PPARG mRNA,27776230
8295,C031324,tris(chloroethyl)phosphate,PPARG,5468,Homo sapiens,9606,tris(chloroethyl)phosphate results in decreased expression of PPARG protein,30966736
8295,C031324,tris(chloroethyl)phosphate,PPARG,5468,Salmo salar,8030,tris(chloroethyl)phosphate results in decreased expression of PPARG protein|tris(chloroethyl)phosphate results in decreased expression of PPARG mRNA,27484134
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PPARG protein]|Diethylhexyl Phthalate results in increased expression of PPARG mRNA,31163220
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Homo sapiens,9606,Diethylhexyl Phthalate binds to and results in decreased activity of PPARG protein,27633901
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Homo sapiens,9606,Diethylhexyl Phthalate binds to and results in increased activity of PPARG protein,33049310
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Homo sapiens,9606,Diethylhexyl Phthalate binds to PPARG protein,23843199|32407875
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Homo sapiens,9606,Diethylhexyl Phthalate metabolite binds to PPARG protein,25314719
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Homo sapiens,9606,Diethylhexyl Phthalate results in increased expression of PPARG protein,28025108|29061543|31163220
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Mus musculus,10090,"[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] promotes the reaction [[Dietary Sucrose co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]",30722647
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Mus musculus,10090,Diethylhexyl Phthalate affects the expression of PPARG mRNA,22588786|25351189
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Mus musculus,10090,[Diethylhexyl Phthalate co-treated with Chlorodiphenyl (54% Chlorine)] results in increased expression of PPARG mRNA,23804495
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Mus musculus,10090,Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form],22197818
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Mus musculus,10090,Diethylhexyl Phthalate results in decreased expression of PPARG mRNA,31211961
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Mus musculus,10090,Diethylhexyl Phthalate results in decreased expression of PPARG protein,29669060
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Mus musculus,10090,Diethylhexyl Phthalate results in increased expression of PPARG mRNA,32325186|32522588
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Mus musculus,10090,Diethylhexyl Phthalate results in increased expression of PPARG protein,21856391|33484791
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Mus musculus,10090,[Ethanol co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA,32325186
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Mus musculus,10090,[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of PPARG protein,33484791
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Rattus norvegicus,10116,[Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA|[Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG protein,20920559
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Rattus norvegicus,10116,Diethylhexyl Phthalate results in decreased expression of PPARG protein,16690193|29669060
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Rattus norvegicus,10116,Diethylhexyl Phthalate results in increased expression of PPARG mRNA,15647598|20920559
8343,D004051,Diethylhexyl Phthalate,PPARG,5468,Rattus norvegicus,10116,Diethylhexyl Phthalate results in increased expression of PPARG protein,15647598|20920559|22279657|28025108
8413,C009501,2-tolidine,PPARG,5468,Homo sapiens,9606,2-tolidine binds to and results in increased activity of PPARG protein,33049310
8425,C004660,clorophene,PPARG,5468,Homo sapiens,9606,clorophene binds to and results in increased activity of PPARG protein,33049310
8434,C012313,ethyl-p-hydroxybenzoate,PPARG,5468,Mus musculus,10090,ethyl-p-hydroxybenzoate results in increased expression of PPARG mRNA,22956630
8437,C542008,diethylene glycol dibenzoate,PPARG,5468,Danio rerio,7955,diethylene glycol dibenzoate affects the expression of PPARG mRNA,29723837
8437,C542008,diethylene glycol dibenzoate,PPARG,5468,Homo sapiens,9606,diethylene glycol dibenzoate results in increased expression of PPARG mRNA|diethylene glycol dibenzoate binds to and results in increased activity of PPARG protein,29410257
8461,C016403,"2,4-dinitrotoluene",PPARG,5468,Mus musculus,10090,"2,4-dinitrotoluene results in increased activity of PPARG protein|2,4-dinitrotoluene results in increased expression of PPARG mRNA",24893713
8461,C016403,"2,4-dinitrotoluene",PPARG,5468,Pimephales promelas,90988,"2,4-dinitrotoluene results in decreased expression of PPARG mRNA",16917068
8515,C432165,pyrazolanthrone,PPARG,5468,Rattus norvegicus,10116,pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PPARG protein],28283887
8515,C432165,pyrazolanthrone,PPARG,5468,Rattus norvegicus,10116,pyrazolanthrone results in increased expression of PPARG mRNA|pyrazolanthrone results in increased expression of PPARG protein,17372590
8554,C024629,dimethyl phthalate,PPARG,5468,Homo sapiens,9606,dimethyl phthalate binds to PPARG protein,23843199
8559,C106479,di-n-propylphthalate,PPARG,5468,Homo sapiens,9606,di-n-propylphthalate binds to PPARG protein,23843199
8560,C049098,diallyl phthalate,PPARG,5468,Homo sapiens,9606,diallyl phthalate binds to and results in increased activity of PPARG protein,33049310
8561,C034171,di-n-pentyl phthalate,PPARG,5468,Danio rerio,7955,di-n-pentyl phthalate binds to and results in increased activity of PPARG protein,33049310
8561,C034171,di-n-pentyl phthalate,PPARG,5468,Homo sapiens,9606,di-n-pentyl phthalate binds to PPARG protein,23843199
8569,C004839,dioxybenzone,PPARG,5468,Homo sapiens,9606,dioxybenzone promotes the reaction [NCOA2 protein binds to PPARG protein]|dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]|dioxybenzone binds to PPARG protein|dioxybenzone results in increased expression of PPARG mRNA,32407875
8575,C028577,monobutyl phthalate,PPARG,5468,Homo sapiens,9606,monobutyl phthalate affects the expression of PPARG mRNA,28381288
8575,C028577,monobutyl phthalate,PPARG,5468,Homo sapiens,9606,monobutyl phthalate binds to PPARG protein,23843199
8575,C028577,monobutyl phthalate,PPARG,5468,Homo sapiens,9606,monobutyl phthalate inhibits the reaction [ciglitazone binds to and results in increased activity of PPARG protein],16326050
8575,C028577,monobutyl phthalate,PPARG,5468,Homo sapiens,9606,monobutyl phthalate results in increased expression of PPARG protein,29089286
8697,C040668,2-ethylhexanoic acid,PPARG,5468,Rattus norvegicus,10116,2-ethylhexanoic acid results in increased expression of PPARG protein|2-ethylhexanoic acid results in increased expression of PPARG mRNA,15647598
8722,D015039,Ziram,PPARG,5468,Homo sapiens,9606,Ziram affects the expression of PPARG mRNA,32712770
8814,C105260,4-tert-octylphenol,PPARG,5468,Sparus aurata,8175,4-tert-octylphenol results in increased expression of PPARG mRNA,26382854
8814,C105260,4-tert-octylphenol,PPARG,5468,Sparus aurata,8175,[nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of PPARG mRNA,28208108
8842,C007078,citronellol,PPARG,5468,Homo sapiens,9606,citronellol inhibits the reaction [PPARG protein results in increased expression of PTGS2 mRNA]|citronellol results in increased activity of PPARG protein,21597168
8858,C008374,mesityl oxide,PPARG,5468,Homo sapiens,9606,mesityl oxide binds to and results in decreased activity of PPARG protein,33049310
9064,D002392,Catechin,PPARG,5468,Rattus norvegicus,10116,Catechin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA],23365609
9154,C007738,fluoranthene,PPARG,5468,Homo sapiens,9606,fluoranthene binds to and results in increased activity of PPARG protein,33049310
9317,C008261,lead acetate,PPARG,5468,Rattus norvegicus,10116,[lead acetate co-treated with sodium arsenite co-treated with Cadmium Chloride] results in increased expression of PPARG protein|[lead acetate co-treated with sodium arsenite] results in increased expression of PPARG protein|PPARG protein affects the reaction [lead acetate results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PPARG protein]|PPARG protein affects the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased expression of and results in increased cleavage of PARP1 protein]|lead acetate results in increased expression of PPARG protein|CR8 compound analog inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PPARG protein]|[lead acetate co-treated with Cadmium Chloride] results in increased expression of PPARG protein,28283887
9317,C008261,lead acetate,PPARG,5468,Rattus norvegicus,10116,[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein|T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]|[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [PPARG protein binds to GFAP promoter]|CR8 compound inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]|T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of PPARG protein]|[[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein|[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein],24481447
9321,D006834,Hydrazines,PPARG,5468,Mus musculus,10090,Hydrazines results in decreased expression of PPARG mRNA|Hydrazines results in decreased expression of PPARG protein,21647536
9444,D001374,Azacitidine,PPARG,5468,Mus musculus,10090,Azacitidine results in increased expression of PPARG mRNA|Azacitidine results in decreased methylation of PPARG promoter,19589179
9502,D008044,Linuron,PPARG,5468,Homo sapiens,9606,Linuron binds to and results in increased activity of PPARG protein,33049310
9554,C023036,perfluorooctanoic acid,PPARG,5468,Danio rerio,7955,perfluorooctanoic acid results in decreased expression of PPARG mRNA,33581636
9554,C023036,perfluorooctanoic acid,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to perfluorooctanoic acid,23978332
9554,C023036,perfluorooctanoic acid,PPARG,5468,Homo sapiens,9606,perfluorooctanoic acid binds to and results in increased activity of PPARG protein,16731579|33049310
9554,C023036,perfluorooctanoic acid,PPARG,5468,Homo sapiens,9606,perfluorooctanoic acid binds to PPARG protein,24998974
9554,C023036,perfluorooctanoic acid,PPARG,5468,Homo sapiens,9606,perfluorooctanoic acid results in decreased expression of PPARG mRNA,32790152
9554,C023036,perfluorooctanoic acid,PPARG,5468,Homo sapiens,9606,perfluorooctanoic acid results in increased activity of PPARG protein,23391484|24998974
9554,C023036,perfluorooctanoic acid,PPARG,5468,Homo sapiens,9606,perfluorooctanoic acid results in increased expression of PPARG mRNA,25868421|28558994
9554,C023036,perfluorooctanoic acid,PPARG,5468,Mus musculus,10090,2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG protein]|[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in decreased methylation of PPARG promoter|[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG protein|[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG mRNA,29094436
9554,C023036,perfluorooctanoic acid,PPARG,5468,Mus musculus,10090,perfluorooctanoic acid results in increased expression of PPARG protein|perfluorooctanoic acid affects the expression of PPARG mRNA|perfluorooctanoic acid results in decreased expression of PPARG mRNA,22154759
9554,C023036,perfluorooctanoic acid,PPARG,5468,Mus musculus,10090,perfluorooctanoic acid results in increased expression of PPARG mRNA,18281256|21499893|22154759|25092180|32822737
9554,C023036,perfluorooctanoic acid,PPARG,5468,Mus musculus,10090,PPARA protein inhibits the reaction [perfluorooctanoic acid results in increased expression of PPARG mRNA],18281256
9554,C023036,perfluorooctanoic acid,PPARG,5468,Rattus norvegicus,10116,perfluorooctanoic acid binds to and results in increased activity of PPARG protein,16731579
9555,C036567,perfluorodecanoic acid,PPARG,5468,Homo sapiens,9606,perfluorodecanoic acid results in increased activity of PPARG protein,23391484|24998974
9638,C108042,perfluorobutane,PPARG,5468,Homo sapiens,9606,perfluorobutane binds to PPARG protein,24998974
9687,D003994,Bucladesine,PPARG,5468,Mus musculus,10090,[ciglitazone co-treated with Bucladesine] affects the expression of PPARG mRNA|[ciglitazone co-treated with Bucladesine] results in increased expression of PPARG protein|Bucladesine results in increased expression of PPARG protein,19698295
9777,C033094,perfluorobutyric acid,PPARG,5468,Homo sapiens,9606,perfluorobutyric acid results in increased activity of PPARG protein,24998974
9880,D017373,Cyproterone Acetate,PPARG,5468,Homo sapiens,9606,Cyproterone Acetate binds to and results in increased activity of PPARG protein,33049310
10133,D002635,Chenodeoxycholic Acid,PPARG,5468,Homo sapiens,9606,Chenodeoxycholic Acid results in increased expression of PPARG mRNA,27174168
10133,D002635,Chenodeoxycholic Acid,PPARG,5468,Rattus norvegicus,10116,Chenodeoxycholic Acid results in increased expression of PPARG mRNA,15980055
10207,C518327,aloe emodin,PPARG,5468,Homo sapiens,9606,aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA],22645054
10228,C046627,osthol,PPARG,5468,Mus musculus,10090,osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA],21854795
10228,C046627,osthol,PPARG,5468,Mus musculus,10090,osthol results in increased expression of PPARG mRNA|osthol results in increased expression of PPARG protein|osthol results in increased activity of PPARG protein,19682441
10229,C091375,9-phenanthrol,PPARG,5468,Homo sapiens,9606,9-phenanthrol binds to and results in increased activity of PPARG protein|9-phenanthrol binds to and affects the activity of PPARG protein,33049310
10251,C028610,flavanone,PPARG,5468,Homo sapiens,9606,flavanone results in increased expression of PPARG protein,22056764
10254,C526470,"2,4,6-trimethylbenzaldehyde",PPARG,5468,Homo sapiens,9606,"2,4,6-trimethylbenzaldehyde binds to and results in increased activity of PPARG protein",27633901
10281,C003466,thymoquinone,PPARG,5468,Homo sapiens,9606,PRKAA1 protein promotes the reaction [thymoquinone results in increased expression of PPARG protein]|thymoquinone results in increased expression of PPARG protein|thymoquinone inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein],27688165
10417,C028716,phytomonic acid,PPARG,5468,NULL,NULL,phytomonic acid binds to PPARG protein,32909075
10444,D053778,Thiazolidines,PPARG,5468,NULL,NULL,Thiazolidines binds to and results in increased activity of PPARG protein,20540935
10522,C004659,chlorobenzilate,PPARG,5468,Danio rerio,7955,chlorobenzilate binds to and results in increased activity of PPARG protein,33049310
10621,D006569,Hesperidin,PPARG,5468,Mus musculus,10090,Hesperidin affects the reaction [LEPR protein affects the expression of PPARG protein],16427799
10621,D006569,Hesperidin,PPARG,5468,Rattus norvegicus,10116,Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]]|Hesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein],24954035
10621,D006569,Hesperidin,PPARG,5468,Rattus norvegicus,10116,Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG protein]|Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA],28935427
10621,D006569,Hesperidin,PPARG,5468,Rattus norvegicus,10116,Hesperidin inhibits the reaction [Isoproterenol results in decreased expression of PPARG protein],30623541
10635,D013196,Dihydrotestosterone,PPARG,5468,Homo sapiens,9606,Dihydrotestosterone results in decreased expression of PPARG mRNA|Dihydrotestosterone results in decreased expression of PPARG protein,18801408
10635,D013196,Dihydrotestosterone,PPARG,5468,Mus musculus,10090,Dihydrotestosterone results in decreased expression of PPARG mRNA|Dihydrotestosterone results in decreased expression of PPARG protein,12960001
10635,D013196,Dihydrotestosterone,PPARG,5468,Mus musculus,10090,Dihydrotestosterone results in increased expression of PPARG mRNA,16990341
10836,D008694,Methamphetamine,PPARG,5468,Mus musculus,10090,2-chloro-5-nitrobenzanilide promotes the reaction [PPARG protein results in increased susceptibility to Methamphetamine]|[Pioglitazone co-treated with Alitretinoin] inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]|Methamphetamine results in increased expression of PPARG protein|PPARG protein results in increased susceptibility to Methamphetamine|ciglitazone inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]|Methamphetamine results in increased activity of PPARG protein|Pioglitazone inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine],17019405
10836,D008694,Methamphetamine,PPARG,5468,Mus musculus,10090,Methamphetamine results in decreased expression of PPARG protein|Ibuprofen inhibits the reaction [Methamphetamine results in decreased expression of PPARG protein],18946735
10917,D002331,Carnitine,PPARG,5468,Rattus norvegicus,10116,Carnitine results in increased expression of PPARG protein|Carnitine inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein],30256492
11045,D014302,Trinitrobenzenesulfonic Acid,PPARG,5468,Mus musculus,10090,Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA,21829567
11045,D014302,Trinitrobenzenesulfonic Acid,PPARG,5468,Rattus norvegicus,10116,Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]|Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]|Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]|Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein],16782535
11045,D014302,Trinitrobenzenesulfonic Acid,PPARG,5468,Rattus norvegicus,10116,geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]|geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]|Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]|Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA],26165751
11045,D014302,Trinitrobenzenesulfonic Acid,PPARG,5468,Rattus norvegicus,10116,Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA],24831514
11045,D014302,Trinitrobenzenesulfonic Acid,PPARG,5468,Rattus norvegicus,10116,Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA,16782535|24831514|26165751
11045,D014302,Trinitrobenzenesulfonic Acid,PPARG,5468,Rattus norvegicus,10116,Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein,16782535|19617644|26165751
11080,D015058,1-Naphthylisothiocyanate,PPARG,5468,Rattus norvegicus,10116,1-Naphthylisothiocyanate results in decreased expression of PPARG mRNA,30723492
11339,D004143,Dioctyl Sulfosuccinic Acid,PPARG,5468,Homo sapiens,9606,Dioctyl Sulfosuccinic Acid results in increased activity of PPARG protein|Dioctyl Sulfosuccinic Acid binds to and results in increased activity of PPARG protein,26135921
11442,D000487,Allethrins,PPARG,5468,Homo sapiens,9606,Allethrins results in increased activity of PPARG protein,20143881
11442,D000487,Allethrins,PPARG,5468,Homo sapiens,9606,Allethrins results in increased expression of PPARG mRNA,32473317
11443,D014051,"Toluene 2,4-Diisocyanate",PPARG,5468,Mus musculus,10090,"PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of IL5 protein]|PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased localization of RELA protein]|PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL11 protein]|Pioglitazone promotes the reaction [Toluene 2,4-Diisocyanate results in increased localization of PPARG protein]|Toluene 2,4-Diisocyanate results in increased localization of PPARG protein|PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein]|PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of IL13 protein]|PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of ICAM1 protein]|PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of IL4 protein]|PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of VCAM1 protein]|Rosiglitazone promotes the reaction [Toluene 2,4-Diisocyanate results in increased localization of PPARG protein]|PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of TGFB1 protein]",17015710
11773,C000613766,triphenylarsine,PPARG,5468,Homo sapiens,9606,triphenylarsine inhibits the reaction [Rosiglitazone binds to PPARG protein],27725436
11774,C076672,triphenyl bismuth,PPARG,5468,Homo sapiens,9606,triphenyl bismuth inhibits the reaction [Rosiglitazone binds to PPARG protein],27725436
11813,C023514,"2,6-dinitrotoluene",PPARG,5468,Colinus virginianus,9014,"2,6-dinitrotoluene results in decreased expression of PPARG mRNA",20406850
11862,C066859,"2,4,6-triiodophenol",PPARG,5468,Danio rerio,7955,"2,4,6-triiodophenol binds to and results in increased activity of PPARG protein",33049310
11862,C066859,"2,4,6-triiodophenol",PPARG,5468,Homo sapiens,9606,"2,4,6-triiodophenol binds to PPARG protein",25314719
12035,D000111,Acetylcysteine,PPARG,5468,Homo sapiens,9606,Acetylcysteine inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species],23964924
12035,D000111,Acetylcysteine,PPARG,5468,Homo sapiens,9606,Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein],16945329
12035,D000111,Acetylcysteine,PPARG,5468,Mus musculus,10090,Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein],22046279
12035,D000111,Acetylcysteine,PPARG,5468,Mus musculus,10090,Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of PPARG protein],27117918
12035,D000111,Acetylcysteine,PPARG,5468,Rattus norvegicus,10116,Acetylcysteine results in increased expression of PPARG protein|Acetylcysteine results in increased expression of PPARG mRNA|Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG mRNA]|Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG protein],17602960
12111,C000611646,bisphenol F,PPARG,5468,Homo sapiens,9606,[bisphenol F co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein|[bisphenol F co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA,33865937
12111,C008745,"4,4'-bisphenol F",PPARG,5468,Homo sapiens,9606,"4,4'-bisphenol F inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]",30138673
12512,C098546,ethyl tert-butyl ether,PPARG,5468,Rattus norvegicus,10116,ethyl tert-butyl ether results in increased expression of PPARG mRNA,24090815
12540,C012594,triphenyltin chloride,PPARG,5468,Homo sapiens,9606,tetrabutyltin inhibits the reaction [triphenyltin chloride binds to PPARG protein]|tributyltin inhibits the reaction [triphenyltin chloride binds to PPARG protein]|triphenyltin chloride inhibits the reaction [Rosiglitazone binds to PPARG protein]|diphenyltin chloride inhibits the reaction [triphenyltin chloride binds to PPARG protein],19497422
12540,C012594,triphenyltin chloride,PPARG,5468,Homo sapiens,9606,triphenyltin chloride binds to and results in increased activity of PPARG protein,19497422|33049310
12540,C012594,triphenyltin chloride,PPARG,5468,Homo sapiens,9606,triphenyltin chloride results in increased activity of PPARG protein,26172262
12540,C012594,triphenyltin chloride,PPARG,5468,Mus musculus,10090,triphenyltin chloride binds to and results in increased activity of PPARG protein,33049310
12699,D008770,Methylnitrosourea,PPARG,5468,Mus musculus,10090,PPARG gene mutant form results in increased susceptibility to Methylnitrosourea,15930296
13583,C003935,dodecylamine,PPARG,5468,Danio rerio,7955,dodecylamine binds to and results in increased activity of PPARG protein,33049310
13940,C544689,endosulfan sulfate,PPARG,5468,Mus musculus,10090,endosulfan sulfate results in increased expression of PPARG mRNA|endosulfan sulfate inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]|Dietary Fats inhibits the reaction [endosulfan sulfate results in increased expression of PPARG mRNA],33070067
14296,C017953,tetramethylpyrazine,PPARG,5468,Homo sapiens,9606,tetramethylpyrazine results in increased expression of PPARG mRNA,28034800
14296,C017953,tetramethylpyrazine,PPARG,5468,Mus musculus,10090,tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PPARG protein],22200888
14296,C017953,tetramethylpyrazine,PPARG,5468,Rattus norvegicus,10116,tetramethylpyrazine results in increased expression of PPARG protein,23022513
14342,C086664,diphenyltin chloride,PPARG,5468,Homo sapiens,9606,diphenyltin chloride inhibits the reaction [Rosiglitazone binds to PPARG protein]|diphenyltin chloride inhibits the reaction [triphenyltin chloride binds to PPARG protein]|diphenyltin chloride binds to and results in increased activity of PPARG protein,19497422
14410,C010902,decabromobiphenyl ether,PPARG,5468,Mus musculus,10090,decabromobiphenyl ether results in increased expression of PPARG protein,30743236
14525,C027327,fenchone,PPARG,5468,Homo sapiens,9606,fenchone binds to and results in decreased activity of PPARG protein,27633901
14716,C018535,2-ethylhexyldiphenylphosphate,PPARG,5468,Homo sapiens,9606,2-ethylhexyldiphenylphosphate results in increased activity of PPARG protein|PPARG protein affects the reaction [2-ethylhexyldiphenylphosphate results in increased expression of HSD3B1 mRNA],28282128
14716,C018535,2-ethylhexyldiphenylphosphate,PPARG,5468,Mus musculus,10090,2-ethylhexyldiphenylphosphate binds to and results in increased activity of PPARG protein,31812418
14805,C028007,nickel monoxide,PPARG,5468,Rattus norvegicus,10116,nickel monoxide results in increased expression of PPARG mRNA,19167457
14982,D019695,Glycyrrhizic Acid,PPARG,5468,Mus musculus,10090,Glycyrrhizic Acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA],34302803
14985,D014810,Vitamin E,PPARG,5468,Sus scrofa,9823,Vitamin E inhibits the reaction [Linoleic Acid results in increased activity of PPARG protein],15051824
15074,C027681,isonicotinamide,PPARG,5468,Mus musculus,10090,isonicotinamide results in decreased expression of PPARG mRNA,16813520
15098,C102881,tetrabutyltin,PPARG,5468,Homo sapiens,9606,tetrabutyltin inhibits the reaction [triphenyltin chloride binds to PPARG protein]|tetrabutyltin inhibits the reaction [Rosiglitazone binds to PPARG protein]|tetrabutyltin binds to and results in increased activity of PPARG protein,19497422
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Cavia porcellus,10141,Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA,18336851
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Homo sapiens,9606,[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPARG mRNA,19619570
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Homo sapiens,9606,Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA,19619570|20106945|21632981|26238291
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein],12758056|15050417
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein],15050417
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,U 0126 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]|EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]|methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]|AG 1879 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]|Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein],16971554
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,Arachidonic Acid promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA]|arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA],19063610
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,"[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] promotes the reaction [[Dietary Sucrose co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]",30722647
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,Tetrachlorodibenzodioxin promotes the reaction [Dietary Fats results in increased expression of PPARG mRNA]|Dietary Fats promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA],27713108
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,MAP2K1 protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein]|MAPK3 protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein]|MAPK1 protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein]|U 0126 inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein],12758056
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,[NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PPARG mRNA,21846477
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,orientin inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein],32044341
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,SRC protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA]]|Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA],14505802
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]|[Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of PPARG mRNA|[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA],16054899
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA,12758056|15050417|16054899|19063610|19770486|19933214|20633992
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,Tetrachlorodibenzodioxin results in decreased expression of PPARG protein,12758056|15050417|32044341
15625,D013749,Tetrachlorodibenzodioxin,PPARG,5468,Mus musculus,10090,Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA,24058054|27713108
15787,C007350,nitrofen,PPARG,5468,Homo sapiens,9606,nitrofen binds to and results in increased activity of PPARG protein,33049310
15787,C007350,nitrofen,PPARG,5468,Rattus norvegicus,10116,nitrofen results in decreased expression of PPARG protein|nitrofen results in decreased expression of PPARG mRNA,22595559
15787,C007350,nitrofen,PPARG,5468,Rattus norvegicus,10116,nitrofen results in increased expression of PPARG mRNA,33484710
15910,C005806,tetrachloroisophthalonitrile,PPARG,5468,Mus musculus,10090,tetrachloroisophthalonitrile results in decreased expression of PPARG mRNA|[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PPARG mRNA,33246813
15939,D010269,Paraquat,PPARG,5468,Mus musculus,10090,PPARG protein results in increased susceptibility to Paraquat|PPARG gene polymorphism results in decreased susceptibility to Paraquat,18083318
15939,D010269,Paraquat,PPARG,5468,Rattus norvegicus,10116,Paraquat results in decreased expression of PPARG protein|2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Paraquat results in decreased expression of PPARG protein]]|Paraquat results in decreased expression of PPARG mRNA|2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Paraquat results in decreased expression of PPARG mRNA]]|Rosiglitazone inhibits the reaction [Paraquat results in decreased expression of PPARG mRNA]|Rosiglitazone inhibits the reaction [Paraquat results in decreased expression of PPARG protein],30797787
16043,C018855,2-tert-butylhydroquinone,PPARG,5468,Homo sapiens,9606,2-tert-butylhydroquinone binds to and results in increased activity of PPARG protein,33049310
16078,D013759,Dronabinol,PPARG,5468,Danio rerio,7955,Dronabinol affects the expression of PPARG mRNA|Dronabinol results in increased expression of PPARG mRNA,33892503
16078,D013759,Dronabinol,PPARG,5468,Homo sapiens,9606,Dronabinol results in increased expression of PPARG mRNA,28853159
16078,D013759,Dronabinol,PPARG,5468,Homo sapiens,9606,[RXRA co-treated with Dronabinol] results in increased expression of PPARG mRNA,16213464
16078,D013759,Dronabinol,PPARG,5468,NULL,NULL,Dronabinol binds to PPARG protein,22971837
16078,D013759,Dronabinol,PPARG,5468,NULL,NULL,Dronabinol results in increased activity of PPARG,19285060
16315,C042577,diallyl trisulfide,PPARG,5468,Mus musculus,10090,diallyl trisulfide results in decreased expression of PPARG mRNA|diallyl trisulfide results in decreased expression of PPARG protein|[diallyl trisulfide results in decreased expression of [CEBPA protein co-treated with CEBPB protein co-treated with PPARG protein]] which results in increased abundance of Lipids|[diallyl trisulfide results in decreased expression of [CEBPA protein co-treated with CEBPB protein co-treated with PPARG protein]] which results in decreased expression of FASN|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [diallyl trisulfide results in decreased expression of and results in decreased activity of PPARG protein]|diallyl trisulfide results in decreased expression of [CEBPA protein co-treated with CEBPB protein co-treated with PPARG protein]|diallyl trisulfide results in decreased activity of PPARG protein,22137902
18283,D018119,Stavudine,PPARG,5468,Homo sapiens,9606,Stavudine results in decreased expression of PPARG mRNA,14518702
18283,D018119,Stavudine,PPARG,5468,Mus musculus,10090,Stavudine results in decreased expression of PPARG mRNA,17926646
18283,D018119,Stavudine,PPARG,5468,Mus musculus,10090,Stavudine results in decreased expression of PPARG protein,15722030
18529,C089796,hexabromocyclododecane,PPARG,5468,Mus musculus,10090,[hexabromocyclododecane co-treated with Dietary Fats] results in increased expression of PPARG mRNA,24398136
18529,C089796,hexabromocyclododecane,PPARG,5468,Ursus maritimus,29073,hexabromocyclododecane inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],27602593
19241,C065565,N-butylbenzenesulfonamide,PPARG,5468,Homo sapiens,9606,N-butylbenzenesulfonamide binds to and results in decreased activity of PPARG protein,27633901
19284,C089799,diheptyl phthalate,PPARG,5468,Homo sapiens,9606,diheptyl phthalate binds to PPARG protein,23843199
20392,C517284,monomethyl phthalate,PPARG,5468,Homo sapiens,9606,monomethyl phthalate binds to PPARG protein,23843199
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Danio rerio,7955,mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARG protein,33049310
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Homo sapiens,9606,"Rosiglitazone promotes the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]|PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]",12927354
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Homo sapiens,9606,mono-(2-ethylhexyl)phthalate affects the expression of PPARG mRNA|mono-(2-ethylhexyl)phthalate affects the activity of PPARG protein,30810372
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Homo sapiens,9606,mono-(2-ethylhexyl)phthalate binds to and affects the folding of and results in increased activity of PPARG protein,30085373
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Homo sapiens,9606,mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARG protein,16326050|33049310
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Homo sapiens,9606,mono-(2-ethylhexyl)phthalate binds to PPARG protein,23843199|35019730
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Homo sapiens,9606,mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA,23118965
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Homo sapiens,9606,mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein,10581215|12927354|21561829|26172262|27551952|28282128|28571686|30138673
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Homo sapiens,9606,PPARG mRNA promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TIMP1 protein]|PPARG mRNA promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein],28416457
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Mus musculus,10090,mono-(2-ethylhexyl)phthalate analog results in increased activity of PPARG protein,25777084
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Mus musculus,10090,mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA,25543134
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Mus musculus,10090,mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein,10581215|15322177|25777084
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Mus musculus,10090,[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA,31884101
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Rattus norvegicus,10116,mono-(2-ethylhexyl)phthalate results in increased expression of PPARG mRNA|mono-(2-ethylhexyl)phthalate results in increased expression of PPARG protein,15647598
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Ursus maritimus,29073,mono-(2-ethylhexyl)phthalate promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA],27602593
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,Xenopus laevis,8355,mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein,21561829
20393,C016599,mono-(2-ethylhexyl)phthalate,PPARG,5468,NULL,NULL,mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARG protein,17400580
21157,D019328,Buthionine Sulfoximine,PPARG,5468,Mus musculus,10090,S-ethyl glutathione inhibits the reaction [Buthionine Sulfoximine results in increased expression of PPARG mRNA]|Buthionine Sulfoximine results in increased expression of PPARG mRNA,21520053
21157,D019328,Buthionine Sulfoximine,PPARG,5468,Mus musculus,10090,PPARG mRNA promotes the reaction [Tamoxifen inhibits the reaction [Buthionine Sulfoximine results in increased expression of CD36 protein]],27358406
21157,D019328,Buthionine Sulfoximine,PPARG,5468,Rattus norvegicus,10116,Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of PPARG mRNA]|Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of PPARG protein]|Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG mRNA]|Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG protein],17602960
21387,C033146,1-hydroxypyrene,PPARG,5468,Homo sapiens,9606,1-hydroxypyrene binds to and results in increased activity of PPARG protein,33049310
21700,D001507,Beclomethasone,PPARG,5468,Danio rerio,7955,Beclomethasone results in decreased expression of PPARG mRNA,23656298
21803,C007031,chlorpyrifos-methyl,PPARG,5468,Homo sapiens,9606,chlorpyrifos-methyl binds to and results in increased activity of PPARG protein,33049310
22278,C476925,"3,4-dimethylbenzaldehyde",PPARG,5468,Homo sapiens,9606,"3,4-dimethylbenzaldehyde binds to and results in decreased activity of PPARG protein",27633901
22463,C018923,"2,2'-dihydroxy-6,6'-dinaphthyldisulfide",PPARG,5468,Homo sapiens,9606,"2,2'-dihydroxy-6,6'-dinaphthyldisulfide binds to and results in increased activity of PPARG protein",33049310
23017,C012587,"3,5,6-trichloro-2-pyridinol",PPARG,5468,Mus musculus,10090,"[3,5,6-trichloro-2-pyridinol co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein|3,5,6-trichloro-2-pyridinol promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]",32017950
23930,D008345,Manganese,PPARG,5468,Rattus norvegicus,10116,"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide]",18041089
23954,D012834,Silver,PPARG,5468,Oncorhynchus mykiss,8022,Silver analog results in decreased expression of PPARG mRNA,22727896
23964,D014414,Tungsten,PPARG,5468,Mus musculus,10090,Tungsten promotes the reaction [Rosiglitazone results in increased expression of PPARG mRNA]|Tungsten results in increased expression of PPARG mRNA,26865663
23973,D002104,Cadmium,PPARG,5468,Mus musculus,10090,Cadmium results in decreased expression of PPARG protein,21848503
23973,D002104,Cadmium,PPARG,5468,Mytilus galloprovincialis,29158,PPARG protein affects the reaction [Cadmium results in increased abundance of Reactive Oxygen Species],16737744
23973,D002104,Cadmium,PPARG,5468,Rattus norvegicus,10116,Cadmium results in increased expression of PPARG mRNA,25388156
23973,D002104,Cadmium,PPARG,5468,Tachysurus fulvidraco,1234273,Cadmium results in decreased expression of PPARG mRNA,24095957
23978,D003300,Copper,PPARG,5468,Homo sapiens,9606,[Chelating Agents binds to Copper] which affects the expression of PPARG mRNA,30911355
23978,D003300,Copper,PPARG,5468,Tachysurus fulvidraco,1234273,[Copper Sulfate results in increased abundance of Copper] which affects the expression of PPARG mRNA|T0901317 promotes the reaction [[Copper Sulfate results in increased abundance of Copper] which results in decreased expression of PPARG mRNA]|[Copper Sulfate results in increased abundance of Copper] which results in decreased expression of PPARG mRNA,30100477
23994,D015032,Zinc,PPARG,5468,Acanthogobius hasta,267130,Zinc results in decreased expression of PPARG mRNA,26602879
23994,D015032,Zinc,PPARG,5468,Homo sapiens,9606,[PCI 5002 co-treated with Zinc] results in increased expression of PPARG mRNA,18593933
23994,D015032,Zinc,PPARG,5468,Mus musculus,10090,[LDLR gene mutant form results in increased susceptibility to Zinc deficiency] which results in increased expression of PPARG mRNA,16140885
23994,D015032,Zinc,PPARG,5468,Mytilus galloprovincialis,29158,PPARG protein affects the reaction [Zinc results in increased abundance of Reactive Oxygen Species],16737744
23994,D015032,Zinc,PPARG,5468,Rattus norvegicus,10116,Zinc deficiency results in decreased expression of PPARG mRNA,20128680
23994,D015032,Zinc,PPARG,5468,Sus scrofa,9823,"Zinc results in increased expression of PPARG mRNA|N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of and results in increased activity of PPARG protein]|N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of PPARG mRNA]|Zinc results in increased expression of and results in increased activity of PPARG protein",14519784
24085,D008627,Mercuric Chloride,PPARG,5468,Mus musculus,10090,Mercuric Chloride results in decreased expression of PPARG mRNA,22019852
24085,D008627,Mercuric Chloride,PPARG,5468,Mus musculus,10090,Mercuric Chloride results in decreased expression of PPARG protein,12883084
24085,D008627,Mercuric Chloride,PPARG,5468,Rattus norvegicus,10116,Mercuric Chloride results in increased expression of PPARG mRNA,30807803
24154,D005688,Galactosamine,PPARG,5468,Mus musculus,10090,"[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in decreased expression of PPARG protein|[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in decreased expression of PPARG mRNA|geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in decreased expression of PPARG mRNA]|geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in decreased expression of PPARG protein]",30550845
24154,D005688,Galactosamine,PPARG,5468,Mus musculus,10090,[Plant Extracts co-treated with Lipopolysaccharides co-treated with Galactosamine] results in increased expression of PPARG protein|[Silymarin co-treated with Lipopolysaccharides co-treated with Galactosamine] results in increased expression of PPARG protein|[Plant Extracts co-treated with Lipopolysaccharides co-treated with Galactosamine] results in increased expression of PPARG mRNA|[Silymarin co-treated with Lipopolysaccharides co-treated with Galactosamine] results in increased expression of PPARG mRNA,30236599
24261,D012822,Silicon Dioxide,PPARG,5468,Homo sapiens,9606,Silicon Dioxide analog results in increased expression of PPARG mRNA,25895662
24261,D012822,Silicon Dioxide,PPARG,5468,Rattus norvegicus,10116,Silicon Dioxide results in increased expression of PPARG mRNA,32721576
24288,C018021,cobaltous chloride,PPARG,5468,Homo sapiens,9606,cobaltous chloride results in decreased expression of PPARG mRNA,15708366
24288,C018021,cobaltous chloride,PPARG,5468,Mus musculus,10090,"[cobaltous chloride co-treated with Phloretin] affects the expression of PPARG mRNA|2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with Phloretin] affects the expression of PPARG mRNA]|[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with Phloretin] results in increased expression of PPARG mRNA",32408695
24288,C018021,cobaltous chloride,PPARG,5468,Mus musculus,10090,cobaltous chloride results in decreased expression of PPARG mRNA,20594416
24462,D019327,Copper Sulfate,PPARG,5468,Salmo salar,8030,Copper Sulfate results in increased expression of PPARG mRNA,26368670
24462,D019327,Copper Sulfate,PPARG,5468,Tachysurus fulvidraco,1234273,Copper Sulfate results in decreased expression of PPARG mRNA,23660017
24462,D019327,Copper Sulfate,PPARG,5468,Tachysurus fulvidraco,1234273,[Copper Sulfate results in increased abundance of Copper] which affects the expression of PPARG mRNA|T0901317 promotes the reaction [[Copper Sulfate results in increased abundance of Copper] which results in decreased expression of PPARG mRNA]|[Copper Sulfate results in increased abundance of Copper] which results in decreased expression of PPARG mRNA,30100477
24470,D012835,Silver Nitrate,PPARG,5468,Oncorhynchus mykiss,8022,Silver Nitrate results in increased expression of PPARG mRNA,22727896
24597,C027373,potassium chromate(VI),PPARG,5468,Mus musculus,10090,potassium chromate(VI) inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein],24576443
24749,D002266,Carboxymethylcellulose Sodium,PPARG,5468,Mus musculus,10090,[Streptozocin co-treated with Dietary Fats co-treated with Carboxymethylcellulose Sodium] results in decreased expression of PPARG protein|naringenin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Carboxymethylcellulose Sodium] results in decreased expression of PPARG protein],31063766
24823,D010126,Ozone,PPARG,5468,Homo sapiens,9606,[Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PPARG mRNA|[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA|[Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA,32699268
24823,D010126,Ozone,PPARG,5468,Rattus norvegicus,10116,Fish Oils inhibits the reaction [Ozone results in increased expression of PPARG mRNA],29329427
24823,D010126,Ozone,PPARG,5468,Rattus norvegicus,10116,Ozone results in decreased expression of PPARG mRNA,33524448
24823,D010126,Ozone,PPARG,5468,Rattus norvegicus,10116,Ozone results in increased expression of PPARG mRNA,16716893|29329427
24934,D018038,Sodium Selenite,PPARG,5468,Rattus norvegicus,10116,Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA],21705299
24934,D018038,Sodium Selenite,PPARG,5468,Rattus norvegicus,10116,Sodium Selenite inhibits the reaction [citreoviridin results in decreased activity of PPARG protein]|Sodium Selenite results in increased activity of PPARG protein,31419397
24934,D018038,Sodium Selenite,PPARG,5468,Rattus norvegicus,10116,Sodium Selenite results in increased expression of PPARG protein,24140496
24947,D019256,Cadmium Chloride,PPARG,5468,Homo sapiens,9606,Cadmium Chloride affects the activity of PPARG protein,25596134
24947,D019256,Cadmium Chloride,PPARG,5468,Micropterus salmoides,27706,Cadmium Chloride results in decreased expression of PPARG mRNA,24794047
24947,D019256,Cadmium Chloride,PPARG,5468,Mus musculus,10090,Cadmium Chloride results in decreased expression of PPARG mRNA,23921151|31152847
24947,D019256,Cadmium Chloride,PPARG,5468,Mus musculus,10090,Cadmium Chloride results in decreased expression of PPARG protein,31152847
24947,D019256,Cadmium Chloride,PPARG,5468,Mus musculus,10090,Cadmium Chloride results in increased expression of PPARG mRNA,26352046
24947,D019256,Cadmium Chloride,PPARG,5468,Mus musculus,10090,[MT2 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in decreased expression of PPARG mRNA|[MT1 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in decreased expression of PPARG mRNA,23921151
24947,D019256,Cadmium Chloride,PPARG,5468,Rattus norvegicus,10116,[lead acetate co-treated with sodium arsenite co-treated with Cadmium Chloride] results in increased expression of PPARG protein|Cadmium Chloride results in increased expression of PPARG protein|PPARG protein affects the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein]|pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PPARG protein]|PPARG protein affects the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased expression of and results in increased cleavage of PARP1 protein]|[Cadmium Chloride co-treated with sodium arsenite] results in increased expression of PPARG protein|CR8 compound analog inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PPARG protein]|[lead acetate co-treated with Cadmium Chloride] results in increased expression of PPARG protein,28283887
24947,D019256,Cadmium Chloride,PPARG,5468,Rattus norvegicus,10116,Cadmium Chloride results in decreased expression of PPARG mRNA,25993096
24947,D019256,Cadmium Chloride,PPARG,5468,Rattus norvegicus,10116,[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein|T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]|[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [PPARG protein binds to GFAP promoter]|CR8 compound inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]|T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of PPARG protein]|[[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein|[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein],24481447
24962,C037123,cadmium sulfate,PPARG,5468,Mus musculus,10090,cadmium sulfate affects the reaction [MTF1 affects the expression of PPARG mRNA],16221973
25419,D004002,Clodronic Acid,PPARG,5468,Homo sapiens,9606,Clodronic Acid affects the activity of PPARG protein,25596134
25517,D000643,Ammonium Chloride,PPARG,5468,Rattus norvegicus,10116,Ammonium Chloride affects the expression of PPARG mRNA,16483693
26042,C009495,titanium dioxide,PPARG,5468,Mus musculus,10090,[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARG mRNA,29950665
26042,C009495,titanium dioxide,PPARG,5468,Mus musculus,10090,titanium dioxide results in decreased expression of PPARG mRNA,23557971
26042,C009495,titanium dioxide,PPARG,5468,Mus musculus,10090,titanium dioxide results in decreased expression of PPARG protein,28646487
26176,C072782,tri-(2-chloroisopropyl)phosphate,PPARG,5468,Homo sapiens,9606,tri-(2-chloroisopropyl)phosphate results in decreased expression of PPARG protein,30966736
26177,C016805,"tris(1,3-dichloro-2-propyl)phosphate",PPARG,5468,Danio rerio,7955,"tris(1,3-dichloro-2-propyl)phosphate binds to and results in increased activity of PPARG protein",33049310
26177,C016805,"tris(1,3-dichloro-2-propyl)phosphate",PPARG,5468,Homo sapiens,9606,"tris(1,3-dichloro-2-propyl)phosphate binds to and results in decreased expression of PPARG protein",30966736
26177,C016805,"tris(1,3-dichloro-2-propyl)phosphate",PPARG,5468,Homo sapiens,9606,"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of PPARG mRNA",26179874
26177,C016805,"tris(1,3-dichloro-2-propyl)phosphate",PPARG,5468,Mus musculus,10090,"[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of PPARG mRNA",29112739
26177,C016805,"tris(1,3-dichloro-2-propyl)phosphate",PPARG,5468,Mus musculus,10090,"[tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in increased expression of PPARG mRNA",32360330
26295,C064809,3-phenoxybenzylalcohol,PPARG,5468,Homo sapiens,9606,3-phenoxybenzylalcohol binds to and results in increased activity of PPARG protein,33049310
26840,D010831,Phytanic Acid,PPARG,5468,Homo sapiens,9606,Phytanic Acid binds to PPARG protein,23843199
27189,C010909,devrinol,PPARG,5468,Homo sapiens,9606,devrinol binds to and results in increased activity of PPARG protein,33049310
27287,C017803,zinc protoporphyrin,PPARG,5468,Homo sapiens,9606,zinc protoporphyrin inhibits the reaction [Cilostazol results in increased activity of PPARG protein]|zinc protoporphyrin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],21660147
27924,D013755,Tetradecanoylphorbol Acetate,PPARG,5468,Homo sapiens,9606,[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]|[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of Troglitazone]|Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]|bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]|MAP2K1 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]|[Tetradecanoylphorbol Acetate results in increased expression of PPARG] which affects the susceptibility to Troglitazone|Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]|Tetradecanoylphorbol Acetate results in increased expression of PPARG protein,16945329
27924,D013755,Tetradecanoylphorbol Acetate,PPARG,5468,Homo sapiens,9606,[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] affects the expression of PPARG mRNA,21511917
27924,D013755,Tetradecanoylphorbol Acetate,PPARG,5468,Homo sapiens,9606,Tetradecanoylphorbol Acetate results in increased activity of PPARG protein,15707588
27924,D013755,Tetradecanoylphorbol Acetate,PPARG,5468,Homo sapiens,9606,Tetradecanoylphorbol Acetate results in increased expression of PPARG mRNA,12044893|16945329
29327,D013311,Streptozocin,PPARG,5468,Mus musculus,10090,ginsenoside Rh4 inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of PPARG mRNA]|[Dietary Fats co-treated with Streptozocin] results in decreased expression of PPARG mRNA,33359794
29327,D013311,Streptozocin,PPARG,5468,Mus musculus,10090,esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of PPARG mRNA]|[Dietary Fats co-treated with Streptozocin] results in increased expression of PPARG mRNA,27769711
29327,D013311,Streptozocin,PPARG,5468,Mus musculus,10090,MIR29A mRNA inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]|Streptozocin results in decreased expression of PPARG mRNA|MIR29A mRNA inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA],30642005
29327,D013311,Streptozocin,PPARG,5468,Mus musculus,10090,[Streptozocin co-treated with Dietary Fats co-treated with Carboxymethylcellulose Sodium] results in decreased expression of PPARG protein|naringenin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Carboxymethylcellulose Sodium] results in decreased expression of PPARG protein],31063766
29327,D013311,Streptozocin,PPARG,5468,Mus musculus,10090,[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG protein|[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of PPARG protein,33484791
29327,D013311,Streptozocin,PPARG,5468,Mus musculus,10090,Streptozocin results in decreased expression of PPARG protein,21381899|30642005
29327,D013311,Streptozocin,PPARG,5468,Mus musculus,10090,Streptozocin results in increased expression of PPARG mRNA,23319174
29327,D013311,Streptozocin,PPARG,5468,Mus musculus,10090,Telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARG protein],21381899
29327,D013311,Streptozocin,PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]]|Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]|Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]]",29953732
29327,D013311,Streptozocin,PPARG,5468,Rattus norvegicus,10116,2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]|[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein|Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]]|Hesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein],24954035
29327,D013311,Streptozocin,PPARG,5468,Rattus norvegicus,10116,[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG protein|allyl isothiocyanate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG protein],30927557
29327,D013311,Streptozocin,PPARG,5468,Rattus norvegicus,10116,Bezafibrate inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA],12967931
29327,D013311,Streptozocin,PPARG,5468,Rattus norvegicus,10116,esculetin inhibits the reaction [Streptozocin results in increased expression of PPARG protein]|Streptozocin results in increased expression of PPARG protein|esculetin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein],21450970
29327,D013311,Streptozocin,PPARG,5468,Rattus norvegicus,10116,Ficusin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]|Pioglitazone inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]|[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA,27350165
29327,D013311,Streptozocin,PPARG,5468,Rattus norvegicus,10116,Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]|naringenin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]|naringenin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]|Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]|mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]|mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA],29223569
29327,D013311,Streptozocin,PPARG,5468,Rattus norvegicus,10116,INS protein promotes the reaction [Streptozocin results in increased expression of PPARG mRNA]|Streptozocin results in increased expression of PPARG mRNA,20219977
29327,D013311,Streptozocin,PPARG,5468,Rattus norvegicus,10116,Olive Oil inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA],25246140
29327,D013311,Streptozocin,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone inhibits the reaction [Streptozocin results in decreased expression of PPARG]|Streptozocin results in decreased expression of PPARG,24136780
29327,D013311,Streptozocin,PPARG,5468,Rattus norvegicus,10116,Streptozocin results in decreased expression of PPARG mRNA,12967931|25246140|29223569|29953732
29327,D013311,Streptozocin,PPARG,5468,Rattus norvegicus,10116,Streptozocin results in decreased expression of PPARG protein,16980342|21450970|29223569|29953732|34175429
29393,C012465,oryzalin,PPARG,5468,Homo sapiens,9606,oryzalin binds to and results in increased activity of PPARG protein,33049310
29732,C012466,oxadiazon,PPARG,5468,Danio rerio,7955,oxadiazon binds to and results in increased activity of PPARG protein,33049310
30323,D003630,Daunorubicin,PPARG,5468,Homo sapiens,9606,Daunorubicin results in decreased activity of PPARG protein,25257666
30323,D003630,Daunorubicin,PPARG,5468,Rattus norvegicus,10116,Daunorubicin results in increased expression of PPARG protein|Telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein],20888384
31070,C002698,fenamiphos,PPARG,5468,Danio rerio,7955,fenamiphos binds to and results in increased activity of PPARG protein,33049310
31200,D005278,Fenitrothion,PPARG,5468,Homo sapiens,9606,Fenitrothion binds to and results in increased activity of PPARG protein,33049310
31283,C032396,ethyl myristate,PPARG,5468,Homo sapiens,9606,ethyl myristate binds to and results in decreased activity of PPARG protein,27633901
31288,C061482,butyl diglycol acetate,PPARG,5468,Homo sapiens,9606,butyl diglycol acetate binds to and results in decreased activity of PPARG protein,27633901
31357,C009524,tributyl phosphate,PPARG,5468,Homo sapiens,9606,tributyl phosphate binds to and results in increased activity of PPARG protein,33049310
31357,C009524,tributyl phosphate,PPARG,5468,Homo sapiens,9606,tributyl phosphate binds to PPARG protein,25314719|30966736
31357,C009524,tributyl phosphate,PPARG,5468,Homo sapiens,9606,tributyl phosphate results in increased activity of PPARG protein,26172262|28282128
31401,D014580,Ursodeoxycholic Acid,PPARG,5468,Homo sapiens,9606,Ursodeoxycholic Acid results in decreased expression of PPARG mRNA,24312631
31404,D002084,Butylated Hydroxytoluene,PPARG,5468,Homo sapiens,9606,Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of PPARG mRNA],17070507
31404,D002084,Butylated Hydroxytoluene,PPARG,5468,Mus musculus,10090,Butylated Hydroxytoluene results in increased expression of PPARG mRNA,19925653
31423,C030984,pyrene,PPARG,5468,Homo sapiens,9606,pyrene binds to and results in increased activity of PPARG protein,33049310
31553,D000077385,Silybin,PPARG,5468,Danio rerio,7955,Silybin results in decreased expression of PPARG mRNA|Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein],25559859
31553,D000077385,Silybin,PPARG,5468,Homo sapiens,9606,Silybin results in increased expression of PPARG protein,27746612
31703,D004317,Doxorubicin,PPARG,5468,Homo sapiens,9606,[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in increased susceptibility to Doxorubicin,23964924
31703,D004317,Doxorubicin,PPARG,5468,Homo sapiens,9606,Doxorubicin results in decreased activity of PPARG protein,25257666
31703,D004317,Doxorubicin,PPARG,5468,Homo sapiens,9606,Doxorubicin results in decreased expression of PPARG mRNA,29803840
31703,D004317,Doxorubicin,PPARG,5468,Homo sapiens,9606,Doxorubicin results in decreased expression of PPARG protein,27417252
31703,D004317,Doxorubicin,PPARG,5468,Homo sapiens,9606,[nimesulide co-treated with Doxorubicin] results in increased expression of PPARG,14567645
31703,D004317,Doxorubicin,PPARG,5468,Rattus norvegicus,10116,caryophyllene inhibits the reaction [Doxorubicin results in decreased expression of PPARG protein]|Doxorubicin results in decreased expression of PPARG protein|iodopravadoline inhibits the reaction [caryophyllene inhibits the reaction [Doxorubicin results in decreased expression of PPARG protein]],30836069
31736,C103325,mono-benzyl phthalate,PPARG,5468,Homo sapiens,9606,mono-benzyl phthalate binds to PPARG protein,23843199
31736,C103325,mono-benzyl phthalate,PPARG,5468,Homo sapiens,9606,mono-benzyl phthalate results in increased activity of PPARG protein,27551952
31736,C103325,mono-benzyl phthalate,PPARG,5468,Homo sapiens,9606,mono-benzyl phthalate results in increased expression of PPARG protein,29089286
31736,C103325,mono-benzyl phthalate,PPARG,5468,Mus musculus,10090,[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA,31884101
32014,D015124,8-Bromo Cyclic Adenosine Monophosphate,PPARG,5468,Rattus norvegicus,10116,8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PPARG mRNA|8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA],15994020
32154,C001059,pronamide,PPARG,5468,Homo sapiens,9606,pronamide binds to and results in increased activity of PPARG protein,33049310
32241,C018520,"2,6-diisopropylnaphthalene",PPARG,5468,Homo sapiens,9606,"2,6-diisopropylnaphthalene binds to and results in increased activity of PPARG protein",27633901
32490,C033205,propamocarb,PPARG,5468,Mus musculus,10090,propamocarb results in decreased expression of PPARG mRNA,29137890
33184,D001397,Azoxymethane,PPARG,5468,Mus musculus,10090,[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARG mRNA,29950665
33584,D006218,Halofenate,PPARG,5468,Homo sapiens,9606,Halofenate binds to and results in increased activity of PPARG protein,20307981
33599,C042080,diisodecyl phthalate,PPARG,5468,Homo sapiens,9606,diisodecyl phthalate binds to and results in increased activity of PPARG protein|diisodecyl phthalate results in increased expression of PPARG mRNA,29410257
33599,C042080,diisodecyl phthalate,PPARG,5468,Homo sapiens,9606,diisodecyl phthalate binds to PPARG protein,23843199
33599,C042080,diisodecyl phthalate,PPARG,5468,Sparus aurata,8175,diisodecyl phthalate results in increased expression of PPARG mRNA,25825955
35370,D015215,Zidovudine,PPARG,5468,Mus musculus,10090,Zidovudine results in decreased expression of PPARG mRNA,17926646
35370,D015215,Zidovudine,PPARG,5468,Mus musculus,10090,Zidovudine results in decreased expression of PPARG protein,15722030
36159,C477694,"2,2',4,4',5-brominated diphenyl ether",PPARG,5468,Homo sapiens,9606,"2,2',4,4',5-brominated diphenyl ether metabolite binds to PPARG protein",25314719
36159,C477694,"2,2',4,4',5-brominated diphenyl ether",PPARG,5468,Homo sapiens,9606,"2,2',4,4',5-brominated diphenyl ether results in increased expression of PPARG mRNA|2,2',4,4',5-brominated diphenyl ether results in increased expression of PPARG protein|2,2',4,4',5-brominated diphenyl ether promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]|2,2',4,4',5-brominated diphenyl ether results in decreased methylation of PPARG promoter",30903904
36159,C477694,"2,2',4,4',5-brominated diphenyl ether",PPARG,5468,Ursus maritimus,29073,"2,2',4,4',5-brominated diphenyl ether results in increased activity of PPARG protein",27602593
36187,C028451,"3,4,3',4'-tetrachlorobiphenyl",PPARG,5468,Mus musculus,10090,"3,4,3',4'-tetrachlorobiphenyl results in increased expression of PPARG mRNA",30935970
36242,C035988,procymidone,PPARG,5468,Danio rerio,7955,procymidone binds to and results in increased activity of PPARG protein,33049310
36242,C035988,procymidone,PPARG,5468,Mus musculus,10090,procymidone results in decreased expression of PPARG mRNA|[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PPARG mRNA,33246813
37034,C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",PPARG,5468,Mus musculus,10090,"NR1I3 protein affects the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of PPARG protein]|2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of PPARG mRNA|NR1I3 protein affects the reaction [[retinol acetate co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of PPARG mRNA]|NR1I3 protein affects the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of PPARG mRNA]|[retinol acetate co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of PPARG mRNA|2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of PPARG protein",31449830
37034,C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",PPARG,5468,Mus musculus,10090,"[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] promotes the reaction [[Dietary Sucrose co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]",30722647
37034,C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",PPARG,5468,Ursus maritimus,29073,"2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]",27602593
37035,C029790,"2,2',3',4,4',5-hexachlorobiphenyl",PPARG,5468,Mus musculus,10090,"2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PPARG protein|2,2',3',4,4',5-hexachlorobiphenyl promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]",29704545
37037,C541131,"2,2',3,3',4,4',5-heptachlorobiphenyl",PPARG,5468,Ursus maritimus,29073,"2,2',3,3',4,4',5-heptachlorobiphenyl results in increased activity of PPARG protein",27602593
37175,C017435,enilconazole,PPARG,5468,Homo sapiens,9606,enilconazole binds to and results in increased activity of PPARG protein,33049310
37517,C033148,iprodione,PPARG,5468,Homo sapiens,9606,iprodione binds to and results in increased activity of PPARG protein,33049310
37517,C033148,iprodione,PPARG,5468,Homo sapiens,9606,iprodione results in increased activity of PPARG protein,20143881
38479,C030856,pendimethalin,PPARG,5468,Homo sapiens,9606,pendimethalin binds to and results in increased activity of PPARG protein,33049310
39042,D001629,Bezafibrate,PPARG,5468,Danio rerio,7955,Bezafibrate affects the expression of PPARG mRNA,21703979
39042,D001629,Bezafibrate,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [Bezafibrate results in increased susceptibility to TNF protein]|[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]],21734263
39042,D001629,Bezafibrate,PPARG,5468,Homo sapiens,9606,Bezafibrate binds to PPARG protein,11779144|23843199
39042,D001629,Bezafibrate,PPARG,5468,Homo sapiens,9606,Bezafibrate results in decreased expression of PPARG mRNA,15708366
39042,D001629,Bezafibrate,PPARG,5468,Homo sapiens,9606,Bezafibrate results in increased activity of [PPARG protein alternative form binds to RXRA protein],11779144
39042,D001629,Bezafibrate,PPARG,5468,Homo sapiens,9606,Bezafibrate results in increased expression of PPARG mRNA,19201410|24759758
39042,D001629,Bezafibrate,PPARG,5468,Mesocricetus auratus,10036,[Bezafibrate co-treated with Dietary Fats] results in increased expression of PPARG mRNA|Bezafibrate binds to PPARG protein,24759758
39042,D001629,Bezafibrate,PPARG,5468,Mus musculus,10090,Bezafibrate results in increased activity of PPARG protein,12401884
39042,D001629,Bezafibrate,PPARG,5468,Mus musculus,10090,Bezafibrate results in increased expression of PPARG mRNA,19201410|21324916
39042,D001629,Bezafibrate,PPARG,5468,Mus musculus,10090,PPARA protein affects the reaction [Bezafibrate results in increased expression of PPARG mRNA],21324916
39042,D001629,Bezafibrate,PPARG,5468,Rattus norvegicus,10116,Bezafibrate inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA],12967931
39042,D001629,Bezafibrate,PPARG,5468,Rattus norvegicus,10116,Bezafibrate results in decreased expression of PPARG mRNA,11473052
39042,D001629,Bezafibrate,PPARG,5468,Sparus aurata,8175,Bezafibrate results in increased expression of PPARG mRNA,30090361
39042,D001629,Bezafibrate,PPARG,5468,NULL,NULL,Bezafibrate binds to and results in increased activity of PPARG protein,17190905|18660453
39042,D001629,Bezafibrate,PPARG,5468,NULL,NULL,Bezafibrate results in increased activity of PPARG protein,12759900|16168052
39484,D015655,1-Methyl-4-phenylpyridinium,PPARG,5468,Homo sapiens,9606,1-Methyl-4-phenylpyridinium affects the expression of PPARG mRNA,24767308
39484,D015655,1-Methyl-4-phenylpyridinium,PPARG,5468,Homo sapiens,9606,PPARGC1A protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of PPARG protein]|[1-Methyl-4-phenylpyridinium co-treated with PPARGC1A protein] results in increased expression of PPARG mRNA,26141122
39484,D015655,1-Methyl-4-phenylpyridinium,PPARG,5468,Homo sapiens,9606,1-Methyl-4-phenylpyridinium results in decreased expression of PPARG protein,26141122|30965670
39484,D015655,1-Methyl-4-phenylpyridinium,PPARG,5468,Homo sapiens,9606,tideglusib inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of PPARG protein]|Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of PPARG protein],30965670
39676,C025643,vinclozolin,PPARG,5468,Homo sapiens,9606,vinclozolin binds to and results in increased activity of PPARG protein,33049310
39800,C011506,2-methyl-4-isothiazolin-3-one,PPARG,5468,Homo sapiens,9606,2-methyl-4-isothiazolin-3-one results in increased expression of PPARG mRNA,31629900
40024,C007262,deoxynivalenol,PPARG,5468,Homo sapiens,9606,"MAPK1 protein promotes the reaction [deoxynivalenol results in increased expression of PPARG mRNA]|15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [deoxynivalenol results in increased expression of PPARG protein]|EGR1 protein promotes the reaction [deoxynivalenol results in increased expression of PPARG mRNA]|MAPK3 protein promotes the reaction [deoxynivalenol results in increased expression of PPARG mRNA]|U 0126 inhibits the reaction [deoxynivalenol results in increased expression of PPARG mRNA]|deoxynivalenol results in increased expression of PPARG mRNA|PPARG protein affects the reaction [deoxynivalenol results in decreased degradation of CXCL8 mRNA]|lipopolysaccharide, E coli O55-B5 affects the reaction [deoxynivalenol results in increased expression of PPARG mRNA]",18485432
40024,C007262,deoxynivalenol,PPARG,5468,Homo sapiens,9606,deoxynivalenol results in decreased activity of PPARG protein,27481073
40326,D026023,Permethrin,PPARG,5468,Homo sapiens,9606,Permethrin binds to and results in increased activity of PPARG protein,33049310
40326,D026023,Permethrin,PPARG,5468,Mus musculus,10090,[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA|Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA],29751049
40326,D026023,Permethrin,PPARG,5468,Mus musculus,10090,Permethrin results in increased expression of PPARG protein|Permethrin results in increased expression of PPARG mRNA,24911977
40470,D020111,Chlorodiphenyl (54% Chlorine),PPARG,5468,Homo sapiens,9606,Chlorodiphenyl (54% Chlorine) results in increased expression of PPARG mRNA,16934159
40470,D020111,Chlorodiphenyl (54% Chlorine),PPARG,5468,Mus musculus,10090,[Diethylhexyl Phthalate co-treated with Chlorodiphenyl (54% Chlorine)] results in increased expression of PPARG mRNA,23804495
40585,C017180,decamethrin,PPARG,5468,Homo sapiens,9606,decamethrin results in decreased expression of PPARG protein,27553674
40585,C017180,decamethrin,PPARG,5468,Mus musculus,10090,decamethrin results in decreased expression of PPARG mRNA,23401056
40585,C017180,decamethrin,PPARG,5468,Mus musculus,10090,decamethrin results in increased expression of PPARG mRNA,34520793
40585,C017180,decamethrin,PPARG,5468,Mus musculus,10090,decamethrin results in increased expression of PPARG protein,28119079
41114,D009529,Nicardipine,PPARG,5468,Homo sapiens,9606,Nicardipine results in decreased activity of PPARG protein,25257666
41322,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",PPARG,5468,Homo sapiens,9606,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PPARG mRNA",19150397
41381,C027392,ethafluralin,PPARG,5468,Homo sapiens,9606,ethafluralin binds to and results in increased activity of PPARG protein,33049310
42890,D015255,Idarubicin,PPARG,5468,Homo sapiens,9606,Idarubicin results in decreased activity of PPARG protein,25257666
43226,C033789,fenarimol,PPARG,5468,Danio rerio,7955,fenarimol binds to and results in increased activity of PPARG protein,33049310
43234,C045950,propiconazole,PPARG,5468,Homo sapiens,9606,propiconazole binds to and results in increased activity of PPARG protein,33049310
47898,C475882,flutolanil,PPARG,5468,Homo sapiens,9606,flutolanil results in increased activity of PPARG protein,20143881
47936,D005576,Colforsin,PPARG,5468,Homo sapiens,9606,Colforsin results in decreased expression of PPARG mRNA,31278978
47936,D005576,Colforsin,PPARG,5468,Salmo salar,8030,Colforsin promotes the reaction [tributyltin results in decreased expression of PPARG mRNA],20211155
51040,C049935,avobenzone,PPARG,5468,Homo sapiens,9606,avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA],31016361
51040,C049935,avobenzone,PPARG,5468,Homo sapiens,9606,avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA],32407875
51040,C049935,avobenzone,PPARG,5468,Homo sapiens,9606,avobenzone results in increased expression of PPARG mRNA,31016361|32407875
51576,C036804,acifran,PPARG,5468,Homo sapiens,9606,HCAR3 protein promotes the reaction [acifran results in increased activity of PPARG protein]|acifran results in increased activity of PPARG protein|HCAR2 protein promotes the reaction [acifran results in increased activity of PPARG protein],16386710
53232,D008148,Lovastatin,PPARG,5468,Homo sapiens,9606,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein]|Lovastatin analog affects the localization of PPARG protein|2-chloro-5-nitrobenzanilide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein],26863638
53232,D008148,Lovastatin,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [Lovastatin results in increased expression of PTEN protein]|PPARG affects the reaction [Lovastatin results in increased expression of PTEN protein],16425225
53232,D008148,Lovastatin,PPARG,5468,Mus musculus,10090,[Dietary Fats co-treated with Lovastatin] affects the expression of PPARG mRNA,29852127
53232,D008148,Lovastatin,PPARG,5468,Rattus norvegicus,10116,Lovastatin results in increased expression of and affects the localization of PPARG protein|Lovastatin results in increased expression of PPARG mRNA|PPARG protein affects the reaction [Lovastatin results in increased expression of MBP mRNA]|geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA]|PPARG protein affects the reaction [Lovastatin results in increased expression of SOX10 mRNA]|Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA],20578043
53518,C064835,quizalofop-ethyl,PPARG,5468,Homo sapiens,9606,quizalofop-ethyl results in increased activity of PPARG protein,31086981
54454,D019821,Simvastatin,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 mRNA]|[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 protein],15781755
54454,D019821,Simvastatin,PPARG,5468,Mus musculus,10090,"Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of PPARG mRNA]|Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of PPARG protein]",20835264
54454,D019821,Simvastatin,PPARG,5468,Rattus norvegicus,10116,Simvastatin results in decreased expression of PPARG,19216230
55245,D015735,Mifepristone,PPARG,5468,Mus musculus,10090,Mifepristone inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA],27145005
55245,D015735,Mifepristone,PPARG,5468,Mus musculus,10090,Mifepristone inhibits the reaction [butylparaben results in increased expression of PPARG mRNA],22956630
55245,D015735,Mifepristone,PPARG,5468,Rattus norvegicus,10116,Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein],30229846
55245,D015735,Mifepristone,PPARG,5468,Rattus norvegicus,10116,Mifepristone results in decreased expression of PPARG mRNA,25972201
57363,D018120,Finasteride,PPARG,5468,Mus musculus,10090,Finasteride binds to and results in increased activity of PPARG protein,33049310
60303,C066021,englitazone,PPARG,5468,Homo sapiens,9606,englitazone results in increased activity of PPARG protein alternative form,23563205
60613,D000077404,Cidofovir,PPARG,5468,Homo sapiens,9606,Cidofovir affects the activity of PPARG protein,25596134
60700,D019772,Topotecan,PPARG,5468,Rattus norvegicus,10116,[Oxaliplatin co-treated with Topotecan] results in decreased expression of PPARG mRNA|Topotecan affects the expression of PPARG mRNA,25729387
60750,C056507,gemcitabine,PPARG,5468,Mus musculus,10090,gemcitabine affects the expression of PPARG mRNA,19427843
60838,D000077146,Irinotecan,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [Rosiglitazone inhibits the reaction [Irinotecan results in increased expression of TNF mRNA]]|PPARG protein affects the reaction [Luteolin inhibits the reaction [Irinotecan results in increased expression of NQO1 mRNA]]|Irinotecan results in decreased expression of PPARG mRNA|PPARG protein affects the reaction [Rosiglitazone inhibits the reaction [Irinotecan results in increased expression of NQO1 mRNA]]|Luteolin inhibits the reaction [Irinotecan results in decreased expression of PPARG mRNA]|PPARG protein affects the reaction [Luteolin inhibits the reaction [Irinotecan results in increased expression of TNF mRNA]]|PPARG protein affects the reaction [Rosiglitazone inhibits the reaction [Irinotecan results in increased expression of NFE2L2 mRNA]],34699766
60846,D000068756,Valsartan,PPARG,5468,Homo sapiens,9606,Valsartan results in decreased expression of PPARG mRNA,22768174
60870,C089948,darglitazone,PPARG,5468,Homo sapiens,9606,darglitazone binds to and results in increased activity of PPARG protein,21557540
60871,C106812,adefovir dipivoxil,PPARG,5468,Homo sapiens,9606,adefovir dipivoxil affects the activity of PPARG protein,25596134
60910,C051602,mifobate,PPARG,5468,NULL,NULL,mifobate results in decreased activity of PPARG protein,22108913
62097,C106572,3-iodo-2-propynylbutylcarbamate,PPARG,5468,Homo sapiens,9606,3-iodo-2-propynylbutylcarbamate binds to and results in increased activity of PPARG protein,33049310
62210,C000617134,flumetralin,PPARG,5468,Mus musculus,10090,flumetralin binds to and results in increased activity of PPARG protein,33049310
62531,C016151,tinuvin,PPARG,5468,Danio rerio,7955,tinuvin analog results in decreased expression of PPARG mRNA,30315675
62857,D005473,Fluoxetine,PPARG,5468,Homo sapiens,9606,Fluoxetine inhibits the reaction [Serotonin results in increased localization of PPARG protein],25766885
63090,C023035,"3,4,5,3',4'-pentachlorobiphenyl",PPARG,5468,Homo sapiens,9606,"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PPARG mRNA|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PPARG mRNA]",25304490
63090,C023035,"3,4,5,3',4'-pentachlorobiphenyl",PPARG,5468,Mus musculus,10090,"3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of PPARG mRNA]",28973532
64139,C098320,efavirenz,PPARG,5468,Homo sapiens,9606,efavirenz results in decreased expression of PPARG mRNA,21619898
64689,D015054,Zymosan,PPARG,5468,Mus musculus,10090,Zymosan results in decreased expression of PPARG mRNA,16847310
64819,C045762,Irganox 1010,PPARG,5468,Homo sapiens,9606,Irganox 1010 binds to and results in decreased activity of PPARG protein|Irganox 1010 binds to and results in increased activity of PPARG protein,27633901
64928,C006012,fenofibric acid,PPARG,5468,Homo sapiens,9606,fenofibric acid results in increased activity of [PPARG protein alternative form binds to RXRA protein]|fenofibric acid binds to PPARG protein,11779144
64928,C006012,fenofibric acid,PPARG,5468,Homo sapiens,9606,fenofibric acid results in increased activity of PPARG protein,15273253
64945,C005466,ursolic acid,PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]]|ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]",27274199
64982,C038044,baicalin,PPARG,5468,Rattus norvegicus,10116,baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein],24312512
65064,C045651,epigallocatechin gallate,PPARG,5468,Homo sapiens,9606,epigallocatechin gallate results in decreased expression of PPARG mRNA,20706672
65084,C057580,gallocatechol,PPARG,5468,Rattus norvegicus,10116,gallocatechol results in decreased expression of PPARG mRNA,21877759
65094,C007997,25-hydroxycholesterol,PPARG,5468,Homo sapiens,9606,[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased expression of ABCA1 mRNA]|[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of Cholesterol],12595494
65126,C018381,salvin,PPARG,5468,Homo sapiens,9606,salvin results in increased activity of PPARG protein,20696231
65238,C013185,beta-penta-O-galloyl-glucose,PPARG,5468,Mus musculus,10090,beta-penta-O-galloyl-glucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG protein]|beta-penta-O-galloyl-glucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA],30721698
65411,C084079,triptonide,PPARG,5468,Mus musculus,10090,triptonide results in decreased expression of PPARG mRNA,33045310
65552,C011126,tetraiodothyroacetic acid,PPARG,5468,Homo sapiens,9606,tetraiodothyroacetic acid binds to and results in increased activity of PPARG protein,33049310
65999,D000077333,Telmisartan,PPARG,5468,Homo sapiens,9606,PPARG mutant form inhibits the reaction [Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]]|PPARG mutant form inhibits the reaction [Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]|PPARG mutant form inhibits the reaction [Telmisartan results in increased expression of CD36 mRNA]|PPARG mutant form inhibits the reaction [Telmisartan results in increased expression of ABCG1 mRNA],22124178
65999,D000077333,Telmisartan,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [Telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein]],18158351
65999,D000077333,Telmisartan,PPARG,5468,Homo sapiens,9606,Telmisartan results in increased activity of PPARG protein,22124178|28728110
65999,D000077333,Telmisartan,PPARG,5468,Mus musculus,10090,Telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARG protein],21381899
65999,D000077333,Telmisartan,PPARG,5468,Mus musculus,10090,Telmisartan results in increased expression of PPARG protein,20176998
65999,D000077333,Telmisartan,PPARG,5468,Rattus norvegicus,10116,Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA],24831514
65999,D000077333,Telmisartan,PPARG,5468,Rattus norvegicus,10116,Telmisartan binds to and affects the activity of PPARG protein|Telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein],20888384
65999,D000077333,Telmisartan,PPARG,5468,NULL,NULL,Telmisartan results in increased activity of PPARG protein,22253423
65999,D000077333,Telmisartan,PPARG,5468,NULL,NULL,Telmisartan results in increased expression of PPARG protein,20307515
66065,C006741,bergenin,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [bergenin inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein]]|bergenin inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein],34499403
67174,C000622346,diphenolic acid,PPARG,5468,Homo sapiens,9606,diphenolic acid binds to and results in decreased activity of PPARG protein,33049310
67296,C025256,nonylphenol,PPARG,5468,Homo sapiens,9606,nonylphenol binds to and results in increased activity of PPARG protein,33049310
67296,C025256,nonylphenol,PPARG,5468,Rattus norvegicus,10116,nonylphenol results in decreased expression of PPARG protein,29641977
67296,C025256,nonylphenol,PPARG,5468,Sparus aurata,8175,[nonylphenol co-treated with bisphenol A] results in increased expression of PPARG mRNA|[nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of PPARG mRNA,28208108
67296,C025256,nonylphenol,PPARG,5468,Sparus aurata,8175,nonylphenol results in increased expression of PPARG mRNA,26382854
67542,C479228,perfluorohexanoic acid,PPARG,5468,Homo sapiens,9606,perfluorohexanoic acid results in increased activity of PPARG protein,23391484
67545,C522391,perfluorododecanoic acid,PPARG,5468,Homo sapiens,9606,perfluorododecanoic acid results in increased activity of PPARG protein,23391484|24998974
67734,C471071,perfluorohexanesulfonic acid,PPARG,5468,Homo sapiens,9606,perfluorohexanesulfonic acid binds to PPARG protein,24998974
67734,C471071,perfluorohexanesulfonic acid,PPARG,5468,Mus musculus,10090,perfluorohexanesulfonic acid results in increased expression of PPARG mRNA,28049043
67815,C539348,perfluorobutanesulfonic acid,PPARG,5468,Mus musculus,10090,perfluorobutanesulfonic acid results in increased expression of PPARG mRNA|perfluorobutanesulfonic acid results in increased expression of PPARG protein,30031040
67821,C101816,perfluoro-n-nonanoic acid,PPARG,5468,Homo sapiens,9606,perfluoro-n-nonanoic acid results in increased expression of PPARG mRNA,28558994
67821,C101816,perfluoro-n-nonanoic acid,PPARG,5468,Rattus norvegicus,10116,perfluoro-n-nonanoic acid results in increased expression of PPARG mRNA,19196829|19878704
68740,D000077211,Zoledronic Acid,PPARG,5468,Homo sapiens,9606,Zoledronic Acid affects the activity of PPARG protein,25596134
69785,C063900,perfluorooctanesulfonamide,PPARG,5468,Salmo salar,8030,perfluorooctanesulfonamide results in increased expression of PPARG mRNA,22594583
72281,C013015,hesperetin,PPARG,5468,Homo sapiens,9606,hesperetin results in decreased expression of PPARG protein|hesperetin results in decreased expression of PPARG mRNA,25345581
72281,C013015,hesperetin,PPARG,5468,Mus musculus,10090,hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]|hesperetin analog inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein]|hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]|hesperetin analog inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG protein]|hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of STAT1 protein]]|[hesperetin analog co-treated with PPARG protein] affects the reaction [Lipopolysaccharides results in increased expression of TNF protein]|hesperetin analog inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]|hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of JAK1 protein]]|hesperetin analog inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA],28428136
72300,C005498,magnolol,PPARG,5468,Homo sapiens,9606,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [magnolol binds to and results in increased activity of PPARG protein]|magnolol binds to and results in increased activity of PPARG protein",20064974
72303,C005499,honokiol,PPARG,5468,Homo sapiens,9606,ALOX15 protein promotes the reaction [honokiol results in decreased expression of PPARG protein]|honokiol results in decreased expression of PPARG mRNA|honokiol results in decreased expression of PPARG protein,20649594
72303,C005499,honokiol,PPARG,5468,Homo sapiens,9606,honokiol binds to and results in increased activity of PPARG protein,23811337
72361,C046905,glucosamine 6-O-sulfate,PPARG,5468,Mus musculus,10090,glucosamine 6-O-sulfate results in decreased expression of PPARG protein|glucosamine 6-O-sulfate results in decreased expression of PPARG mRNA,19520133
73219,C513957,"3,5-di-tert-butyl-4-hydroxybenzaldehyde",PPARG,5468,Homo sapiens,9606,"3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of PPARG protein",27633901
73398,C119129,18alpha-glycyrrhetinic acid,PPARG,5468,Rattus norvegicus,10116,18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG protein]|18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA],28414158
73665,C045362,prochloraz,PPARG,5468,Homo sapiens,9606,prochloraz binds to and results in increased activity of PPARG protein,33049310
73665,C045362,prochloraz,PPARG,5468,Homo sapiens,9606,prochloraz results in decreased expression of PPARG mRNA,30879083
73864,C583074,"4,4'-hexafluorisopropylidene diphenol",PPARG,5468,Danio rerio,7955,"4,4'-hexafluorisopropylidene diphenol binds to and results in increased activity of PPARG protein|4,4'-hexafluorisopropylidene diphenol binds to and results in decreased activity of PPARG protein",33049310
73864,C583074,"4,4'-hexafluorisopropylidene diphenol",PPARG,5468,Homo sapiens,9606,"4,4'-hexafluorisopropylidene diphenol metabolite inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]",30408883
73864,C583074,"4,4'-hexafluorisopropylidene diphenol",PPARG,5468,Homo sapiens,9606,"4,4'-hexafluorisopropylidene diphenol results in increased expression of PPARG mRNA",32763284
73864,C583074,"4,4'-hexafluorisopropylidene diphenol",PPARG,5468,Homo sapiens,9606,"[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone co-treated with 4,4'-hexafluorisopropylidene diphenol] results in increased expression of PPARG mRNA",31596606
73864,C583074,"4,4'-hexafluorisopropylidene diphenol",PPARG,5468,Mus musculus,10090,"4,4'-hexafluorisopropylidene diphenol results in decreased expression of PPARG mRNA",30145421
74483,C076994,perfluorooctane sulfonic acid,PPARG,5468,Danio rerio,7955,[NFE2L2A gene mutant form affects the susceptibility to perfluorooctane sulfonic acid] which results in increased expression of PPARG mRNA,29524743
74483,C076994,perfluorooctane sulfonic acid,PPARG,5468,Homo sapiens,9606,perfluorooctane sulfonic acid affects the expression of PPARG mRNA,30738844
74483,C076994,perfluorooctane sulfonic acid,PPARG,5468,Homo sapiens,9606,perfluorooctane sulfonic acid binds to and results in increased activity of PPARG protein,33049310
74483,C076994,perfluorooctane sulfonic acid,PPARG,5468,Homo sapiens,9606,perfluorooctane sulfonic acid results in decreased expression of PPARG mRNA,32790152
74483,C076994,perfluorooctane sulfonic acid,PPARG,5468,Homo sapiens,9606,perfluorooctane sulfonic acid results in increased activity of PPARG protein,24998974
74483,C076994,perfluorooctane sulfonic acid,PPARG,5468,Homo sapiens,9606,perfluorooctane sulfonic acid results in increased expression of PPARG mRNA,22269386|26548598|28558994
74483,C076994,perfluorooctane sulfonic acid,PPARG,5468,Mus musculus,10090,[Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of PPARG mRNA,32979393
74483,C076994,perfluorooctane sulfonic acid,PPARG,5468,Mus musculus,10090,perfluorooctane sulfonic acid results in increased expression of PPARG mRNA,23500012|26548598
74483,C076994,perfluorooctane sulfonic acid,PPARG,5468,Rattus norvegicus,10116,perfluorooctane sulfonic acid results in decreased acetylation of PPARG protein,28973641
74483,C076994,perfluorooctane sulfonic acid,PPARG,5468,Rattus norvegicus,10116,perfluorooctane sulfonic acid results in increased expression of PPARG mRNA,23500012
74483,C076994,perfluorooctane sulfonic acid,PPARG,5468,Salmo salar,8030,perfluorooctane sulfonic acid results in increased expression of PPARG mRNA,18424238|19747560
75318,C581825,monoethyl phthalate,PPARG,5468,Homo sapiens,9606,monoethyl phthalate affects the expression of PPARG mRNA,28381288
75318,C581825,monoethyl phthalate,PPARG,5468,Homo sapiens,9606,monoethyl phthalate binds to PPARG protein,23843199
75318,C581825,monoethyl phthalate,PPARG,5468,Mus musculus,10090,[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA,31884101
75575,C047969,"2,2'-bisphenol F",PPARG,5468,Danio rerio,7955,"2,2'-bisphenol F binds to and results in increased activity of PPARG protein",33049310
77222,C586085,perfluoroundecanoic acid,PPARG,5468,Homo sapiens,9606,perfluoroundecanoic acid binds to and affects the folding of PPARG protein,24998974
77547,C018063,ethyl protocatechuate,PPARG,5468,Mus musculus,10090,ethyl protocatechuate inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA],24338020
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone binds to and affects the activity of PPARG protein|[Rosiglitazone binds to and affects the activity of PPARG protein] which results in increased abundance of Nitric Oxide,16527820
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone binds to and affects the localization of and results in increased activity of PPARG protein,29408570
77999,D000077154,Rosiglitazone,PPARG,5468,Bos taurus,9913,Cycloheximide inhibits the reaction [Rosiglitazone results in increased expression of PPARG protein]|[Rosiglitazone co-treated with Hydrogen Peroxide] results in increased expression of PPARG protein|Rosiglitazone results in increased expression of and results in increased activity of PPARG protein|Hydrogen Peroxide inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|Rosiglitazone results in increased expression of PPARG mRNA,17622750
77999,D000077154,Rosiglitazone,PPARG,5468,Chlorocebus aethiops,9534,Rosiglitazone binds to and results in increased activity of PPARG protein,16239165
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Ethanol inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|Fomepizole inhibits the reaction [Ethanol inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]]|Acetaldehyde inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|U 0126 inhibits the reaction [Acetaldehyde inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]]|Cyanamide inhibits the reaction [Ethanol inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]],17030193
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,"tetrabromobisphenol A inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|Diclofenac inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|4,4'-bisphenol F inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|tetrachlorodian inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|bisphenol F diglycidyl ether inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|bis(4-hydroxyphenyl)sulfone inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]",30138673
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone affects the localization of PPARG protein|2-chloro-5-nitrobenzanilide affects the reaction [Rosiglitazone affects the localization of PPARG protein],22321707
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]],21333731
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],21660147|23964924|30138673
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA],18949406|21354099|22321707
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone results in increased expression of PPARG protein],22321707|24793810
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,"4,4'-hexafluorisopropylidene diphenol metabolite inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]",30408883
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid inhibits the reaction [Rosiglitazone promotes the reaction [PPARG protein binds to CREBBP protein]]|Rosiglitazone promotes the reaction [PPARG protein binds to CREBBP protein],21296151
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,bisphenol A inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30138673|30408883
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,delta(9)-tetrahydrocannabinolic acid inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA]|Rosiglitazone results in decreased expression of PPARG protein,28853159
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,tetrabutyltin inhibits the reaction [Rosiglitazone binds to PPARG protein]|tributyltin inhibits the reaction [Rosiglitazone binds to PPARG protein]|diphenyltin chloride inhibits the reaction [Rosiglitazone binds to PPARG protein]|triphenyltin chloride inhibits the reaction [Rosiglitazone binds to PPARG protein],19497422
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,"Rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]|FASN protein promotes the reaction [Rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]]|FASN protein promotes the reaction [Rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]]|UCP1 protein promotes the reaction [Rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]]|Rosiglitazone promotes the reaction [PPARG protein results in increased expression of FASN protein]|UCP1 protein promotes the reaction [Rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]]|Rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]",26670611
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,fluoxastrobin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|Proflavine inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|pyridaben inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|kresoxim-methyl inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|picoxystrobin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|Rotenone inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30818834
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,HMOX1 protein promotes the reaction [Rosiglitazone results in increased activity of PPARG protein]|zinc protoporphyrin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],21660147
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Indomethacin inhibits the reaction [Rosiglitazone binds to PPARG protein],9013583
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,"[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of PPARG protein|[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone co-treated with 4,4'-hexafluorisopropylidene diphenol] results in increased expression of PPARG mRNA|[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of PPARG mRNA",31596606
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,INT 131 inhibits the reaction [Rosiglitazone binds to PPARG protein]|INT 131 inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA]|INT 131 inhibits the reaction [[Rosiglitazone binds to MED1 protein modified form] which binds to PPARG protein]|[Rosiglitazone binds to MED1 protein modified form] which binds to PPARG protein,19452630
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,NFE2L2 protein promotes the reaction [Rosiglitazone results in increased expression of PPARG protein]|[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide,22684020
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,PPARG gene polymorphism affects the susceptibility to Rosiglitazone,16084854
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,PPARG mRNA affects the susceptibility to Rosiglitazone,17535976|20663321
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,PPARG promotes the reaction [Rosiglitazone results in increased expression of CD36 mRNA],27358406
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [Rosiglitazone inhibits the reaction [Irinotecan results in increased expression of TNF mRNA]]|Rosiglitazone results in decreased expression of PPARG mRNA|PPARG protein affects the reaction [Rosiglitazone inhibits the reaction [Irinotecan results in increased expression of NQO1 mRNA]]|PPARG protein affects the reaction [Rosiglitazone inhibits the reaction [Irinotecan results in increased expression of NFE2L2 mRNA]],34699766
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [Rosiglitazone results in increased expression of CD36 mRNA]|PPARG protein affects the reaction [Rosiglitazone results in increased expression of FABP4 mRNA]|PPARG protein affects the reaction [Rosiglitazone results in increased expression of NR1H3 mRNA],31778932
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [Rosiglitazone results in increased expression of PTEN protein]|PPARG affects the reaction [Rosiglitazone results in increased expression of PTEN protein],16425225
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein results in increased susceptibility to [Rosiglitazone co-treated with Cisplatin]|[PPARG protein co-treated with Rosiglitazone] results in decreased expression of AKR1B10 protein,27417252
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [Rosiglitazone results in decreased expression of FN1 protein],15908479
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [Rosiglitazone results in decreased expression of ICAM1 mRNA]|[Rosiglitazone results in increased activity of PPARG protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]|[Rosiglitazone results in increased activity of PPARG protein] inhibits the reaction [TNF protein results in increased expression of CXCL1 mRNA],19417127
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [Rosiglitazone results in decreased expression of TPM3 protein alternative form],19369484
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [Rosiglitazone results in increased expression of ANGPTL4 mRNA],29729928
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Quercetin promotes the reaction [Rosiglitazone results in increased expression of PPARG protein],25765892
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Ro 41-5253 inhibits the reaction [Rosiglitazone binds to PPARG protein],17290005
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein|[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA|rosemarinic acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein],33476690
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone affects the activity of PPARG protein,25596134
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone affects the expression of PPARG,15254749
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone binds to and results in increased activity of PPARG protein,10871190|11139385|15254749|15491415|15729575|15866424|16674924|16731579|19369484|20307981|21218783|22684020|24155963|24489787|28962521|29410257|30382123|33049310|9836514
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased susceptibility to Cisplatin|[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased susceptibility to MT19c compound|[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Cisplatin,21781307
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of ANGPTL4 mRNA,28962521
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone binds to PPARG protein,11779144|12554792|12839938|12927354|17290005|19452630|19497422|21511917|22070604|25062436|25314719|27725436|30033591|31195007|9013583
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone promotes the reaction [PPARG protein results in increased expression of FABP4 mRNA]|Troglitazone inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein]|[Rosiglitazone binds to PPARG protein] which affects the localization of NCOA1 protein|[Rosiglitazone binds to PPARG protein] which affects the localization of EP300 protein|Rosiglitazone promotes the reaction [PPARG protein results in increased expression of SORBS1 mRNA],10871190
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,[Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA|[Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein,20206132|33865937
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,[Rosiglitazone co-treated with Rotenone] results in increased expression of PPARG protein,24374061
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARG protein],30362509
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone inhibits the reaction [Chlorpyrifos results in decreased expression of PPARG protein],24793810
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,"Rosiglitazone inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of PPARG mRNA]",14625208
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone inhibits the reaction [PPARG protein alternative form results in decreased activity of SLC2A4 promoter]|Rosiglitazone inhibits the reaction [[PPARG protein co-treated with RXRA protein] binds to SLC2A4 promoter],12777391
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],19186324
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone promotes the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]],12927354
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone results in increased activity of PPARG protein,12814394|15273253|16112107|17030193|17185614|17255338|20143881|21622945|21660147|23150725|23964924|24998974|26172262|26778350|27506419|28728110|29288688|30138673|30408883|30818834
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone results in increased activity of PPARG protein alternative form,23563205
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,[Rosiglitazone results in increased activity of PPARG protein] which results in increased abundance of Tretinoin,16982809
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone results in increased expression of PPARG,17018897
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone results in increased expression of PPARG mRNA,15277403|16799780|17030193|18949406|19452630|19462893|20003221|20021931|21354099|22291955|22321707|22684020|22763116|25062436|26961604|28743512|28853159|29408570|29787037|30903904|31778932
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone results in increased expression of PPARG mRNA alternative form,20860658|30382123
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,Rosiglitazone results in increased expression of PPARG protein,17030193|17461445|19462893|20506517|21376716|22321707|22684020|24374061|24793810|25765892
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,[RXRA co-treated with Rosiglitazone] results in increased expression of PPARG mRNA,16213464
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,T 0070907 inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|[T 0070907 binds to PPARG protein] which results in decreased susceptibility to Rosiglitazone|T 0070907 inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA alternative form],30382123
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,T 0070907 inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA],21354099
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,TGFB1 protein inhibits the reaction [[Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA],20206132
77999,D000077154,Rosiglitazone,PPARG,5468,Homo sapiens,9606,triphenyl bismuth inhibits the reaction [Rosiglitazone binds to PPARG protein]|triphenylarsine inhibits the reaction [Rosiglitazone binds to PPARG protein],27725436
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased susceptibility to Rosiglitazone,17394460
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone results in increased degradation of and results in increased ubiquitination of PPARG protein|Rosiglitazone results in decreased expression of PPARG protein|epoxomicin inhibits the reaction [Rosiglitazone results in decreased expression of PPARG protein]|Rosiglitazone results in decreased expression of PPARG mRNA|benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Rosiglitazone results in decreased expression of PPARG protein],18555852
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,bis(4-hydroxyphenyl)sulfone inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],27273607
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Cannabidiol analog inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|T 0070907 inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30033591
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]|[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA|[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA],16054899
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone promotes the reaction [PPARG protein binds to EGLN3 promoter]|ethyl protocatechuate inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA]|Rosiglitazone promotes the reaction [PPARG protein binds to EGLN1 promoter],24338020
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA|[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA alternative form|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA alternative form]|[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG protein|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA]|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG protein],33412187
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,(+)-JQ1 compound inhibits the reaction [Rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]|Rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],26972250
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,kaempferol inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein]|Quercetin inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein],18262572
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,NFE2L2 protein affects the reaction [Rosiglitazone results in increased expression of PPARG mRNA],33137425
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,PPARG affects the reaction [Rosiglitazone results in decreased expression of CX3CR1 mRNA],19850645
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,PPARG affects the susceptibility to Rosiglitazone,17463185|19075043
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,[PPARG protein co-treated with RXRA protein] promotes the reaction [Rosiglitazone results in increased expression of PPARGC1A mRNA]|PPARG protein promotes the reaction [Rosiglitazone results in increased expression of PPARGC1A mRNA],16513826
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,PPARG protein promotes the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein]|T 0070907 inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein],24155963
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone affects the expression of PPARG mRNA|Rosiglitazone affects the reaction [Ivermectin affects the expression of PPARG mRNA],31199990
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,[Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA|[Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein,29288687
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone binds to and affects the localization of PPARG protein,15174093
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone binds to and results in increased activity of PPARG protein,10871190|12758056|16731579|17726147|18262572|18292206|20512989|24155963|30611848|33049310
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of GDF15 mRNA|[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of GDF15 protein,20512989
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone binds to and results in increased sumoylation of PPARG protein,22046279
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,[Rosiglitazone co-treated with Ethanol] results in increased expression of PPARG mRNA,20007851
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,[Rosiglitazone co-treated with TNFSF11 protein] results in increased expression of PPARG mRNA,22286232
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone inhibits the reaction [Acrolein results in decreased expression of PPARG protein],34813903
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone inhibits the reaction [Bleomycin results in decreased expression of PPARG mRNA],19147827
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA],18302760
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG protein]|Rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA],18991162
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone inhibits the reaction [Ethanol results in decreased expression of PPARG mRNA],22173916
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,"Rosiglitazone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of PPARG protein]",29338785
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARG mRNA]|Rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARG protein],21531777
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone inhibits the reaction [Resveratrol analog results in decreased expression of PPARG mRNA],24779192
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone promotes the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA],32473317
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|Rosiglitazone promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein],29094436
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],28595985|30611848
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone promotes the reaction [[PPARG protein binds to EDNRB promoter] which results in increased expression of EDNRB mRNA],20516393
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,"Rosiglitazone promotes the reaction [Toluene 2,4-Diisocyanate results in increased localization of PPARG protein]",17015710
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone results in decreased methylation of PPARG promoter,30903904
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone results in increased activity of PPARG protein,18555852|19417127|23086663|24338020|25777084|26135921|27273607|28527915|29127035|30033591
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,[Rosiglitazone results in increased activity of PPARG protein] inhibits the reaction [Triclosan results in decreased phosphorylation of AKT1 protein],28973666
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone results in increased activity of [RXRA protein binds to PPARG protein],15997096
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone results in increased expression of PPARG mRNA,18534569|20007851|21352814|21392566|22173916|22763116|23086663|23322813|24338020|24513447|25932594|26865663|28528971|28611668|29127035|29410257|29787037|29910772|30027469|30611848|33137425
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Rosiglitazone results in increased expression of PPARG protein,20007851|21847688
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,T 0070907 inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA],29787037
77999,D000077154,Rosiglitazone,PPARG,5468,Mus musculus,10090,Tungsten promotes the reaction [Rosiglitazone results in increased expression of PPARG mRNA],26865663
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,"Rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG mRNA]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG protein]]|Rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG protein]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG mRNA]]",24612634
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to Rosiglitazone,19732122
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG protein]]|2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA]]|Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA],16617452
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone inhibits the reaction [Paraquat results in decreased expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Paraquat results in decreased expression of PPARG mRNA]]|2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Paraquat results in decreased expression of PPARG protein]]|Rosiglitazone inhibits the reaction [Paraquat results in decreased expression of PPARG mRNA],30797787
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone inhibits the reaction [Cyclosporine results in decreased expression of PPARG protein]|Rosiglitazone inhibits the reaction [Cyclosporine results in decreased expression of PPARG mRNA]|Cyclosporine inhibits the reaction [Rosiglitazone results in increased expression of PPARG protein],17461532
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone binds to and affects the activity of PPARG protein|Indomethacin inhibits the reaction [Rosiglitazone binds to and affects the activity of PPARG protein],12897060
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,PPARG mRNA affects the susceptibility to Rosiglitazone,20404217
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,[Rosiglitazone co-treated with AGT protein] results in increased expression of PPARG protein|Rosiglitazone promotes the reaction [AGT protein results in increased expression of PPARG mRNA]|PPARG mutant form inhibits the reaction [Rosiglitazone inhibits the reaction [AGT protein results in increased expression of KLF5 protein]]|Rosiglitazone inhibits the reaction [AGT protein results in decreased activity of PPARG protein],25874449
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,"PPARG mutant form inhibits the reaction [Rosiglitazone inhibits the reaction [Pyruvaldehyde results in increased expression of IL1B protein]]|PPARG mutant form inhibits the reaction [Rosiglitazone inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]|PPARG mutant form inhibits the reaction [Rosiglitazone inhibits the reaction [Pyruvaldehyde results in increased expression of TNF protein]]",23954466
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone binds to and results in increased activity of PPARG protein,15150131|16731579|16751799|18543250|24188201|24612634|28973641
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of GFAP mRNA|T 0070907 inhibits the reaction [[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of MBP mRNA]|Rosiglitazone promotes the reaction [PPARG protein results in increased expression of PPARB protein]|[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of MBP mRNA|[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of MOG mRNA,18543250
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone binds to PPARG protein,15726020
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone inhibits the reaction [AGT protein results in decreased expression of PPARG protein]|Rosiglitazone inhibits the reaction [AGT protein results in decreased expression of PPARG mRNA],18278065
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA],12055599
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone inhibits the reaction [Palmitates results in increased expression of PPARG mRNA],16620699
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein],30551535
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone inhibits the reaction [Streptozocin results in decreased expression of PPARG],24136780
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone promotes the reaction [Fructose results in increased expression of PPARG mRNA],19196556
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone results in decreased expression of PPARG mRNA,21515302
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone results in increased activity of PPARG protein,19103650|22842585
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone results in increased expression of PPARG mRNA,17461532|20519551|21373642|23500012
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone results in increased expression of PPARG protein,16344371|17461532|18278065|18455351|18543250|22726273|26670611
77999,D000077154,Rosiglitazone,PPARG,5468,Rattus norvegicus,10116,T 0070907 inhibits the reaction [Rosiglitazone results in increased expression of PPARG protein]|[T 0070907 binds to PPARG protein] which results in decreased susceptibility to Rosiglitazone,18455351
77999,D000077154,Rosiglitazone,PPARG,5468,Sus scrofa,9823,Rosiglitazone affects the reaction [IL6 protein affects the expression of PPARG mRNA],20921996
77999,D000077154,Rosiglitazone,PPARG,5468,Ursus maritimus,29073,"[Polychlorinated Biphenyls analog co-treated with Dichlorodiphenyl Dichloroethylene analog] inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|Endosulfan inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|bisphenol A inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|oxychlordane inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|[Polychlorinated Biphenyls co-treated with Halogenated Diphenyl Ethers co-treated with Hydrocarbons, Chlorinated] inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|hexabromocyclododecane inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|Dichlorodiphenyl Dichloroethylene inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|Rosiglitazone results in increased activity of PPARG protein",27602593
77999,D000077154,Rosiglitazone,PPARG,5468,Xenopus tropicalis,8364,Rosiglitazone results in increased activity of PPARG protein,27894914
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [LEP protein inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA]]|fludarabine inhibits the reaction [LEP protein inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA]]|LEP protein inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA],21352814
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein]",10636887
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein],24025786
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone promotes the reaction [PPARG protein results in increased activity of INSIG1 promoter]]|Rosiglitazone promotes the reaction [PPARG protein results in increased activity of INSIG1 promoter],15073165
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,PD 068235 inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],11416043
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,Resveratrol inhibits the reaction [Rosiglitazone binds to PPARG protein],24796862
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,Rosiglitazone binds to and results in increased activity of PPARG protein,10393202|10529360|10636887|11714655|12083418|12401879|12414803|12970094|14709329|14744930|15334371|15381068|15504970|15640776|15684043|15751073|16034372|16215386|16321982|16425225|16499875|16539667|16609881|16617452|16750656|16757903|16799780|17107731|17188145|17245590|17261469|17264099|17266988|17437057|17445544|17453334|17456854|17461532|17475839|17506947|17555498|17594812|17597835|17932317|17950491|17951467|17970706|18053798|18155663|18238811|18269641|18269830|18276752|18387855|18562925|18565938|18599600|18652780|18700276|18948087|18954260|18998217|19147827|19193937|19201733|19226370|19321784|19356226|19451898|19464576|19474210|19508902|19520784|19631733|19641680|19706614|19850645|19902320|19906946|20003221|20007851|20032081|20068562|20336061|20506517|20507283|20733306|20814411|20840543|20965162|21034554|21113404|21172411|21212935|21269478|21490083|21515302|21531777|21559208|21741058|21757225|21781307|21798686|21798687|24025786|24412557
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,Rosiglitazone binds to PPARG protein,10813377|19632256|20860658|21525782|24796862
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,Rosiglitazone binds to [PPARG protein binds to RXRA protein],10882139
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,[Rosiglitazone binds to PPARG protein] which binds to RXRA protein,15715931
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,TLR4 mRNA affects the reaction [Rosiglitazone inhibits the reaction [AGT protein results in increased expression of PPARG protein]]|Rosiglitazone inhibits the reaction [AGT protein results in decreased expression of PPARG protein]|Rosiglitazone inhibits the reaction [AGT protein results in decreased expression of PPARG mRNA],19451898
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,Rosiglitazone promotes the reaction [NCOA6 protein binds to PPARG protein]|Rosiglitazone promotes the reaction [PPARGC1A protein binds to PPARG protein],30920877
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,Rosiglitazone results in increased activity of PPARG protein,10799317|11416043|16775433|16819505|16982809|19277604|19666838|19951259|21347706|21484566|21720023
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,Rosiglitazone results in increased activity of [RXRA protein binds to PPARG protein],11752099
77999,D000077154,Rosiglitazone,PPARG,5468,NULL,NULL,Rosiglitazone results in increased expression of PPARG,17614770
78435,C480398,atraric acid,PPARG,5468,Homo sapiens,9606,atraric acid binds to and results in increased activity of PPARG protein,33049310
79362,C041260,mono-n-octyl phthalate,PPARG,5468,Homo sapiens,9606,mono-n-octyl phthalate binds to PPARG protein,23843199
81131,C584787,2-acetylphenothiazine,PPARG,5468,Homo sapiens,9606,2-acetylphenothiazine inhibits the reaction [torcetrapib results in increased expression of PPARG mRNA],25617244
82145,C022776,2-bromopalmitate,PPARG,5468,Rattus norvegicus,10116,2-bromopalmitate results in increased expression of PPARG protein,10650946
82755,C005975,"3,4-dihydroxyphenylethanol",PPARG,5468,Mus musculus,10090,"3,4-dihydroxyphenylethanol results in decreased expression of PPARG mRNA",21569430
86102,C087114,tebuconazole,PPARG,5468,Homo sapiens,9606,tebuconazole binds to and results in increased activity of PPARG protein,33049310
86210,C000627121,metconazole,PPARG,5468,Homo sapiens,9606,metconazole binds to and results in increased activity of PPARG protein,33049310
86354,C429623,"4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide",PPARG,5468,Homo sapiens,9606,"4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased activity of PPARG protein",20143881
86398,C108339,fludioxonil,PPARG,5468,Danio rerio,7955,fludioxonil binds to and results in increased activity of PPARG protein,33049310
86412,C099403,"S-methyl benzo(1,2,3)thiadiazole-7-carbothioate",PPARG,5468,Homo sapiens,9606,"S-methyl benzo(1,2,3)thiadiazole-7-carbothioate binds to and results in increased activity of PPARG protein",33049310
89440,C033116,acetyl methyl tetramethyl tetralin,PPARG,5468,Danio rerio,7955,acetyl methyl tetramethyl tetralin binds to and results in decreased activity of PPARG protein|acetyl methyl tetramethyl tetralin binds to and affects the activity of PPARG protein,33049310
89440,C033116,acetyl methyl tetramethyl tetralin,PPARG,5468,Homo sapiens,9606,acetyl methyl tetramethyl tetralin binds to and results in increased activity of PPARG protein,24155963
89594,D009538,Nicotine,PPARG,5468,Mus musculus,10090,Nicotine results in decreased expression of PPARG protein,33082140
89594,D009538,Nicotine,PPARG,5468,Mus musculus,10090,Nicotine results in increased expression of PPARG mRNA,31622651
90532,C049841,mono-n-hexyl phthalate,PPARG,5468,Homo sapiens,9606,mono-n-hexyl phthalate binds to PPARG protein,23843199
91511,C423722,bisphenol F diglycidyl ether,PPARG,5468,Homo sapiens,9606,bisphenol F diglycidyl ether inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30138673
91649,C014290,hydroxyflutamide,PPARG,5468,Homo sapiens,9606,hydroxyflutamide binds to and results in increased activity of PPARG protein,33049310
91693,C087058,penconazole,PPARG,5468,Mus musculus,10090,penconazole results in increased expression of PPARG mRNA,31733957
91699,C053549,triflumizol,PPARG,5468,Homo sapiens,9606,triflumizol binds to and results in increased activity of PPARG protein,33049310
91699,C053549,triflumizol,PPARG,5468,Homo sapiens,9606,triflumizol results in increased activity of PPARG protein,20143881
91699,C053549,triflumizol,PPARG,5468,Mus musculus,10090,triflumizol results in increased expression of PPARG mRNA|triflumizol results in increased activity of PPARG protein,23086663
91754,C428725,pyridaben,PPARG,5468,Homo sapiens,9606,pyridaben binds to and results in increased activity of PPARG protein,33049310
91754,C428725,pyridaben,PPARG,5468,Homo sapiens,9606,pyridaben inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30818834
91757,C071869,dithiopyr,PPARG,5468,Danio rerio,7955,dithiopyr binds to and results in increased activity of PPARG protein,33049310
92094,C479072,delta-tocopherol,PPARG,5468,Rattus norvegicus,10116,[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]|[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA],22389237
92272,C575690,mono-isobutyl phthalate,PPARG,5468,Mus musculus,10090,[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA,31884101
92729,D024504,gamma-Tocopherol,PPARG,5468,Homo sapiens,9606,gamma-Tocopherol results in increased expression of PPARG protein|gamma-Tocopherol results in increased expression of PPARG mRNA,14521714
92729,D024504,gamma-Tocopherol,PPARG,5468,Rattus norvegicus,10116,[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]|[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA],22389237
94140,C017725,stearoyl-coenzyme A,PPARG,5468,Homo sapiens,9606,stearoyl-coenzyme A binds to and results in increased activity of PPARG protein,11139385
95168,C485800,osajin,PPARG,5468,Homo sapiens,9606,osajin results in decreased expression of PPARG mRNA,20706672
95170,C511295,"2,2',4,4'-tetrabromodiphenyl ether",PPARG,5468,Chlorocebus aethiops,9534,"2,2',4,4'-tetrabromodiphenyl ether results in decreased methylation of PPARG promoter|2,2',4,4'-tetrabromodiphenyl ether results in increased activity of PPARG protein",24559133
95170,C511295,"2,2',4,4'-tetrabromodiphenyl ether",PPARG,5468,Homo sapiens,9606,"2,2',4,4'-tetrabromodiphenyl ether analog results in increased activity of PPARG protein",28282128
95170,C511295,"2,2',4,4'-tetrabromodiphenyl ether",PPARG,5468,Homo sapiens,9606,"2,2',4,4'-tetrabromodiphenyl ether binds to and results in increased activity of PPARG protein",23398518
95170,C511295,"2,2',4,4'-tetrabromodiphenyl ether",PPARG,5468,Homo sapiens,9606,"2,2',4,4'-tetrabromodiphenyl ether binds to PPARG protein|2,2',4,4'-tetrabromodiphenyl ether metabolite binds to PPARG protein",25314719
95170,C511295,"2,2',4,4'-tetrabromodiphenyl ether",PPARG,5468,Homo sapiens,9606,"2,2',4,4'-tetrabromodiphenyl ether metabolite results in increased activity of PPARG protein|2,2',4,4'-tetrabromodiphenyl ether results in increased activity of PPARG protein",26172262
95170,C511295,"2,2',4,4'-tetrabromodiphenyl ether",PPARG,5468,Homo sapiens,9606,"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PPARG mRNA",23146750
95170,C511295,"2,2',4,4'-tetrabromodiphenyl ether",PPARG,5468,Mus musculus,10090,"Dietary Fats promotes the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PPARG mRNA]|2,2',4,4'-tetrabromodiphenyl ether promotes the reaction [Dietary Fats results in increased expression of PPARG mRNA]",29523931
95170,C511295,"2,2',4,4'-tetrabromodiphenyl ether",PPARG,5468,Mus musculus,10090,"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PPARG mRNA",24559133|29112739|29523931
95170,C511295,"2,2',4,4'-tetrabromodiphenyl ether",PPARG,5468,Mus musculus,10090,"ESR1 gene mutant form inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PPARG mRNA]",29112739
95170,C511295,"2,2',4,4'-tetrabromodiphenyl ether",PPARG,5468,Ursus maritimus,29073,"2,2',4,4'-tetrabromodiphenyl ether results in increased activity of PPARG protein",27602593
98523,C025351,delta(9)-tetrahydrocannabinolic acid,PPARG,5468,Homo sapiens,9606,delta(9)-tetrahydrocannabinolic acid inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA]|delta(9)-tetrahydrocannabinolic acid results in decreased expression of PPARG protein|delta(9)-tetrahydrocannabinolic acid results in increased expression of PPARG mRNA,28853159
99474,D004144,Diosgenin,PPARG,5468,Homo sapiens,9606,Diosgenin results in increased expression of PPARG mRNA,32347045
99474,D004144,Diosgenin,PPARG,5468,Mus musculus,10090,Diosgenin results in decreased expression of PPARG mRNA|PPARG protein inhibits the reaction [Diosgenin results in decreased expression of FABP4 mRNA]|Diosgenin inhibits the reaction [RXRA protein binds to PPARG protein]|Diosgenin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]|[Diosgenin inhibits the reaction [RXRA protein binds to PPARG protein]] which results in decreased activity of PPARG protein|Fulvestrant inhibits the reaction [Diosgenin results in decreased expression of PPARG mRNA]|PPARG protein results in decreased susceptibility to Diosgenin,26408789
99474,D004144,Diosgenin,PPARG,5468,Mus musculus,10090,Diosgenin results in increased expression of PPARG protein,24001619
99474,D004144,Diosgenin,PPARG,5468,Mus musculus,10090,PPARG protein inhibits the reaction [Diosgenin results in decreased expression of PPARG mRNA],26408789|26408789
104741,D000077267,Fulvestrant,PPARG,5468,Homo sapiens,9606,Fulvestrant inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]|PPARG protein affects the reaction [Fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]],32623698
104741,D000077267,Fulvestrant,PPARG,5468,Mus musculus,10090,Fulvestrant inhibits the reaction [Diethylstilbestrol results in increased activity of PPARG protein],22710028
104741,D000077267,Fulvestrant,PPARG,5468,Mus musculus,10090,Fulvestrant inhibits the reaction [Diosgenin results in decreased expression of PPARG mRNA],26408789
104775,D002087,Butyrates,PPARG,5468,Homo sapiens,9606,Butyrates results in increased expression of PPARG mRNA|PPARG protein affects the reaction [Butyrates results in increased expression of CDKN1B mRNA],16112107
104850,D000077285,Rimonabant,PPARG,5468,Mus musculus,10090,Rimonabant affects the expression of PPARG mRNA,20110567
104865,D000077300,Bosentan,PPARG,5468,Homo sapiens,9606,Bosentan results in decreased expression of PPARG mRNA,29761207
104926,C052570,cyfluthrin,PPARG,5468,Danio rerio,7955,cyfluthrin binds to and results in increased activity of PPARG protein,33049310
105059,C064116,"S-(1,1,2,2-tetrafluoroethyl)cysteine",PPARG,5468,Mus musculus,10090,"S-(1,1,2,2-tetrafluoroethyl)cysteine results in increased expression of PPARG mRNA",16678137
107650,C042431,S-ethyl glutathione,PPARG,5468,Mus musculus,10090,S-ethyl glutathione inhibits the reaction [Buthionine Sulfoximine results in increased expression of PPARG mRNA],21520053
107720,D007306,Insecticides,PPARG,5468,Mus musculus,10090,Insecticides results in decreased expression of PPARG mRNA,23401056
107807,D020913,Perindopril,PPARG,5468,Rattus norvegicus,10116,Perindopril results in increased expression of PPARG mRNA|Perindopril results in increased expression of PPARG protein|Perindopril inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA]|Perindopril inhibits the reaction [Methotrexate results in decreased expression of PPARG protein],34737150
108007,C007095,cobaltiprotoporphyrin,PPARG,5468,Homo sapiens,9606,cobaltiprotoporphyrin affects the expression of PPARG protein,23497794
108223,D003847,Deoxyglucose,PPARG,5468,Mus musculus,10090,PPARG protein affects the uptake of Deoxyglucose|PPARG gene polymorphism results in increased uptake of Deoxyglucose,18083318
110394,C471400,monoisononylphthalate,PPARG,5468,Homo sapiens,9606,monoisononylphthalate binds to PPARG protein,23843199
110394,C471400,monoisononylphthalate,PPARG,5468,Homo sapiens,9606,monoisononylphthalate results in increased activity of PPARG protein,27551952
110394,C471400,monoisononylphthalate,PPARG,5468,Mus musculus,10090,[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA,31884101
114481,C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",PPARG,5468,Homo sapiens,9606,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of PPARG mRNA",32790152
114917,C021751,tanshinone,PPARG,5468,Mus musculus,10090,tanshinone results in decreased expression of PPARG mRNA,20854809
117291,C576262,"bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate",PPARG,5468,Homo sapiens,9606,"bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate metabolite binds to PPARG protein",25314719
117291,C576262,"bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate",PPARG,5468,Homo sapiens,9606,"bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate metabolite results in increased activity of PPARG protein|bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate results in increased activity of PPARG protein",27506419
117291,C576262,"bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate",PPARG,5468,Mus musculus,10090,"PPARG mutant form inhibits the reaction [bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate metabolite results in increased expression of FABP4 mRNA]",23014847
119096,C080276,mono(2-ethyl-5-oxohexyl)phthalate,PPARG,5468,Homo sapiens,9606,mono(2-ethyl-5-oxohexyl)phthalate binds to and affects the folding of and results in increased activity of PPARG protein,30085373
122162,C057154,luzindole,PPARG,5468,Homo sapiens,9606,luzindole inhibits the reaction [Pioglitazone results in increased expression of PPARG protein]|luzindole inhibits the reaction [Melatonin results in increased expression of PPARG protein],29734669
122724,C050414,celastrol,PPARG,5468,Mus musculus,10090,celastrol affects the expression of PPARG protein|celastrol affects the expression of PPARG mRNA,27085773
123351,C494474,perchlorate,PPARG,5468,Xenopus laevis,8355,perchlorate results in decreased expression of PPARG mRNA,17403546
123976,C076996,27-hydroxycholesterol,PPARG,5468,Rattus norvegicus,10116,27-hydroxycholesterol results in increased expression of PPARG protein|27-hydroxycholesterol results in increased expression of PPARG mRNA,28167099
126941,D008727,Methotrexate,PPARG,5468,Rattus norvegicus,10116,18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG protein]|18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA],28414158
126941,D008727,Methotrexate,PPARG,5468,Rattus norvegicus,10116,[Methotrexate co-treated with Leucovorin] results in increased expression of PPARG protein|[Methotrexate co-treated with Leucovorin] results in increased expression of PPARG mRNA|Methotrexate results in increased expression of PPARG protein,25187349
126941,D008727,Methotrexate,PPARG,5468,Rattus norvegicus,10116,Methotrexate results in decreased expression of PPARG protein|Methotrexate results in decreased expression of PPARG mRNA,28414158|34737150
126941,D008727,Methotrexate,PPARG,5468,Rattus norvegicus,10116,Perindopril inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA]|Perindopril inhibits the reaction [Methotrexate results in decreased expression of PPARG protein],34737150
127019,C087130,SR 11237,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [ciglitazone promotes the reaction [SR 11237 results in increased expression of RARB protein]],12839938
134601,D001218,Aspartame,PPARG,5468,Mus musculus,10090,"[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA",23783067
145068,D009569,Nitric Oxide,PPARG,5468,Homo sapiens,9606,[Rosiglitazone binds to and affects the activity of PPARG protein] which results in increased abundance of Nitric Oxide,16527820
145068,D009569,Nitric Oxide,PPARG,5468,Mus musculus,10090,"PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]|ciglitazone inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]|PPARG protein affects the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]|15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]|GW 1929 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]",12847270
145068,D009569,Nitric Oxide,PPARG,5468,Rattus norvegicus,10116,"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide]|[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] promotes the reaction [manganese chloride promotes the reaction [[IFNG protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]]|[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [manganese chloride promotes the reaction [[IFNG protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]]",18041089
145068,D009569,Nitric Oxide,PPARG,5468,Rattus norvegicus,10116,Nitric Oxide deficiency results in increased expression of PPARG protein,17063326
148124,D000077143,Docetaxel,PPARG,5468,Homo sapiens,9606,[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in increased susceptibility to Docetaxel,23964924
148124,D000077143,Docetaxel,PPARG,5468,Mus musculus,10090,[Celecoxib co-treated with Docetaxel] results in increased expression of PPARG protein,16052515
151183,C116017,"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide",PPARG,5468,Homo sapiens,9606,"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide binds to and results in increased activity of PPARG protein",11139385|9836514
151183,C116017,"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide",PPARG,5468,Homo sapiens,9606,"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide results in increased activity of PPARG protein",15273253
151183,C116017,"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide",PPARG,5468,NULL,NULL,"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide binds to and results in decreased activity of PPARG protein",12676649
151183,C116017,"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide",PPARG,5468,NULL,NULL,"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide binds to and results in increased activity of PPARG protein",11712408|12808885
151183,C116017,"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide",PPARG,5468,NULL,NULL,"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide results in increased activity of PPARG protein",10799317
151289,C049639,evodiamine,PPARG,5468,Mus musculus,10090,evodiamine results in decreased expression of PPARG,17884939
154005,C112100,"5-((4-(2-(1-indolyl)ethoxy)-phenyl)methyl)thiazolidine-2,4-dione",PPARG,5468,Homo sapiens,9606,"5-((4-(2-(1-indolyl)ethoxy)-phenyl)methyl)thiazolidine-2,4-dione results in increased activity of PPARG protein alternative form",23563205
154083,C517827,pentabrominated diphenyl ether 100,PPARG,5468,Ursus maritimus,29073,pentabrominated diphenyl ether 100 results in increased activity of PPARG protein,27602593
155160,C542058,4-O-methylhonokiol,PPARG,5468,Mus musculus,10090,[Ethanol co-treated with Carbon Tetrachloride co-treated with 4-O-methylhonokiol] results in decreased expression of PPARG mRNA,28689299
155166,C517828,hexabrominated diphenyl ether 153,PPARG,5468,Ursus maritimus,29073,hexabrominated diphenyl ether 153 results in increased activity of PPARG protein,27602593
156391,D009288,Naproxen,PPARG,5468,Rattus norvegicus,10116,Naproxen results in increased activity of PPARG protein,11755111
156422,C452139,doramapimod,PPARG,5468,Mus musculus,10090,doramapimod results in increased expression of PPARG mRNA,21328587
156703,C484543,3-hydroxystilbene,PPARG,5468,Mus musculus,10090,3-hydroxystilbene results in decreased expression of PPARG mRNA,23748787
158103,C015499,schizandrin B,PPARG,5468,Rattus norvegicus,10116,schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PPARG mRNA],31150632
158333,C046393,tert-butylphenyl diphenyl phosphate,PPARG,5468,Homo sapiens,9606,tert-butylphenyl diphenyl phosphate results in increased activity of PPARG protein,26172262
158501,C529607,25-hydroxyprotopanaxadiol,PPARG,5468,Rattus norvegicus,10116,dorsomorphin inhibits the reaction [25-hydroxyprotopanaxadiol results in increased phosphorylation of PPARG protein]|25-hydroxyprotopanaxadiol results in increased phosphorylation of PPARG protein|SB 239063 inhibits the reaction [25-hydroxyprotopanaxadiol results in increased phosphorylation of PPARG protein],33676887
159325,C483909,torcetrapib,PPARG,5468,Homo sapiens,9606,torcetrapib results in increased expression of PPARG mRNA|setanaxib inhibits the reaction [torcetrapib results in increased expression of PPARG mRNA]|2-acetylphenothiazine inhibits the reaction [torcetrapib results in increased expression of PPARG mRNA],25617244
160511,C496492,abrine,PPARG,5468,Homo sapiens,9606,abrine results in increased expression of PPARG mRNA,31054353
160512,C078098,ar-turmerone,PPARG,5468,Homo sapiens,9606,ar-turmerone binds to PPARG protein,15713005
160570,C006884,cannabidiolic acid,PPARG,5468,Homo sapiens,9606,cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|cannabidiolic acid results in increased expression of PPARG mRNA|cannabidiolic acid binds to and results in increased activity of PPARG protein,30611848
160570,C006884,cannabidiolic acid,PPARG,5468,Homo sapiens,9606,cannabidiolic acid results in decreased expression of PPARG protein|cannabidiolic acid results in increased expression of PPARG mRNA,28853159
162166,C011875,ingenol dibenzoate,PPARG,5468,Homo sapiens,9606,ingenol dibenzoate results in increased activity of PPARG protein,15707588
162859,C108953,platycodin D,PPARG,5468,Homo sapiens,9606,platycodin D results in decreased expression of PPARG protein,30599906
162859,C108953,platycodin D,PPARG,5468,Mus musculus,10090,CTNNB1 affects the reaction [platycodin D results in increased expression of PPARG mRNA],21798269
162859,C108953,platycodin D,PPARG,5468,Mus musculus,10090,KLF2 affects the reaction [platycodin D results in decreased expression of PPARG mRNA]|platycodin D results in decreased activity of PPARG protein|KLF2 affects the reaction [platycodin D results in decreased activity of PPARG protein],20024897
162859,C108953,platycodin D,PPARG,5468,Mus musculus,10090,platycodin D results in decreased expression of PPARG mRNA,20024897|26244589
162859,C108953,platycodin D,PPARG,5468,Mus musculus,10090,platycodin D results in decreased expression of PPARG protein,21798269|22872592|26244589|30599906
169870,D000077713,17 alpha-Hydroxyprogesterone Caproate,PPARG,5468,Danio rerio,7955,17 alpha-Hydroxyprogesterone Caproate binds to and results in increased activity of PPARG protein,33049310
170364,C422415,farglitazar,PPARG,5468,Homo sapiens,9606,farglitazar binds to and results in increased activity of PPARG protein,33049310
170364,C422415,farglitazar,PPARG,5468,Rattus norvegicus,10116,farglitazar results in increased expression of PPARG mRNA|farglitazar binds to and results in increased activity of PPARG protein,15475592
170364,C422415,farglitazar,PPARG,5468,NULL,NULL,farglitazar binds to [PPARG protein binds to RXRA protein],10882139
176155,C093642,SB 203580,PPARG,5468,Mus musculus,10090,[SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form],14984747
176155,C093642,SB 203580,PPARG,5468,Mus musculus,10090,SB 203580 results in decreased expression of PPARG protein|SB 203580 results in decreased expression of PPARG mRNA,23603106
176155,C093642,SB 203580,PPARG,5468,Rattus norvegicus,10116,SB 203580 results in increased expression of PPARG protein|SB 203580 inhibits the reaction [Ethanol results in decreased expression of PPARG protein]|SB 203580 results in increased expression of PPARG mRNA,24412557
186907,D016604,Aflatoxin B1,PPARG,5468,Homo sapiens,9606,Aflatoxin B1 results in decreased methylation of PPARG gene,27153756
186907,D016604,Aflatoxin B1,PPARG,5468,Mus musculus,10090,Aflatoxin B1 results in increased expression of PPARG mRNA,19770486
204109,C115174,netoglitazone,PPARG,5468,Homo sapiens,9606,netoglitazone results in increased expression of PPARG mRNA,21354099
204109,C115174,netoglitazone,PPARG,5468,NULL,NULL,netoglitazone binds to and results in increased activity of PPARG protein,14977855|16112107
206044,C500085,muraglitazar,PPARG,5468,Homo sapiens,9606,muraglitazar binds to and results in increased activity of PPARG protein,17426106|17675651
206044,C500085,muraglitazar,PPARG,5468,Mus musculus,10090,muraglitazar binds to and results in increased activity of PPARG protein,17675651
206044,C500085,muraglitazar,PPARG,5468,Rattus norvegicus,10116,muraglitazar results in decreased expression of PPARG mRNA,21515302
206044,C500085,muraglitazar,PPARG,5468,NULL,NULL,muraglitazar affects the activity of PPARG protein,16168052
206044,C500085,muraglitazar,PPARG,5468,NULL,NULL,muraglitazar binds to and results in increased activity of PPARG protein,17132713|21515302
206044,C500085,muraglitazar,PPARG,5468,NULL,NULL,muraglitazar results in increased activity of PPARG protein,16506266
208901,C501413,tesaglitazar,PPARG,5468,Homo sapiens,9606,tesaglitazar binds to and results in increased activity of PPARG protein,17610302
208901,C501413,tesaglitazar,PPARG,5468,Homo sapiens,9606,tesaglitazar results in increased activity of PPARG protein,12401884
208901,C501413,tesaglitazar,PPARG,5468,Rattus norvegicus,10116,tesaglitazar affects the expression of PPARG mRNA,21270424
208901,C501413,tesaglitazar,PPARG,5468,NULL,NULL,tesaglitazar affects the activity of PPARG protein,16168052
208901,C501413,tesaglitazar,PPARG,5468,NULL,NULL,tesaglitazar binds to and results in increased activity of PPARG protein,12401884|17468185|21270424|21515302
222528,D003840,Deoxycholic Acid,PPARG,5468,Mus musculus,10090,Deoxycholic Acid results in decreased expression of PPARG mRNA,23911798
223368,D004857,Equilin,PPARG,5468,Danio rerio,7955,Equilin binds to and results in decreased activity of PPARG protein,33049310
253613,D001572,Benzofurans,PPARG,5468,Mus musculus,10090,Benzofurans results in decreased expression of PPARG protein|Benzofurans results in decreased expression of PPARG mRNA,20863820
304599,C002469,fusarenon-X,PPARG,5468,Homo sapiens,9606,fusarenon-X results in decreased activity of PPARG protein,27481073
312145,D000077191,Wortmannin,PPARG,5468,Rattus norvegicus,10116,Wortmannin inhibits the reaction [bisphenol A results in decreased expression of PPARG mRNA],23399309
392622,D019438,Ritonavir,PPARG,5468,Homo sapiens,9606,Ritonavir results in increased expression of PPARG mRNA,17879945
392622,D019438,Ritonavir,PPARG,5468,Mus musculus,10090,Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein],11101056
400769,C445068,bardoxolone methyl,PPARG,5468,Mus musculus,10090,bardoxolone methyl results in increased expression of PPARG mRNA|bardoxolone methyl results in increased expression of PPARG protein,21289052
433294,D018021,Lithium Chloride,PPARG,5468,Homo sapiens,9606,Lithium Chloride results in increased expression of PPARG mRNA,23527032
439213,D005944,Glucosamine,PPARG,5468,Homo sapiens,9606,Glucosamine results in increased expression of PPARG|Glucosamine promotes the reaction [IL1B results in increased expression of PPARG],22089456
439213,D005944,Glucosamine,PPARG,5468,Mus musculus,10090,Glucosamine results in increased expression of PPARG mRNA,15694357
439217,C001293,glucosamine 6-phosphate,PPARG,5468,Mus musculus,10090,glucosamine 6-phosphate results in decreased expression of PPARG protein,19427183
439230,D008798,Mevalonic Acid,PPARG,5468,Rattus norvegicus,10116,Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA],20578043
439260,D009638,Norepinephrine,PPARG,5468,Rattus norvegicus,10116,Norepinephrine results in increased expression of PPARG mRNA,19109942
441140,D006118,Griseofulvin,PPARG,5468,Mus musculus,10090,Griseofulvin results in increased expression of PPARG mRNA,9548566
441203,D002945,Cisplatin,PPARG,5468,Homo sapiens,9606,Cisplatin affects the activity of PPARG protein,25596134
441203,D002945,Cisplatin,PPARG,5468,Homo sapiens,9606,Cisplatin affects the expression of PPARG mRNA,23300844
441203,D002945,Cisplatin,PPARG,5468,Homo sapiens,9606,PPARG protein results in increased susceptibility to [Rosiglitazone co-treated with Cisplatin]|Cisplatin results in decreased expression of PPARG protein,27417252
441203,D002945,Cisplatin,PPARG,5468,Homo sapiens,9606,[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased susceptibility to Cisplatin|[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Cisplatin,21781307
441203,D002945,Cisplatin,PPARG,5468,Mus musculus,10090,Melatonin inhibits the reaction [Cisplatin results in decreased expression of PPARG protein]|Cisplatin results in decreased expression of PPARG protein,34428482
441203,D002945,Cisplatin,PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA]|Pioglitazone inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA]",22989705
441203,D002945,Cisplatin,PPARG,5468,Rattus norvegicus,10116,7-hydroxycoumarin inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA],33522649
441203,D002945,Cisplatin,PPARG,5468,Rattus norvegicus,10116,Cisplatin results in decreased expression of PPARG mRNA,22989705|33522649
441203,D002945,Cisplatin,PPARG,5468,Rattus norvegicus,10116,wogonin inhibits the reaction [Cisplatin results in decreased expression of PPARG protein]|Cisplatin results in decreased expression of PPARG protein,31103702
441921,C049864,ginsenoside Re,PPARG,5468,Mus musculus,10090,ginsenoside Re results in increased expression of PPARG mRNA,23545455
441934,C072936,notoginsenoside R1,PPARG,5468,Mus musculus,10090,notoginsenoside R1 results in increased expression of PPARG|2-chloro-5-nitrobenzanilide inhibits the reaction [notoginsenoside R1 results in increased expression of PPARG],25714973
442089,C012043,stevioside,PPARG,5468,Mus musculus,10090,stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA],25554529
442428,C005274,naringin,PPARG,5468,Mus musculus,10090,naringin affects the reaction [LEPR protein affects the expression of PPARG protein],16427799
442428,C005274,naringin,PPARG,5468,Mus musculus,10090,naringin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA],22198281
442428,C005274,naringin,PPARG,5468,Rattus norvegicus,10116,naringin inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA]|[naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA],30130594
442530,C025589,ochratoxin A,PPARG,5468,Homo sapiens,9606,ochratoxin A results in decreased activity of PPARG protein,20590410|27481073
442530,C025589,ochratoxin A,PPARG,5468,Homo sapiens,9606,ochratoxin A results in decreased expression of PPARG|ochratoxin A results in increased phosphorylation of PPARG protein,20590410
442530,C025589,ochratoxin A,PPARG,5468,Homo sapiens,9606,ochratoxin A results in increased expression of PPARG mRNA,32905824
442530,C025589,ochratoxin A,PPARG,5468,Rattus norvegicus,10116,"ochratoxin A results in increased expression of PPARG mRNA|15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA]|8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA]",15994020
442793,C007845,gingerol,PPARG,5468,Mus musculus,10090,gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG mRNA]|gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein],22285432
442793,C007845,gingerol,PPARG,5468,Mus musculus,10090,GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG mRNA]|GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG protein]|gingerol results in decreased expression of PPARG protein|gingerol results in decreased expression of PPARG mRNA,26498061
443495,C017947,sodium arsenite,PPARG,5468,Danio rerio,7955,sodium arsenite results in decreased expression of PPARG mRNA,29361514
443495,C017947,sodium arsenite,PPARG,5468,Gallus gallus,9031,sodium arsenite results in decreased expression of PPARG mRNA,20308225
443495,C017947,sodium arsenite,PPARG,5468,Homo sapiens,9606,sodium arsenite results in decreased expression of PPARG mRNA,23221991
443495,C017947,sodium arsenite,PPARG,5468,Mus musculus,10090,gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG mRNA]|sodium arsenite results in decreased expression of PPARG protein|gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein],22285432
443495,C017947,sodium arsenite,PPARG,5468,Mus musculus,10090,[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of PPARG mRNA|[sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of PPARG mRNA|[Palmitic Acid co-treated with sodium arsenite] results in decreased expression of PPARG mRNA,34968464
443495,C017947,sodium arsenite,PPARG,5468,Mus musculus,10090,sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA],23152186
443495,C017947,sodium arsenite,PPARG,5468,Mus musculus,10090,sodium arsenite inhibits the reaction [Dietary Fats results in increased expression of PPARG protein],28283972
443495,C017947,sodium arsenite,PPARG,5468,Mus musculus,10090,sodium arsenite inhibits the reaction [[INS1 protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA],11812925
443495,C017947,sodium arsenite,PPARG,5468,Mus musculus,10090,sodium arsenite results in decreased expression of PPARG mRNA,21396911|22285432|23221991|34968464
443495,C017947,sodium arsenite,PPARG,5468,Mus musculus,10090,sodium arsenite results in increased expression of PPARG mRNA,26151952|31170414
443495,C017947,sodium arsenite,PPARG,5468,Mus musculus,10090,sodium arsenite results in increased expression of PPARG protein,25367288
443495,C017947,sodium arsenite,PPARG,5468,Rattus norvegicus,10116,[lead acetate co-treated with sodium arsenite co-treated with Cadmium Chloride] results in increased expression of PPARG protein|[lead acetate co-treated with sodium arsenite] results in increased expression of PPARG protein|sodium arsenite results in increased expression of PPARG protein|pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PPARG protein]|PPARG protein affects the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased expression of and results in increased cleavage of PARP1 protein]|[Cadmium Chloride co-treated with sodium arsenite] results in increased expression of PPARG protein|PPARG protein affects the reaction [sodium arsenite results in increased cleavage of PARP1 protein]|CR8 compound analog inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PPARG protein],28283887
443495,C017947,sodium arsenite,PPARG,5468,Rattus norvegicus,10116,[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein|T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]|[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [PPARG protein binds to GFAP promoter]|CR8 compound inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]|T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of PPARG protein]|[[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein|[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein],24481447
443495,C017947,sodium arsenite,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein]|sodium arsenite results in decreased expression of PPARG protein|Taurine inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein],30551535
444036,D000068298,Fluticasone,PPARG,5468,Homo sapiens,9606,Fluticasone promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]],15531761
444539,C029010,cinnamic acid,PPARG,5468,Mus musculus,10090,cinnamic acid results in increased expression of PPARG mRNA,21870829
444795,D014212,Tretinoin,PPARG,5468,Homo sapiens,9606,[PPARG protein results in increased expression of ALDH1A2 protein] which results in increased chemical synthesis of Tretinoin|[Rosiglitazone results in increased activity of PPARG protein] which results in increased abundance of Tretinoin|[PPARG protein results in increased expression of RDH10 protein] which results in increased chemical synthesis of Tretinoin,16982809
444795,D014212,Tretinoin,PPARG,5468,Homo sapiens,9606,[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PPARG protein,32929351
444795,D014212,Tretinoin,PPARG,5468,Homo sapiens,9606,Tretinoin results in increased expression of PPARG mRNA,21934132|23724009
444795,D014212,Tretinoin,PPARG,5468,Mus musculus,10090,Tretinoin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA],32473317
444795,D014212,Tretinoin,PPARG,5468,Mus musculus,10090,Tretinoin results in decreased expression of PPARG mRNA,11237167
444795,D014212,Tretinoin,PPARG,5468,Mus musculus,10090,Tretinoin results in increased expression of PPARG mRNA,17198874
444795,D014212,Tretinoin,PPARG,5468,Rattus norvegicus,10116,Tretinoin results in increased expression of PPARG protein|Tretinoin results in increased expression of PPARG mRNA,14568882
444899,D016718,Arachidonic Acid,PPARG,5468,Homo sapiens,9606,Arachidonic Acid results in decreased expression of PPARG protein|Arachidonic Acid results in decreased expression of PPARG mRNA,11172467
444899,D016718,Arachidonic Acid,PPARG,5468,Mus musculus,10090,Arachidonic Acid promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA],19063610
444899,D016718,Arachidonic Acid,PPARG,5468,Rattus norvegicus,10116,Arachidonic Acid results in increased expression of PPARG protein,12604186
445070,D005204,Farnesol,PPARG,5468,Homo sapiens,9606,[Farnesol analog co-treated with Oleic Acid] results in increased expression of PPARG mRNA|Farnesol analog results in increased expression of PPARG mRNA,30611723
445154,D000077185,Resveratrol,PPARG,5468,Canis lupus familiaris,9615,Resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein]|[Resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]] inhibits the reaction [Niacinamide results in increased expression of PPARG]|[Resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of PPARG protein|[Resveratrol results in decreased acetylation of RUNX2 protein] inhibits the reaction [Niacinamide results in increased expression of PPARG],22539994
445154,D000077185,Resveratrol,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Resveratrol results in increased expression of AGER protein]|[Resveratrol results in increased activity of PPARG protein] which results in decreased expression of AGER protein|[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Resveratrol results in decreased abundance of Cholesterol]|[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to Resveratrol,20372816
445154,D000077185,Resveratrol,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [Resveratrol results in increased expression of ABCG1 mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [Resveratrol results in increased expression of PPARG mRNA]|PPARG protein promotes the reaction [Resveratrol results in increased expression of CYP27A1 mRNA]|PPARG protein promotes the reaction [Resveratrol results in increased expression of ABCA1 protein]|PPARG protein promotes the reaction [Resveratrol results in increased expression of ABCA1 mRNA]|PPARG protein promotes the reaction [Resveratrol results in increased expression of CYP27A1 protein],23041272
445154,D000077185,Resveratrol,PPARG,5468,Homo sapiens,9606,dorsomorphin inhibits the reaction [Resveratrol results in decreased expression of PPARG mRNA],24584901
445154,D000077185,Resveratrol,PPARG,5468,Homo sapiens,9606,Resveratrol analog binds to PPARG protein|[Resveratrol analog co-treated with Dietary Fats] results in increased expression of PPARG mRNA|Resveratrol analog results in increased expression of PPARG mRNA,24759758
445154,D000077185,Resveratrol,PPARG,5468,Homo sapiens,9606,Resveratrol binds to and results in increased activity of PPARG protein,24454499
445154,D000077185,Resveratrol,PPARG,5468,Homo sapiens,9606,Resveratrol inhibits the reaction [Linoleic Acid results in increased expression of PPARG protein]|Resveratrol results in decreased expression of PPARG protein,25672876
445154,D000077185,Resveratrol,PPARG,5468,Homo sapiens,9606,"Resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in decreased activity of PPARG protein]|Resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased phosphorylation of and results in increased activity of PPARG protein]",18776171
445154,D000077185,Resveratrol,PPARG,5468,Homo sapiens,9606,Resveratrol results in decreased expression of PPARG mRNA,20706672|21713995|24584901
445154,D000077185,Resveratrol,PPARG,5468,Homo sapiens,9606,Resveratrol results in increased activity of PPARG protein,16849586|17007354|17055343|20372816
445154,D000077185,Resveratrol,PPARG,5468,Homo sapiens,9606,Resveratrol results in increased expression of PPARG mRNA,23041272|23750556
445154,D000077185,Resveratrol,PPARG,5468,Homo sapiens,9606,Resveratrol results in increased expression of PPARG protein,20372816|20709957|23041272
445154,D000077185,Resveratrol,PPARG,5468,Mus musculus,10090,Resveratrol results in decreased stability of and results in decreased activity of PPARG protein|Resveratrol results in increased degradation of and results in increased ubiquitination of PPARG protein|benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Resveratrol results in decreased expression of PPARG protein]|epoxomicin inhibits the reaction [Resveratrol results in decreased expression of PPARG protein],18555852
445154,D000077185,Resveratrol,PPARG,5468,Mus musculus,10090,splitomicin promotes the reaction [Resveratrol results in decreased expression of PPARG mRNA]|Resveratrol affects the activity of PPARG protein|splitomicin promotes the reaction [Resveratrol results in decreased expression of PPARG protein]|PPARG protein affects the susceptibility to Resveratrol,23525482
445154,D000077185,Resveratrol,PPARG,5468,Mus musculus,10090,Resveratrol analog results in decreased expression of PPARG mRNA,23748787|24779192
445154,D000077185,Resveratrol,PPARG,5468,Mus musculus,10090,[Resveratrol co-treated with Dietary Fats] results in decreased expression of PPARG mRNA,24985011
445154,D000077185,Resveratrol,PPARG,5468,Mus musculus,10090,[Resveratrol co-treated with Oxygen deficiency] results in increased expression of PPARG protein,21113404
445154,D000077185,Resveratrol,PPARG,5468,Mus musculus,10090,Resveratrol inhibits the reaction [Acrolein results in decreased expression of PPARG protein],34813903
445154,D000077185,Resveratrol,PPARG,5468,Mus musculus,10090,Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of PPARG protein],29197120
445154,D000077185,Resveratrol,PPARG,5468,Mus musculus,10090,Resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA],18755807
445154,D000077185,Resveratrol,PPARG,5468,Mus musculus,10090,Resveratrol metabolite results in decreased expression of PPARG mRNA,22945685
445154,D000077185,Resveratrol,PPARG,5468,Mus musculus,10090,Resveratrol results in decreased expression of PPARG mRNA,16813520|18555852|18930334|21109418|21467634|22659145|23525482|23748787|24722352|25338179
445154,D000077185,Resveratrol,PPARG,5468,Mus musculus,10090,Resveratrol results in decreased expression of PPARG protein,18555852|18930334|22935344|23525482|25761413
445154,D000077185,Resveratrol,PPARG,5468,Mus musculus,10090,Resveratrol results in increased expression of PPARG protein,24036142
445154,D000077185,Resveratrol,PPARG,5468,Mus musculus,10090,Rosiglitazone inhibits the reaction [Resveratrol analog results in decreased expression of PPARG mRNA],24779192
445154,D000077185,Resveratrol,PPARG,5468,Rattus norvegicus,10116,Resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA],18793633
445154,D000077185,Resveratrol,PPARG,5468,Rattus norvegicus,10116,Resveratrol inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA],25108154
445154,D000077185,Resveratrol,PPARG,5468,Rattus norvegicus,10116,Resveratrol results in decreased acetylation of and results in decreased activity of PPARG protein,28973641
445154,D000077185,Resveratrol,PPARG,5468,Rattus norvegicus,10116,Resveratrol results in decreased expression of PPARG mRNA,23848300
445154,D000077185,Resveratrol,PPARG,5468,Sus scrofa,9823,Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of PPARG protein],21739664
445154,D000077185,Resveratrol,PPARG,5468,Sus scrofa,9823,Resveratrol results in decreased expression of PPARG mRNA,17851734
445154,D000077185,Resveratrol,PPARG,5468,Sus scrofa,9823,Resveratrol results in decreased expression of PPARG protein,21575630
445154,D000077185,Resveratrol,PPARG,5468,NULL,NULL,Resveratrol binds to PPARG protein|Resveratrol metabolite binds to PPARG protein|Resveratrol inhibits the reaction [Rosiglitazone binds to PPARG protein],24796862
445154,D000077185,Resveratrol,PPARG,5468,NULL,NULL,Resveratrol inhibits the reaction [NCOA6 protein binds to PPARG protein],30920877
445154,D000077185,Resveratrol,PPARG,5468,NULL,NULL,Resveratrol inhibits the reaction [TNF protein results in decreased activity of and results in decreased expression of PPARG protein],20943792
445354,D014801,Vitamin A,PPARG,5468,Rattus norvegicus,10116,Vitamin A inhibits the reaction [Safflower Oil results in increased expression of PPARG mRNA],15203375
445354,D014801,Vitamin A,PPARG,5468,Rattus norvegicus,10116,Vitamin A results in increased expression of PPARG mRNA,16180333
445580,D004281,Docosahexaenoic Acids,PPARG,5468,Homo sapiens,9606,"Docosahexaenoic Acids results in increased activity of PPARG protein|Docosahexaenoic Acids results in increased expression of PPARG mRNA|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Docosahexaenoic Acids results in increased activity of PPARG protein]",15698426
445580,D004281,Docosahexaenoic Acids,PPARG,5468,Mus musculus,10090,Docosahexaenoic Acids promotes the reaction [Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein]]|Docosahexaenoic Acids promotes the reaction [Benzo(a)pyrene results in increased activity of PPARG protein]|Docosahexaenoic Acids results in increased activity of PPARG protein|Docosahexaenoic Acids promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein],27329536
445580,D004281,Docosahexaenoic Acids,PPARG,5468,Mus musculus,10090,Docosahexaenoic Acids results in decreased expression of PPARG mRNA,21569430
445580,D004281,Docosahexaenoic Acids,PPARG,5468,Mus musculus,10090,Docosahexaenoic Acids results in increased expression of PPARG mRNA,21164549
445639,D019301,Oleic Acid,PPARG,5468,Homo sapiens,9606,[Farnesol analog co-treated with Oleic Acid] results in increased expression of PPARG mRNA|[GW 4064 co-treated with Oleic Acid] results in decreased expression of PPARG mRNA,30611723
445639,D019301,Oleic Acid,PPARG,5468,Homo sapiens,9606,Oleic Acid binds to and results in increased activity of PPARG protein,27131391
445639,D019301,Oleic Acid,PPARG,5468,Homo sapiens,9606,Oleic Acid binds to PPARG protein,24998974
445639,D019301,Oleic Acid,PPARG,5468,Homo sapiens,9606,[Oleic Acid co-treated with Fenofibrate] results in increased expression of PPARG mRNA,24534255
445639,D019301,Oleic Acid,PPARG,5468,Homo sapiens,9606,Oleic Acid results in increased expression of PPARG mRNA|Oleic Acid results in increased expression of PPARG protein,11172467
445639,D019301,Oleic Acid,PPARG,5468,Mus musculus,10090,Oleic Acid results in increased expression of PPARG mRNA,18154422
445639,D019301,Oleic Acid,PPARG,5468,Rattus norvegicus,10116,Ethanol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA]|[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA],26854922
445639,D019301,Oleic Acid,PPARG,5468,Rattus norvegicus,10116,[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA,25048947|26190035|26854922
445639,D019301,Oleic Acid,PPARG,5468,Rattus norvegicus,10116,Triiodothyronine inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA]|tetrabromobisphenol A inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA],25048947
445643,D016559,Tacrolimus,PPARG,5468,Homo sapiens,9606,[Sirolimus co-treated with Tacrolimus] results in increased expression of PPARG protein,17016853
445858,C004999,ferulic acid,PPARG,5468,Mus musculus,10090,ferulic acid results in increased expression of PPARG mRNA,21870829
446284,D015118,Eicosapentaenoic Acid,PPARG,5468,Homo sapiens,9606,"Eicosapentaenoic Acid results in increased activity of PPARG protein|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eicosapentaenoic Acid results in increased activity of PPARG protein]",15698426
446284,D015118,Eicosapentaenoic Acid,PPARG,5468,Homo sapiens,9606,Eicosapentaenoic Acid results in increased expression of PPARG mRNA,11172467|15698426
446284,D015118,Eicosapentaenoic Acid,PPARG,5468,Homo sapiens,9606,Eicosapentaenoic Acid results in increased expression of PPARG protein,11172467
446284,D015118,Eicosapentaenoic Acid,PPARG,5468,NULL,NULL,Eicosapentaenoic Acid binds to and results in increased activity of PPARG protein,10753628
447277,C002963,geranylgeranyl pyrophosphate,PPARG,5468,Rattus norvegicus,10116,geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA],20578043
447458,C432703,ragaglitazar,PPARG,5468,NULL,NULL,ragaglitazar binds to and results in increased activity of PPARG protein,15655531
447715,C464660,obeticholic acid,PPARG,5468,Rattus norvegicus,10116,obeticholic acid results in increased expression of PPARG mRNA|obeticholic acid results in increased expression of PPARG protein,15980055
447912,C423915,T0901317,PPARG,5468,Homo sapiens,9606,T0901317 affects the expression of PPARG mRNA,28903485
447912,C423915,T0901317,PPARG,5468,Tachysurus fulvidraco,1234273,T0901317 promotes the reaction [[Copper Sulfate results in increased abundance of Copper] which results in decreased expression of PPARG mRNA]|T0901317 results in decreased expression of PPARG mRNA,30100477
448042,C108830,Y 27632,PPARG,5468,Rattus norvegicus,10116,Y 27632 results in increased expression of PPARG mRNA,20578043
448457,D015230,Prostaglandin D2,PPARG,5468,Homo sapiens,9606,Prostaglandin D2 affects the localization of and results in increased expression of PPARG protein,23943857
448457,D015230,Prostaglandin D2,PPARG,5468,Homo sapiens,9606,Prostaglandin D2 affects the localization of PPARG protein,23220503
448457,D015230,Prostaglandin D2,PPARG,5468,NULL,NULL,Prostaglandin D2 binds to and results in increased activity of PPARG protein,18387855
448537,D004054,Diethylstilbestrol,PPARG,5468,Danio rerio,7955,Diethylstilbestrol binds to and results in decreased activity of PPARG protein,33049310
448537,D004054,Diethylstilbestrol,PPARG,5468,Mus musculus,10090,Diethylstilbestrol results in increased activity of PPARG protein|Diethylstilbestrol results in increased expression of PPARG protein|Diethylstilbestrol results in increased expression of PPARG mRNA|2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of PPARG protein]|Fulvestrant inhibits the reaction [Diethylstilbestrol results in increased activity of PPARG protein]|[Troglitazone co-treated with Diethylstilbestrol] results in increased expression of PPARG protein,22710028
448537,D004054,Diethylstilbestrol,PPARG,5468,Mus musculus,10090,Diethylstilbestrol inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein],26944108
449171,D000077556,Alitretinoin,PPARG,5468,Homo sapiens,9606,MG 262 promotes the reaction [Alitretinoin results in increased activity of PPARG protein]|benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Alitretinoin results in increased activity of PPARG protein]|Alitretinoin results in increased activity of PPARG protein,15707588
449171,D000077556,Alitretinoin,PPARG,5468,Mus musculus,10090,[Pioglitazone co-treated with Alitretinoin] inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine],17019405
449171,D000077556,Alitretinoin,PPARG,5468,Mus musculus,10090,PPARG protein promotes the reaction [Alitretinoin results in increased expression of PPARGC1A mRNA],16513826
449171,D000077556,Alitretinoin,PPARG,5468,Rattus norvegicus,10116,[9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter],15150131
449171,D000077556,Alitretinoin,PPARG,5468,Rattus norvegicus,10116,Alitretinoin binds to and results in increased activity of PPARG protein,18063688
449171,D000077556,Alitretinoin,PPARG,5468,NULL,NULL,Alitretinoin binds to [PPARG protein binds to RXRA protein],10882139
449459,C016601,afimoxifene,PPARG,5468,Homo sapiens,9606,afimoxifene binds to and results in increased activity of PPARG protein,33049310
449459,C016601,afimoxifene,PPARG,5468,Homo sapiens,9606,afimoxifene inhibits the reaction [PPARG protein binds to CD36 promoter]|afimoxifene inhibits the reaction [PPARG protein results in increased expression of CD36 mRNA]|afimoxifene results in decreased expression of and results in increased phosphorylation of PPARG protein|PPARG mRNA promotes the reaction [afimoxifene results in decreased expression of CD36 protein],27358406
451668,D000077209,Decitabine,PPARG,5468,Homo sapiens,9606,Decitabine affects the expression of PPARG mRNA,23300844
451668,D000077209,Decitabine,PPARG,5468,Homo sapiens,9606,Decitabine results in increased expression of PPARG mRNA,16763620
452967,C012042,steviol,PPARG,5468,Mus musculus,10090,steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA],25554529
454937,D006051,Aurothioglucose,PPARG,5468,Mus musculus,10090,[Dietary Fats co-treated with Aurothioglucose] results in decreased expression of PPARG protein,21382165
462382,C072553,benzyloxycarbonylleucyl-leucyl-leucine aldehyde,PPARG,5468,Homo sapiens,9606,"benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein]|benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Alitretinoin results in increased activity of PPARG protein]|benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of PPARG protein",15707588
462382,C072553,benzyloxycarbonylleucyl-leucyl-leucine aldehyde,PPARG,5468,Mus musculus,10090,benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Resveratrol results in decreased expression of PPARG protein]|benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Rosiglitazone results in decreased expression of PPARG protein],18555852
471002,C515005,ganoderic acid A,PPARG,5468,Mus musculus,10090,[Dietary Fats co-treated with ganoderic acid A] affects the expression of PPARG mRNA,29852127
480775,C548688,dehydroglyasperin C,PPARG,5468,Homo sapiens,9606,dehydroglyasperin C binds to PPARG protein,14608046
490002,C423917,MG 262,PPARG,5468,Homo sapiens,9606,"MG 262 promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein]|MG 262 promotes the reaction [Alitretinoin results in increased activity of PPARG protein]|MG 262 results in increased activity of PPARG protein",15707588
518605,D000077237,Arsenic Trioxide,PPARG,5468,Homo sapiens,9606,Arsenic Trioxide results in decreased expression of PPARG protein|Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARG protein]|Rosiglitazone inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARG protein],30362509
518605,D000077237,Arsenic Trioxide,PPARG,5468,Homo sapiens,9606,[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PPARG protein|Arsenic Trioxide results in increased expression of and results in decreased activity of PPARG protein,32929351
518605,D000077237,Arsenic Trioxide,PPARG,5468,Homo sapiens,9606,KEAP1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of PPARG mRNA]|Arsenic Trioxide results in increased expression of PPARG protein|NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of PPARG mRNA]|Arsenic Trioxide results in increased expression of PPARG mRNA|[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide|[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide|KEAP1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of PPARG protein],22684020
518605,D000077237,Arsenic Trioxide,PPARG,5468,Homo sapiens,9606,PPARG protein results in decreased susceptibility to Arsenic Trioxide,20707922
518605,D000077237,Arsenic Trioxide,PPARG,5468,Mus musculus,10090,Arsenic Trioxide inhibits the reaction [AKT1 protein binds to PPARG protein]|Arsenic Trioxide inhibits the reaction [RXRA protein binds to PPARG protein],15916724
518605,D000077237,Arsenic Trioxide,PPARG,5468,Mus musculus,10090,Arsenic Trioxide results in decreased expression of PPARG protein,15916724|30362509
518605,D000077237,Arsenic Trioxide,PPARG,5468,Rattus norvegicus,10116,Arsenic Trioxide results in decreased expression of PPARG mRNA,31258454
590836,C012125,diisononyl phthalate,PPARG,5468,Homo sapiens,9606,diisononyl phthalate results in increased expression of PPARG mRNA|diisononyl phthalate binds to and results in increased activity of PPARG protein,29410257
590836,C012125,diisononyl phthalate,PPARG,5468,Homo sapiens,9606,diisononyl phthalate binds to PPARG protein,23843199
590836,C012125,diisononyl phthalate,PPARG,5468,Sparus aurata,8175,diisononyl phthalate results in decreased expression of PPARG mRNA,30600365
590836,C012125,diisononyl phthalate,PPARG,5468,Homo sapiens,9606,diisononyl phthalate affects the activity of PPARG protein,26172262
608583,C586321,mansonone G,PPARG,5468,Mus musculus,10090,mansonone G analog results in decreased activity of PPARG protein|mansonone G analog results in decreased expression of PPARG protein|mansonone G results in decreased expression of PPARG mRNA|mansonone G analog results in decreased expression of PPARG mRNA,28625492
616765,C053370,paclobutrazol,PPARG,5468,Sebastiscus marmoratus,41446,paclobutrazol results in increased expression of PPARG mRNA,23202249
637511,C012843,cinnamaldehyde,PPARG,5468,Mus musculus,10090,cinnamaldehyde results in decreased expression of PPARG mRNA,21401097
637542,C495469,p-coumaric acid,PPARG,5468,Mus musculus,10090,p-coumaric acid results in decreased expression of PPARG protein,23810795
637542,C495469,p-coumaric acid,PPARG,5468,Mus musculus,10090,p-coumaric acid results in increased expression of PPARG mRNA,21870829
637566,C007836,geraniol,PPARG,5468,Homo sapiens,9606,geraniol results in decreased expression of PPARG mRNA,27683099
637566,C007836,geraniol,PPARG,5468,Homo sapiens,9606,geraniol results in increased activity of PPARG protein,21597168
637566,C007836,geraniol,PPARG,5468,Mus musculus,10090,"geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in decreased expression of PPARG mRNA]|geraniol inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in decreased expression of PPARG protein]",30550845
637566,C007836,geraniol,PPARG,5468,Rattus norvegicus,10116,geraniol inhibits the reaction [Fructose results in decreased activity of PPARG protein],25679220
637566,C007836,geraniol,PPARG,5468,Rattus norvegicus,10116,geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]|geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA],26165751
637760,D002599,Chalcone,PPARG,5468,Mus musculus,10090,Chalcone analog results in increased expression of PPARG mRNA,28528971
638034,C009166,retinol acetate,PPARG,5468,Mus musculus,10090,"[retinol acetate co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of PPARG mRNA|NR1I3 protein affects the reaction [[retinol acetate co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of PPARG mRNA]",31449830
638278,C040920,isoliquiritigenin,PPARG,5468,Mus musculus,10090,isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of PPARG protein],27117918
641818,C097470,4'-methoxychalcone,PPARG,5468,Mus musculus,10090,4'-methoxychalcone analog results in increased expression of PPARG mRNA|4'-methoxychalcone analog inhibits the reaction [TNF protein results in decreased expression of PPARG mRNA]|4'-methoxychalcone analog results in increased expression of and results in increased activity of PPARG protein,28528971
644019,D002185,Cannabidiol,PPARG,5468,Danio rerio,7955,Cannabidiol affects the expression of PPARG mRNA,33892503
644019,D002185,Cannabidiol,PPARG,5468,Homo sapiens,9606,T 0070907 inhibits the reaction [Cannabidiol analog results in increased expression of PPARG mRNA alternative form]|Cannabidiol analog results in increased expression of PPARG mRNA alternative form|Cannabidiol analog binds to and results in increased activity of PPARG protein,30382123
644019,D002185,Cannabidiol,PPARG,5468,Homo sapiens,9606,Cannabidiol analog binds to PPARG protein|Cannabidiol analog inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|Cannabidiol analog results in increased activity of PPARG protein,30033591
644019,D002185,Cannabidiol,PPARG,5468,Homo sapiens,9606,Cannabidiol inhibits the reaction [Lipopolysaccharides promotes the reaction [PPARG protein binds to CMPK2 promoter]]|Cannabidiol inhibits the reaction [Lipopolysaccharides promotes the reaction [PPARG protein results in increased expression of CMPK2 mRNA]],34269108
644019,D002185,Cannabidiol,PPARG,5468,Homo sapiens,9606,Cannabidiol results in decreased expression of PPARG protein,28853159
644019,D002185,Cannabidiol,PPARG,5468,Homo sapiens,9606,Cannabidiol results in increased expression of and affects the localization of PPARG protein,23220503|30007266
644019,D002185,Cannabidiol,PPARG,5468,Homo sapiens,9606,Cannabidiol results in increased expression of PPARG mRNA|N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Cannabidiol affects the localization of PPARG protein],23220503
644019,D002185,Cannabidiol,PPARG,5468,Mus musculus,10090,Cannabidiol results in increased expression of PPARG mRNA|Cannabidiol binds to PPARG protein,19285060
644019,D002185,Cannabidiol,PPARG,5468,Mus musculus,10090,"[lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of PPARG mRNA",30742662
644019,D002185,Cannabidiol,PPARG,5468,NULL,NULL,Cannabidiol binds to PPARG protein,22971837
644109,D010171,Palmitoyl Coenzyme A,PPARG,5468,Homo sapiens,9606,Palmitoyl Coenzyme A binds to and results in increased activity of PPARG protein,11139385
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,"2-chloro-5-nitrobenzanilide inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased expression of PPARG protein]",28834734
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA],31075703
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Celecoxib affects the localization of PPARG protein],23943857
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Cilostazol results in increased activity of PPARG protein],21660147
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PPARG protein],31163220
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein],26863638
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Danio rerio,7955,2-chloro-5-nitrobenzanilide results in increased expression of PPARG mRNA,33892503
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide affects the reaction [Rosiglitazone affects the localization of PPARG protein],22321707
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein,12927354|15254749|18485432|19908241
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]]|[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [TNF protein results in decreased susceptibility to FSHB protein],21734263
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Resveratrol results in increased expression of AGER protein]|[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Resveratrol results in decreased abundance of Cholesterol]|[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to Resveratrol,20372816
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 mRNA]|[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 protein],15781755
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Troglitazone results in increased abundance of Reactive Oxygen Species]|[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Troglitazone results in increased expression of PRODH]|[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Troglitazone affects the localization of CYCS protein],22108328
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to perfluorooctanoic acid,23978332
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,"2-chloro-5-nitrobenzanilide inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane results in increased activity of PPARG protein]",15345676
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxyprostaglandin J2 results in increased activity of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [3-methylquercetin results in increased activity of PPARG protein],22992727
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species],23964924
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide results in increased expression of PPARG mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide promotes the reaction [PPARG binds to PPARG promoter]],15705899
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]],12927354
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide results in decreased expression of PPARG mRNA|2-chloro-5-nitrobenzanilide inhibits the reaction [Resveratrol results in increased expression of PPARG mRNA],23041272
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]],21333731
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],21660147|23964924|30138673
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA],18949406|21354099|22321707
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone results in increased expression of PPARG protein],22321707|24793810
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [Troglitazone results in increased activity of PPARG protein],15345676|23964924
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein,15345676|21543282
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [9-deoxy-delta-9-prostaglandin D2 results in increased expression of GDF15 protein],14662774
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,"[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of FADS2 mRNA]|[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of SCD mRNA]|[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased uptake of 1-acyl-2-(12-((7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl)phosphatidylcholine]",21123845
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of Troglitazone],16945329
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide results in decreased expression of PPARG protein,21376716
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Mus musculus,10090,2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein,19797938
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Mus musculus,10090,2-chloro-5-nitrobenzanilide inhibits the reaction [butylparaben results in increased expression of PPARG mRNA],22956630
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Mus musculus,10090,2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG mRNA],29094436
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Mus musculus,10090,2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of PPARG protein],22710028
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Mus musculus,10090,2-chloro-5-nitrobenzanilide inhibits the reaction [notoginsenoside R1 results in increased expression of PPARG],25714973
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Mus musculus,10090,2-chloro-5-nitrobenzanilide inhibits the reaction [tetrabromobisphenol A results in decreased expression of PPARG protein],24132472
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Mus musculus,10090,2-chloro-5-nitrobenzanilide promotes the reaction [PPARG protein results in increased susceptibility to Methamphetamine],17019405
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Mus musculus,10090,[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased expression of FABP4 mRNA|[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased expression of RETN protein|[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased expression of RETN mRNA|[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased expression of NAMPT mRNA|[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased expression of SCD1 mRNA|[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased expression of NAMPT protein,20863820
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Mus musculus,10090,[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased susceptibility to Rosiglitazone,17394460
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Mus musculus,10090,2-chloro-5-nitrobenzanilide results in decreased expression of PPARG protein,30328325
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Rattus norvegicus,10116,2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein,28973641
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Rattus norvegicus,10116,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to Rosiglitazone,19732122
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Rattus norvegicus,10116,2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased expression of PPARG mRNA],17531121
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Rattus norvegicus,10116,2-chloro-5-nitrobenzanilide inhibits the reaction [Genistein results in increased activity of PPARG protein],19903033
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Rattus norvegicus,10116,2-chloro-5-nitrobenzanilide inhibits the reaction [rosmarinic acid affects the expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [rosmarinic acid affects the expression of PPARG mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone affects the expression of PPARG mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone affects the expression of PPARG protein],28744220
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Rattus norvegicus,10116,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG protein]]|2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA]],16617452
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Rattus norvegicus,10116,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Paraquat results in decreased expression of PPARG mRNA]]|2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Paraquat results in decreased expression of PPARG protein]],30797787
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Rattus norvegicus,10116,2-chloro-5-nitrobenzanilide inhibits the reaction [[Troglitazone results in increased activity of PPARG protein] which results in increased expression of SFTPA1 mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]|2-chloro-5-nitrobenzanilide inhibits the reaction [[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]],21153920
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Rattus norvegicus,10116,hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased expression of PPARG protein]]|hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Vehicle Emissions results in decreased expression of PPARG protein]]|2-chloro-5-nitrobenzanilide promotes the reaction [Vehicle Emissions results in decreased expression of PPARG protein]|2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased expression of PPARG protein],24192212
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Rattus norvegicus,10116,2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]|Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]],24954035
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,Ursus maritimus,29073,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],27602593
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,NULL,NULL,2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein,12897060|15751073|15809511|15992368|15993011|16091010|16215386|16539667|16647253|16825603|17019405|17047030|17215434|17341418|17602619|18041089|18308446|18577375|18948087|19139119|19226370|19477051|19903033|19997048|20003221|20032081|20372816|20506517|20545756|21212935|21525782|21734263|21765445|21798687|22108328|22135674|22381257|22450444|23978332
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,NULL,NULL,[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] promotes the reaction [manganese chloride promotes the reaction [[IFNG protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]],18041089
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,NULL,NULL,2-chloro-5-nitrobenzanilide binds to and results in increased activity of PPARG protein,21067863
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,NULL,NULL,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [Sodium Dodecyl Sulfate binds to and results in increased activity of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [dodecylbenzenesulfonic acid binds to and results in increased activity of PPARG protein],24025786
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,NULL,NULL,2-chloro-5-nitrobenzanilide inhibits the reaction [NCOA6 protein binds to PPARG protein],30920877
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,NULL,NULL,2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone promotes the reaction [PPARG protein results in increased activity of INSIG1 promoter]],15073165
644213,C457499,2-chloro-5-nitrobenzanilide,PPARG,5468,NULL,NULL,2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein,14662774|16303758|16945329|16982809|17394460|17475839|19140230|30830211
657048,C105715,GW 2331,PPARG,5468,Homo sapiens,9606,GW 2331 results in increased activity of PPARG protein,15273253
657237,C024352,fludarabine,PPARG,5468,Mus musculus,10090,fludarabine inhibits the reaction [LEP protein inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA]]|fludarabine results in increased expression of PPARG mRNA|fludarabine results in increased expression of PPARG protein,21352814
657298,D011441,Propylthiouracil,PPARG,5468,Rattus norvegicus,10116,Propylthiouracil results in decreased expression of PPARG mRNA,24780913
657298,D011441,Propylthiouracil,PPARG,5468,Xenopus laevis,8355,Propylthiouracil results in decreased expression of PPARG mRNA,17403546
667639,C041525,"3,3',4,5'-tetrahydroxystilbene",PPARG,5468,Mus musculus,10090,"3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]|3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]",22298784
689043,C040048,caffeic acid,PPARG,5468,Mus musculus,10090,caffeic acid results in increased expression of PPARG mRNA,21870829
969516,D003474,Curcumin,PPARG,5468,Homo sapiens,9606,Curcumin binds to PPARG protein,15713005
969516,D003474,Curcumin,PPARG,5468,Homo sapiens,9606,Curcumin results in increased activity of PPARG protein|Curcumin results in decreased expression of PPARG protein modified form,15486348
969516,D003474,Curcumin,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [Curcumin results in decreased expression of CCN2 mRNA],17965732
969516,D003474,Curcumin,PPARG,5468,Mus musculus,10090,Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]],28595985
969516,D003474,Curcumin,PPARG,5468,Mus musculus,10090,Curcumin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA],19297423
969516,D003474,Curcumin,PPARG,5468,Mus musculus,10090,Curcumin results in decreased expression of and results in decreased activity of PPARG protein|Curcumin results in decreased expression of PPARG mRNA,23603106
969516,D003474,Curcumin,PPARG,5468,Rattus norvegicus,10116,"Curcumin inhibits the reaction [Lipopolysaccharides results in decreased activity of PPARG protein]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Curcumin inhibits the reaction [Lipopolysaccharides results in decreased activity of PPARG protein]]",29480285
969516,D003474,Curcumin,PPARG,5468,Rattus norvegicus,10116,Curcumin affects the localization of PPARG protein|2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased expression of PPARG mRNA],17531121
969516,D003474,Curcumin,PPARG,5468,Rattus norvegicus,10116,Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of PPARG mRNA]|Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of PPARG protein],17602960
969516,D003474,Curcumin,PPARG,5468,Rattus norvegicus,10116,Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA],18006644
969516,D003474,Curcumin,PPARG,5468,Rattus norvegicus,10116,Curcumin inhibits the reaction [EGF protein results in decreased expression of PPARG mRNA]|Curcumin inhibits the reaction [EGF protein results in decreased expression of PPARG protein],17372590
969516,D003474,Curcumin,PPARG,5468,Rattus norvegicus,10116,Curcumin inhibits the reaction [[SMAD4 protein binds to SMAD3 protein] which binds to PPARG promoter]|Curcumin inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA],16959952
969516,D003474,Curcumin,PPARG,5468,Rattus norvegicus,10116,Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]|Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein],16782535
969516,D003474,Curcumin,PPARG,5468,Rattus norvegicus,10116,Curcumin results in decreased expression of PPARG protein,19225048
969516,D003474,Curcumin,PPARG,5468,Rattus norvegicus,10116,Curcumin results in increased activity of PPARG protein,18332871
969516,D003474,Curcumin,PPARG,5468,Rattus norvegicus,10116,Curcumin results in increased expression of PPARG protein|Curcumin results in increased expression of PPARG mRNA,16959952|17531121|17602960|18332871
969516,D003474,Curcumin,PPARG,5468,NULL,NULL,Curcumin results in increased expression of PPARG,18462866
1231560,C558243,5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid,PPARG,5468,Homo sapiens,9606,5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid binds to and results in decreased activity of PPARG protein|5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid inhibits the reaction [Rosiglitazone promotes the reaction [PPARG protein binds to CREBBP protein]],21296151
1349907,D008713,Methimazole,PPARG,5468,Xenopus laevis,8355,Methimazole results in decreased expression of PPARG mRNA,17403546
1383884,C500528,cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester,PPARG,5468,Mus musculus,10090,cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester results in increased expression of PPARG mRNA,27659731
1548943,D002211,Capsaicin,PPARG,5468,Homo sapiens,9606,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Capsaicin results in increased activity of PPARG protein]|Capsaicin results in increased activity of PPARG protein",15383218
1548943,D002211,Capsaicin,PPARG,5468,Homo sapiens,9606,Capsaicin results in decreased expression of PPARG mRNA,18769453
1548943,D002211,Capsaicin,PPARG,5468,Mus musculus,10090,Capsaicin results in decreased expression of PPARG protein,17295509
1548943,D002211,Capsaicin,PPARG,5468,Rattus norvegicus,10116,Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA],20359164
1712094,D010081,Oxazolone,PPARG,5468,Mus musculus,10090,tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PPARG protein]|Oxazolone results in increased expression of PPARG protein,22200888
1794427,D002726,Chlorogenic Acid,PPARG,5468,Homo sapiens,9606,Chlorogenic Acid results in decreased expression of PPARG mRNA,20706672
1794427,D002726,Chlorogenic Acid,PPARG,5468,Mus musculus,10090,Chlorogenic Acid results in increased expression of PPARG mRNA,21870829
2723650,D005031,Ethylenethiourea,PPARG,5468,Danio rerio,7955,Ethylenethiourea results in decreased expression of PPARG mRNA,32738127
2723949,D013853,Thioacetamide,PPARG,5468,Rattus norvegicus,10116,Thioacetamide results in increased expression of PPARG mRNA,23411599
2724354,D004113,Succimer,PPARG,5468,Mus musculus,10090,[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PPARG mRNA,26378955
2727594,C000708209,HET0016,PPARG,5468,Rattus norvegicus,10116,HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]],31063766
2733489,C056934,fumonisin B2,PPARG,5468,Homo sapiens,9606,fumonisin B2 results in decreased activity of PPARG protein,27481073
2733526,D013629,Tamoxifen,PPARG,5468,Homo sapiens,9606,Tamoxifen results in decreased expression of PPARG protein|Tamoxifen inhibits the reaction [PPARG protein results in increased expression of CD36 mRNA]|PPARG mRNA promotes the reaction [Tamoxifen inhibits the reaction [Buthionine Sulfoximine results in increased expression of CD36 protein]]|Tamoxifen results in decreased expression of and results in increased phosphorylation of PPARG protein|Tamoxifen inhibits the reaction [PPARG protein binds to CD36 promoter]|PPARG mRNA promotes the reaction [Tamoxifen results in decreased expression of CD36 protein]|PPARG mRNA promotes the reaction [Tamoxifen results in decreased expression of CD36 mRNA],27358406
2733526,D013629,Tamoxifen,PPARG,5468,Mus musculus,10090,Tamoxifen binds to and results in decreased activity of PPARG protein,33049310
2733526,D013629,Tamoxifen,PPARG,5468,Mus musculus,10090,Tamoxifen results in increased expression of PPARG mRNA,25123088
2773624,C104672,4-hydroxyisoleucine,PPARG,5468,Homo sapiens,9606,4-hydroxyisoleucine results in increased expression of PPARG mRNA,32347045
2773624,C104672,4-hydroxyisoleucine,PPARG,5468,Rattus norvegicus,10116,4-hydroxyisoleucine results in decreased expression of PPARG mRNA,25454462
2777391,C458508,T 0070907,PPARG,5468,Homo sapiens,9606,T 0070907 inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA alternative form]|T 0070907 inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|[T 0070907 binds to PPARG protein] which results in decreased susceptibility to Rosiglitazone|T 0070907 inhibits the reaction [Cannabidiol analog results in increased expression of PPARG mRNA alternative form]|T 0070907 binds to PPARG protein,30382123
2777391,C458508,T 0070907,PPARG,5468,Homo sapiens,9606,T 0070907 inhibits the reaction [di-n-butyltin results in increased expression of PPARG mRNA]|T 0070907 results in decreased expression of PPARG mRNA|T 0070907 inhibits the reaction [tributyltin results in increased expression of PPARG mRNA]|T 0070907 inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA],29787037
2777391,C458508,T 0070907,PPARG,5468,Homo sapiens,9606,T 0070907 inhibits the reaction [glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA],21511917
2777391,C458508,T 0070907,PPARG,5468,Homo sapiens,9606,T 0070907 inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA],21354099
2777391,C458508,T 0070907,PPARG,5468,Homo sapiens,9606,T 0070907 results in decreased activity of PPARG protein|T 0070907 promotes the reaction [Arsenic results in decreased expression of PPARG protein],23108036
2777391,C458508,T 0070907,PPARG,5468,Mus musculus,10090,T 0070907 inhibits the reaction [tributyltin binds to and results in increased activity of PPARG protein]|T 0070907 inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein]|T 0070907 binds to and results in decreased activity of PPARG protein,24155963
2777391,C458508,T 0070907,PPARG,5468,Mus musculus,10090,T 0070907 inhibits the reaction [[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein],26944108
2777391,C458508,T 0070907,PPARG,5468,Mus musculus,10090,T 0070907 inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30033591
2777391,C458508,T 0070907,PPARG,5468,Mus musculus,10090,[T 0070907 results in decreased activity of PPARG protein] which results in decreased expression of ERO1A mRNA,17452443
2777391,C458508,T 0070907,PPARG,5468,Rattus norvegicus,10116,T 0070907 inhibits the reaction [[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of MBP mRNA]|T 0070907 binds to and results in decreased activity of PPARG protein,18543250
2777391,C458508,T 0070907,PPARG,5468,Rattus norvegicus,10116,T 0070907 inhibits the reaction [Rosiglitazone results in increased expression of PPARG protein]|[T 0070907 binds to PPARG protein] which results in decreased susceptibility to Rosiglitazone,18455351
2777391,C458508,T 0070907,PPARG,5468,Rattus norvegicus,10116,T 0070907 inhibits the reaction [rosmarinic acid affects the expression of PPARG mRNA]|T 0070907 inhibits the reaction [Pioglitazone affects the expression of PPARG mRNA]|T 0070907 inhibits the reaction [rosmarinic acid affects the expression of PPARG protein]|T 0070907 inhibits the reaction [Pioglitazone affects the expression of PPARG protein],28744220
2777391,C458508,T 0070907,PPARG,5468,Rattus norvegicus,10116,T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]|T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of PPARG protein],24481447
2777391,C458508,T 0070907,PPARG,5468,NULL,NULL,T 0070907 binds to and results in decreased activity of PPARG protein,16091293|19321784
2777391,C458508,T 0070907,PPARG,5468,NULL,NULL,T 0070907 binds to and results in increased activity of PPARG protein,21067863
2800647,C547957,4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide,PPARG,5468,Mus musculus,10090,4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide results in increased expression of PPARG mRNA|4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide inhibits the reaction [GW 1929 results in increased expression of PPARG mRNA],20516370
3006531,C113580,U 0126,PPARG,5468,Homo sapiens,9606,U 0126 inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]|U 0126 inhibits the reaction [Acetaldehyde inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]],17030193
3006531,C113580,U 0126,PPARG,5468,Homo sapiens,9606,U 0126 inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA],31075703
3006531,C113580,U 0126,PPARG,5468,Homo sapiens,9606,U 0126 inhibits the reaction [deoxynivalenol results in increased expression of PPARG mRNA],18485432
3006531,C113580,U 0126,PPARG,5468,Homo sapiens,9606,U 0126 promotes the reaction [PPARG protein results in increased expression of PCSK9 protein],22593575
3006531,C113580,U 0126,PPARG,5468,Mus musculus,10090,U 0126 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]],16971554
3006531,C113580,U 0126,PPARG,5468,Mus musculus,10090,U 0126 inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein],12758056
3016570,C438457,"3,3,5-trimethylcyclohexanone",PPARG,5468,Homo sapiens,9606,"3,3,5-trimethylcyclohexanone binds to and results in decreased activity of PPARG protein",27633901
3034010,D000077403,Orlistat,PPARG,5468,Homo sapiens,9606,Orlistat results in increased expression of PPARG mRNA,32347045
3083542,C471849,lenabasum,PPARG,5468,Mus musculus,10090,lenabasum inhibits the reaction [Bleomycin results in decreased expression of PPARG protein],27153807
3091786,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,PPARG,5468,Homo sapiens,9606,"2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PPARG mRNA]",25304490
3391107,C470613,quinoxyfen,PPARG,5468,Homo sapiens,9606,quinoxyfen results in increased expression of PPARG mRNA,32473317
3392731,C453899,GW 7647,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [GW 7647 results in increased activity of DIO2 protein]|GW 7647 binds to and results in increased activity of PPARG protein,19036883
3392731,C453899,GW 7647,PPARG,5468,Homo sapiens,9606,GW 7647 results in increased activity of PPARG protein,20143881
3392731,C453899,GW 7647,PPARG,5468,Mus musculus,10090,[PPARA protein co-treated with GW 7647] results in increased expression of PPARG mRNA,21324916
3423265,D012967,Sodium Dodecyl Sulfate,PPARG,5468,NULL,NULL,2-chloro-5-nitrobenzanilide inhibits the reaction [Sodium Dodecyl Sulfate binds to and results in increased activity of PPARG protein]|Sodium Dodecyl Sulfate binds to and results in increased activity of PPARG protein,24025786
3651377,C060893,MK-886,PPARG,5468,Homo sapiens,9606,Indomethacin promotes the reaction [MK-886 results in increased activity of PPARG protein]|MK-886 affects the localization of PPARG protein|MK-886 results in increased activity of PPARG protein|[Indomethacin co-treated with MK-886] affects the localization of PPARG protein|MK-886 results in increased expression of PPARG mRNA,15899809
4166922,C551471,EPI 001,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [EPI 001 results in decreased expression of AR mRNA],25669987
4302963,C094023,iodopravadoline,PPARG,5468,Rattus norvegicus,10116,iodopravadoline results in decreased expression of PPARG protein|iodopravadoline inhibits the reaction [caryophyllene inhibits the reaction [Doxorubicin results in decreased expression of PPARG protein]],30836069
4302963,C094023,iodopravadoline,PPARG,5468,Rattus norvegicus,10116,"iodopravadoline inhibits the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of PPARG protein]]",30529211
4521392,C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",PPARG,5468,Homo sapiens,9606,"[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPARG mRNA",27188386
4668801,C548651,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester,PPARG,5468,Mus musculus,10090,2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of PPARG mRNA,19933214
5273284,C499731,resveratrol-4'-O-glucuronide,PPARG,5468,NULL,NULL,resveratrol-4'-O-glucuronide binds to PPARG protein,24796862
5274585,C443401,quercetin 3-O-glucuronide,PPARG,5468,Homo sapiens,9606,quercetin 3-O-glucuronide results in increased expression of PPARG mRNA,25765892
5280343,D011794,Quercetin,PPARG,5468,Homo sapiens,9606,Quercetin inhibits the reaction [ciglitazone results in increased activity of PPARG protein],18393431
5280343,D011794,Quercetin,PPARG,5468,Homo sapiens,9606,Quercetin results in increased expression of PPARG mRNA|Quercetin promotes the reaction [Rosiglitazone results in increased expression of PPARG protein]|Quercetin results in increased expression of PPARG protein,25765892
5280343,D011794,Quercetin,PPARG,5468,Mus musculus,10090,Quercetin inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein]|Quercetin binds to and results in increased activity of PPARG protein,18262572
5280343,D011794,Quercetin,PPARG,5468,Mus musculus,10090,Quercetin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein],18586010
5280343,D011794,Quercetin,PPARG,5468,Mus musculus,10090,Quercetin inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPARG mRNA],21462320
5280343,D011794,Quercetin,PPARG,5468,Mus musculus,10090,Quercetin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA],22447684|24025686
5280343,D011794,Quercetin,PPARG,5468,Rattus norvegicus,10116,[Dietary Fats co-treated with Quercetin] affects the expression of PPARG mRNA,20580672
5280343,D011794,Quercetin,PPARG,5468,Rattus norvegicus,10116,Quercetin inhibits the reaction [AGT protein results in decreased expression of PPARG protein]|PPARG protein affects the reaction [Quercetin inhibits the reaction [AGT protein results in increased expression of NPPA mRNA]]|PPARG protein affects the reaction [Quercetin inhibits the reaction [AGT protein results in increased expression of JUN protein]]|PPARG protein affects the reaction [Quercetin inhibits the reaction [AGT protein results in increased expression of NPPB mRNA]]|PPARG protein affects the reaction [Quercetin inhibits the reaction [AGT protein results in increased expression of FOS protein]],24039778
5280343,D011794,Quercetin,PPARG,5468,Sus scrofa,9823,Quercetin inhibits the reaction [Linoleic Acid results in increased activity of PPARG protein],15051824
5280343,D011794,Quercetin,PPARG,5468,NULL,NULL,Quercetin inhibits the reaction [TNF protein results in decreased activity of and results in decreased expression of PPARG protein],20943792
5280363,D015237,Dinoprost,PPARG,5468,Mus musculus,10090,[Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG mRNA|[Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG protein,21236357
5280373,C004541,biochanin A,PPARG,5468,Mus musculus,10090,biochanin A binds to and results in increased activity of PPARG protein,33049310
5280378,C007768,formononetin,PPARG,5468,NULL,NULL,formononetin results in increased activity of PPARG protein,19924040
5280436,C081565,arachidonyltrifluoromethane,PPARG,5468,Mus musculus,10090,arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA],19063610
5280443,D047310,Apigenin,PPARG,5468,Homo sapiens,9606,Apigenin binds to and results in increased activity of PPARG protein,33049310
5280443,D047310,Apigenin,PPARG,5468,Mus musculus,10090,Apigenin binds to and results in increased activity of PPARG protein,11343698|33049310
5280443,D047310,Apigenin,PPARG,5468,Mus musculus,10090,Apigenin results in decreased expression of PPARG mRNA,18359623
5280443,D047310,Apigenin,PPARG,5468,Mus musculus,10090,PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]|PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]],11343698
5280445,D047311,Luteolin,PPARG,5468,Homo sapiens,9606,Luteolin inhibits the reaction [Irinotecan results in decreased expression of PPARG mRNA]|Luteolin results in increased expression of PPARG mRNA|PPARG protein affects the reaction [Luteolin inhibits the reaction [Irinotecan results in increased expression of NQO1 mRNA]]|PPARG protein affects the reaction [Luteolin inhibits the reaction [Irinotecan results in increased expression of TNF mRNA]],34699766
5280450,D019787,Linoleic Acid,PPARG,5468,Homo sapiens,9606,Linoleic Acid binds to PPARG protein,23843199
5280450,D019787,Linoleic Acid,PPARG,5468,Homo sapiens,9606,Linoleic Acid results in decreased expression of PPARG mRNA,11172467|15708366
5280450,D019787,Linoleic Acid,PPARG,5468,Homo sapiens,9606,Linoleic Acid results in decreased expression of PPARG protein,11172467
5280450,D019787,Linoleic Acid,PPARG,5468,Homo sapiens,9606,Linoleic Acid results in increased activity of PPARG protein,25786526
5280450,D019787,Linoleic Acid,PPARG,5468,Homo sapiens,9606,Resveratrol inhibits the reaction [Linoleic Acid results in increased expression of PPARG protein]|Linoleic Acid results in increased expression of PPARG protein,25672876
5280450,D019787,Linoleic Acid,PPARG,5468,Mus musculus,10090,Linoleic Acid binds to and results in increased activity of PPARG protein,16731579
5280450,D019787,Linoleic Acid,PPARG,5468,Mus musculus,10090,Linoleic Acid binds to PPARG protein,12021203
5280450,D019787,Linoleic Acid,PPARG,5468,Mus musculus,10090,Linoleic Acid results in increased expression of PPARG mRNA,18154422
5280450,D019787,Linoleic Acid,PPARG,5468,Sus scrofa,9823,Quercetin inhibits the reaction [Linoleic Acid results in increased activity of PPARG protein]|Linoleic Acid results in increased activity of PPARG protein|Vitamin E inhibits the reaction [Linoleic Acid results in increased activity of PPARG protein],15051824
5280450,D019787,Linoleic Acid,PPARG,5468,Sus scrofa,9823,PPARG protein promotes the reaction [Linoleic Acid results in increased activity of RELA protein]|PPARG protein promotes the reaction [Linoleic Acid results in increased expression of IL6 protein],14519784
5280453,D002117,Calcitriol,PPARG,5468,Mus musculus,10090,Calcitriol results in decreased expression of PPARG mRNA,15036392|16368784|16813520
5280453,D002117,Calcitriol,PPARG,5468,Mus musculus,10090,Calcitriol results in decreased expression of PPARG protein,15036392
5280453,D002117,Calcitriol,PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]]|Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]|Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]]",29953732
5280489,D019207,beta Carotene,PPARG,5468,Mus musculus,10090,beta Carotene results in decreased expression of PPARG mRNA,21569430
5280647,C059922,gossypetin,PPARG,5468,Mus musculus,10090,PPARG protein affects the susceptibility to gossypetin,23845592
5280795,D014807,Vitamin D,PPARG,5468,Homo sapiens,9606,Vitamin D affects the expression of PPARG mRNA,20368581
5280795,D014807,Vitamin D,PPARG,5468,Homo sapiens,9606,[Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] affects the expression of PPARG mRNA,33836827
5280805,D005419,Flavonoids,PPARG,5468,Rattus norvegicus,10116,Flavonoids results in decreased expression of PPARG mRNA,23238999
5280863,C006552,kaempferol,PPARG,5468,Homo sapiens,9606,kaempferol binds to and results in increased activity of PPARG protein,33049310
5280863,C006552,kaempferol,PPARG,5468,Homo sapiens,9606,kaempferol results in increased expression of PPARG protein|kaempferol results in increased expression of PPARG mRNA,25765892
5280863,C006552,kaempferol,PPARG,5468,Mus musculus,10090,kaempferol binds to and results in increased activity of PPARG protein,11343698|18262572|33049310
5280863,C006552,kaempferol,PPARG,5468,Mus musculus,10090,kaempferol inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein],18262572
5280863,C006552,kaempferol,PPARG,5468,Mus musculus,10090,PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]|PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]],11343698
5280884,C037112,9-deoxy-delta-9-prostaglandin D2,PPARG,5468,Danio rerio,7955,9-deoxy-delta-9-prostaglandin D2 results in increased expression of PPARG protein,15964169
5280884,C037112,9-deoxy-delta-9-prostaglandin D2,PPARG,5468,Homo sapiens,9606,[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [9-deoxy-delta-9-prostaglandin D2 results in increased expression of GDF15 protein],14662774
5280884,C037112,9-deoxy-delta-9-prostaglandin D2,PPARG,5468,Homo sapiens,9606,9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein,11343236|15491415
5280884,C037112,9-deoxy-delta-9-prostaglandin D2,PPARG,5468,Homo sapiens,9606,[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased expression of ABCA1 mRNA]|[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [APOA1 protein results in increased transport of Cholesterol]|[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] which results in increased expression of ABCA1 mRNA|[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of Cholesterol]|[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] inhibits the reaction [IL1B protein results in decreased expression of ABCA1 mRNA]|[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] which results in increased expression of NR1H3 mRNA,12595494
5280884,C037112,9-deoxy-delta-9-prostaglandin D2,PPARG,5468,Homo sapiens,9606,9-deoxy-delta-9-prostaglandin D2 results in increased activity of PPARG protein|Ethanol inhibits the reaction [9-deoxy-delta-9-prostaglandin D2 results in increased activity of PPARG protein],17030193
5280884,C037112,9-deoxy-delta-9-prostaglandin D2,PPARG,5468,Homo sapiens,9606,9-deoxy-delta-9-prostaglandin D2 results in increased expression of PPARG mRNA,12595494|14512786
5280884,C037112,9-deoxy-delta-9-prostaglandin D2,PPARG,5468,Rattus norvegicus,10116,[9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter],15150131
5280884,C037112,9-deoxy-delta-9-prostaglandin D2,PPARG,5468,Rattus norvegicus,10116,9-deoxy-delta-9-prostaglandin D2 promotes the reaction [PPARG protein alternative form results in decreased activity of SLC2A4 promoter],12777391
5280884,C037112,9-deoxy-delta-9-prostaglandin D2,PPARG,5468,NULL,NULL,9-deoxy-delta-9-prostaglandin D2 binds to and affects the activity of PPARG protein,11409902
5280884,C037112,9-deoxy-delta-9-prostaglandin D2,PPARG,5468,NULL,NULL,9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein,12065618|12595494|17215434
5280884,C037112,9-deoxy-delta-9-prostaglandin D2,PPARG,5468,NULL,NULL,9-deoxy-delta-9-prostaglandin D2 binds to PPARG protein,11401521
5280914,C040527,lipoxin A4,PPARG,5468,Rattus norvegicus,10116,lipoxin A4 binds to and results in increased activity of PPARG protein,19321784
5280933,D017965,gamma-Linolenic Acid,PPARG,5468,Homo sapiens,9606,gamma-Linolenic Acid binds to and results in increased activity of PPARG protein,15318936
5280933,D017965,gamma-Linolenic Acid,PPARG,5468,Oryctolagus cuniculus,9986,gamma-Linolenic Acid results in increased expression of PPARG mRNA,25560393
5280934,D017962,alpha-Linolenic Acid,PPARG,5468,Homo sapiens,9606,alpha-Linolenic Acid binds to and results in increased activity of PPARG protein,16731579
5280934,D017962,alpha-Linolenic Acid,PPARG,5468,Homo sapiens,9606,alpha-Linolenic Acid results in increased activity of PPARG protein,20696231
5280934,D017962,alpha-Linolenic Acid,PPARG,5468,Mus musculus,10090,alpha-Linolenic Acid results in increased expression of PPARG mRNA,18154422
5280953,D006247,Harmine,PPARG,5468,Mus musculus,10090,Harmine results in increased expression of PPARG protein,27805061
5280953,D006247,Harmine,PPARG,5468,Mus musculus,10090,[phenylamil co-treated with Harmine] results in increased expression of PPARG mRNA,20519739
5280961,D019833,Genistein,PPARG,5468,Homo sapiens,9606,Genistein results in decreased expression of PPARG mRNA,20706672
5280961,D019833,Genistein,PPARG,5468,Mus musculus,10090,Genistein results in decreased expression of PPARG mRNA,18359623
5280961,D019833,Genistein,PPARG,5468,Rattus norvegicus,10116,"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Genistein results in increased activity of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [Genistein results in increased activity of PPARG protein]|Genistein results in increased activity of PPARG protein",19903033
5280961,D019833,Genistein,PPARG,5468,Rattus norvegicus,10116,Genistein inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]|Genistein inhibits the reaction [Dietary Fats results in increased expression of PPARG protein],27171397
5280961,D019833,Genistein,PPARG,5468,Rattus norvegicus,10116,Genistein results in increased expression of PPARG mRNA,24361872
5280961,D019833,Genistein,PPARG,5468,NULL,NULL,Genistein promotes the reaction [PPARGC1A protein binds to PPARG protein]|Genistein promotes the reaction [NCOA6 protein binds to PPARG protein],30920877
5281104,C084656,paricalcitol,PPARG,5468,Homo sapiens,9606,[Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein,17715259
5281239,C025164,fucoxanthin,PPARG,5468,Mus musculus,10090,fucoxanthin results in decreased expression of PPARG mRNA,20519145
5281316,C041246,cucurbitacin B,PPARG,5468,Mus musculus,10090,cucurbitacin B results in decreased expression of PPARG mRNA|STAT3 protein affects the reaction [cucurbitacin B results in decreased expression of PPARG mRNA],24316209
5281321,C038106,cucurbitacin I,PPARG,5468,Mus musculus,10090,cucurbitacin I results in decreased expression of PPARG mRNA,24316209
5281416,C007628,esculetin,PPARG,5468,Mus musculus,10090,esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of PPARG mRNA],27769711
5281416,C007628,esculetin,PPARG,5468,Rattus norvegicus,10116,esculetin inhibits the reaction [Streptozocin results in increased expression of PPARG protein]|esculetin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein],21450970
5281426,C031477,7-hydroxycoumarin,PPARG,5468,Rattus norvegicus,10116,7-hydroxycoumarin inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA]|7-hydroxycoumarin results in increased expression of PPARG mRNA,33522649
5281515,C024714,caryophyllene,PPARG,5468,Rattus norvegicus,10116,caryophyllene inhibits the reaction [Doxorubicin results in decreased expression of PPARG protein]|iodopravadoline inhibits the reaction [caryophyllene inhibits the reaction [Doxorubicin results in decreased expression of PPARG protein]],30836069
5281515,C024714,caryophyllene,PPARG,5468,Rattus norvegicus,10116,"caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of PPARG protein]|iodopravadoline inhibits the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of PPARG protein]]",30529211
5281544,C002769,oleuropein,PPARG,5468,Rattus norvegicus,10116,"oleuropein inhibits the reaction [Cholesterol, Dietary results in increased expression of PPARG protein]",27019295
5281576,D015025,Zearalenone,PPARG,5468,Homo sapiens,9606,Zearalenone results in decreased activity of PPARG protein,27481073
5281576,D015025,Zearalenone,PPARG,5468,Homo sapiens,9606,Zearalenone results in decreased methylation of PPARG promoter|Zearalenone results in increased expression of PPARG mRNA|Zearalenone results in increased expression of PPARG protein,32119988
5281600,C011164,amentoflavone,PPARG,5468,Homo sapiens,9606,"amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of PPARG protein]|CD36 protein inhibits the reaction [amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of PPARG protein]]",34599948
5281605,C006680,baicalein,PPARG,5468,Danio rerio,7955,baicalein results in decreased expression of PPARG protein|baicalein results in decreased expression of PPARG mRNA,24560969
5281607,C043561,chrysin,PPARG,5468,Homo sapiens,9606,chrysin binds to and results in increased activity of PPARG protein,33049310
5281607,C043561,chrysin,PPARG,5468,Mus musculus,10090,chrysin binds to and results in increased activity of PPARG protein,11343698|33049310
5281607,C043561,chrysin,PPARG,5468,Mus musculus,10090,PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]|PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]],11343698
5281628,C055957,hispidulin,PPARG,5468,Mus musculus,10090,hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA]|hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG protein],30055130
5281647,C013592,mangiferin,PPARG,5468,Mus musculus,10090,[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein,32417366
5281647,C013592,mangiferin,PPARG,5468,Rattus norvegicus,10116,mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]|mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein],29223569
5281654,C047368,3-methylquercetin,PPARG,5468,Homo sapiens,9606,3-methylquercetin binds to and results in increased activity of PPARG protein|2-chloro-5-nitrobenzanilide inhibits the reaction [3-methylquercetin results in increased activity of PPARG protein]|3-methylquercetin results in increased expression of PPARG protein,22992727
5281656,C069053,norathyriol,PPARG,5468,Homo sapiens,9606,norathyriol inhibits the reaction [ciglitazone results in increased activity of PPARG protein],18393431
5281673,C008577,myricitrin,PPARG,5468,Homo sapiens,9606,myricitrin inhibits the reaction [Hydrogen Peroxide results in increased expression of PPARG mRNA],25130202
5281675,C065886,orientin,PPARG,5468,Mus musculus,10090,orientin inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein],32044341
5281703,C085514,wogonin,PPARG,5468,Rattus norvegicus,10116,wogonin inhibits the reaction [Cisplatin results in decreased expression of PPARG protein],31103702
5281708,C004742,daidzein,PPARG,5468,NULL,NULL,daidzein promotes the reaction [NCOA6 protein binds to PPARG protein],30920877
5281717,C034912,puag-haad,PPARG,5468,Mus musculus,10090,puag-haad results in decreased expression of PPARG mRNA,30577593
5281744,C013672,riddelliine,PPARG,5468,Rattus norvegicus,10116,riddelliine results in decreased expression of PPARG mRNA,18047727
5281787,C055494,caffeic acid phenethyl ester,PPARG,5468,Mus musculus,10090,caffeic acid phenethyl ester results in decreased expression of PPARG mRNA,21467634
5281792,C041376,rosmarinic acid,PPARG,5468,Rattus norvegicus,10116,T 0070907 inhibits the reaction [rosmarinic acid affects the expression of PPARG mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [rosmarinic acid affects the expression of PPARG mRNA]|T 0070907 inhibits the reaction [rosmarinic acid affects the expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [rosmarinic acid affects the expression of PPARG protein]|rosmarinic acid affects the expression of PPARG protein|rosmarinic acid affects the expression of PPARG mRNA,28744220
5281794,C040115,shogaol,PPARG,5468,Mus musculus,10090,shogaol results in increased activity of PPARG protein,18577375
5281807,C033607,puerarin,PPARG,5468,Homo sapiens,9606,puerarin results in decreased expression of PPARG mRNA,20706672
5281807,C033607,puerarin,PPARG,5468,Rattus norvegicus,10116,puerarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein],23500774
5281847,C085746,rottlerin,PPARG,5468,Homo sapiens,9606,rottlerin inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein],17030193
5281855,D004610,Ellagic Acid,PPARG,5468,Homo sapiens,9606,Ellagic Acid results in increased expression of PPARG protein,23811531
5281873,C037304,cyhalothrin,PPARG,5468,Rattus norvegicus,10116,cyhalothrin results in increased expression of PPARG mRNA,27348886
5282054,D002569,Cerulenin,PPARG,5468,Mus musculus,10090,Cerulenin results in decreased expression of PPARG mRNA,15707987
5282138,C065927,cilnidipine,PPARG,5468,Homo sapiens,9606,cilnidipine results in decreased activity of PPARG protein,25257666
5282280,C094503,glyceryl 2-arachidonate,PPARG,5468,Homo sapiens,9606,T 0070907 inhibits the reaction [glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA]|glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA|glyceryl 2-arachidonate metabolite binds to PPARG protein,21511917
5282280,C094503,glyceryl 2-arachidonate,PPARG,5468,Mus musculus,10090,PPARG protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased phosphorylation of RELA protein]]|glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein]|PPARG protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased expression of PTGS2 protein]],26209559
5282379,D015474,Isotretinoin,PPARG,5468,Rattus norvegicus,10116,Isotretinoin results in increased expression of PPARG mRNA,19041696|19212007
5282796,C046938,"9,11-linoleic acid",PPARG,5468,Homo sapiens,9606,"9,11-linoleic acid binds to PPARG protein",23843199
5282796,C046938,"9,11-linoleic acid",PPARG,5468,Homo sapiens,9606,"9,11-linoleic acid results in increased activity of PPARG protein",18155510
5282796,C046938,"9,11-linoleic acid",PPARG,5468,Mesocricetus auratus,10036,"9,11-linoleic acid results in increased expression of PPARG mRNA",15778275
5282796,C046938,"9,11-linoleic acid",PPARG,5468,Oryctolagus cuniculus,9986,"[9,11-linoleic acid co-treated with 10,12-octadecadienoic acid] results in decreased expression of PPARG mRNA",31923252
5282796,D044243,"Linoleic Acids, Conjugated",PPARG,5468,Homo sapiens,9606,"Resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased phosphorylation of and results in increased activity of PPARG protein]|Resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in decreased activity of PPARG protein]|Linoleic Acids, Conjugated results in increased phosphorylation of and results in increased activity of PPARG protein|Linoleic Acids, Conjugated results in decreased activity of PPARG protein",18776171
5282796,D044243,"Linoleic Acids, Conjugated",PPARG,5468,Homo sapiens,9606,"Linoleic Acids, Conjugated results in decreased expression of PPARG protein",16933788
5282796,D044243,"Linoleic Acids, Conjugated",PPARG,5468,Homo sapiens,9606,"Linoleic Acids, Conjugated results in increased expression of PPARG protein|Linoleic Acids, Conjugated results in increased expression of PPARG mRNA",15961301
5282796,D044243,"Linoleic Acids, Conjugated",PPARG,5468,Mus musculus,10090,"Linoleic Acids, Conjugated results in increased expression of PPARG mRNA",17322064
5282800,C496197,"trans-10,cis-12-conjugated linoleic acid",PPARG,5468,Homo sapiens,9606,"trans-10,cis-12-conjugated linoleic acid results in increased expression of PPARG mRNA",17951470
5282800,C496197,"trans-10,cis-12-conjugated linoleic acid",PPARG,5468,Mus musculus,10090,"trans-10,cis-12-conjugated linoleic acid results in decreased expression of PPARG mRNA",15888570
5282800,C496197,"trans-10,cis-12-conjugated linoleic acid",PPARG,5468,Sus scrofa,9823,"trans-10,cis-12-conjugated linoleic acid results in increased expression of PPARG mRNA",17217567
5282801,C094849,"10,12-octadecadienoic acid",PPARG,5468,Oryctolagus cuniculus,9986,"[9,11-linoleic acid co-treated with 10,12-octadecadienoic acid] results in decreased expression of PPARG mRNA",31923252
5282820,C004934,eleostearic acid,PPARG,5468,Homo sapiens,9606,eleostearic acid results in increased expression of PPARG protein|eleostearic acid results in increased expression of PPARG mRNA,15961301
5282944,C024347,"9-hydroxy-10,12-octadecadienoic acid",PPARG,5468,Homo sapiens,9606,"9-hydroxy-10,12-octadecadienoic acid results in increased expression of PPARG",16647253
5282958,C120038,"9,10-dihydroxy-12-octadecenoic acid",PPARG,5468,Mus musculus,10090,"9,10-dihydroxy-12-octadecenoic acid binds to PPARG protein",12021203
5283018,C051208,"9,10-epoxy-12-octadecenoic acid",PPARG,5468,Mus musculus,10090,"9,10-epoxy-12-octadecenoic acid binds to PPARG protein",12021203
5283344,C027576,4-hydroxy-2-nonenal,PPARG,5468,Homo sapiens,9606,4-hydroxy-2-nonenal results in decreased expression of PPARG protein,27417252
5283387,C029407,oleylamide,PPARG,5468,Homo sapiens,9606,oleylamide analog results in increased activity of PPARG protein,29288688
5284373,D016572,Cyclosporine,PPARG,5468,Homo sapiens,9606,Cyclosporine affects the activity of PPARG protein,25596134
5284373,D016572,Cyclosporine,PPARG,5468,Homo sapiens,9606,Cyclosporine results in increased expression of PPARG mRNA,20106945
5284373,D016572,Cyclosporine,PPARG,5468,Homo sapiens,9606,[Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein,17016853
5284373,D016572,Cyclosporine,PPARG,5468,Rattus norvegicus,10116,Rosiglitazone inhibits the reaction [Cyclosporine results in decreased expression of PPARG mRNA]|Cyclosporine results in decreased expression of PPARG protein|Cyclosporine results in decreased expression of PPARG mRNA|Cyclosporine inhibits the reaction [Rosiglitazone results in increased expression of PPARG protein]|Rosiglitazone inhibits the reaction [Cyclosporine results in decreased expression of PPARG protein],17461532
5284433,C038405,nivalenol,PPARG,5468,Homo sapiens,9606,nivalenol results in decreased activity of PPARG protein,27481073
5284461,D013605,T-2 Toxin,PPARG,5468,Rattus norvegicus,10116,T-2 Toxin results in increased expression of PPARG mRNA,26141394
5284462,D013751,Tetrachlorvinphos,PPARG,5468,Danio rerio,7955,Tetrachlorvinphos binds to and results in increased activity of PPARG protein,33049310
5284650,C064297,4-hydroxystilbene,PPARG,5468,Mus musculus,10090,4-hydroxystilbene results in decreased expression of PPARG mRNA,23748787
5288209,D017313,Fenretinide,PPARG,5468,Homo sapiens,9606,Fenretinide results in increased activity of PPARG protein,16274795
5288209,D017313,Fenretinide,PPARG,5468,Mus musculus,10090,Fenretinide results in decreased expression of PPARG mRNA,28973697
5289501,C038864,"4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid",PPARG,5468,Sus scrofa,9823,"4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of PPARG mRNA",15583048
5311100,C006326,fluprostenol,PPARG,5468,Mus musculus,10090,fluprostenol inhibits the reaction [Niacin results in increased expression of PPARG mRNA],21236357
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Rattus norvegicus,10116,"15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of PPARG mRNA",10662598|15994020
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Rattus norvegicus,10116,"15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of PPARG protein",10662598|15212945|18278065
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,NULL,NULL,"15-deoxy-delta(12,14)-prostaglandin J2 binds to and affects the activity of PPARG protein",16303604
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Homo sapiens,9606,"15-deoxy-delta(12,14)-prostaglandin J2 affects the expression of PPARG",15254749
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Homo sapiens,9606,"15-deoxy-delta(12,14)-prostaglandin J2 affects the localization of and results in increased expression of PPARG protein",23943857
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Homo sapiens,9606,"15-deoxy-delta(12,14)-prostaglandin J2 binds to and results in decreased activity of PPARG protein",12839938
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Homo sapiens,9606,"15-deoxy-delta(12,14)-prostaglandin J2 binds to and results in increased activity of PPARG protein",12065695|12604364|14979731|14998300|15254749|15491415|15729575|15866424|18485432|9013583
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Homo sapiens,9606,"15-deoxy-delta(12,14)-prostaglandin J2 binds to and results in increased localization of and results in increased activity of PPARG protein",11030710
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Homo sapiens,9606,"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [deoxynivalenol results in increased expression of PPARG protein]",18485432
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Homo sapiens,9606,"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of PPARG mRNA]",14625208
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Homo sapiens,9606,"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]",12604364
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Homo sapiens,9606,"15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of PPARG protein",17341418
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Homo sapiens,9606,"15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein",15707588|26172262|30138673
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Homo sapiens,9606,"MG 262 promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein]|benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein]",15707588
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Homo sapiens,9606,"PPARG protein affects the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of TBXA2R mRNA alternative form]",16499875
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Homo sapiens,9606,"PPARG protein mutant form results in decreased susceptibility to 15-deoxy-delta(12,14)-prostaglandin J2",19922793
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Mus musculus,10090,"15-deoxy-delta(12,14)-prostaglandin J2 binds to and results in increased activity of PPARG protein|15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]",12847270
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Mus musculus,10090,"15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein",15322177
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Mus musculus,10090,"MED1 protein promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein]",16324150
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Rattus norvegicus,10116,"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [AGT protein results in decreased expression of PPARG protein]",18278065
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,Rattus norvegicus,10116,"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA]",15994020
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,NULL,NULL,"15-deoxy-delta(12,14)-prostaglandin J2 binds to and results in increased activity of PPARG protein",11687581|12970094|15212945|15751073|16037295|16844232|17341418|21957481
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,NULL,NULL,"[15-deoxy-delta(12,14)-prostaglandin J2 binds to and results in increased activity of PPARG protein] which results in decreased secretion of LEP protein",16037295
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,NULL,NULL,"15-deoxy-delta(12,14)-prostaglandin J2 binds to PPARG protein",10813377|11078701|12468449|16573735|17400580|9920814
5311211,C097240,"15-deoxy-delta(12,14)-prostaglandin J2",PPARG,5468,NULL,NULL,"15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein",16712844
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,Homo sapiens,9606,15-deoxyprostaglandin J2 promotes the reaction [Berberine affects the localization of and results in increased activity of PPARG protein]|Berberine promotes the reaction [15-deoxyprostaglandin J2 affects the localization of and results in increased activity of PPARG protein]|15-deoxyprostaglandin J2 affects the localization of and results in increased activity of PPARG protein,29408570
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,Homo sapiens,9606,15-deoxyprostaglandin J2 affects the localization of PPARG protein,23220503
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,Homo sapiens,9606,Fluticasone promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]]|15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]|Salmeterol Xinafoate promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]],15531761
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,Homo sapiens,9606,15-deoxyprostaglandin J2 results in increased activity of PPARG protein,10866999|12517972|22992727|23964924
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,Homo sapiens,9606,[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in increased susceptibility to Docetaxel|[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein|Acetylcysteine inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species]|[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in increased susceptibility to Doxorubicin|[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species|2-chloro-5-nitrobenzanilide inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species],23964924
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,Homo sapiens,9606,15-deoxyprostaglandin J2 results in increased expression of PPARG mRNA,21354099|21511917
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,Homo sapiens,9606,2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxyprostaglandin J2 results in increased activity of PPARG protein],22992727
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,Mus musculus,10090,15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein,17891158
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,Oryctolagus cuniculus,9986,15-deoxyprostaglandin J2 affects the localization of and results in increased activity of PPARG protein,16912651
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,Rattus norvegicus,10116,15-deoxyprostaglandin J2 promotes the reaction [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide binds to and results in increased activity of PPARG protein]|4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide promotes the reaction [15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein]|15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein,15876570
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,Rattus norvegicus,10116,[15-deoxyprostaglandin J2 co-treated with AGT protein] results in increased expression of PPARG protein|PPARG mutant form inhibits the reaction [15-deoxyprostaglandin J2 inhibits the reaction [AGT protein results in increased expression of KLF5 protein]]|15-deoxyprostaglandin J2 inhibits the reaction [AGT protein results in decreased activity of PPARG protein],25874449
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,NULL,NULL,15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein,16034372|24025786
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,NULL,NULL,15-deoxyprostaglandin J2 binds to PPARG protein,10600944|17425601|18946735
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,NULL,NULL,15-deoxyprostaglandin J2 results in increased activity of PPARG protein,17430113
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,NULL,NULL,15-deoxyprostaglandin J2 results in increased activity of [RXRA protein binds to PPARG protein],11752099
5311211,C477819,15-deoxyprostaglandin J2,PPARG,5468,NULL,NULL,2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein],24025786
5311217,C060285,lacidipine,PPARG,5468,Homo sapiens,9606,lacidipine results in increased activity of PPARG protein,25257666
5311238,C121227,AL 8810,PPARG,5468,Mus musculus,10090,AL 8810 results in increased expression of PPARG mRNA,21236357
5312115,C076126,"disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate",PPARG,5468,Rattus norvegicus,10116,"disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate results in increased expression of PPARG mRNA alternative form|disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate results in increased expression of PPARG mRNA",20184727
5312120,C084904,Ro 41-5253,PPARG,5468,Homo sapiens,9606,Ro 41-5253 inhibits the reaction [Pioglitazone results in increased activity of PPARG protein]|[Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein|Ro 41-5253 results in increased activity of and results in decreased expression of PPARG protein|Ro 41-5253 binds to and results in increased activity of PPARG protein|Ro 41-5253 inhibits the reaction [Rosiglitazone binds to PPARG protein],17290005
5315263,C054133,casticin,PPARG,5468,Homo sapiens,9606,casticin results in increased expression of PPARG mRNA,27862857
5315472,C034786,bisdemethoxycurcumin,PPARG,5468,Homo sapiens,9606,bisdemethoxycurcumin binds to PPARG protein,15713005
5315615,C530393,rosemarinic acid,PPARG,5468,Homo sapiens,9606,rosemarinic acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein],33476690
5315659,C037036,cannabigerol,PPARG,5468,Homo sapiens,9606,cannabigerol promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|cannabigerol binds to and results in increased activity of PPARG protein,30611848
5315659,C037036,cannabigerol,PPARG,5468,Homo sapiens,9606,cannabigerol results in increased expression of PPARG mRNA|cannabigerol results in decreased expression of PPARG protein,28853159
5315659,C037036,cannabigerol,PPARG,5468,NULL,NULL,cannabigerol binds to PPARG protein,22971837
5317756,C515155,glycycoumarin,PPARG,5468,Homo sapiens,9606,glycycoumarin binds to PPARG protein,14608046
5318517,C030419,andrographolide,PPARG,5468,Mus musculus,10090,andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein],27475717
5318980,C499403,icaritin,PPARG,5468,Homo sapiens,9606,icaritin inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA]|icaritin results in increased expression of PPARG mRNA|PPARG protein affects the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]|PPARG protein affects the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]]|icaritin results in increased expression of PPARG protein,34153405
5319022,C027820,ligustilide,PPARG,5468,Mus musculus,10090,"ligustilide inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of PPARG mRNA]|ligustilide inhibits the reaction [Dextran Sulfate affects the localization of PPARG protein]|ligustilide inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of PPARG protein]",33130971
5329102,D000077210,Sunitinib,PPARG,5468,Homo sapiens,9606,Sunitinib results in decreased expression of PPARG mRNA,31533062
5352425,D007854,Lead,PPARG,5468,Mus musculus,10090,Lead results in increased expression of PPARG mRNA|Lead results in increased expression of PPARG,23086611
5352425,D007854,Lead,PPARG,5468,Mus musculus,10090,Lead results in increased expression of PPARG mRNA,26518054
5352624,C025462,sulindac sulfide,PPARG,5468,Homo sapiens,9606,PPARG protein affects the reaction [sulindac sulfide analog results in increased expression of FABP1 protein]|sulindac sulfide analog inhibits the reaction [Troglitazone binds to PPARG protein]|sulindac sulfide analog binds to PPARG protein|PPARG protein affects the reaction [sulindac sulfide analog results in increased expression of FABP4 protein],18665581
5352624,C025462,sulindac sulfide,PPARG,5468,Homo sapiens,9606,PPARG protein promotes the reaction [sulindac sulfide results in increased expression of CDKN1A mRNA]|sulindac sulfide binds to and results in increased activity of PPARG protein,16091736
5352624,C025462,sulindac sulfide,PPARG,5468,Homo sapiens,9606,sulindac sulfide analog binds to and results in increased activity of PPARG protein,17602619
5352624,C025462,sulindac sulfide,PPARG,5468,Homo sapiens,9606,[sulindac sulfide results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein|sulindac sulfide results in increased activity of PPARG protein,10866999
5352624,C025462,sulindac sulfide,PPARG,5468,Homo sapiens,9606,sulindac sulfide results in increased expression of PPARG mRNA,11948457
5353272,D019377,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid",PPARG,5468,Mus musculus,10090,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid binds to and results in increased activity of PPARG protein",12069687
5355130,C118580,octylmethoxycinnamate,PPARG,5468,Homo sapiens,9606,octylmethoxycinnamate binds to and results in decreased activity of PPARG protein,27633901
5357402,C030665,triphenyltin,PPARG,5468,Danio rerio,7955,triphenyltin results in increased expression of PPARG mRNA,32173372
5357402,C030665,triphenyltin,PPARG,5468,Homo sapiens,9606,triphenyltin binds to and results in increased activity of PPARG protein,24786373
5357402,C030665,triphenyltin,PPARG,5468,Homo sapiens,9606,triphenyltin binds to PPARG protein,25314719|27725436
5357402,C030665,triphenyltin,PPARG,5468,Lithobates sylvaticus,45438,triphenyltin results in decreased expression of PPARG mRNA,24177218
5357402,C030665,triphenyltin,PPARG,5468,Mus musculus,10090,triphenyltin results in increased activity of PPARG protein,25777084
5357402,C030665,triphenyltin,PPARG,5468,Rattus norvegicus,10116,triphenyltin results in decreased expression of PPARG mRNA,32504733
5357402,C030665,triphenyltin,PPARG,5468,Xenopus tropicalis,8364,triphenyltin results in decreased expression of PPARG mRNA,27894914
5359367,D001729,Bismuth,PPARG,5468,Homo sapiens,9606,[Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of PPARG mRNA,34560244
5359596,D001151,Arsenic,PPARG,5468,Homo sapiens,9606,Arsenic affects the expression of PPARG mRNA|[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA,28793237
5359596,D001151,Arsenic,PPARG,5468,Homo sapiens,9606,Arsenic inhibits the reaction [CEBPB protein binds to PPARG protein]|Troglitazone inhibits the reaction [Arsenic results in decreased expression of PPARG protein]|Arsenic results in decreased expression of PPARG protein|Arsenic results in decreased expression of PPARG mRNA|Troglitazone inhibits the reaction [Arsenic results in decreased expression of PPARG mRNA]|Arsenic inhibits the reaction [CEBPA protein binds to PPARG protein]|T 0070907 promotes the reaction [Arsenic results in decreased expression of PPARG protein],23108036
5360373,D001761,Bleomycin,PPARG,5468,Homo sapiens,9606,Berberine inhibits the reaction [Bleomycin binds to PPARG protein],29408570
5360373,D001761,Bleomycin,PPARG,5468,Mus musculus,10090,Rosiglitazone inhibits the reaction [Bleomycin results in decreased expression of PPARG mRNA]|Bleomycin results in decreased expression of PPARG mRNA,19147827
5360373,D001761,Bleomycin,PPARG,5468,Mus musculus,10090,Bleomycin results in decreased expression of PPARG protein|lenabasum inhibits the reaction [Bleomycin results in decreased expression of PPARG protein],27153807
5360545,D012964,Sodium,PPARG,5468,Mus musculus,10090,PPARG protein affects the abundance of Sodium,16007095
5362440,D019469,Indinavir,PPARG,5468,Mus musculus,10090,Indinavir results in decreased expression of PPARG mRNA,17926646
5364509,C005576,methyl oleate,PPARG,5468,Homo sapiens,9606,methyl oleate binds to and results in increased activity of PPARG protein,27633901
5368831,C062198,"octa-2,4,6-trienoic acid",PPARG,5468,Homo sapiens,9606,"octa-2,4,6-trienoic acid results in increased expression of PPARG mRNA",16951191
5371562,D008999,Monocrotophos,PPARG,5468,Rattus norvegicus,10116,Monocrotophos results in increased expression of PPARG mRNA,32267039
5372174,C494862,alpha-isomethylionone,PPARG,5468,Homo sapiens,9606,alpha-isomethylionone binds to and results in increased activity of PPARG protein,33049310
5386591,C048980,ajoene,PPARG,5468,Homo sapiens,9606,ajoene analog results in increased expression of PPARG protein|ajoene analog promotes the reaction [RELA protein binds to PPARG protein],27449564
5388962,D004656,Enalapril,PPARG,5468,Rattus norvegicus,10116,Enalapril inhibits the reaction [Isoproterenol results in decreased expression of PPARG protein],30623541
5388962,D004656,Enalapril,PPARG,5468,Rattus norvegicus,10116,Enalapril results in decreased expression of PPARG protein,19225048
5458510,C043247,3-acetyldeoxynivalenol,PPARG,5468,Homo sapiens,9606,3-acetyldeoxynivalenol results in decreased activity of PPARG protein,27481073
5460048,D014280,Triglycerides,PPARG,5468,Rattus norvegicus,10116,[Pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Triglycerides],19403437
5460048,D014280,Triglycerides,PPARG,5468,Rattus norvegicus,10116,[Pioglitazone results in increased activity of PPARG protein] which results in decreased abundance of Triglycerides,19439812
5460048,D014280,Triglycerides,PPARG,5468,Rattus norvegicus,10116,[[[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides|[Thiazolidinediones binds to and results in increased activity of PPARG protein] which results in decreased abundance of Triglycerides,19248225
5462310,D037742,"Nanotubes, Carbon",PPARG,5468,Homo sapiens,9606,"Nanotubes, Carbon results in increased expression of PPARG mRNA",23634900
5462310,D037742,"Nanotubes, Carbon",PPARG,5468,Homo sapiens,9606,"Nanotubes, Carbon results in increased expression of PPARG protein",23634900|32649966
5462310,D037742,"Nanotubes, Carbon",PPARG,5468,Homo sapiens,9606,"PPARG protein affects the reaction [Nanotubes, Carbon results in increased expression of PLIN2 protein]",32649966
5462310,D037742,"Nanotubes, Carbon",PPARG,5468,Mus musculus,10090,"Nanotubes, Carbon analog results in decreased expression of PPARG mRNA|Nanotubes, Carbon results in decreased expression of PPARG mRNA",25554681
5462310,D037742,"Nanotubes, Carbon",PPARG,5468,Mus musculus,10090,"Nanotubes, Carbon analog results in increased expression of PPARG mRNA",25620056
5462310,D037742,"Nanotubes, Carbon",PPARG,5468,Mus musculus,10090,"Nanotubes, Carbon results in increased expression of PPARG mRNA",25926378
5462310,D053260,Soot,PPARG,5468,Homo sapiens,9606,Soot results in decreased activity of PPARG protein|[Soot co-treated with Benzo(a)pyrene] results in decreased activity of PPARG protein|PPARG protein affects the susceptibility to Soot,24464499
5463781,C076154,dimethomorph,PPARG,5468,Homo sapiens,9606,dimethomorph binds to and results in increased activity of PPARG protein,33049310
5469424,C050229,demethoxycurcumin,PPARG,5468,Homo sapiens,9606,demethoxycurcumin binds to PPARG protein,15713005
5472495,C025463,sulindac sulfone,PPARG,5468,Homo sapiens,9606,[sulindac sulfone results in increased activity of PPARG protein] promotes the reaction [PPARG protein binds to SAT1 enhancer]|PPARG protein promotes the reaction [sulindac sulfone results in increased expression of SAT1 mRNA],14506281
5472495,C025463,sulindac sulfone,PPARG,5468,Homo sapiens,9606,sulindac sulfone results in increased expression of PPARG mRNA,11948457
5481350,D000068698,Tenofovir,PPARG,5468,Homo sapiens,9606,Tenofovir affects the expression of PPARG mRNA,20032539
5488186,C026423,"3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one",PPARG,5468,Homo sapiens,9606,"3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one results in increased expression of PPARG protein",23811531
5497111,C017585,oleoyl-coenzyme A,PPARG,5468,Homo sapiens,9606,oleoyl-coenzyme A binds to and results in increased activity of PPARG protein,11139385
5497152,C032881,lysophosphatidic acid,PPARG,5468,NULL,NULL,lysophosphatidic acid analog binds to and results in increased activity of PPARG protein,16321982
5708351,C495626,"14-deoxy-11,12-didehydroandrographolide",PPARG,5468,Mus musculus,10090,"14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA]|14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]",30248417
6026790,D004075,Diglycerides,PPARG,5468,Rattus norvegicus,10116,[Pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Diglycerides],19403437
6026790,D004075,Diglycerides,PPARG,5468,Rattus norvegicus,10116,[Pioglitazone results in increased activity of PPARG protein] which results in increased abundance of Diglycerides,19439812
6112114,C469328,kresoxim-methyl,PPARG,5468,Homo sapiens,9606,kresoxim-methyl inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30818834
6326970,D012643,Selenium,PPARG,5468,Mus musculus,10090,"PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]]|Selenium promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of PPARG protein]",17439952
6327000,C019003,methaneselenol,PPARG,5468,Homo sapiens,9606,methaneselenol results in increased expression of PPARG mRNA,19625696
6327546,C507805,diphenyl phosphite,PPARG,5468,Homo sapiens,9606,diphenyl phosphite binds to and results in increased activity of PPARG protein,33049310
6327657,C007567,triphenyltin hydroxide,PPARG,5468,Homo sapiens,9606,triphenyltin hydroxide results in increased expression of PPARG mRNA,32473317
6419725,D002338,Carotenoids,PPARG,5468,Mus musculus,10090,Carotenoids results in decreased expression of PPARG mRNA,11237167
6422843,C513428,pyrachlostrobin,PPARG,5468,Homo sapiens,9606,pyrachlostrobin binds to and results in increased activity of PPARG protein,33049310
6422843,C513428,pyrachlostrobin,PPARG,5468,Mus musculus,10090,pyrachlostrobin results in decreased expression of PPARG mRNA,29127035
6433556,D001865,Bongkrekic Acid,PPARG,5468,Homo sapiens,9606,Bongkrekic Acid results in increased activity of PPARG protein|Bongkrekic Acid analog results in increased activity of PPARG protein,25786526
6435901,C420162,linoleamide,PPARG,5468,Homo sapiens,9606,linoleamide analog results in increased activity of PPARG protein,29288688
6436023,C014416,citreoviridin,PPARG,5468,Rattus norvegicus,10116,Sodium Selenite inhibits the reaction [citreoviridin results in decreased activity of PPARG protein]|Thiamine inhibits the reaction [citreoviridin results in decreased activity of PPARG protein]|citreoviridin results in decreased activity of PPARG protein,31419397
6436173,D000078262,Rifaximin,PPARG,5468,Homo sapiens,9606,[NR1I2 results in increased susceptibility to Rifaximin] which results in increased expression of PPARG mRNA,22790967
6436605,C049346,diniconazole,PPARG,5468,Danio rerio,7955,diniconazole binds to and results in increased activity of PPARG protein,33049310
6437847,C038649,"13-hydroperoxy-9,11-octadecadienoic acid",PPARG,5468,Rattus norvegicus,10116,"13-hydroperoxy-9,11-octadecadienoic acid results in increased expression of PPARG protein",22135674
6438135,C061091,lithospermate B,PPARG,5468,Rattus norvegicus,10116,lithospermate B inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA],34165232
6439179,C062894,"17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid",PPARG,5468,Mus musculus,10090,"17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid binds to and affects the activity of PPARG protein",17056761
6442842,C099952,bifenthrin,PPARG,5468,Homo sapiens,9606,bifenthrin binds to and results in increased activity of PPARG protein,33049310
6442842,C099952,bifenthrin,PPARG,5468,Homo sapiens,9606,bifenthrin results in increased expression of PPARG mRNA,29554630
6443665,C085278,hydroxysafflor yellow A,PPARG,5468,Rattus norvegicus,10116,hydroxysafflor yellow A inhibits the reaction [Particulate Matter results in decreased expression of PPARG protein]|hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased expression of PPARG protein]]|hydroxysafflor yellow A inhibits the reaction [Vehicle Emissions results in decreased expression of PPARG protein]|hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Vehicle Emissions results in decreased expression of PPARG protein]],24192212
6449999,C100679,cannabigerolic acid,PPARG,5468,Homo sapiens,9606,cannabigerolic acid binds to and results in increased activity of PPARG protein|cannabigerolic acid results in increased expression of PPARG mRNA|cannabigerolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],30611848
6449999,C100679,cannabigerolic acid,PPARG,5468,Homo sapiens,9606,cannabigerolic acid results in decreased expression of PPARG protein|cannabigerolic acid results in increased expression of PPARG mRNA,28853159
6518171,C120099,GW 1929,PPARG,5468,Homo sapiens,9606,GW 1929 inhibits the reaction [GW 1929 binds to PPARG protein]|Pioglitazone inhibits the reaction [GW 1929 binds to PPARG protein]|tributyltin inhibits the reaction [GW 1929 binds to PPARG protein]|butylbenzyl phthalate inhibits the reaction [GW 1929 binds to PPARG protein],31016361
6518171,C120099,GW 1929,PPARG,5468,Homo sapiens,9606,[GW 1929 binds to and results in increased activity of PPARG protein] promotes the reaction [TNF protein results in decreased susceptibility to FSHB protein],21734263
6518171,C120099,GW 1929,PPARG,5468,Homo sapiens,9606,GW 1929 binds to PPARG protein,20008677|31016361|32407875
6518171,C120099,GW 1929,PPARG,5468,Homo sapiens,9606,GW 1929 inhibits the reaction [Pioglitazone results in increased expression of PPARG protein]|GW 1929 inhibits the reaction [Melatonin results in increased expression of PPARG protein],29734669
6518171,C120099,GW 1929,PPARG,5468,Homo sapiens,9606,GW 1929 promotes the reaction [NCOA6 protein binds to PPARG protein]|GW 1929 promotes the reaction [PPARGC1A protein binds to PPARG protein]|GW 1929 promotes the reaction [NRIP1 protein binds to PPARG protein]|GW 1929 promotes the reaction [NCOA2 protein binds to PPARG protein]|GW 1929 promotes the reaction [C14ORF28 protein binds to PPARG protein],32407875
6518171,C120099,GW 1929,PPARG,5468,Homo sapiens,9606,GW 1929 results in increased activity of PPARG protein,21543282
6518171,C120099,GW 1929,PPARG,5468,Homo sapiens,9606,GW 1929 results in increased activity of [PPARG protein binds to RXRA protein]|ZNF366 protein promotes the reaction [GW 1929 results in increased activity of [PPARG protein binds to RXRA protein]],20008677
6518171,C120099,GW 1929,PPARG,5468,Mus musculus,10090,GW 1929 results in increased expression of PPARG mRNA|4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide inhibits the reaction [GW 1929 results in increased expression of PPARG mRNA],20516370
6518171,C120099,GW 1929,PPARG,5468,Mus musculus,10090,GW 1929 binds to and results in increased activity of PPARG protein,12847270|18292206
6518171,C120099,GW 1929,PPARG,5468,Mus musculus,10090,GW 1929 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]],12847270
6518171,C120099,GW 1929,PPARG,5468,Mus musculus,10090,GW 1929 inhibits the reaction [tetrabromobisphenol A results in decreased expression of PPARG protein],24132472
6518171,C120099,GW 1929,PPARG,5468,Rattus norvegicus,10116,GW 1929 results in increased expression of PPARG mRNA,19420904
6518171,C120099,GW 1929,PPARG,5468,NULL,NULL,GW 1929 binds to and results in increased activity of PPARG protein,15809511|20032081|20840543|21734263
6518171,C120099,GW 1929,PPARG,5468,NULL,NULL,GW 1929 results in increased activity of [RXRA protein binds to PPARG protein],11752099
6537961,C412303,triticonazole,PPARG,5468,Mus musculus,10090,triticonazole binds to and results in increased activity of PPARG protein,33049310
6540277,C116322,4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine,PPARG,5468,Homo sapiens,9606,4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [Niacin results in increased activity of PPARG protein],16386710
6603901,C520164,4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid,PPARG,5468,Homo sapiens,9606,4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid binds to PPARG protein,11779144
6603901,C520164,4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid,PPARG,5468,Homo sapiens,9606,4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased activity of PPARG protein,15273253
6711157,C098340,"2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose",PPARG,5468,Rattus norvegicus,10116,"PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]|PPARG mutant form inhibits the reaction [Rosiglitazone inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]",23954466
6850743,C052901,lemongrass oil,PPARG,5468,Canis lupus familiaris,9615,lemongrass oil results in increased expression of PPARG mRNA,25660481
6857447,D024503,beta-Tocopherol,PPARG,5468,Rattus norvegicus,10116,[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]|[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA],22389237
6918373,C108709,oleoyl-estrone,PPARG,5468,Rattus norvegicus,10116,oleoyl-estrone results in decreased expression of PPARG mRNA alternative form,20184727
6918540,C411602,dalcetrapib,PPARG,5468,Homo sapiens,9606,dalcetrapib results in increased expression of PPARG mRNA,25617244
6918840,C025474,rebaudioside A,PPARG,5468,Mus musculus,10090,rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA],25554529
9570290,C003135,phoxim,PPARG,5468,Homo sapiens,9606,phoxim binds to and results in increased activity of PPARG protein,33049310
9803963,C425931,GW 501516,PPARG,5468,Danio rerio,7955,GW 501516 results in decreased expression of PPARG mRNA,34302850
9803963,C425931,GW 501516,PPARG,5468,Homo sapiens,9606,GW 501516 results in increased activity of PPARG protein,16386710
9803963,C425931,GW 501516,PPARG,5468,Homo sapiens,9606,GW 501516 results in increased expression of PPARG mRNA,19201410
9811606,C102521,GGTI 298,PPARG,5468,Rattus norvegicus,10116,GGTI 298 results in increased expression of PPARG mRNA,20578043
9823887,C529148,rosavin,PPARG,5468,Homo sapiens,9606,rosavin results in decreased expression of PPARG mRNA,20706672
9826528,C506614,mirdametinib,PPARG,5468,Mus musculus,10090,mirdametinib inhibits the reaction [Protein Kinase Inhibitors results in increased phosphorylation of and results in decreased activity of PPARG protein],26670611
9831414,C405603,Omacor,PPARG,5468,Homo sapiens,9606,Omacor results in increased activity of PPARG protein,24597798
9839306,C055818,"d,d-T80-prallethrin",PPARG,5468,Danio rerio,7955,"d,d-T80-prallethrin binds to and results in increased activity of PPARG protein",33049310
9839306,C055818,"d,d-T80-prallethrin",PPARG,5468,Homo sapiens,9606,"d,d-T80-prallethrin results in increased expression of PPARG mRNA",32473317
9861219,C099958,acanthoic acid,PPARG,5468,Mus musculus,10090,acanthoic acid inhibits the reaction [Dietary Fats results in increased expression of PPARG protein],31421115
9861219,C099958,acanthoic acid,PPARG,5468,Mus musculus,10090,acanthoic acid inhibits the reaction [Ethanol results in increased expression of PPARG protein],28964808
9865808,C119130,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,PPARG,5468,Rattus norvegicus,10116,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide binds to and results in increased activity of PPARG protein|4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in increased expression of PPARG mRNA|4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]|15-deoxyprostaglandin J2 promotes the reaction [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide binds to and results in increased activity of PPARG protein]|4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide promotes the reaction [15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein],15876570
9870584,C401311,GW 7845,PPARG,5468,Mus musculus,10090,PPARG protein promotes the reaction [GW 7845 results in increased expression of ADIPOQ mRNA],20519739
9870584,C401311,GW 7845,PPARG,5468,NULL,NULL,GW 7845 binds to and results in increased activity of PPARG protein,12670479|17400580|20519739
9881506,C406734,4-methylene-2-octyl-5-oxofuran-3-carboxylic acid,PPARG,5468,Mus musculus,10090,4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of PPARG mRNA,15707987
9888484,C517861,naveglitazar,PPARG,5468,NULL,NULL,naveglitazar binds to and results in increased activity of PPARG protein,19700659
9890319,C453901,LY 465608,PPARG,5468,NULL,NULL,LY 465608 binds to and results in increased activity of PPARG protein,17255113
9893571,C412815,GW 4064,PPARG,5468,Homo sapiens,9606,[GW 4064 co-treated with Oleic Acid] results in decreased expression of PPARG mRNA|GW 4064 results in increased expression of PPARG mRNA,30611723
9893571,C412815,GW 4064,PPARG,5468,Rattus norvegicus,10116,GW 4064 results in increased expression of PPARG mRNA,15980055
9908833,C495944,DRF 2519,PPARG,5468,Homo sapiens,9606,DRF 2519 results in increased activity of PPARG protein,21543282
9908833,C495944,DRF 2519,PPARG,5468,Homo sapiens,9606,DRF 2519 results in increased activity of PPARG protein alternative form,23563205
9917968,C441128,"3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate",PPARG,5468,Equus caballus,9796,"3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate affects the expression of and results in increased secretion of PPARG",33536069
9920342,C018665,sorbitan monooleate,PPARG,5468,Homo sapiens,9606,sorbitan monooleate binds to and results in increased activity of PPARG protein,27131391
9929731,C116893,"2,2-dichloro-12-(p-chlorophenyl)-dodecanoic acid",PPARG,5468,Homo sapiens,9606,"2,2-dichloro-12-(p-chlorophenyl)-dodecanoic acid results in increased activity of PPARG protein",15273253
9947731,C487401,"2-methyl-c-5-(4-(5-methyl-2-(4-methylphenyl)-4-oxazolyl)butyl)-1,3-dioxane-r-2-carboxylic acid",PPARG,5468,Homo sapiens,9606,"2-methyl-c-5-(4-(5-methyl-2-(4-methylphenyl)-4-oxazolyl)butyl)-1,3-dioxane-r-2-carboxylic acid results in increased activity of PPARG protein",14982965
9954280,C479635,5-chloro-1-(4-chlorobenzyl)-3-(phenylthio)indole-2-carboxylic acid,PPARG,5468,Homo sapiens,9606,5-chloro-1-(4-chlorobenzyl)-3-(phenylthio)indole-2-carboxylic acid binds to PPARG protein,12554792
9955612,C580960,CAY10506,PPARG,5468,Homo sapiens,9606,CAY10506 results in increased activity of PPARG protein alternative form,23563205
10017512,C091768,3'-methoxy-4'-nitroflavone,PPARG,5468,Mus musculus,10090,3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein],15050417
10025649,C483845,2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid,PPARG,5468,NULL,NULL,2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid binds to and results in increased activity of PPARG protein,17259670
10068800,C471831,"5-(4-(2-(2-ethyl-4-methyl-6-oxo-1,6-dihydro-1-pyrimidinyl)ethoxy)phenylmethyl)thiazolidine-2,4-dione",PPARG,5468,Homo sapiens,9606,"5-(4-(2-(2-ethyl-4-methyl-6-oxo-1,6-dihydro-1-pyrimidinyl)ethoxy)phenylmethyl)thiazolidine-2,4-dione results in increased activity of PPARG protein alternative form",23563205
10109594,C551630,dehydroglyasperin D,PPARG,5468,Homo sapiens,9606,dehydroglyasperin D binds to PPARG protein,14608046
10202734,C528847,sargahydroquinoic acid,PPARG,5468,Homo sapiens,9606,sargahydroquinoic acid results in increased expression of PPARG mRNA,25019995
10229498,C541917,INT 131,PPARG,5468,Homo sapiens,9606,INT 131 inhibits the reaction [[Rosiglitazone binds to MED1 protein modified form] which binds to PPARG protein]|INT 131 inhibits the reaction [Rosiglitazone binds to PPARG protein]|INT 131 inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA]|[INT 131 binds to MED1 protein modified form] which binds to PPARG protein|INT 131 binds to PPARG protein|INT 131 results in increased expression of PPARG mRNA,19452630
10229498,C541917,INT 131,PPARG,5468,Mus musculus,10090,INT 131 results in increased expression of PPARG mRNA,28611668
10313045,D007501,Iron,PPARG,5468,Acanthogobius hasta,267130,Iron affects the expression of PPARG mRNA|Troglitazone affects the reaction [Iron affects the expression of PPARG mRNA],28411055
10313045,D007501,Iron,PPARG,5468,Homo sapiens,9606,Iron deficiency results in increased expression of PPARG mRNA,20368581
10382483,C046760,15-acetyldeoxynivalenol,PPARG,5468,Homo sapiens,9606,15-acetyldeoxynivalenol results in decreased activity of PPARG protein,27481073
10429214,C550453,dioxinodehydroeckol,PPARG,5468,Mus musculus,10090,dioxinodehydroeckol results in decreased expression of PPARG protein|dioxinodehydroeckol results in decreased expression of PPARG mRNA,20385110
10429242,C580959,CAY10415,PPARG,5468,Homo sapiens,9606,CAY10415 results in increased activity of PPARG protein alternative form,23563205
11048796,C550006,fluoxastrobin,PPARG,5468,Homo sapiens,9606,fluoxastrobin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30818834
11226684,C078846,epoxomicin,PPARG,5468,Mus musculus,10090,epoxomicin inhibits the reaction [Resveratrol results in decreased expression of PPARG protein]|epoxomicin inhibits the reaction [Rosiglitazone results in decreased expression of PPARG protein],18555852
11285653,C556557,picoxystrobin,PPARG,5468,Homo sapiens,9606,picoxystrobin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],30818834
11313622,C520571,tideglusib,PPARG,5468,Homo sapiens,9606,tideglusib inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of PPARG protein],30965670
11393311,C073718,cannabidiol hydroxyquinone,PPARG,5468,NULL,NULL,cannabidiol hydroxyquinone binds to PPARG protein,22971837
11524144,C516138,dorsomorphin,PPARG,5468,Homo sapiens,9606,dorsomorphin inhibits the reaction [Resveratrol results in decreased expression of PPARG mRNA],24584901
11524144,C516138,dorsomorphin,PPARG,5468,Homo sapiens,9606,"[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPARG mRNA",27188386
11524144,C516138,dorsomorphin,PPARG,5468,Mus musculus,10090,dorsomorphin inhibits the reaction [rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]],30446312
11524144,C516138,dorsomorphin,PPARG,5468,Rattus norvegicus,10116,dorsomorphin inhibits the reaction [25-hydroxyprotopanaxadiol results in increased phosphorylation of PPARG protein],33676887
11546596,C513115,1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester,PPARG,5468,Homo sapiens,9606,PPARG mRNA affects the susceptibility to 1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester|1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester binds to and results in increased activity of PPARG protein,17535976
11556427,C530884,anacetrapib,PPARG,5468,Homo sapiens,9606,anacetrapib results in increased expression of PPARG mRNA,25617244
11970143,D008070,Lipopolysaccharides,PPARG,5468,Homo sapiens,9606,"ciglitazone inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]|pirinixic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]|Lipopolysaccharides results in decreased expression of PPARG mRNA|15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]",12604364
11970143,D008070,Lipopolysaccharides,PPARG,5468,Homo sapiens,9606,[Butyric Acid co-treated with Lipopolysaccharides] results in increased expression of PPARG mRNA,29751049
11970143,D008070,Lipopolysaccharides,PPARG,5468,Homo sapiens,9606,Cannabidiol inhibits the reaction [Lipopolysaccharides promotes the reaction [PPARG protein binds to CMPK2 promoter]]|Lipopolysaccharides promotes the reaction [PPARG protein binds to CMPK2 promoter]|Cannabidiol inhibits the reaction [Lipopolysaccharides promotes the reaction [PPARG protein results in increased expression of CMPK2 mRNA]],34269108
11970143,D008070,Lipopolysaccharides,PPARG,5468,Homo sapiens,9606,PPARG mutant form inhibits the reaction [Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]]|PPARG mutant form inhibits the reaction [Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]],22124178
11970143,D008070,Lipopolysaccharides,PPARG,5468,Homo sapiens,9606,[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 mRNA]|[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 protein],21617575
11970143,D008070,Lipopolysaccharides,PPARG,5468,Mus musculus,10090,"GW 1929 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]|ciglitazone inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]|PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]|15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]",12847270
11970143,D008070,Lipopolysaccharides,PPARG,5468,Mus musculus,10090,Docosahexaenoic Acids promotes the reaction [Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein]]|Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein]|Docosahexaenoic Acids promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein]|Lipopolysaccharides results in increased activity of PPARG protein,27329536
11970143,D008070,Lipopolysaccharides,PPARG,5468,Mus musculus,10090,hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]|hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]|hesperetin analog inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG protein]|PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]|PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]|Silymarin inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]|PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL6 protein]|PPARG protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of JAK1 protein]|PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of TNF protein]|hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of STAT1 protein]]|[hesperetin analog co-treated with PPARG protein] affects the reaction [Lipopolysaccharides results in increased expression of TNF protein]|hesperetin analog inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]|hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of JAK1 protein]]|PPARG protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of STAT1 protein]|PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]|Silymarin inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG protein],28428136
11970143,D008070,Lipopolysaccharides,PPARG,5468,Mus musculus,10090,Lipopolysaccharides results in decreased expression of PPARG mRNA,16847310|22240665|28428136
11970143,D008070,Lipopolysaccharides,PPARG,5468,Mus musculus,10090,Lipopolysaccharides results in decreased expression of PPARG protein,16847310|28428136
11970143,D008070,Lipopolysaccharides,PPARG,5468,Mus musculus,10090,[Plant Extracts co-treated with Lipopolysaccharides co-treated with Galactosamine] results in increased expression of PPARG protein|[Silymarin co-treated with Lipopolysaccharides co-treated with Galactosamine] results in increased expression of PPARG protein|[Plant Extracts co-treated with Lipopolysaccharides co-treated with Galactosamine] results in increased expression of PPARG mRNA|[Silymarin co-treated with Lipopolysaccharides co-treated with Galactosamine] results in increased expression of PPARG mRNA,30236599
11970143,D008070,Lipopolysaccharides,PPARG,5468,Mus musculus,10090,PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]|PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]|PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]|PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]|PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]|PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]],11343698
11970143,D008070,Lipopolysaccharides,PPARG,5468,Mus musculus,10090,PPARG protein promotes the reaction [Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]|PPARG protein promotes the reaction [Lipopolysaccharides results in increased expression of EGR1 mRNA],22046279
11970143,D008070,Lipopolysaccharides,PPARG,5468,Rattus norvegicus,10116,"Curcumin inhibits the reaction [Lipopolysaccharides results in decreased activity of PPARG protein]|Lipopolysaccharides results in decreased activity of PPARG protein|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Curcumin inhibits the reaction [Lipopolysaccharides results in decreased activity of PPARG protein]]",29480285
11970143,D008070,Lipopolysaccharides,PPARG,5468,Rattus norvegicus,10116,[Troglitazone results in increased activity of PPARG protein] which results in decreased susceptibility to Lipopolysaccharides|2-chloro-5-nitrobenzanilide inhibits the reaction [[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]|[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]|[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]|2-chloro-5-nitrobenzanilide inhibits the reaction [[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]],21153920
11970143,D008070,Lipopolysaccharides,PPARG,5468,Rattus norvegicus,10116,baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein]|Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein,24312512
11970143,D008070,Lipopolysaccharides,PPARG,5468,Rattus norvegicus,10116,Pioglitazone inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA]|[Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA,15318101
11976122,C047628,8-hydroxyeicosatetraenoic acid,PPARG,5468,Danio rerio,7955,8-hydroxyeicosatetraenoic acid results in increased expression of PPARG protein,15964169
12110098,C533760,tribromodiphenyl ether 28,PPARG,5468,Ursus maritimus,29073,tribromodiphenyl ether 28 results in increased activity of PPARG protein,27602593
12118082,C517880,monascin,PPARG,5468,Homo sapiens,9606,"PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of TNF protein]]|monascin binds to and results in increased activity of PPARG protein|PPARG protein results in increased susceptibility to monascin|PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of IL1B protein]]|monascin affects the localization of PPARG protein|PPARG mutant form inhibits the reaction [monascin results in increased expression of NFE2L2 mRNA]|PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]",23954466
12118082,C517880,monascin,PPARG,5468,Homo sapiens,9606,monascin results in increased expression of PPARG protein|monascin results in decreased phosphorylation of PPARG protein,22381257
12358480,D004732,Endrin,PPARG,5468,Mus musculus,10090,Endrin results in decreased expression of PPARG protein,10385688
12855920,C425564,ginsenoside Rh1,PPARG,5468,Mus musculus,10090,ginsenoside Rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]|ginsenoside Rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG protein],32623698
13422573,C573233,"5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one",PPARG,5468,Mus musculus,10090,"5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one affects the expression of PPARG protein|5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one affects the expression of PPARG mRNA",24646949
13785700,C008743,oxychlordane,PPARG,5468,Ursus maritimus,29073,oxychlordane inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein],27602593
14009349,D061207,Calcium Ionophores,PPARG,5468,Homo sapiens,9606,[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] affects the expression of PPARG mRNA,21511917
14030006,D010938,Plant Oils,PPARG,5468,Homo sapiens,9606,Plant Oils results in increased activity of PPARG protein,21597168
14030006,D010938,Plant Oils,PPARG,5468,Homo sapiens,9606,Plant Oils results in increased expression of PPARG mRNA|Plant Oils results in increased expression of PPARG protein,15961301
14030006,D010938,Plant Oils,PPARG,5468,Mus musculus,10090,Plant Oils inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA],30597221
16129675,D002108,Ceruletide,PPARG,5468,Mus musculus,10090,PPARG affects the reaction [Ceruletide results in increased expression of CXCL1 mRNA]|PPARG affects the reaction [Ceruletide results in increased expression of CCL2 mRNA],17463185
16213884,D010713,Phosphatidylcholines,PPARG,5468,Mus musculus,10090,Phosphatidylcholines results in increased expression of PPARG mRNA,23911798
16682746,C005961,bis(tri-n-butyltin)oxide,PPARG,5468,Mus musculus,10090,bis(tri-n-butyltin)oxide results in increased expression of PPARG mRNA,18958704
16719220,C510342,efatutazone,PPARG,5468,Homo sapiens,9606,efatutazone results in increased activity of PPARG protein alternative form,23563205
16756850,C572961,4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid,PPARG,5468,Mus musculus,10090,4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid results in increased activity of PPARG protein,25377915
16759173,D017035,Pravastatin,PPARG,5468,Homo sapiens,9606,Pravastatin inhibits the reaction [[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol],12044893
16760658,D012980,Sodium Salicylate,PPARG,5468,Cavia,10140,Sodium Salicylate results in increased expression of PPARG mRNA,18560754
18541395,C576882,1-(2-trifluoromethoxyphenyl)-2-nitroethanone,PPARG,5468,Rattus norvegicus,10116,1-(2-trifluoromethoxyphenyl)-2-nitroethanone affects the activity of PPARG protein,25596134
18666097,C078632,"1-acyl-2-(12-((7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl)phosphatidylcholine",PPARG,5468,Homo sapiens,9606,"[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased uptake of 1-acyl-2-(12-((7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl)phosphatidylcholine]",21123845
20057064,D002996,Clomiphene,PPARG,5468,Danio rerio,7955,Clomiphene binds to and results in increased activity of PPARG protein,33049310
21256123,D058185,Magnetite Nanoparticles,PPARG,5468,Mus musculus,10090,[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PPARG mRNA,26378955
21599928,C101280,ginsenoside Rh4,PPARG,5468,Mus musculus,10090,ginsenoside Rh4 inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of PPARG mRNA],33359794
21633857,C575740,gnetin C,PPARG,5468,Homo sapiens,9606,gnetin C binds to and results in increased activity of PPARG protein,24454499
21944094,D020123,Sirolimus,PPARG,5468,Homo sapiens,9606,[Sirolimus co-treated with Tacrolimus] results in increased expression of PPARG protein|Sirolimus affects the expression of PPARG protein|[Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein,17016853
21944094,D020123,Sirolimus,PPARG,5468,Mus musculus,10090,Sirolimus results in decreased expression of PPARG mRNA,15358118
22186063,C410666,tetradecylselenoacetic acid,PPARG,5468,Homo sapiens,9606,tetradecylselenoacetic acid results in increased activity of PPARG protein,17185614
23665730,C013173,osteum,PPARG,5468,Homo sapiens,9606,[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA,32613381
23672308,D012970,Sodium Glutamate,PPARG,5468,Mus musculus,10090,"[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA",23783067
23672308,D012970,Sodium Glutamate,PPARG,5468,Mus musculus,10090,PPARG protein affects the susceptibility to Sodium Glutamate,15231871
23672308,D012970,Sodium Glutamate,PPARG,5468,Mus musculus,10090,Sodium Glutamate results in increased expression of PPARG mRNA,21205225
24816385,C548544,"2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid",PPARG,5468,Homo sapiens,9606,"2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid binds to and results in increased activity of PPARG protein",19934399
24857286,C557331,TAK-875,PPARG,5468,Mus musculus,10090,TAK-875 results in increased expression of PPARG mRNA,30243991
24978544,C568608,PCI 5002,PPARG,5468,Homo sapiens,9606,[PCI 5002 co-treated with Zinc] results in increased expression of PPARG mRNA,18593933
25021165,C534333,JZL 184,PPARG,5468,Mus musculus,10090,JZL 184 inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein],26209559
44566108,C525131,UVI 3003,PPARG,5468,Xenopus tropicalis,8364,UVI 3003 results in decreased expression of PPARG mRNA|UVI 3003 results in increased activity of PPARG protein,27894914
44581800,C430895,PD 068235,PPARG,5468,NULL,NULL,PD 068235 inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]|PD 068235 binds to and results in decreased activity of PPARG protein,11416043
45588096,D000077270,Exenatide,PPARG,5468,Homo sapiens,9606,Exenatide inhibits the reaction [Palmitates results in increased expression of PPARG mRNA],30253173
46853873,D014805,Vitamin B 12,PPARG,5468,Rattus norvegicus,10116,Vitamin B 12 inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA]|[Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA],23935743
46907787,C561695,(+)-JQ1 compound,PPARG,5468,Homo sapiens,9606,(+)-JQ1 compound results in decreased expression of PPARG mRNA,25961927|26752646
46907787,C561695,(+)-JQ1 compound,PPARG,5468,Mus musculus,10090,(+)-JQ1 compound inhibits the reaction [JMJD6 protein binds to PPARG enhancer]|(+)-JQ1 compound inhibits the reaction [POLR2E protein binds to PPARG gene]|(+)-JQ1 compound inhibits the reaction [BRD4 protein binds to PPARG gene]|(+)-JQ1 compound inhibits the reaction [BRD4 protein binds to PPARG enhancer]|(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein]|(+)-JQ1 compound inhibits the reaction [POLR2E protein binds to PPARG enhancer]|(+)-JQ1 compound inhibits the reaction [JMJD6 protein binds to PPARG gene],26117538
46907787,C561695,(+)-JQ1 compound,PPARG,5468,Mus musculus,10090,(+)-JQ1 compound inhibits the reaction [Rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]|(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA],26972250
50925396,C000598659,"5-(3-methoxy-5-(4-methoxystyryl)phenoxy)-2,2-dimethylpentanoic acid",PPARG,5468,NULL,NULL,"5-(3-methoxy-5-(4-methoxystyryl)phenoxy)-2,2-dimethylpentanoic acid results in increased activity of PPARG protein|5-(3-methoxy-5-(4-methoxystyryl)phenoxy)-2,2-dimethylpentanoic acid analog results in increased activity of PPARG protein",30745416
51051622,C108732,methyl-beta-cyclodextrin,PPARG,5468,Mus musculus,10090,methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]],16971554
53310417,C561058,"3-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-2-ethyl-5-isobutyl-7-methyl-3H-imidazo(4,5-b)pyridine",PPARG,5468,Homo sapiens,9606,"3-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-2-ethyl-5-isobutyl-7-methyl-3H-imidazo(4,5-b)pyridine binds to and results in increased activity of PPARG protein",21557540
53377584,C581223,VCE-003,PPARG,5468,Mus musculus,10090,"VCE-003 inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of PPARG protein]",29338785
53377584,C581223,VCE-003,PPARG,5468,NULL,NULL,VCE-003 binds to PPARG protein,22971837
54350316,C578987,"3,4'-dihydroxystilbene",PPARG,5468,Mus musculus,10090,"3,4'-dihydroxystilbene results in decreased expression of PPARG mRNA",23748787
54670067,D001205,Ascorbic Acid,PPARG,5468,Dicentrarchus labrax,13489,Ascorbic Acid affects the expression of PPARG mRNA,21281732
54670067,D001205,Ascorbic Acid,PPARG,5468,Homo sapiens,9606,[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA,25932594
54670067,D001205,Ascorbic Acid,PPARG,5468,Mus musculus,10090,Rosiglitazone promotes the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA]|[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA|Tretinoin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA],32473317
54670067,D001205,Ascorbic Acid,PPARG,5468,Mus musculus,10090,SRC protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA]]|[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA|Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA],14505802
54670067,D001205,Ascorbic Acid,PPARG,5468,Sus scrofa,9823,"Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA]|[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA",30481989
54675776,D013752,Tetracycline,PPARG,5468,Danio rerio,7955,Tetracycline results in increased expression of PPARG mRNA,32283355
54680085,C021636,bromadiolone,PPARG,5468,Danio rerio,7955,bromadiolone binds to and results in increased activity of PPARG protein,33049310
54680783,D002953,Citrinin,PPARG,5468,Homo sapiens,9606,Citrinin results in decreased activity of PPARG protein,27481073
56842075,C072026,rhodostomin,PPARG,5468,Rattus norvegicus,10116,rhodostomin results in decreased expression of PPARG mRNA,16197920
56842239,D015525,"Fatty Acids, Omega-3",PPARG,5468,Bos taurus,9913,"Fatty Acids, Omega-3 results in increased expression of PPARG mRNA",22464816
56842239,D015525,"Fatty Acids, Omega-3",PPARG,5468,Rattus norvegicus,10116,"Fatty Acids, Omega-3 inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein]",30256492
57426056,D005230,"Fatty Acids, Nonesterified",PPARG,5468,Homo sapiens,9606,"Fatty Acids, Nonesterified results in decreased expression of PPARG mRNA|Rosiglitazone inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of PPARG mRNA]|15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of PPARG mRNA]",14625208
57426056,D005230,"Fatty Acids, Nonesterified",PPARG,5468,Homo sapiens,9606,"FASN protein promotes the reaction [Rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]]|PPARG protein mutant form results in increased abundance of Fatty Acids, Nonesterified|UCP1 protein promotes the reaction [PPARG protein mutant form results in increased abundance of Fatty Acids, Nonesterified]|PPARG protein results in increased abundance of Fatty Acids, Nonesterified|UCP1 protein promotes the reaction [Rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]]|Rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]",26670611
58496428,C576694,setanaxib,PPARG,5468,Homo sapiens,9606,setanaxib inhibits the reaction [torcetrapib results in increased expression of PPARG mRNA],25617244
68210102,C577920,GSK-2816126,PPARG,5468,Homo sapiens,9606,GSK-2816126 results in decreased expression of PPARG mRNA,26424790
71316600,C576261,"2-ethylhexyl 2,3,4,5-tetrabromobenzoate",PPARG,5468,Homo sapiens,9606,"2-ethylhexyl 2,3,4,5-tetrabromobenzoate metabolite binds to PPARG protein",25314719
71316600,C576261,"2-ethylhexyl 2,3,4,5-tetrabromobenzoate",PPARG,5468,Homo sapiens,9606,"2-ethylhexyl 2,3,4,5-tetrabromobenzoate results in increased activity of PPARG protein",27506419
71402018,C515629,chiglitazar,PPARG,5468,Homo sapiens,9606,chiglitazar results in increased activity of PPARG protein,23150725
71402018,C515629,chiglitazar,PPARG,5468,Rattus norvegicus,10116,chiglitazar binds to and results in increased activity of PPARG protein,16751799
71552624,C000712072,rotenoisin A,PPARG,5468,Mus musculus,10090,rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]|dorsomorphin inhibits the reaction [rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]|rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein],30446312
76853645,C570539,5-(3-((3-(5-methoxybenzisoxazol-3-yl)benzimidazol-1-yl)methyl)phenyl)-5-methyloxazolidinedione,PPARG,5468,Homo sapiens,9606,5-(3-((3-(5-methoxybenzisoxazol-3-yl)benzimidazol-1-yl)methyl)phenyl)-5-methyloxazolidinedione analog binds to PPARG protein|5-(3-((3-(5-methoxybenzisoxazol-3-yl)benzimidazol-1-yl)methyl)phenyl)-5-methyloxazolidinedione analog results in increased activity of PPARG protein,22070604
86278622,D017638,"Asbestos, Crocidolite",PPARG,5468,Homo sapiens,9606,"Asbestos, Crocidolite results in increased expression of PPARG protein|Asbestos, Crocidolite results in increased expression of PPARG mRNA",23634900
129868948,C492909,"1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane",PPARG,5468,Homo sapiens,9606,"2-chloro-5-nitrobenzanilide inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane results in increased activity of PPARG protein]|1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane results in increased activity of PPARG protein",15345676
129868948,C492909,"1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane",PPARG,5468,Rattus norvegicus,10116,"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]|[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with IFNG protein co-treated with TNF protein] results in increased expression of BAX protein]|[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with TNF protein co-treated with IFNG protein] promotes the reaction [NCOR2 protein binds to NOS2 enhancer]]|[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein]|[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [manganese chloride promotes the reaction [[IFNG protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]]|[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide]|[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] results in decreased susceptibility to [manganese chloride co-treated with IFNG protein co-treated with TNF protein]|[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with TNF protein co-treated with IFNG protein] promotes the reaction [RELA protein binds to NOS2 promoter]]|1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein",18041089
135398658,D005492,Folic Acid,PPARG,5468,Gallus gallus,9031,Folic Acid results in decreased expression of PPARG mRNA,31328769
135398658,D005492,Folic Acid,PPARG,5468,Mus musculus,10090,"[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPARG mRNA",22206623
135398658,D005492,Folic Acid,PPARG,5468,Rattus norvegicus,10116,Folic Acid inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA]|[Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA],23935743
135398735,D012293,Rifampin,PPARG,5468,Mus musculus,10090,Rifampin results in increased expression of and affects the localization of PPARG protein|Rifampin results in increased expression of PPARG mRNA,27806127
135398735,D012293,Rifampin,PPARG,5468,Mus musculus,10090,Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA alternative form]|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG mRNA]|[Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of PPARG mRNA alternative form|Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of PPARG protein]|[Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of PPARG mRNA,33412187
135398737,D003024,Clozapine,PPARG,5468,Mus musculus,10090,Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA]|Clozapine results in increased expression of PPARG mRNA|Clozapine results in increased expression of PPARG protein|Berberine inhibits the reaction [Clozapine results in increased expression of PPARG protein],20564506
135398744,D000068677,Sildenafil Citrate,PPARG,5468,Mus musculus,10090,"Sildenafil Citrate results in increased expression of PPARG protein|8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of PPARG protein]|Sildenafil Citrate results in increased expression of PPARG mRNA",20471953
135398745,D000077152,Olanzapine,PPARG,5468,Mus musculus,10090,Olanzapine results in increased expression of PPARG protein alternative form,17651982
135403648,D002955,Leucovorin,PPARG,5468,Rattus norvegicus,10116,[Methotrexate co-treated with Leucovorin] results in increased expression of PPARG protein|[Methotrexate co-treated with Leucovorin] results in increased expression of PPARG mRNA,25187349
135403792,C047088,phenylamil,PPARG,5468,Mus musculus,10090,PPARG protein promotes the reaction [phenylamil results in increased expression of FABP4 mRNA]|[phenylamil co-treated with Harmine] results in increased expression of PPARG mRNA|PPARG protein affects the susceptibility to phenylamil|PPARG protein promotes the reaction [phenylamil results in increased expression of ADIPOQ mRNA]|phenylamil results in increased expression of PPARG mRNA|PPARG protein promotes the reaction [phenylamil results in increased expression of AQP7 mRNA],20519739
135449333,C479889,LY 518674,PPARG,5468,Homo sapiens,9606,LY 518674 results in increased expression of PPARG mRNA,19201410
135529082,C090860,"8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate",PPARG,5468,Mus musculus,10090,"8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in increased expression of PPARG protein]|8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of PPARG protein]",20471953
136035350,C055656,"8-((4-chlorophenyl)thio)cyclic-3',5'-GMP",PPARG,5468,Mus musculus,10090,"8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in increased expression of PPARG protein]|8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in increased expression of PPARG protein",20471953
